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Abstract 
Background: Dietary fibre has been associated with risk of cardiovascular disease (CVD) in 
some cohort studies around the world. Key health messages may be created by examining the 
types or sources of fibre in the diet and associated risk of different CVD events but few studies 
have explored this. 
Methods: I conducted a systematic literature review of published studies investigating dietary 
fibre intake and CVD. Associations were explored using dose-response meta-analysis in 
addition to potential non-linear associations. CVD event data for the UK Women’s Cohort 
Study were obtained from death records, hospital episode statistics (HES) and the Myocardial 
Ischaemia National Audit Project (MINAP). Capture-recapture methods were then applied to 
estimate the potential for missing cases. 
Survival analyses for coronary heart disease (CHD), stroke and total CVD risk in association with 
total fibre intake and fibre from key food sources were conducted using a cohort approach for 
food frequency data and case-cohort methods were used for analyses with food diary data. 
Results: Meta-analyses broadly supported inverse associations between CVD and fibre intake. 
Combined data from 9 studies indicate lower CVD risk per 7g/day greater intake in total fibre, 
relative risk 0.91 (95% confidence intervals (CI) 0.88, 0.94). 
After 14 years, 821 CHD and 388 stroke cases were observed. Total fibre, soluble, insoluble and 
fibre from cereals assessed using FFQs were associated with lower risk of stroke. With each 
6g/day higher total fibre intake, hazard ratio (HR) 0.89 (95% CI: 0.81, 0.99). Higher fibre density 
was associated with lower risk of myocardial infarction, for every 2g/1000kcal/day higher 
intake, HR 0.89 (95% CI: 0.81, 0.98). Higher cereal fibre intake, calculated using food diaries, 
was associated with lower risk of acute coronary events HR 0.76 (95% CI: 0.58, 1.00). 
Conclusion: Fibre intake is inversely associated with CVD risk in a dose response relationship 
after accounting for other potentially confounding influences. Associations were stronger for 
stroke risk, when the source of fibre was cereals and in those without hypertension.  
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Chapter 1 Introduction and Objectives 
1.1 Overview of Cardiovascular Disease 
Cardiovascular disease (CVD) is a broad term for conditions that affect the heart and blood 
vessels such as coronary heart disease (CHD), cerebrovascular disease and peripheral arterial 
disease. Acute events are typically classed as either coronary or cerebrovascular (WHO, 2013) 
and vessels are either occluded by a process involving atherosclerotic plaque ruptures that 
cause a clotting cascade (described below) or vessels may rupture. Both occlusion and 
haemorrhage result in downstream tissue damage, with significant consequences. 
Atherosclerotic CVD is a chronic condition that develops throughout the life course and is 
normally advanced by the time symptoms present. CVD remains the primary cause of 
premature death within Europe but over 80% of total CVD mortality worldwide occurs in 
developing countries (Perk et al., 2012). 
1.1.1 Cardiovascular disease in the UK 
The past few decades have brought declining incidence and mortality rates for CVD in many 
developed countries (AHA, 2011, Allender et al., 2008, Roger et al., 2012, Pearson-Stuttard et 
al., 2012). For example, the age standardised death rates (for deaths under 65 years) in the 
United Kingdom (UK) have fallen from 143/100,000 in 1980 to 33/100,000 in 2009 in males 
and from 36/100,000 to 8/100,000 in females (Nichols et al., 2012). Prevalence rates in the UK 
have not followed the same trajectory of decline and have increased over the past few 
decades, peaking in the early to mid 2000’s. Since 2002, prevalence rates have remained 
relatively stable in men and a slight decrease in the prevalence rate has been observed in 
women (Townsend et al., 2012). Today, there are an estimated 600,000 individuals of each sex 
in the UK who have suffered a stroke and for CHD the prevalence rates are even greater, with 
over 1.6 million males and over 1 million females having CHD (Townsend et al., 2012). CHD 
mortality rates vary greatly between countries and substantial changes over short periods of 
time reflect changing environmental rather than genetic factors. CVD mortality rates in the UK 
are not declining as fast as in some other developed countries (Capewell et al., 2008).  
Despite impressive improvements in CVD incidence, it remains a significant social and financial 
burden with over 3 million people in the UK living with CVD (Townsend et al., 2012) and annual 
costs of CVD are estimated to exceed £30 billion in the UK (Allender et al., 2008). The burden 
of disease is set to increase over coming decades, with the growing size of the ageing 
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population in the UK (Capewell et al., 2008). Additionally, the burden of disease remains 
unequal across the socioeconomic gradient in the UK; for example the risk of myocardial 
infarction (MI) hospital admission in patients under 55 years in the most deprived quintile of 
the UK was double that in the least deprived quintile (Pearson-Stuttard et al., 2012). Uptake of 
treatments for CVD are however equitable across social groups and the disparity is therefore 
likely related to differences in major CVD risk factors (Pearson-Stuttard et al., 2012).  
1.1.2 Cardiovascular disease types and pathogenesis 
Strokes and acute coronary events occur when blood flow to cardiac or cerebral tissue is 
disrupted causing myocardial damage or neurological deficits. Coronary artery disease 
manifests as angina, silent ischaemia, unstable angina, myocardial infarction (MI), arrhythmias, 
heart failure and sudden death (Grech, 2003). Strokes can be grouped into two main types, the 
more common ischaemic type which is caused by a vessel blockage and the less common 
haemorrhagic type which results from a ruptured vessel (Frizzell, 2005) (Figure 1.1). Ischaemic 
strokes are either caused by atherosclerosis within vessels or from a thrombus (blood clot) 
that often originates from the heart region. It is estimated that approximately 20% of strokes 
are cardiothrombotic and occur after recent MI, as a result of atrial fibrillation or the thrombus 
may originate in the aortic arch or carotid arteries (Frizzell, 2005).  
 
Figure 1.1 Overview of Cardiovascular Disease Sub-types 
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Coronary artery disease is almost always due to atheromatus narrowing and subsequent 
occlusion of vessels (Grech, 2003) and the same atherosclerotic plaques in cerebrovascular 
vessels are responsible for the majority of stroke events (Frizzell, 2005). Athoerosclerosis is a 
dynamic process that develops and worsens over several decades. The sequence of 
atherosclerotic plaque development is covered in detail by George and Lyon (George and Lyon, 
2010) and is briefly summarised below: 
1) Endothelial dysfunction, caused by many CVD risk factors, results in lipids and 
inflammatory cells being allowed into the artery wall. 
2) Monocytes differentiate into macrophages and these then take in the excess lipids to 
become foam cell macrophages. 
3) Engorged with lipids, the foam cells begin to die, resulting in the formation of a necrotic 
core within lesions. The release of cytoplasmic contents of the necrotic foam cells causes 
extracellular lipid accumulation and growth factors that cause inflammation. 
4) Vascular smooth muscle cells proliferate and migrate to form a fibrous cap around lesions 
that protrude into the vessel lumen. 
5) Plaques may rupture, triggering a cascade that produces a thrombus and this can partially 
or completely occlude blood flow (George and Lyon, 2010). 
Endothelial damage, inflammation and excess lipids are the triggers for atherosclerosis, one of 
the main causes of CVD development and these factors are all influenced through modifiable 
lifestyle behaviour such as diet. Potential mechanisms for the effect of dietary fibre on these 
risk factors for CVD are described below (Section 1.3).  
1.1.3 Women and cardiovascular disease 
Heart disease was once considered as a ‘man’s disease’ but significant changes over the past 
few decades have debunked this myth (Mosca et al., 2011) and now there is recognition of the 
importance of CVD in women (Stranges and Guallar, 2012). Differences in CVD progression and 
age of onset are observed between the sexes (Novella et al., 2012) but CVD remains as much a 
serious concern for women as men. There are suggestions that risk of CHD in women 
accelerates during the menopause but recent work suggests that it may be the deceleration in 
rates of male CHD mortality and not an acceleration in females that explains the apparent 
imbalance between sexes in age of CVD onset (Lam and Little, 2012, Vaidya et al., 2011).  
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It has been suggested that this difference in risk is partly due to hormonal changes during the 
menopause, potentially the loss of vascular protective effects exerted by oestrogen (Novella et 
al., 2012). However, a study that employed data from the UK and US to model CHD risk 
identified that heart disease mortality increased in women of all ages, with no additional 
notable increase around menopausal age. The concern about CVD risk in women is therefore 
justified but focus should be placed on overall lifetime risk rather than increased risk 
surrounding the menopause (Vaidya et al., 2011). Additionally, suggestions that changing 
hormone levels throughout menopause are responsible for this increased risk are disputed in a 
recent narrative synthesis of the menopause and CHD (Barrett-Connor, 2013). This work 
indicates that age-related changes in weight, blood pressure, cholesterol and waist 
circumference, may determine hormonal changes and the age of menopause and not vice 
versa. A systematic review of observational studies also indicated risk of CVD was not greater 
in postmenopausal compared to premenopausal women after controlling for age and smoking, 
although there was a high degree of heterogeneity between the pooled studies (Atsma et al., 
2006). Despite the lack of an apparent increase in heart disease mortality in women at 
menopausal ages, risk continued to increase exponentially as age increased (Vaidya et al., 
2011) and while women appear to be at lower CVD risk than men, this is misleading as risk is 
deferred by 10 years rather than avoided (Perk et al., 2012).  
Women have historically been underrepresented in randomised controlled trials (RCT) of 
lifestyle and pharmacological interventions for prevention of CVD but there has been a 
rebalance over recent years and women are now well represented in clinical studies (Stranges 
and Guallar, 2012). Clinical studies are however limited in that they only provide information 
on short-term prevention for CVD, while recent guidelines for the prevention of CVD in women 
place emphasis on overall lifetime risk and prevention of risk factors throughout the life course 
(Mosca et al., 2011). As a consequence, observational study data and extrapolations from 
short-term trials will need to be relied upon for preventative strategies for CVD (Stranges and 
Guallar, 2012). 
1.1.4 Risk factors for cardiovascular disease 
As discussed above, sex is a general risk factor for CVD and influences the age of symptom 
onset and potentially mediates disease development. Other non-modifiable risk factors include 
age and family history of premature CVD (Mosca et al., 2011). However, CVD risk is considered 
largely modifiable (Stampfer et al., 2000, Mosca et al., 2011), with much of the improvement 
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in CVD rates in the UK between 1981 and 2000 being attributed to reductions in smoking and 
improvements in other lifestyle behaviour such as the reduction in total cholesterol level of 
the UK population (Unal et al., 2004). The presence of non-modifiable and modifiable risk 
factors for stroke, CHD or overall CVD may be used to calculate individual risk for an event, 
over a specified time frame, such as applying the Framingham score or European CVD risk 
assessment model ‘SCORE’ (Systematic Coronary Risk Evaluation) (Perk et al., 2012, NIH, 2013). 
In the UK, the QRISK2 score is more commonly applied to estimate CVD risk (Hippisley-Cox et 
al., 2008).    
Non-modifiable risk factors for stroke include, greater age, sex (being male) and family history 
of stroke or other genetic risk factors but the primary modifiable risk factor for stroke is the 
presence of hypertension (Goldstein et al., 2011). This, in addition to smoking, poor glycaemic 
control or diabetes, dyslipidaemia, poor diet, physical inactivity and other risk factors may be 
used to develop strategies for reducing risk of first stroke occurrence (Goldstein et al., 2011). 
The Interstroke study collated data from 22 countries worldwide and identified that 90% of 
stroke risk was associated with 10 risk factors; history of hypertension, smoking, waist to hip 
ratio, diet risk score, regular physical activity, diabetes mellitus, alcohol, psychosocial stress, 
depression, cardiac causes and ratio of apolipoprotein B:A1 (O'Donnell et al., 2010).  
Risk factors for CHD are similar to those for stroke and include hypercholesterolemia, 
hypertension, obesity and type two diabetes (Lattimer and Haub, 2010). According to the 
Cardio and Vascular Coalition report that modelled the UK burden of CVD to 2020, the most 
important modifiable factors for determining total CVD risk are smoking, elevated cholesterol, 
hypertension, diabetes, obesity and deprivation, with other smaller risk factors making only a 
minimal contribution to overall risk (Capewell et al., 2008).  
It is known that risk varies by geographical location and socio-economic status (SES) and it is 
therefore accepted that lifestyle or dietary factors must influence the variation in risk, aside 
from genetic influences or the effects of ageing (British Nutrition Foundation, 2005). Using 
data from the Nurses’ Health Study, an estimated 82% of CHD events were attributed to lack 
of adherence to a low risk pattern for diet, physical activity and cigarette use (Stampfer et al., 
2000). These poor lifestyle habits and increased risk may be mediated through socio-economic 
position and for example in the Framingham study, low socio-economic position in childhood 
and over the life course was associated with risk factors for CHD that the authors thought were 
potentially mediated through smoking, hypertension, diabetes and obesity (in women) (Loucks 
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et al., 2009). In UK cohort studies, lower socio-economic position is also associated with worse 
health outcomes (McFadden et al., 2008, Elovainio et al., 2011). However, in the UK Whitehall 
II Study the association was found to be bi-directional with socio-economic position in adult 
life determining metabolic health disparity but heath status at younger ages was associated 
with the degree of social mobility (Elovainio et al., 2011). 
The existing disparity between CVD rates in South-East England (lower) compared to the rest 
of the UK (higher) indicates that large improvements in CHD mortality are still attainable 
within the UK (Capewell et al., 2008). Given the large influence of lifestyle factors on overall 
risk, the key prevention strategy for morbidity free survival is to target smoking, physical 
activity and promote healthy diets.  
1.1.4.1 Diet as a risk factor 
Diet is a central modifiable risk factor for the prevention and risk reduction of CVD. Early 
research in this area focused on the relationship of single nutrients to risk profiles such folic 
acid and vitamin E, which proved to be ineffective when tested in clinical trials (Bhupathiraju 
and Tucker, 2011). The focus shifted to examine whole food intake and in the past decade a 
paradigm shift has been seen in examining associations between dietary patterns and health 
and evidence now indicates that it is a complicated set of different nutrients that may interact 
to influence risk (Bhupathiraju and Tucker, 2011).   
Fruits and vegetables have been consistently associated with lower CHD risk and although the 
mechanisms of action are not entirely clear they likely include antioxidant and anti-
inflammatory properties (Bhupathiraju and Tucker, 2011). Higher intake of fatty fish, nuts and 
other plant based n-3 fatty acids such as those found in rapeseed oil and soy beans have also 
been associated with lower CHD risk (Van Horn et al., 2008, Bhupathiraju and Tucker, 2011). 
The cardio-protective mechanisms of long chain n-3 polyunsaturated fats thought to be 
involved include the displacement of undesirable fats (saturated and trans fats) in the diet or 
more direct influences on lowering triacylglycerol levels and inhibition of pro-inflammatory 
cytokines (de Roos et al., 2009). Moderate alcohol intake is also associated with lowering of 
CVD risk, potentially because of a favourable effect on thrombolytic and coagulation processes 
or by indirectly inhibiting removal of high density lipoprotein cholesterol (HDL-C) (Rimm et al., 
1999).  
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Whole-grains have been associated with lower CHD risk for many decades (Trowell, 1972), 
regularly feature in dietary recommendations and are a feature of dietary patterns that are 
associated with lower CVD risk, such as the Mediterranean diet (Bach et al., 2006). The 
potentially protective components within whole-grains that are removed or reduced during 
processing include minerals such as magnesium and phytosterols, which are associated with 
reducing serum cholesterol levels (Slavin, 2003). The removal of potentially beneficial non-
starch polysaccharides (NSP) during grain processing is also a concern and dietary fibre is 
discussed at length below. In order to direct efforts towards minimising the loss of grain 
constituents that are potentially physiologically important, the most protective components of 
whole-grains need to be identified (Slavin, 2003). 
1.2 Dietary fibre 
Dietary fibre is a broad term that encompasses a heterogeneous mix of plant components that 
are indigestible in the small intestine (Dreher, 2001). The concept of ‘dietary fibre’ is not so 
clear-cut with definitions, chemical analysis methods and recommended intakes differing 
greatly across the world (Lunn and Buttriss, 2007). There are disagreements as to which 
specific carbohydrates should be included in definitions and which analytical methods should 
be used to assess them (Buttriss and Stokes, 2008). The following sections cover each of these 
different issues but firstly, the separate components of plants, which may be classified as 
dietary fibre, are discussed. 
1.2.1 Constituents of dietary fibre 
Non-digestible oligosaccharides 
Oligosaccharides are carbohydrates with chain lengths between 3-15 monomer units (Lunn 
and Buttriss, 2007, Lean, 2006), are not generally digested in the small intestine, but may be 
broken down in the colon by bacterial enzymes (Lean, 2006, Cummings and Mann, 2007, 
Buttriss and Stokes, 2008, Lunn and Buttriss, 2007). Oligosaccharides include raffinose, 
stachyose and verbascose and main food sources of non-digestible oligosaccharides include 
onions, chicory and Jerusalem artichokes (Buttriss and Stokes, 2008, Lunn and Buttriss, 2007). 
Oligosaccharides may also be chemically or industrially produced from enzymatic hydrolysis of 
polysaccharides or from mono- and disaccharides (Buttriss and Stokes, 2008). 
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Non-starch polysaccharides 
NSPs are defined as carbohydrates with longer chain length than oligosaccharides although 
there is a degree of overlap. NSP comprises many separate components, all of which are 
principally found in the pant cell wall: cellulose, hemicelluloses, pectins, arabinoxylans, beta-
glucan, glucomannans, plant gums, mucilages and hydrocolloids (Cummings and Mann, 2007). 
Plant cell walls are made from a rigid scaffolding of cellulose fibres embedded amongst a jelly-
like matrix of water soluble gums such as pectin (Lean, 2006). NSP may be considered in two 
broad categories, those that are insoluble in water (cellulose and hemicelluloses) and water-
soluble types (pectin, gums, mucilage and hemicelluloses) (Lyons-Wall, 2007).  
Soluble fibre can be found at high levels in foods such as oats, fruits, vegetables and pulses 
(British Nutrition Foundation, 2009). In the small intestine, viscous forms of soluble fibre may 
slow the absorption of lipids and glucose (SACN, 2008) and in the large intestine the fibres may 
undergo significant fermentation, by bacterial action (Lean, 2006, Cummings and Mann, 2007).  
Insoluble fibre components have a greater influence on bowel habits and also undergo partial 
fermentation in the colon (SACN, 2008). The digestion of soluble and some insoluble fibres, by 
bacteria, results in the production of short-chain fatty acids (SCFA) (Lean, 2006, Cummings and 
Mann, 2007). These SCFAs make their own nutritional contribution and it is estimated that NSP 
provides 2-3kcal/g when digested, although estimates vary by cooking method and bowel 
absorption (Lean, 2006). In the UK about half of NSP is provided by fruit and vegetables (Lean, 
2006) and cereal grain foods contribute 37% of total NSP intake in British adults (Bates et al., 
2009). Grains such as rice, wheat and maize provide mainly insoluble NSP, whilst oats, barley 
and rye also provide soluble NSP (Lean, 2006).  
The division of fibre into soluble and insoluble is not always appropriate as the classification is 
extremely pH dependent (SACN, 2008). Some insoluble fibres are completely fermented whilst 
not all soluble fibres have effects on glucose and lipid absorption (SACN, 2008, Lunn and 
Buttriss, 2007). In addition, other food components, such as resistant starch, have similar 
physiological properties to some soluble or insoluble fibres but are not classified as either. 
Resistant starch 
Resistant starch is not available for normal digestion for a number of reasons, either it is 
contained within the food matrix or within starch granules or it is retrograde starch, produced 
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during food manufacture and preparation, which leaves starch crystals resistant to enzymatic 
digestion (Englyst et al., 2007, Lunn and Buttriss, 2007). Resistant starch is present in foods 
such as in unripe bananas, legumes, whole-grains and cooked then cooled potatoes and is 
unavailable for digestion in the small intestine and so passes to the colon, where it is partially 
digested in a similar way to soluble fibre (Lyons-Wall, 2007, Lunn and Buttriss, 2007). The exact 
quantification of resistant starch in food is difficult because storage and cooking methods for 
foods determine the levels present (Buttriss and Stokes, 2008). 
Lignin 
Lignin is not classified as a carbohydrate as it is a polymer of phenylpropane units and it is 
chemically linked with hemicelluloses in plant cell walls (Lunn and Buttriss, 2007). Lignin is 
considered as a component of dietary fibre, using some definitions (discussed below). 
1.2.2 Dietary fibre chemical analysis methods 
The chemical diversity of molecules classed as dietary fibre makes laboratory analysis 
challenging and hence, a number of different techniques have developed (Lyons-Wall, 2007). 
All of the approaches use a dried and defatted food sample but each method measures a 
different chemical fraction. The methods may be broadly categorised as enzymatic-chemical 
and enzymatic-gravimetric (Lunn and Buttriss, 2007). 
Enzymatic-chemical methods include the approaches of Englyst & Cummings (1988) and 
Southgate (1969). The ‘Englyst’ method identifies NSP present in foods, whilst the ‘Southgate’ 
approach is similar and also estimates the lignin fraction of dietary fibre (Lunn and Buttriss, 
2007). In the UK, the common technique used to determine ‘fibre’ in foods is the method 
developed by Englyst and Cummings, which can be used to distinguish between soluble and 
insoluble NSP. In this method, starch is initially removed with strong amylases then free sugars 
are measured after acidic hydrolysis for both the soluble and insoluble fractions. The sum of 
the two fractions produces the total NSP value. In this method, lignin is not detected because 
it is not a carbohydrate and resistant starch is also not captured with this method (Lyons-Wall, 
2007).  
Enzymatic-gravimetric methods of fibre estimation include those used by the Association of 
Official Analytical Chemists (AOAC). These methods attempt to estimate the fraction of food 
components that resist digestion in the gastrointestinal tract and the method therefore 
33 
 
 
 
measures a variety of components. Again, enzymes are used to mimic digestion then the 
remaining fraction is weighed (Lunn and Buttriss, 2007). This approach involves less analytical 
work and therefore is much more economical to use (Lyons-Wall, 2007). The AOAC method 
gives a value including soluble and insoluble NSP and lignin combined (Lyons-Wall, 2007). 
The presence of resistant starch complicates analytical methods for determining dietary fibre 
but the AOAC and Southgate methods both include some resistant starch in the estimated 
fibre value (Lyons-Wall, 2007). 
For many vegetables, fruits and many unprocessed cereals, the values generated by the 
Englyst and AOAC methods produce similar results but values for heat processed cereals are 
far higher when the AOAC method is used (Lean, 2006). The Southgate and AOAC methods 
produce notably higher values for foods that are good sources of resistant starch such as 
legumes, compared to the Englyst method (Lyons-Wall, 2007). On average, over different food 
groups, AOAC values are 1.33 times greater than NSP estimates (Lunn and Buttriss, 2007).  
1.2.3 UK and international definitions of ‘dietary fibre’ 
Although the term ‘dietary fibre’ is practical for public health messages, it is not necessarily 
useful for classifying carbohydrates based on their molecular composition but rather, is useful 
in classifying groups of molecules with similar physiological properties.  
In 2008 the UK Scientific Advisory Committee on Nutrition (SACN) panel  issued a statement on 
dietary fibre and considered that a material could be classified as dietary fibre if it was 
“resistant to digestion and absorption in the small intestine and has a demonstrable 
physiological effect potentially associated with health benefits in the body such as increasing 
stool bulk, decreasing intestinal transit time or decreasing post prandial glycaemia”. The panel 
considered that evidence only of fermentation in the gut was not sufficient to be included 
within the definition without an associated physiological effect (SACN, 2008). 
SACN commented that using this definition and available evidence, NSP and soluble fibre 
would be the only two components included in the definition, without the need for further 
evidence of physiological effect but for other components to be included further evidence is 
required (SACN, 2008). 
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In contrast to this, the European Food Safety Authority (EFSA) definition is more inclusive, with 
no necessity for an observed physiological effect, but rather the definition focuses on chemical 
composition. Dietary fibre is therefore defined as any non-digestible carbohydrate: cellulose, 
hemicelluloses, pectins, hydrocolloids (i.e. gums, mucilages, beta-glucans), resistant 
oligosaccharides (fructooligosaccharides, galactooligosaccharides, other resistant 
oligosaccharides) and resistant starch (including physically enclosed starch, some types of raw 
starch granules, retrograde amylase, chemically and/or physically modified starches) and lignin 
(where this is associated with dietary fibre polysaccharides) (EFSA, 2010). 
For a time, fibre was commonly categorised as insoluble (resisted fermentation in the large 
bowel) or soluble fractions (does not resist fermentation), but molecular structures and 
therefore solubility exists on a scale and this simplistic categorisation has since been 
recognised as misleading (Buttriss and Stokes, 2008). Additionally, newer carbohydrate-
derived components of interest, such as resistant starches and oligosaccharides, do not fit 
completely into either category (Buttriss and Stokes, 2008). 
A comprehensive article reviewed definitions and guidelines for dietary fibre in many countries 
across the world and summarised that:  
“a workable definition of dietary fibre should: clarify the constituent makeup of dietary fibre; 
recognise that a primary characteristic is resistance to digestion and absorption in the small 
intestine and fermentation in the large intestine; and demonstrate that fibre has physiological 
properties” (Lunn and Buttriss, 2007). 
1.2.4 UK and international intakes of dietary fibre and recommendations 
The lack of a universal definition for carbohydrates that resist digestion has lead to 
complications in both establishing and communicating consistent recommendations, health 
claims and food labels (Buttriss and Stokes, 2008). Both the recommended intake levels and 
the way that dietary fibre is defined varies greatly across different countries around the world 
(Lunn and Buttriss, 2007). An additional complication is that current estimation methods may 
underestimate fibre content of foods, such as using the definition advised by the EFSA because 
resistant oligosaccharides and inulin are not currently captured by assessment methods and 
must be assessed separately (Buttriss and Stokes, 2008).  
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In the United States (US), the average fibre (AOAC) intake is estimated at around 15g/day, 
significantly lower than the recommended intake level of 25g/day for women and 38g/day for 
men (approximately 14g/1000kcal/day) (USDA/HHS, 2010). An EFSA panel consensus was that 
the role of fibre in bowel function was the most suitable criterion for setting recommended 
intakes and based on available evidence considered 25g/day to be adequate for normal 
laxation in adults (EFSA, 2010). 
In the UK, dietary recommendations appear lower due to fewer components of plant cells 
walls being classified as fibre, namely the exclusion of lignin and resistant starch as these are 
not detected with the Englyst method of fibre estimation. The recommended intake level for 
British adults is 18g/day (COMA, 1991). This value corresponds to recommendations of around 
24g/day using the AOAC method (Buttriss and Stokes, 2008). However it is estimated that the 
average person in the UK doesn’t meet the recommended intake level. In the most recent 
National Diet and Nutrition Survey (NDNS) mean fibre intakes were estimated well below 
recommended levels at 13.3-13.8g/day (Bates et al., 2012). 
1.3 Potential mechanisms for fibre and CVD risk factors 
As dietary fibre encompasses a range of non-digestible carbohydrates, many mechanisms for 
the protective action of dietary fibre have been proposed (Liu et al., 2002a). Dietary fibre 
intake has been associated with improvements in key modifiable risk factors for CVD such as 
overweight (Du et al., 2010), hypertension (Ludwig et al., 1999, Ascherio et al., 1992) and 
hypercholesterolaemia (Brown et al., 1999) and these key risk factors are considered, in turn, 
below. 
1.3.1 Circulating lipid levels 
Bacterial fermentation of resistant starch, soluble fibres and some insoluble types of fibre, in 
the large intestine, produces SCFAs (principally butyrate, proprionate and acetate) (Lunn and 
Buttriss, 2007). These SCFAs inhibit hepatic cholesterol synthesis, consequently lowering 
serum levels (Coultate, 2009, Lunn and Buttriss, 2007, British Nutrition Foundation, 2005).  
In addition to the partial fermentation of insoluble fibre molecules discussed above, bile-acids 
present in the gastrointestinal tract also physically bind to insoluble fibre molecules. This 
binding, together with the presence of viscous soluble fibre gels in the gut, slows the rate of 
unbound bile acid reabsorption into the blood stream. Bile acids contain cholesterol and when 
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absorption is slowed, blood cholesterol is shunted into bile acid production, thus lowering 
circulating levels (James et al., 2003, Lunn and Buttriss, 2007). 
Wheat bran has been shown to have little effect on plasma cholesterol levels but in contrast to 
this, oat bran seems to reduce total plasma and low-density lipoprotein cholesterol (LDL-C) 
levels, possibly via the increased gut viscosity seen with soluble fibre intake. This high viscosity 
may interfere with bile acid reabsorption, resulting in a negative sterol balance (Truswell, 
2002, Van Horn et al., 2008). 
Meta-analyses of trials using soluble fibre have found consistent results with respect to blood 
cholesterol levels. Brown and colleagues identified that greater soluble fibre intake was 
associated with reductions in both total and LDL-C, with no influence on HDL-C or triglyceride 
levels. The authors however concluded that soluble fibre intake can form only a part of any 
therapy to reduce blood cholesterol levels given the relatively small effect sizes observed in 
the studies (Brown et al., 1999). In a more recent meta-analysis of fibre derived from barley 
(high in soluble fibre), reductions were also observed in total cholesterol, LDL-C and 
triglycerides, but no changes in HDL-C were observed (Talati et al., 2009). 
1.3.2 Overweight 
There appears to be an inverse association between fibre intake and body weight or weight 
gain (Slavin, 2005) and it is well documented that increasing obesity is a major factor 
contributing towards CVD risk (Van Horn et al., 2008, Logue et al., 2011).  
Soluble fibres form gel-like substances in the stomach and small intestine in the presence of 
water and these gels can slow the rate of gastric emptying, contributing to greater feelings of 
satiety and could ultimately contribute to lower weight gains (James et al., 2003, Lunn and 
Buttriss, 2007). Soluble fibre gels also moderate the absorption of nutrients in the small 
intestine and the slower rate at which glucose is received in the blood stream may also 
contribute to improved feelings of satiety (Lunn and Buttriss, 2007). In addition, dietary fibre 
may act as a physical barrier to normal enzymatic digestion of other macronutrients, resulting 
in lower energy absorption (Du et al., 2010). The fermentation of soluble fibre is also believed 
to influence hormones associated with inducing satiety, glucagon-like peptide and peptide YY 
(Johansson et al., 2013, Nilsson et al., 2013, Reimer et al., 2010). 
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Few epidemiological studies have examined the effects of different sources or types of fibre on 
weight gain but pooled data from five countries in the European Prospective Investigation into 
Cancer and Nutrition (EPIC) study, including the UK, indicates that greater total fibre intake 
and greater cereal fibre intake were associated with lower annual weight gains, for each 
10g/day greater intake of total fibre, weight gain was -39g/year (95% confidence interval (CI)   
-71 to -7 g/year). Greater intake of total fibre, cereal fibre and fibre from fruit and vegetables 
were also associated with lower annual waist circumference gains but higher intake of fruit 
and vegetable fibre were not associated with lower weight gains (Du et al., 2010).  
Findings relating fibre intake to appetite, weight changes and energy intake are relatively 
mixed, with a recent systematic review identifying that the effects of fibre on energy intake 
and weight were relatively small and distinct dose-response relationships were not observed 
from the included studies. More viscous types of fibre were more often associated with 
reduced appetite than non-viscous fibres but this review focussed primarily on fibre isolates 
rather than high fibre diets (Wanders et al., 2011).  
1.3.3 Blood pressure 
Greater intake of dietary fibre has been associated with lower blood pressure in some 
observational and intervention studies (Streppel et al., 2005, Ascherio et al., 1992), although 
not in one cohort study of women in the US (Ascherio et al., 1996). Significant reductions in 
diastolic blood pressure and a decrease, although not significant for systolic blood pressure 
were observed with greater fibre intake in two meta-analyses, with the effects being more 
pronounced in older and hypertensive individuals (Whelton et al., 2005, Streppel et al., 2005). 
Little is actually known about the potential mechanism for the effects of fibre on blood 
pressure and the observations may be attributed to concurrent increases in potassium and 
magnesium with greater fibre intake (Streppel et al., 2005) or reductions in bodyweight which 
were seen in many of the included studies.   
1.3.4 Glucose metabolism and diabetes 
In a recent review paper, Lattimer and Haub succinctly discuss the many potential mechanisms 
through which dietary fibre may act on components of metabolic health. Briefly, the higher 
glycaemic index (GI) of foods is related to higher blood glucose levels and over the long-term 
this could lead to pancreatic beta cell dysfunction and decreased insulin release. Additionally, 
cell tissues may become resistant to insulin with chronic hyperglycaemia (Lattimer and Haub, 
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2010). The consequence of displacing high GI foods for fibre-rich and lower GI foods may 
therefore be one potential mode of action for fibre-rich diets. 
The potential action of soluble-type fibre gels on blood glucose levels, noted above, may be 
through the slowed nutrient absorption from the small intestine into the blood stream, thus 
attenuating post-prandial blood glucose levels (James et al., 2003, Lunn and Buttriss, 2007).  
Insoluble fibre may act to moderate long term risk of diabetes by stimulating accelerated 
secretion of glucose-dependent insulinotropic polypeptide, which stimulates postprandial 
insulin release, or through its effect on appetite reduction and thereby lowering weight gain. 
Additionally, SCFAs produced during the fermentation of soluble and some insoluble fibres 
may reduce post-prandial glucose response (Lattimer and Haub, 2010). 
1.3.5 Inflammation 
As noted above, there are many potential mechanisms via which fibre intake can influence 
energy intake and body weight. Another biological effect of obesity, in addition to traditional 
associations with risk factors for CVD is the influence on inflammation (Logue et al., 2011). 
Inflammation mediates the well known but poorly understood links between obesity, 
cardiovascular pathology and common comorbidities such as hypertension, diabetes and 
dyslipidaemia (Berg and Scherer, 2005).  
Inflammation is not simply a reactive response to atherosclerosis but is itself an important 
contributor to CVD risk. Adipose tissue acts as an endocrine organ and directly augments 
systemic inflammation by releasing proinflammatory cytokines.  The inflammatory proteins 
that are secreted from adipocytes and adipose tissue work in a complex and reciprocal matrix 
and it appears that these circulating mediators of inflammation are directly involved in the 
mechanism of vascular damage and atheromatous changes that progress into CVD (Berg and 
Scherer, 2005). 
1.4 Gaps in current epidemiological research 
Many studies have examined the relationship between dietary fibre intake and CVD risk (refer 
to Chapter 2 where other literature is discussed in depth). However, few studies have explored 
key important elements in addressing this question. Firstly, as the physiological consequences 
of diets with high fibre content may depend on the types of fibre and the food source (Rimm 
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et al., 1996), it is crucial to address this and explore which types or sources of fibre may be 
more closely associated with potential benefits. In identifying potentially beneficial 
components, a more targeted approach to disease prevention could be taken, thus maximising 
any benefits. Secondly, many studies combine CVD cases when assessing risk associations and 
do not explore risk in disease sub-types. For example, many studies present only ‘total stroke’ 
cases and not haemorrhagic or ischaemic types separately but it has been noted that risk 
factors differ for these conditions (Andersen et al., 2009).  
Exploring different fibre sources and types in relation to total CVD and sub-classifications of 
the disease could lead to tailored advice for disease prevention, potentially targeting low 
consumers of specific fibre types or those at greater risk of different types of CVD.  
Many studies from the US, other parts of Europe, Australia and Japan provided evidence on 
the association between both total fibre and sources of fibre in relation to CVD (refer to 
Chapter 2) but diets and population characteristics within these countries may differ 
significantly from the UK. The UK Women’s Cohort Study (UKWCS) therefore has the potential 
to be extremely useful for exploring associations between dietary fibre intake and CVD in the 
context of the British diet and population. 
1.5 Aims 
Given the potential benefits in CVD risk reduction linked to dietary fibre intake, indicated with 
evidence from both intervention and observational studies, the primary aim for this work is to 
explore this association using data collected as part of the UKWCS and thus contribute to the 
growing body of evidence on this topic. The specific project aims include: 
1) Update existing systematic reviews: Identify literature from observational studies 
concerning dietary fibre intake and risk of CHD, stroke and CVD (Chapter 2). 
2) Obtain mortality records, in addition to non-fatal events recorded within the Myocardial 
Infarction National Audit Project (MINAP) and Hospital Episode Statistics (HES) and link this 
CVD event data with lifestyle variables from the UKWCS (Chapter 4).  
3) Compare and thus assess the completeness of event data from different sources using a 
capture-recapture approach (Chapter 4). 
4) Explore the association between CVD risk and fibre intake estimated using food frequency 
questionnaires (FFQ) (Chapters 5 and 6) and food diaries (Chapter 7). 
5) Examine associations between total fibre or key types and sources of fibre with CVD risk. 
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1.6 Summary 
The human and economic impact of CVD is difficult to overstate and since most CVD risk is 
modifiable, prevention is possible and is paramount to the health of every nation (Mosca et al., 
2007). Interplay between key risk factors for CVD such as hypertension, 
hypercholesterolaemia, poor glucose regulation and overweight make pinpointing specific 
mechanistic pathways for the action of fibre molecules on total CVD risk a challenge.  
The collective evidence from studies examining risk factors for CVD suggests that there are 
many modes of action of different dietary fibre components. Examining soluble and insoluble 
fibre along with fibre from key food sources, where the relative ratio of soluble and insoluble 
types of fibre will differ, may elucidate specific associations with CHD or stroke and hint at 
potential mechanisms for the action of fibre on overall risk. Additionally, quantifying risk 
reduction in relation to specific levels of fibre intake, and with different sources or types of 
fibre, may allow for tailored recommendations for CVD prevention to be developed. At the 
very least, it is apparent that CVD risk is largely modifiable and maintaining optimum health 
over the life course may contribute to lower overall risk and lengthen disease-free survival 
time. Exploring this question in a sample of British women, where intakes in the sample are 
diverse, will contribute to the growing body of evidence in this important area. 
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Chapter 2 Systematic literature review and meta-
analysis 
2.1 Chapter overview 
Observational study data relating to dietary fibre intake and primary CVD events have been 
identified through systematically reviewing literature published since 1990. This chapter 
details the methods used in both the main systematic review (noted in the Declaration and 
Acknowledgments on pages 3-6) plus update searches, to highlight my separate contribution 
to this work. The role of the review team was to collate evidence and present it to SACN, for 
their interpretation. Thus, aside from using the identified literature, any interpretation, 
discussion and conclusions drawn are my own. Findings are presented separately for total CVD, 
CHD and stroke, where sufficient data were identified. 
Results from this chapter have subsequently been further extended with additional, up-to-date 
literature searches and have been published (Threapleton et al., 2013d, Threapleton et al., 
2013e). One of these publications includes results for the UKWCS which are presented in 
Chapter 5 (Threapleton et al., 2013b) and these more recently published results are therefore 
not included in the work presented here as were not available at the time.  Both full 
manuscripts were written largely by me, with the exception of the statistical methods sections 
which were written mainly by Dr Darren Greenwood. Other author and reviewer suggestions 
on style and content were also incorporated into the final manuscript submissions. Abstracts 
presenting work from this chapter were also submitted and accepted for presentation at the 
winter meeting of the Nutrition Society 2012 (Threapleton et al., 2012c, Threapleton et al., 
2012d). 
Total fibre intake was associated with CVD, CHD and stroke risk reduction and insoluble fibre, 
vegetable and cereal sources of fibre were also associated with CHD risk reduction. 
Unfortunately, for stroke or CVD outcomes and some subtypes of fibre presented in this 
chapter, too few studies were identified that reported data in a suitable format to permit 
meta-analysis. However, in the recent publication discussed above (Threapleton et al., 2013e) 
additional studies were included from a further updated literature search and thus more meta-
analyses could be conducted.  
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2.2 Background 
In recent years, a decline in total CVD and CHD incidence has been seen in many developed 
countries (AHA, 2011, Allender et al., 2008). Although rates of CVD have long since peaked for 
many developed countries and CVD mortality is declining (Unal et al., 2004), it remains a 
significant issue, accounting for a third (34.3%) of all fatalities in the US and almost half (48%) 
of all deaths in Europe (AHA, 2011, Allender et al., 2008).  
A similar trend for declining stroke incidence is also reported in many of the worlds developed 
countries, a reduction largely attributed to improvements in hypertension management. 
However, the absolute number of strokes continues to increase with the expansion of the 
aging population in these counties (Mackay and Mensah, 2004). Stroke and other 
cerebrovascular diseases are the second most common cause of death worldwide, and in 2008 
accounted for 6.2 million deaths (11% of fatalities) (WHO, 2008). Data from the US suggests 
that 78% of strokes are first attacks (Roger et al., 2012) with ischaemic stroke being ten times 
more common than haemorrhagic stroke in most western countries (Andersen et al., 2009). 
Moreover, stroke is the leading cause of disability in many developed countries and its primary 
prevention should, therefore, be a key public health priority (He et al., 2006). 
The previous chapter includes detailed discussion of the many proposed mechanisms for the 
action of dietary fibre on various risk factors for CVD. Many experimental studies have 
examined the relationship between dietary fibre or fibre-rich foods and CVD risk factors such 
as hypertension, central obesity, insulin sensitivity and elevated plasma cholesterol (Ludwig et 
al., 1999, Brown et al., 1999, Truswell, 2002, Van Horn et al., 2008). A number of literature 
reviews published in the past decade have also explored the association between dietary fibre 
and CVD or CHD risk using observational study data (Liu et al., 2002a, Pereira et al., 2004, 
Mente et al., 2009, Hauner et al., 2012, Ye et al., 2012) but although many individual 
epidemiological studies have examined stroke risk in relation to dietary fibre intake (Ascherio 
et al., 1998, Bazzano et al., 2003, Eshak et al., 2010, Kaushik et al., 2009, Kokubo et al., 2011, 
Larsson et al., 2009, Oh et al., 2005, Wallstrom et al., 2012), when this work was undertaken 
there were no published meta-data relating to stroke occurrence. 
Taking the existing evidence base from observational study reviews and meta-analyses 
together, there appears to be an inverse association between total dietary fibre and CVD risk. 
One meta-analysis of 9 publications identified a 7% risk reduction for every 10g/day increase in 
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fibre, RR 0.83 (95% CI: 0.78 to 0.89) (Liu et al., 2002a), although studies were not identified 
through a systematic review of literature. A pooling project, using raw study data from 11 
cohorts also reported a risk reduction for total fibre 0.81 (95% CI: 0.73 to 0.91) and additionally 
for fruit fibre 0.84 (95% CI: 0.70 to 0.99), but not for cereal fibre 0.90 (95% CI: 0.77 to 1.07) or 
vegetable fibre 1.00 (95% CI: 0.88 to 1.13) (Pereira et al., 2004). 
Of the publications reporting systematically reviewed literature in this area, two meta-analyses 
identified around 20% lower CHD risk in high compared to low fibre consumers, RR 0.78 (95% 
CI: 0.72 to 0.84) (Mente et al., 2009) and RR 0.81 (95% CI: 0.77 to 0.86) (Ye et al., 2012). A 
protective association of similar magnitude was also reported for high compared to low cereal 
fibre consumers 0.80 (95% CI: 0.73 to 0.88) (Ye et al., 2012) although no other sources of fibre 
or types (soluble or insoluble fibre) were examined in these publications. 
A narrative synthesis of systematically reviewed literature used to inform evidence-based 
guidelines for the German Nutrition Society was also recently published (Hauner et al., 2012). 
Increased dietary fibre intake and greater whole-grain intake were judged as ‘probably’ 
associated with primary prevention of CHD and evidence of cereal fibre, soluble fibre and 
insoluble fibre was judged as ‘possibly’ being inversely related. For vegetable fibre, evidence 
was judged as ‘possibly’ indicative of there being no association (Hauner et al., 2012).  
The aim of this work was to review literature published since 1990, in generally healthy 
populations, concerning dietary fibre intake and cardiovascular disease risk, to update reports 
published in the UK by the Committee on Medical Aspects of Food Policy, in the early 1990’s 
(COMA, 1991, COMA, 1994). The aim was to systematically review the evidence base and 
combine study data in order to calculate dose-response estimates for total dietary fibre in 
addition to fibre from major food sources, thus improving upon previously published reviews 
that were either not systematic (Liu et al., 2002a, Pereira et al., 2004), calculated risk in high 
compared to low consumers (Mente et al., 2009, Ye et al., 2012) or did not explore key sources 
or types of dietary fibre (Liu et al., 2002a, Mente et al., 2009). A further aim was to report on 
potential sources of heterogeneity between studies to give insight into population 
characteristics or study design issues that may introduce bias and influence whether significant 
associations were observed. 
Systematically reviewing literature using a strict protocol is important to ensure the quality of 
a review and to minimise bias in study identification and inclusion and reduce random errors 
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(Egger et al., 2008a, Bowers et al., 2006b). The term meta-analysis, used to describe the 
integration of analyses from multiple studies, was coined in the 1970’s (Glass, 1976) and has 
become a widely accepted method for orderly summarising information from many studies, 
which may present opposing findings.  
Strengths of combining data from RCTs include the greater statistical power achieved by 
adding many smaller studies together, whilst maintaining the validity of results, because of the 
use of randomised groups.  However, issues with validity in observational studies are largely a 
reflection of confounding and bias (Willett, 1998b). Meta-analysis may therefore produce 
precise but spurious results because the issues of confounding are not addressed through the 
statistical combination of data (Egger et al., 2008b). The estimate of effect resulting from the 
combination of data should therefore not outweigh the careful examination of potential 
sources of heterogeneity between the results of observational studies (Egger et al., 2008b). 
Heterogeneity, or differences in observed findings, may occur because of different 
methodological features between studies such as dietary assessment method, outcome 
assessment and length of follow-up. Meta-analysis can provide great value in examining the 
potential reasons for heterogeneity through meta-regression and also allows for questions not 
posed in individual studies to be answered, such as establishing dose-response relationships 
(Willett, 1998b). 
2.3 Methods 
2.3.1 Literature searches 
Main review: The following online databases were searched for prospective cohort studies 
and RCTs published in English language from 1st January 1990 to November 2009: The 
Cochrane Library, MEDLINE, MEDLINE in-process, Embase, CAB Abstracts, ISI Web of Science 
and BIOSIS. Search strategies for the Cochrane Library and Medline (and Medline in-process 
articles) were developed by an information specialist. I adapted the Medline search strategy 
for CAB full-text articles and the Web of Science databases whilst other colleagues adapted the 
strategy to Embase and BIOSIS.  
Hand-searching of the following selected journals was carried out to supplement the electronic 
searches: Journal of Nutrition, Journal of the American Dietetic Association, American Journal 
of Clinical Nutrition, Diabetes Care, European Journal of Clinical Nutrition and British Journal of 
Nutrition. Additionally, bibliographies of relevant published systematic literature reviews and 
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meta-analyses were cross checked against the articles identified from electronic search 
databases.  
Update: The majority of studies identified in the main review were found via Medline and 
Embase databases. These two resources were therefore used for the update search, in 
addition to the Medline in-process and non-indexed citations database. Databases were 
searched from 1st January 2009 to 31st May 2012. Search strategies used for Medline and 
Embase were based on those used during the large systematic review, but only search terms 
for fibre and cardiovascular disease were retained (Appendix I). Key terms used for the update 
search included, among others, ‘fibre’ ‘fiber’, ‘cellulose’, ‘lignin’, various other fibre sub-
fractions and sub-types, ‘cardiovascular diseases’, ‘coronary diseases’, ‘myocardial ischaemia’, 
‘stroke’ and ‘transient ischaemic accident/incident’. 
2.3.2 Screening articles 
Main review: The electronically retrieved bibliographies were downloaded into Reference 
Manager software and automated removal of duplicate references was carried out. Titles and 
abstracts of unique references were scanned for non-relevancy by one of several review team 
members, using structured guidelines (Appendix II), to ensure consistency. A 10% sample of 
the articles deemed ‘not-relevant’ were cross-checked by a second team member to ensure an 
acceptable level of agreement (>99%). Where the title and abstract did not provide enough 
information to determine that the article was clearly not relevant to the review, it was marked 
as potentially relevant.  
Full-text versions of all articles not excluded during screening were retrieved and reviewed 
independently by two members of the research team. Any disagreements were resolved by a 
third reviewer. A structured flow-chart plus detailed information sheets were used to 
determine eligibility for inclusion (Appendix III).  
Prospective cohort studies with follow-up duration less than three years were excluded. 
Multiple reports from the same cohort study were reviewed for instances where papers 
presented the same results at multiple follow-up periods. Papers with the longest follow-up 
for identical results were preferentially included unless the paper with longer follow-up did not 
report sufficient information to allow inclusion in dose-response meta-analysis. 
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The focus of this review was prevention of cardio-metabolic diseases (not secondary 
prevention or reversal of CVD risk factors) and as such, studies were only included where 
participants were considered generally healthy or had an intermediate stage of illness at 
baseline. Studies where greater than 50% of participants were chronically ill, or where data on 
the ‘healthy’ participants were not presented separately, were excluded. Examples of ill 
populations include studies where >50% of participants had a history of CVD, diabetes, cancer, 
hypertension, hypercholesterolaemia or hyperinsulinaemia. However, studies including pre-
hypertensive, glucose intolerant or obese participants were permitted. In addition to this, 
studies where the majority (>50%) of participants were taking medications for chronic illnesses 
(e.g. lipid-lowing or anti-hypertensive medication) were excluded. 
Update: Duplicate articles were manually identified and removed from the reference database. 
Titles and abstracts of unique references were screened for relevancy using the same criteria 
as applied for the main review. Screening was undertaken independently by Dr Victoria Burley 
and I, with any disagreements being settled through discussion. Any articles identified as 
potentially relevant by either of us were obtained in full-text and were further screened, in 
duplicate, using the same formal inclusion criteria as applied for other studies in the main 
review.  
2.3.3 Data Extraction 
Data were extracted into a Microsoft Access database, with pre-defined fields that capture 
aspects of study design and quality as well as individual results (RRs and CIs), including 
exposure type and quantity, case numbers, definition of outcome and adjustments used within 
analyses. This method of data extraction was based on the approach used for the World 
Cancer Research Fund Second Expert Report (WCRF, 2007). Methodological quality of studies 
was not evaluated using a formal scoring approach but aspects of study quality, such as follow-
up duration, case ascertainment and adjustment for various important confounders were 
extracted for investigation through meta-regression.  
2.3.4 Statistical analysis 
Main and update review: Dose-response trends for fibre exposures in relation to CVD 
outcomes were generated for each cohort (Greenland and Longnecker, 1992, Orsini et al., 
2006) and these were then combined using random effects models. Random effects models 
incorporate an estimate of between-study variation into the combined effect calculation and 
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are therefore appropriate to use when heterogeneity between studies is likely to exist, as it is 
with observational studies (Deeks et al., 2008).  
Summary estimates are only considered reliable when heterogeneity (I2) does not exceed 75% 
and are only presented when studies had included appropriate adjustments because 
unadjusted results are liable to potentially substantial bias. Where results were presented by 
diagnostic category only e.g. fatal and non-fatal events presented separately, the method of 
Hamling and colleagues was used to first combine data in a random effects meta-analysis 
(2008). This approach allows for a more consistent comparison between different study results 
and thus potentially improves reliability of a meta-analysis (Hamling et al., 2008).  
For comparability, fibre increments presented in the dose-response figures were chosen to be 
approximately one standard deviation (SD) of population intake level. Fibre intake SDs were 
obtained from multiple sources and reflect a realistic increase in daily intakes (Bates et al., 
2009, Larsson et al., 2009, Streppel et al., 2008, Pietinen et al., 1996). The SDs for fibre 
estimated as NSP were multiplied by 1.33, a standard conversion factor (Lunn and Buttriss, 
2007) in order to be comparable to fibre values estimated using the AOAC method.  
Restricted cubic splines were used to model the nonlinear dose-response association between 
fibre exposures and CVD, CHD or stroke for each study (Orsini and Greenland, 2011), based on 
fixed knots at 10%, 50% and 90% through the distribution of intake, then combined using 
multivariate meta-analysis (White, 2009).  
Heterogeneity between studies was tested using Cochran’s Q statistic, alongside the 
proportion of total variation in study estimates that is due to heterogeneity (I2) (Higgins and 
Thompson, 2002). The following methodological features were explored through pre-defined 
meta-regression: method used to assess fibre intake (AOAC/non-AOAC), whether results 
include non-fatal events, follow up length (<10years/≥10years), geographic location 
(US/European Union/Other) and also whether the results were adjusted for the following: age, 
alcohol, anthropometry, energy intake, physical activity and gender. All analyses were 
performed by Dr Darren Greenwood using Stata 12.1 (StataCorp, 2011).  
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2.4 Results 
2.4.1 Included articles 
Main review: In total 42,518 references were obtained from both electronic and hand-
searching. After removal of duplicates, 23,165 unique references remained. On first screening 
1,736 of these references were deemed to be potentially relevant and 21,429 were marked as 
not relevant for this review. Just over 10% of the references (2,214) marked as not relevant 
were screened independently by a second reviewer. Of this checking sample, 0.8% (17 articles) 
were identified as potentially relevant and these were re-marked as potentially relevant 
articles to include. The number identified in this check process was lower than the pre-
specified cut-off of 1% and no further checking was carried out. At this stage, 16 additional 
unique references were identified during hand-searching and were included into the 
potentially relevant file, bringing the total of potentially relevant articles to 1,769.  
Of the 17 papers identified during the quality check process, five were eventually included into 
the review. Four of these five papers would have been included in the review, had the 
checking process not identified them, as they were also identified during hand-searching of 
relevant journals and reference lists of relevant literature reviews. In summary, the screening 
and hand-searching processes seem acceptably thorough since just one article from the 10% 
(n=2,214 papers) check sample would have otherwise been missed from the full review. 
In total 396 articles were included in the full carbohydrate and cardio-metabolic heath review 
and of these, dietary fibre intake in relation to cardiovascular events were reported in 17 
publications from 14 cohorts. 
Update searches: A total of 879 unique references were identified and from these, 19 were 
flagged as being potentially relevant to the review (Figure 2.1). After screening the 19 full-text 
articles, 8 were excluded; one was a cross-sectional study (Oba et al., 2010), one included 
diabetic participants only (He et al., 2010), three reported diet scores or foods rather than 
fibre as a single dietary component (Heroux et al., 2010, Van Horn et al., 2012, Hlebowicz et 
al., 2011), one paper published in 2009 had already been identified from the main review 
search (Kaushik et al., 2009) and two articles reported narrow and specific cardiovascular 
events (atrial fibrillation and venous thromboembolism) rather than CVD or CHD (Shen et al., 
2011, Varraso et al., 2012).  
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From the update search, 11 articles from 8 cohorts were included. Five reported only total CVD 
(Akbaraly et al., 2011, Baer et al., 2011, Buyken et al., 2010, Park et al., 2011, Chuang et al., 
2012), three reported only CHD (Bernstein et al., 2011, Crowe et al., 2012, Ward et al., 2012) 
and three reported incident CVD, CHD and stroke events (Eshak et al., 2010, Kokubo et al., 
2011, Wallstrom et al., 2012).  
Figure 2.1 Flow chart for update search publication identification and inclusion 
 
Searches combined: A total of 28 articles from the main plus update searches were identified 
from 1st January 1990 to 31st May 2012, reporting data from healthy cohorts concerning 
dietary fibre and incident cardiovascular events, with follow-up of at least 3 years (Figure 2.2). 
Studies reported combinations of exposures and outcomes (Table 2.1). Four of the articles 
didn’t report risk estimates but instead provided a description of baseline dietary fibre intakes 
in those that subsequently became a case or not. These four publications will not be discussed 
here further as results were only minimally adjusted or were not adjusted for any potential 
confounders and are likely subject to substantial bias (Drogan et al., 2007, Fehily et al., 1993, 
Knekt et al., 1994, Laaksonen et al., 2005).  
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Total number of references retrieved from 
electronic searches (n=42,040)
Unique references retrieved from electronic 
searches (n=23,165)
References 
identified as not 
relevant to the 
review (n=21,429)
Checking 
sample 10% 
(n=2,214)
0.8% of checking 
sample identified 
for status change 
to potentially 
relevant (n=17)
References initially identified as Potentially 
Relevant (n= 1,736)
Total references identified as potentially 
relevant- ordered as full text papers for 
detailed exclusion      (n= 1,769)
References excluded at detailed 
exclusion phase (n=1,372)
Missing: British Library could not 
source  as reference was 
incomplete (n=1)Total included references (n=396)
Total number of 
references retrieved from 
hand-searches (n=478)
Duplicate
references
removed
Unique references 
from hand-
searching (n=16)
References reporting incident CVD events 
and dietary fibre intake (n=17)
References reporting other 
outcomes and exposures from 
the main review (n=379)
Electronic and hand-search 
update review for incident 
CVD events and dietary fibre
intake  (n=934)
Total references reporting incident CVD 
events and dietary fibre intake from main 
and update review (n=28)
Unique references from 
update search (n=879)
Unique references from 
update search (n=11)
References 
identified as 
not relevant to 
update review 
(n=868)
 
Figure 2.2 Main plus update search flow diagram for publication identification and inclusion for CHD, stroke and CVD outcomes combined
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Table 2.1 Summary of outcomes and exposures reported in cohort studies identified during the systematic review and update searches 
Reference/ Authors Cohort name 
Reported study outcomes Dietary exposures 
Total 
CVD 
CHD Stroke 
Dietary 
fibre 
Fibre 
density 
Soluble 
fibre 
Insoluble 
fibre 
Fibre from specific food sources Fibre fractions 
Fruit Veg Cereal Le Oth Po Cell’ Lignin 
*Akbaraly et al., 2011 Whitehall II X F 
 
 X            
Appleby et al., 1999 Oxford Vegetarian Study  X  F  X            
Ascherio et al., 1998 Health Professionals Follow-Up Study   X  C X            
* Baer et al., 2011 Nurses’ Health Study X F         X      
Bazzano et al., 2003 NHANES I X F,C X F,C X  F,C  X X          
*Bernstein et al., 2011 Nurses’ Health Study 
 
X  C  
 
   
  
X      
*Buyken et al., 2010 Blue Mountains Eye Study X F   X    X X X      
* Chuang et al., 2012 EPIC X F   X 
 
  X X X      
* Crowe et al., 2012 EPIC-Heart 
 
X F  X 
 
  X X X  X    
*Eshak et al., 2010 Japan Collaborative Cohort Study X F X F X F X  X X X X X      
Kaushik et al., 2009 Blue Mountains Eye Study  X  F X  F       X      
* Kokubo et al., 2011 Finnish Mobile Clinic Health Surveys X  C X  C X  C X  X X         
Larsson et al., 2009 Alpha-tocopherol beta-carotene Study   X  C X  X X X X X      
Liu et al., 2002 The Women’s Health Study X  C X  C  X  X X X X X      
Mozaffarian et al., 2003 Cardiovascular Health Study  X  C  X    X X X      
Oh et al., 2005 Nurses’ Health Study   X  C X    X X X      
* Park et al., 2011 NIH-AARP Diet and Health Study X F 
 
 X  
  
X X X X   
  
Pietinen et al., 1996 Alpha-tocopherol beta-carotene Study  X F,C  X  X X X X X    X X 
Rimm et al., 1996 Health Professionals Follow-Up Study  X F,NF,C  X  X X X X X      
Streppel et al., 2008 Zutphen Elderly Study  X  F  X    X X X X  X   
Todd et al., 1999 Scottish Heart Health Study  X  C  X 
 
          
* Wallstrom et al., 2012 Malmo Diet and Cancer Cohort X C † X C † X C †  X   
   
     
* Ward et al., 2012 EPIC-Norfolk  X C  X    X X X      
Wolk et al., 1999 Nurses’ Health Study  X F,NF,C  X X   X X X      
Key: *Identified in update review; † Events were ischaemic only;  C=fatal and non fatal events combined; Cell=cellulose; F=fatal events; Le= Legume; NF=non-fatal events; Oth= 
other sources of fibre (fibre after cereal, fruit and vegetable fibre deducted); Po=potato fibre; Veg=vegetable; X=reported in the paper 
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Cohort characteristics: Identified publications all included adult participants and were mainly 
from Europe (10) and the US (10), but were also from Japan (2) and Australia (2) (Table 2.2). 
Studies varied greatly in follow-up duration, the shortest being the Women’s Health study 
which reported at 6 years from baseline (Liu et al., 2002a), and the longest follow-up was in 
the Zutphen Elderly Study that reported at 40 years (Streppel et al., 2008). The mean follow-up 
duration of studies was around 14 years. 
Most cohorts included males and female except two reporting on just women, the Nurses’ 
Health Study (Baer et al., 2011, Bernstein et al., 2011, Oh et al., 2005, Wolk et al., 1999) and 
the Women’s Health study (Liu et al., 2002a) and three reporting only on men, the Health-
Professional’s Follow-Up Study (HPFS) (Ascherio et al., 1998, Rimm et al., 1996), the Zutphen 
Elderly Study (Streppel et al., 2008) and the Finnish Alpha-Tocopherol Beta-Carotene (ATBC) 
Study of male smokers (Larsson et al., 2009, Pietinen et al., 1996). 
Included cohorts varied greatly in terms of participant numbers and cases for the different 
outcomes. The smallest included study was the Zutphen Elderly Study with just 1,373 
participants included at baseline but because of the long follow-up period, 348 fatal CHD 
events were reported at 40 years (Streppel et al., 2008). The pooled pan-European data 
presented in the two publications from EPIC included the largest number of participants at 
baseline, 519,978 and 518,408 and reported on 2,381 CHD and 4,604 CVD mortality cases 
(Crowe et al., 2012, Chuang et al., 2012). 
Dietary intake was assessed with FFQs in the majority of studies, the exceptions being a single 
24-hour recall used in the National Health and Nutrition Examination Survey I (NHANES) 
(Bazzano et al., 2003) and diet history or food-diaries being used in two Finnish studies (Knekt 
et al., 1994, Laaksonen et al., 2005) and in the Zutphen Elderly Study (Streppel et al., 2008). 
Intakes were assessed from nutrient tables that derived fibre intakes using the AOAC method 
in most of the cohorts. The methods used in the NHANES I study and Framingham Heart study 
were not reported but as these were both conducted in the US, are likely to have used AOAC 
methods (Bazzano et al., 2003, Shen et al., 2011). The two Japanese cohort studies reportedly 
employed analysis methods similar to AOAC methods (Eshak et al., 2010, Kokubo et al., 2011). 
The four British studies, the Malmo Diet and Cancer Cohort and the Finnish ATBC study 
assessed fibre as NSP (Akbaraly et al., 2011, Appleby et al., 1999, Todd et al., 1999, Ward et al., 
2012, Larsson et al., 2009, Pietinen et al., 1996, Wallstrom et al., 2012). 
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Table 2.2 Characteristics of cohort studies identified during the systematic review and update searches 
Reference Cohort name 
(Country) 
Population 
characteristics/ 
notes 
Sex Age at 
baseline 
years 
Initial cohort size: 
and case numbers 
Dietary assessment Fibre 
estimation 
method 
Outcome definition by ICD 
codes † 
Follow up 
duration 
(loss) 
*Akbaraly et 
al., 2011 
Whitehall II 
(England) 
London-based civil 
servants 
M/F Mean 49 7319: 141 CVD 
deaths 
Semi-quantitative 127-
item FFQ. 
Englyst CVD: 9th 390.0-458.9/ 10th I00-
I99 
17.7years  
Appleby et al., 
1999 
Oxford 
Vegetarian 
Study (UK) 
Half of sample were 
vegetarian 
M/F 16-79 
(mean 
46) 
11140: 525 IHD 
deaths 
Simple validated FFQ  Not reported, 
likely Southgate  
IHD: 9th edition ICD codes used 
to identify IHD (no further 
details reported) 
13.3 years  
Ascherio et al., 
1998 
Health 
professionals 
follow-up study 
(US) 
Male health 
professionals free of 
CHD at baseline 
M 40-47 51529: 328 fatal  
and non-fatal stroke 
cases  
Validated 131 item FFQ 
referring to diet over 
previous year. 
AOAC Stroke: all stroke included and 
sub-classifications identified 
with criteria from National 
Survey of Stroke (embolism/ 
thrombosis) 
8 years 
* Baer et al., 
2011 
Nurses’ Health 
Study (US) 
Health professionals 
free of CHD at 
baseline 
F 30-55 121700: 1026  CVD 
deaths 
Validated 116 item FFQ 
administered 3 times. 
AOAC CVD: 8th:390.0-458.9 and 
795.0-795.9 
18 years 
Bazzano et al., 
2003 
NHANES I (US) Nationally 
representative 
sample free of CVD 
M/F 25-74    
(mean 
49) 
14407:  928 stroke, 
1843 CHD events.  
One 24 hour recall 
including portion size 
estimates. 
Assessment not 
reported, likely 
AOAC 
CHD: 9th  410-414/ CVD: 9th 
390-459/ Stroke: 9th 430-438 
19 years 
(4% loss) 
* Bernstein et 
al., 2011 
Nurses’ Health 
Study (US) 
Health professionals 
free of CHD at 
baseline 
F 30-55 72266: 2500 CHD 
cases 
Validated 116 item FFQ 
administered multiple 
times. 
AOAC CHD defined using criteria from 
the WHO, symptoms plus 
either ECG changes or elevated 
cardiac enzyme levels 
22 years 
* Buyken et al., 
2010 
Blue Mountains 
Eye Study 
(Australia) 
Older age 
population cohort 
M/F Median 
65 
3654: 260 fatal CVD 
cases 
Validated 145 item FFQ. AOAC Total CVD classification not 
reported in publication 
13 years 
*Chuang et al., 
2012 
EPIC (Europe) Samples from 23 
centres across 10 
countries in Europe 
M/F Mean 
50.8 
518408: 4604 fatal 
CVD cases 
Various: FFQ, semi-
quantitative FFQ and diet 
history. 
AOAC and 
standardised 
values 
Circulatory disease 10th I00-I99 12.7 
* Crowe et al., 
2012 
EPIC-Heart 
(Europe) 
Samples from 23 
centres across 10 
countries in Europe 
M/F Mean 54  519978: IHD 2381 
deaths 
Various: FFQ, semi-
quantitative FFQ and diet 
history. 
AOAC and 
standardised 
values 
IHD: 9th 410-414/ 10th  I20-I25 11.5 years 
*Eshak et al., 
2010 
Japan 
Collaborative 
Cohort Study 
(Japan) 
Sample from the 
general population 
M/F 40-79 110792: 2080 CVD, 
422 CHD and 983 
stroke deaths 
Validated 40-item FFQ. Method similar 
to AOAC 
(Prosky et al., 
1988) 
CHD: 10th I20-I25. Other CVD 
10th I30-I52, total CVD 10th I01-
I99. Stroke 10th I60-I69 
14.3years 
(4.2% loss 
to follow-
up) 
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Reference Cohort name 
(Country) 
Population 
characteristics/ 
notes 
Sex Age at 
baseline 
years 
Initial cohort size: 
and case numbers 
Dietary assessment Fibre 
estimation 
method 
Outcome definition by ICD 
codes † 
Follow up 
duration 
(loss) 
Kaushik et al., 
2009 
Blue Mountains 
Eye Study 
(Australia) 
Older age 
population cohort 
M/F Median 
65 
3654: 95 stroke 
deaths, CHD cases 
not reported 
Validated 145 item FFQ. AOAC Stroke 9th 430-438.9/ 10th 
I60.0-I69.9. IHD not defined 
13 years  
(29% loss 
to follow-
up) 
*Kokubo et al., 
2011 
Japan Public 
Health Centre-
based cohort 
(Japan) 
Representative 
sample from many 
regions 
M/F 40-69 133323: 2553 
stroke, 684 CHD 
cases 
Validated 138-item FFQ. Method similar 
to AOAC 
(Prosky et al., 
1985) 
CVD I00-I99. Stroke confirmed 
with National Survey Stroke 
criteria. CHD, symptoms plus 
ECG or cardiac enzyme 
abnormalities 
10.4years 
Larsson et al., 
2009 
The ATBC study 
(Finland) 
Male smokers 
recruited into RCT 
M 50-69 29133: 2381 fatal 
+non-fatal stroke 
cases  
Validated 276 item FFQ 
referring to diet over 
previous year. 
Englyst Stroke, 8th 430-434 and 436, 9th 
430-431, 433-434, 436. 10th 
I60, I61, I63-I64. Excluding 8th 
431.01 and 431.91 and 9th 
4330X, 4331X, 4339X, 4349X  
13.6 years 
Liu et al., 2002 The Women’s 
Health Study 
(US) 
Health professionals 
in RCT for aspirin 
and Vitamin E 
supplementation 
F Mean 54 39876: 570 CVD and 
171 MI cases 
Validated semi-
quantitative 131-item FFQ. 
AOAC CVD: MI, stroke, PTCA, CABG. 
IHD defined using WHO criteria 
for symptoms plus ECG 
changes or cardiac enzyme 
changes 
6 years 
Mozaffarian et 
al., 2003 
Cardiovascular 
Health Study 
(US) 
Randomly selected 
older participants 
from communities 
M/F >65 5201: 811 fatal and 
non-fatal CHD cases 
Validated 99 item FFQ 
referring to diet over 
previous year. 
AOAC CHD: ICD codes not reported  8.6 years 
Oh et al., 2005 Nurses’ Health 
Study (US) 
Health professionals 
free of CHD at 
baseline 
F 30-55 121700: 1020 cases 
of stroke 
61 and 116 item FFQs. Diet 
assessed 4 times between 
1980-94. 
AOAC Stroke classified according to 
(Walker et al., 1981) and 
excluding infection, trauma or 
malignancy 
18 years 
* Park et al., 
2011 
NIH-AARP Diet 
and Health 
Study (US) 
Representative 
sample from many 
US states 
M/F 50-71 388122: 7665 CVD 
deaths 
124 item FFQ. Intake over 
prior 12 months. 
AOAC CVD 10th I00-I78 9 years 
Pietinen et al., 
1996 
The ATBC Study 
(Finland) 
Male smokers 
recruited into RCT 
M 50-69 29133: 1399 fatal 
and non fatal CHD 
events 
Validated 276 item FFQ 
referring to diet over 
previous year. 
Englyst CHD 9th 410-414 6.1 years 
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Reference Cohort name 
(Country) 
Population 
characteristics/ 
notes 
Sex Age at 
baseline 
years 
Initial cohort size: 
and case numbers 
Dietary assessment Fibre 
estimation 
method 
Outcome definition by ICD 
codes † 
Follow up 
duration 
(loss) 
Rimm et al., 
1996 
Health 
Professionals’ 
Follow-up study 
(US) 
Male health 
professionals free of 
CHD at baseline 
M 40-75 51529: 740 CHD 
events 
Validated 131 item FFQ 
referring to diet over 
previous year. 
AOAC MI defined using WHO criteria. 
IDC codes used to define CHD 
were not reported 
6 years (6% 
loss) 
Streppel et al., 
2008 
Zutphen Elderly 
Study (The 
Netherlands) 
Random sample of 
men from industrial 
town in Netherlands 
M Mean 49 1373: 348 fatal CHD 
events 
Diet history, several times. 
Intake over prior 6 to 12 
months. 
AOAC CHD 9th 410-414 40 years 
(0.2% loss 
to follow-
up) 
Todd et al., 
1999 
Scottish Heart 
Health Study 
(Scotland) 
Recruited via GP 
surgeries in 
Scotland 
M/F 40-59 11629: 292 male 
and 97 female CHD 
cases                                                               
Validated 60-item semi-
quantitative FFQ. 
Englyst and 
Southgate 
CHD 9th  410-414 9 years 
(0.1% loss 
to follow-
up) 
* Wallstrom et 
al., 2012 
Malmo Diet and 
Cancer Cohort 
(Sweden) 
Adults living around 
Malmo identified 
from national 
registries 
M/F 58 28098: 1764 
ischaemic CVD 
cases, 743 strokes 
Interview based diet 
history method. 
Non-starch 
polysaccharide 
Ischaemic CVD 10th I20-I25, I63, 
I64/ 9th 410-414, 434, 436. 
Ischaemic CHD 10th I20-I25/ 
9th 410-414. Ischaemic stroke 
10th I63, I64/ 9th  434, 436 
13 years  
* Ward et al., 
2012 
EPIC-Norfolk 
(England) 
Recruited via GP 
registers 
M/F 40-79 25639: 2151 CHD 
cases 
FFQ and 7-day diaries. Englyst CHD 9th 410-414/ 10th I20-I25 11 years 
Wolk et al., 
1999 
Nurses’ Health 
Study (US) 
Health professionals 
free of CHD at 
baseline 
F 30-55 121700: 591 CHD 
cases 
Validated 116 item FFQ. 
Diet assessed at least 3 
times. 
AOAC ICD codes used to define CHD 
were not detailed 
10 years 
(20% loss) 
Key: *Identified during update search; † International Classification of Disease Codes, 8
th
 and 9
th
 versions start with a number, 10
th
 edition codes start with the letter ‘I’.  
Abbreviations: AOAC Association of Official Analytical Chemists; CABG coronary artery bypass graft; CHD coronary heart disease; CVD cardiovascular disease;  ECG electro-cardio 
graph; EPIC European Prospective Investigation into Cancer and Nutrition; F female; FFQ food frequency questionnaire; GP general practitioner; IHD ischaemic heart disease; M 
male; MI myocardial infarction; PTCA percutaneous transluminal coronary angioplasty; RCT randomised controlled trial; US United States; WHO world health organisation. 
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2.4.2 Meta-analyses and comparison across similar studies 
In total, ten publications reported total circulatory or CVD events (Akbaraly et al., 2011, Baer et 
al., 2011, Bazzano et al., 2003, Buyken et al., 2010, Chuang et al., 2012, Eshak et al., 2010, 
Kokubo et al., 2011, Liu et al., 2002a, Park et al., 2011, Wallstrom et al., 2012), sixteen 
reported coronary events (Appleby et al., 1999, Bazzano et al., 2003, Bernstein et al., 2011, 
Crowe et al., 2012, Eshak et al., 2010, Kaushik et al., 2009, Kokubo et al., 2011, Liu et al., 
2002a, Mozaffarian et al., 2003, Pietinen et al., 1996, Rimm et al., 1996, Streppel et al., 2008, 
Todd et al., 1999, Wallstrom et al., 2012, Ward et al., 2012, Wolk et al., 1999), and eight cohort 
studies were indentified reporting stroke events (Ascherio et al., 1998, Bazzano et al., 2003, 
Eshak et al., 2010, Kaushik et al., 2009, Kokubo et al., 2011, Larsson et al., 2009, Oh et al., 
2005, Wallstrom et al., 2012). Individual study results are detailed in Appendix IV. 
Individual study and combined estimates are displayed on forest plots (e.g. Figure 2.3a). The 
black squares and horizontal lines display individual study risk estimates and 95% CIs around 
the estimate. The area of the black boxes reflects the contributing weight of each study to the 
summary estimate and loosely reflects study size. The weight contribution of each study is 
related to the inverse of the variance (standard error) (Juni et al., 2008) and as larger studies 
tend to have smaller variance, larger studies are represented by larger squares. The combined 
estimate is represented with a diamond shape, with the left and right extremes showing the 
95% CIs. 
The cubic spline figures (e.g. Figure 2.3b) display dose-response associations. Marks on the x-
axis indicate category mean fibre intakes reported from each study, so it is possible to see 
where, throughout the intake range, evidence is greatest and that data become sparse at 
lower and higher levels. The line of best fit indicates a summary estimate for risk along the 
range of intakes with 95% CIs. CIs meet the line of best fit at a point of no uncertainty, where 
the RR=1. This is the reference intake that was set according to the mean fibre intake reported 
in included studies.   
Since data are sparse at lower and higher intakes, it is important not to extrapolate risk 
associations outside normal or plausible intake ranges and not to over interpret non-linearity 
of lines where the spread of data points and CIs widen. For the reasons discussed above, spline 
graphs remain mainly informative for displaying general patterns rather than indicating risk at 
specific intake levels. 
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Total dietary fibre 
Total fibre and CVD: Nine publications reported total CVD risk and total dietary fibre intake 
and all were included in the dose-response meta-analysis (Liu et al., 2002a, Bazzano et al., 
2003, Buyken et al., 2010, Chuang et al., 2012, Eshak et al., 2010, Akbaraly et al., 2011, Kokubo 
et al., 2011, Park et al., 2011, Wallstrom et al., 2012). Different criteria were employed by each 
study to classify CVD cases. Five studies included any circulatory condition (equivalent to the 
International Classification of Disease (ICD) codes 10th Edition I00-I99) (Buyken et al., 2010, 
Chuang et al., 2012, Eshak et al., 2010, Akbaraly et al., 2011, Kokubo et al., 2011) and four 
studies used narrower definitions (Liu et al., 2002a, Buyken et al., 2010, Park et al., 2011, 
Wallstrom et al., 2012).  
The summary RR per 7g/day increase in total fibre was 0.91 (95% CI: 0.88 to 0.94) with some 
evidence of heterogeneity between studies I2=51% (95% CI: 0 to 77%) (Figure 2.3a). The dose-
risk association for total fibre intake and CVD is displayed in Figure 2.3b where it appears that 
event risk steadily reduces with increasing total fibre intake.  
Total fibre and CHD: Eleven of fourteen publications reporting coronary event risk and total 
fibre intake were included in the dose-response meta-analysis (Pietinen et al., 1996, Rimm et 
al., 1996, Wolk et al., 1999, Liu et al., 2002a, Bazzano et al., 2003, Mozaffarian et al., 2003, 
Streppel et al., 2008, Eshak et al., 2010, Kokubo et al., 2011, Crowe et al., 2012, Wallstrom et 
al., 2012). Results concerning fatal and non-fatal events from the Norfolk arm of the EPIC study 
(Ward et al., 2012) were not included as fatal cases were additionally included in another 
publication (Crowe et al., 2012). The Scottish Heart Health Study could not be included as only 
data for fibre density were reported and it was not possible to quantify intakes in each quartile 
(Todd et al., 1999). Results from the Oxford Vegetarian Study (Appleby et al., 1999) were also 
not included in the meta-analysis as participants from this cohort had been invited to 
participate in the Oxford branch of the EPIC study (Davey et al., 2003), which formed part of 
another included cohort (Chuang et al., 2012).  
The combined risk estimate per 7g/day increase in fibre was 0.90 (95% CI: 0.87 to 0.94) and 
there was moderate evidence of heterogeneity between studies, I2=38% (95% CI: 0 to 70%) 
Figure 2.3c. The dose-risk figure shows CHD risk steadily decreased with greater total fibre 
intake but CIs around the estimate widened towards the upper intake levels, where data are 
sparse, so interpretation of risk at these higher intakes should be undertaken cautiously 
(Figure 2.3d). 
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Total fibre and all stroke: Seven studies reported total dietary fibre intake in relation to 
stroke risk, all of which were included in the dose-response meta-analysis (Figure 2.3e) 
(Ascherio et al., 1998, Bazzano et al., 2003, Eshak et al., 2010, Kokubo et al., 2011, Larsson et 
al., 2009, Oh et al., 2005, Wallstrom et al., 2012). The combined RR per 7g/day increase was 
0.93 (95% CI: 0.88 to 0.98) and there was some evidence of heterogeneity between studies 
I2=59% (95% CI: 7 to 82%). Stroke risk appeared to steadily reduce with increasing total fibre 
intake (Figure 2.3f). Data points became especially sparse above 25g/day and so extrapolation 
of risk at higher intakes should be undertaken with caution.  
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 a. total fibre intake and total CVD b. total fibre intake and total CVD 
  
 
c. total fibre intake and CHD d. total fibre intake and CHD 
  
e. total fibre intake and stroke f. total fibre intake and stroke 
  
Figure 2.3 Forest plots and restricted cubic spline figures for total fibre intake and CVD, CHD 
and stroke 
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Total fibre and haemorrhagic or ischaemic stroke: Four cohorts reported results for total 
fibre intake and ischaemic stroke and three for haemorrhagic stroke (Table 2.3). Risk of 
intracerebral haemorrhagic stroke was significantly reduced with greater fibre intake in 
Japanese women (Kokubo et al., 2011), but this significance did not remain across the trend or 
for haemorrhagic stroke in the other two cohorts reporting this outcome (Larsson et al., 2009, 
Oh et al., 2005).  
Case numbers for ischaemic stroke or cerebral infarction were greater than for haemorrhagic 
events and a significant risk reduction was observed with greater fibre intake, again in 
Japanese women (Kokubo et al., 2011), and also Swedish men (Wallstrom et al., 2012) but not 
in either the Nurses’ Health Study or the ATBC study (Oh et al., 2005, Larsson et al., 2009). 
Table 2.3 Total fibre intake and stroke risk by stroke subtype 
Cohort  Fibre intake/ 
comparison 
Outcomes measured Cases Relative Risk (95% 
Confidence Interval) 
p-trend 
Japan public 
health centre-
based cohort 
(Kokubo et al., 
2011) 
M: 19.9 vs.6.0 
F:21.6 vs. 7.8 
g/day 
Cerebral infarction 910 
518 
Male:0.94 (0.66, 1.34) 
Female: 0.73 (0.55, 0.97) 
0.540 
0.029 
Subarachnoid 
haemorrhage 
133 
226 
Male:1.02 (0.45, 2.54) 
Female: 0.72 (0.37, 1.43) 
0.672 
0.419 
Intracerebral 
haemorrhage 
456 
310 
Male:1.08 (0.66, 1.78) 
Female: 0.53 (0.28, 0.97) 
0.588 
0.100 
Alpha- 
Tocopherol 
Beta- Carotene 
Study (Larsson 
et al., 2009) 
35.8 vs. 16.1 
g/day 
Cerebral infarction 2702 Male: 1.01 (0.85, 1.19) 0.83 
Subarachnoid 
haemorrhage 
196 Male: 0.86 (0.47, 1.59) 0.49 
Intracerebral 
haemorrhage 
383 Male: 0.97 (0.61, 1.54) 0.63 
Nurses’ Health 
Study (Oh et 
al., 2005) 
21 vs.10g/day Ischaemic stroke 515 Female: 0.78 (0.56, 1.09) 0.09 
Haemorrhagic stroke 279 Female: 0.84 (0.54, 1.30) 0.34 
Malmo diet 
and cancer 
cohort 
(Wallstrom et 
al., 2012) 
M:11.4 vs. 5.8 
F:12.9 vs. 6.5 
g/1000kcal 
Ischaemic stroke 397 
346 
Male: 0.69 (0.49, 0.96) 
Female: 0.73 (0.52, 1.04) 
0.05 
0.18 
Key: M=male, F=female 
Insoluble fibre 
Insoluble fibre and CVD: Three studies reported water-insoluble fibre and risk of total CVD 
(Eshak et al., 2010, Kokubo et al., 2011, Liu et al., 2002a). Meta-analysis of results was not 
possible as one study did not report details of insoluble fibre intake (Kokubo et al., 2011). A 
protective association was observed in both Japanese cohorts (Eshak et al., 2010, Kokubo et 
al., 2011) but not in the American Women’s Health Study (Liu et al., 2002a). 
Insoluble fibre and CHD: Five publications reported incident CHD risk and insoluble fibre 
intake and four were included in the meta-analysis (Pietinen et al., 1996, Rimm et al., 1996, Liu 
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et al., 2002a, Eshak et al., 2010). Results from the Japan Public Health Centre-Based Cohort 
were not included in the meta-analysis because no estimate of insoluble fibre intake was 
presented (Kokubo et al., 2011). 
The summary estimate per 7g/day increase in insoluble type fibre was 0.78 (95% CI: 0.62 to 
0.97) and evidence of heterogeneity was reasonably high, I2=79% (95% CI: 44 to 92%) (Figure 
2.4a). From the spline graph (Figure 2.4b) it is possible to see CHD risk gradually decrease with 
increasing intakes of insoluble fibre. It is important to note that data across the range of 
intakes are sparse and are provided only by four studies.  
Insoluble fibre and stroke: Three cohorts reported stroke risk and insoluble fibre (Eshak et al., 
2010, Kokubo et al., 2011, Larsson et al., 2009) but a meta-analysis could not be conducted as 
one paper did not provide an estimate for insoluble fibre intake in the sample (Kokubo et al., 
2011). Significant risk reduction was observed for total stroke, cerebral infarction and 
intracerebral haemorrhage in Japanese women in one study (results for men not presented in 
paper) (Kokubo et al., 2011) but this was not observed for total stroke risk in either men or 
women in another Japanese cohort (Eshak et al., 2010). Non-significant results were also seen 
in the participants of the Finnish ATBC study for ischaemic and haemorrhagic stroke (Larsson 
et al., 2009).  
Soluble fibre 
Soluble fibre and CVD: Two Japanese and two American studies reported risk estimates for 
water-soluble fibre and total CVD. One study from each country observed protective 
associations with greater soluble fibre intake (Bazzano et al., 2003, Kokubo et al., 2011) but the 
other studies did not (Eshak et al., 2010, Liu et al., 2002a).   
Soluble fibre and CHD: Six cohorts reported incident CHD risk and soluble fibre intake, five of 
these were included in the meta-analysis (Pietinen et al., 1996, Rimm et al., 1996, Liu et al., 
2002a, Bazzano et al., 2003, Eshak et al., 2010). Results from the Japan Public Health Centre-
Based Cohort were not included in the meta-analysis because no estimate of soluble fibre 
intake was presented (Kokubo et al., 2011). 
The combined risk estimate per 4g/day increase in soluble type fibre was 0.88 (95% CI: 0.75 to 
1.04) and evidence of heterogeneity was moderate, I2=57% (95% CI: 0 to 84%) (Figure 2.4c). 
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Figure 2.4d illustrates a trend for decreasing CHD risk with increasing soluble fibre intake but 
CIs around the estimate remain wide across intake levels as data are thinly spread. 
Soluble fibre and stroke: Four studies presented stroke risk in relation to soluble fibre intake 
(Bazzano et al., 2003, Eshak et al., 2010, Kokubo et al., 2011, Larsson et al., 2009) and all but 
one, which did not present an estimate of soluble fibre intake (Kokubo et al., 2011), were 
included in the meta-analysis (Figure 2.4e).  
For each 4g/day increase in soluble fibre, risk was reduced by 6%: RR 0.94 (95% CI: 0.88 to 
1.01). Evidence of heterogeneity between studies was relatively low, I2=21% (95% CI: 0 to 92%) 
but since the summary estimate was based on only three studies, it should be interpreted with 
care. The study that could not be included did not observe significant risk reduction in total 
stroke or sub-types of stroke with soluble fibre intake and only reported results in women 
(Kokubo et al., 2011). 
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a. Insoluble fibre intake and CHD b. Insoluble fibre intake and CHD 
 
 
 
c. Soluble fibre intake and CHD d. Soluble fibre intake and CHD 
  
e. Soluble fibre intake and stroke  
 
 
Figure 2.4 Forest plots and restricted cubic spline figures for insoluble and soluble fibre 
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Cereal fibre 
Cereal fibre and CVD: Three American studies, the pooled EPIC study and one Australian 
cohort reported total CVD risk and cereal fibre intake. Greater intake was significantly 
associated with risk reduction in three of the studies (Baer et al., 2011, Park et al., 2011, 
Chuang et al., 2012) and not in the others (Buyken et al., 2010, Liu et al., 2002a).  
Cereal fibre and CHD: CHD risk in relation to cereal fibre intake was reported in 11 
publications. Eight were included in the meta-analysis (Pietinen et al., 1996, Rimm et al., 1996, 
Liu et al., 2002a, Mozaffarian et al., 2003, Streppel et al., 2008, Eshak et al., 2010, Bernstein et 
al., 2011, Crowe et al., 2012). Results from the EPIC Norfolk study (Ward et al., 2012) were not 
included as this cohort was included in the pooled EPIC estimate (Crowe et al., 2012). Two 
results from the Nurses’ Health study were identified and the results from Bernstein et 
al.(Bernstein et al., 2011) were included over Wolk et al. (Wolk et al., 1999) because of longer 
follow-up. Results from the Australian Blue Mountain Eye Study were not included because 
data presented were insufficient to derive a dose-response trend (Kaushik et al., 2009).  
The combined estimate per 7g/day increase in fibre from cereal sources was 0.83 (95% CI: 0.74 
to 0.93) and evidence of heterogeneity between studies was high, I2=68% (95% CI: 33 to 85%) 
(Figure 2.5a). The dose-response curve (Figure 2.5b) illustrates that CHD risk continues to fall 
with increasing intakes of fibre from cereals, although data are concentrated around lower 
intake levels so less weight should be placed on risk estimates at higher intakes.  
Cereal fibre and stroke: Three cohorts reported stroke risk and cereal fibre intake (Kaushik et 
al., 2009, Larsson et al., 2009, Oh et al., 2005). When combined, heterogeneity between 
studies was very high I2=90% (95% CI: 73 to 96%) and a summary estimate is therefore not 
presented since this would be unreliable (Figure 2.5c). The Nurses’ Health Study reported 
significant risk reduction for total and haemorrhagic, but not ischaemic stroke (Oh et al., 2005) 
and the Australian cohort also reported a significant risk reduction for total stroke with greater 
cereal fibre intake (Kaushik et al., 2009). No significant association was seen in the ATBC study 
(Larsson et al., 2009). 
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Figure 2.5 Forest plots and restricted cubic spline figures for cereal fibre 
 
Vegetable fibre  
Vegetable fibre and CVD: No significantly protective association was observed in three of the 
four cohorts reporting total CVD risk and vegetable fibre intake (Buyken et al., 2010, Liu et al., 
2002a, Park et al., 2011). However, an inverse association for vegetable fibre and circulatory 
death disease was reported in the EPIC heart study, which included data pooled from 10 
European countries (Chuang et al., 2012).  
Vegetable fibre and CHD: Eight of nine publications that reported vegetable fibre intake and 
CHD risk were included in the meta-analysis (Pietinen et al., 1996, Rimm et al., 1996, Wolk et 
al., 1999, Liu et al., 2002a, Mozaffarian et al., 2003, Streppel et al., 2008, Eshak et al., 2010, 
Crowe et al., 2012), again the result from EPIC Norfolk was not included here (Ward et al., 
2012).  
a. Cereal fibre intake and CHD b. Cereal fibre intake and CHD 
  
 
c. Cereal fibre intake and stroke  
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The summary estimate per 4g/day increase in fibre from vegetable sources was 0.94 (95% CI: 
0.89 to 1.00) and there was no evidence of heterogeneity between studies, I2=0% (95% CI: 0 to 
41%) (Figure 2.6a). CHD risk decreases with increasing intakes of vegetable fibre up to intakes 
around 6g/day, where the risk reduction appears to levels out, but again, data become sparse 
at upper intakes (Figure 2.6b).  
Vegetable fibre and stroke: Stroke risk was reported in association with vegetable fibre in the 
ATBC study and also the American Nurses’ Health Study. No significant associations were 
reported from the Nurses’ Health Study for either total, haemorrhagic or ischaemic stroke (Oh 
et al., 2005). In the ATBC study, vegetable fibre only was associated with ischaemic stroke risk 
reduction and not haemorrhagic stroke (Larsson et al., 2009). 
Fruit fibre 
Fruit fibre and CVD: Four studies reported total CVD risk and fruit fibre intake. A significant 
CVD risk reduction was observed only in the male participants of the Australian Blue Mountain 
Eye Study (Buyken et al., 2010). No significant association was reported in the Women’s Health 
Study, the NIH-AARP diet and health study or the EPIC heart study (Liu et al., 2002a, Park et al., 
2011, Chuang et al., 2012).  
Fruit fibre and CHD: Eight of nine publications that reported fibre intake from fruit and CHD 
risk were included in the meta-analysis (Pietinen et al., 1996, Rimm et al., 1996, Wolk et al., 
1999, Liu et al., 2002a, Mozaffarian et al., 2003, Streppel et al., 2008, Eshak et al., 2010, Crowe 
et al., 2012). The results reported in the EPIC Norfolk paper were again not included as 
discussed earlier (Ward et al., 2012).  
The combined risk estimate per 4g/day increase in fibre from fruit was 0.91 (95% CI: 0.82 to 
1.02) and evidence of heterogeneity between studies was high, I2=67% (95% CI: 30 to 84%) 
(Figure 2.6c). Similar to the dose-risk curve for vegetable fibre (Figure 2.6b), with fruit fibre 
(Figure 2.6d) there is some evidence that risk reduction continues with intakes of up to around 
4 or 5g/day and there is some evidence of a possible threshold effect where the line flattens 
over higher intakes. As with vegetable fibre, data are sparse at upper intake levels.  
Fruit fibre and stroke: Stroke risk was reported in association with fruit fibre in the ATBC 
study and also the Nurses’ Health Study but no significant associations were reported in either 
(Oh et al., 2005, Larsson et al., 2009). 
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a. Vegetable fibre intake and CHD b. Vegetable fibre intake and CHD 
  
c. Fruit fibre intake and CHD d. Fruit fibre intake and CHD 
  
Figure 2.6 Forest plots and restricted cubic spline figures for fruit and vegetable fibre 
 
Other sources of fibre 
Too few studies reported results for fibre fractions or from other sources to permit meta-
analysis but findings from the Finnish cohort study of male smokers suggest a possible 
protective association for cellulose and lignin intake for fatal CHD risk; however this 
association was not evident when non-fatal myocardial infarction events were combined with 
the fatal CHD cases (Pietinen et al., 1996).  
The EPIC-Heart study did not see a protective association for ‘other fibre’ (non cereal, 
vegetable or fruit-derived) (Crowe et al., 2012), nor did the Zutphen Elderly Study which 
examined both long-term and recent legume and potato fibre intake (Streppel et al., 2008). An 
American study however did see a protective association for legume fibre in women but not 
men for fatal CVD risk (Park et al., 2011). 
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Meta-regression 
Meta-regression was conducted to explore possible heterogeneity created by differing study 
characteristics or through adjustment for different confounding variables (Table 2.4). These 
results should be considered more exploratory than confirmatory because of the smaller 
numbers of studies combined to give risk estimates and also because of the increased 
potential for finding false positives, by chance, through multiple testing.  
Gender: 
There was no evidence of significant heterogeneity between subgroups of studies when results 
were combined for those reporting in males, females or mixed-gender (p>0.05). There was 
however, suggestion that fibre was protectively associated with all three outcomes in males 
and fibre also appeared to be protectively associated with CHD risk reduction in the two 
studies reporting results for women RR 0.84 (95% CI: 0.72 to 0.97). 
Method used to assess fibre intake: 
For total CVD and stroke outcomes, risk estimates were similar for studies estimating fibre as 
NSP and those estimating fibre as NSP plus resistant starch and lignin (AOAC method). For 
CHD, the protective association for fibre appeared stronger when calculated using the AOAC 
method, RR 0.90 (95% CI: 0.84 to 0.96) although the combined estimate for the two studies 
estimating fibre as NSP was also indicative of a protective association, with CIs just stretching 
to the line of no effect, RR 0.95 (95% CI: 0.90 to 1.00).   
Fatal or total events: 
Reporting fatal events only or incidence data marginally influenced risk estimates for total CVD 
and CHD but the combined study estimates remained indicative of a significant protective 
association. Only one study reported fatal stroke risk and greater fibre intake did not appear to 
be significantly associated with risk, RR 0.89 (95% CI: 0.73 to 1.10). This observation was in 
contrast to the combined estimate for the studies reporting stroke incidence data, RR 0.93 
(95% CI: 0.88 to 0.98). 
Length of follow-up: 
Studies were divided based on follow-up duration being shorter or longer than 10 years.  There 
was no marked difference in results using this criterion and there was no evidence of 
significant heterogeneity between studies when grouped in this way. 
69 
 
 
 
Geographic location: 
For CVD and CHD risk, significant protective associations were reported for greater fibre intake 
in studies conducted in the US, Europe or other parts of the world. For stroke risk, the 
combined estimate for the two European studies indicated very high heterogeneity and 
therefore an unreliable not-significant estimate, RR 0.94 (95% CI: 0.81 to 1.08) I2=82%. Stroke 
risk however was significantly lower with greater fibre intake in the studies conducted both in 
the US, RR 0.91 (95% CI: 0.83 to 1.00) or other parts of the world RR 0.90 (95% CI: 0.82 to 
0.99). 
Adjustment for confounding factors: 
Almost all studies included adjustments for age, anthropometry, gender (where appropriate), 
smoking, physical activity and energy intake so it is not possible to explore study results based 
on adjustment for these factors.  
Two studies reporting CVD events did not adjust for alcohol intake and the combined result for 
these two differed from the main result for CVD and was not significant because of wide CIs, 
RR 0.89 (95% CI: 0.69 to 1.14). Removing these two study results did not change the overall 
summary estimate for CVD events.  
The majority of studies did not include adjustment for family history of CVD. One study 
reporting CVD events and that had included adjustment for family history, reported a non-
significant inverse association but removing this result did not impact the overall summary 
estimate. Three studies reporting CHD included adjustment for family history of CVD and the 
summary estimate indicated a stronger inverse association RR 0.83 (95% CI: 0.76 to 0.90) 
compared to those studies not including this adjustment RR 0.93 (95% CI: 0.90 to 0.96), 
although both estimates were statistically significant and the within subgroup heterogeneity 
was low for both combined values. There was evidence of heterogeneity (p=0.02) between the 
subgroup combined estimates for CHD risk. 
Two studies presenting stroke outcome data had included adjustment for parental myocardial 
infarction. The combined risk estimate for these indicated a stronger inverse association RR 
0.86 (95% CI: 0.78 to 0.95) than those studies not adjusting for family history, where the risk 
estimate was weaker and CIs reached the line of no effect RR 0.95 (95% CI: 0.90 to 1.00).  
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Table 2.4 Study subgroup combined risk estimates for total fibre intake and CVD, CHD and stroke 
Subgroup of studies  CVD CHD Stroke 
Subgroup RR (95% CI) I
2
 n Phet* Phet† RR (95% CI) I
2
 n Phet* Phet† RR (95% CI) I
2
 n Phet* Phet† 
subjects' gender  Male 0.91 (0.89, 0.92) 0% 5 0.8 0.2 0.90 (0.84, 0.96) 53% 5 0.07 0.6 0.91 (0.83, 1.00) 75% 4 0.07 0.8 
Mixed 0.86 (0.73, 1.02) 73% 3 0.03 0.92 (0.87, 0.98)  33% 4 0.2 0.97 (0.92, 1.02) 0% 2 0.4 
Female 0.90 (0.77, 1.04)                   1  0.84 (0.72, 0.97) 0% 2 0.7 0.88 (0.77, 1.01)  1  
gender in same study  Male 0.91 (0.89, 0.92) 0% 5 0.8 0.9 0.90 (0.84, 0.96) 53% 5 0.07 0.3 0.91 (0.83, 1.00) 75% 4 0.07 0.6 
Female 0.90 (0.77, 1.04)                   1  0.84 (0.72, 0.97) 0% 2 0.7 0.88 (0.77, 1.01)  1  
method used to 
assess fibre  
AOAC 0.91 (0.88, 0.94)      60% 7 0.02 1 0.88 (0.83, 0.93)  45% 9 0.07 0.2 0.92 (0.87, 0.97) 26% 5 0.2 0.5 
not AOAC  0.89 (0.75, 1.06)                   14% 2 0.3 0.95 (0.90, 1.00)  0% 2 0.09 0.94 (0.81, 1.08) 82% 2 0.2 
includes non-fatal 
events (incidence) 
No 0.89 (0.82, 0.95) 36% 4 0.2 0.6 0.85 (0.75, 0.96)  71% 2 0.3 0.3 0.89 (0.73, 1.10)  1  0.8 
Yes 0.91 (0.88, 0.95)       46% 5 0.1 0.91 (0.88, 0.95)  36% 9 0.1 0.93 (0.88, 0.98) 65% 6 0.01 
length of follow-up <10 years  0.91 (0.89, 0.92) 0% 2 0.9 0.2 0.89 (0.82, 0.97) 57% 4 0.07 0.9 0.84 (0.73, 0.97)  1  0.4 
≥10 years  0.90 (0.86, 0.95)      55% 7 0.04 0.91 (0.87, 0.96)  30% 7 0.2 0.94 (0.89, 0.99) 56% 6 0.05 
geographic location  US 0.93 (0.89, 0.96) 75% 3 0.02 0.7 0.89 (0.82, 0.96)  58% 5 0.05 0.4 0.91 (0.83, 1.00) 56% 3 0.1 0.6 
EU 0.89 (0.85, 0.94)      40% 3 0.4 0.93 (0.89, 0.97)  37% 4 0.5 0.94 (0.81, 1.08) 82% 2 0.2 
Other 0.88 (0.80, 0.95)      32% 3 0.2 0.80 (0.68, 0.92) 0% 2 0.6 0.90 (0.82, 0.99) 0% 2 0.9 
adjusted for age Yes 0.91 (0.88, 0.94)      51% 9 0.04  0.90 (0.87, 0.94)  38% 11 0.1  0.93 (0.88, 0.98) 59% 7 0.06  
No              
adjusted for alcohol Yes 0.91 (0.88, 0.94)      60% 7 0.02 0.9 0.90 (0.87, 0.94)  38% 11 0.1  0.93 (0.88, 0.98) 59% 7 0.06  
No 0.89 (0.69, 1.14)      24% 2 0.2         
adjusted for 
anthropometry 
Yes  0.91 (0.88, 0.94)      51% 9 0.04  0.90 (0.86, 0.94)  44% 10 0.06 0.7 0.93 (0.88, 0.98) 59% 7 0.06  
No     0.93 (0.82, 1.05)   1      
adjusted for energy 
intake 
Yes  0.91 (0.88, 0.94)      51% 9 0.04  0.90 (0.87, 0.94)  38% 11 0.1  0.93 (0.88, 0.98) 59% 7 0.06  
No             
adjusted for family 
history 
Yes 0.90 (0.77, 1.04)  1  0.9 0.83 (0.76, 0.90)  0% 3 0.9 0.02 0.86 (0.78, 0.95) ‡ 0% 2 0.7 0.2 
No 0.91 (0.88, 0.94)      58% 8 0.02 0.93 (0.90, 0.96)  10% 8 0.4 0.95 (0.90, 1.00) 56% 5 0.06 
adjusted for physical 
activity 
Yes 0.91 (0.88, 0.94)      58% 8 0.02 0.6 0.91 (0.87, 0.95)  41% 10 0.08 0.7 0.93 (0.88, 0.98) 59% 7 0.06  
No 0.94 (0.82, 1.08)                   1  0.88 (0.78, 0.99)  1      
adjusted for gender Yes 0.91 (0.88, 0.94)      51% 9 0.04  0.90 (0.87, 0.94)  38% 11 0.1  0.93 (0.88, 0.98) 59% 7 0.06  
No             
adjusted for smoking Yes 0.91 (0.88, 0.94)      51% 9 0.04  0.90 (0.87, 0.94)  38% 11 0.1  0.93 (0.88, 0.98) 59% 7 0.06  
No             
P het* Heterogeneity within each subgroup; P het† Heterogeneity between each subgroup; ‡Adjustment for parental history of myocardial infarction in both cases  
Abbreviations: AOAC Association of Official Analytical Chemists; CI confidence intervals; EU European Union; n Number of studies; RR relative risk; US united states
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2.5 Discussion 
2.5.1 Result summary 
A significant risk reduction of around 10% was seen for both CVD and CHD and a reduction of 
7% for stroke risk was identified with every additional 7g/day of total fibre consumed (Figure 
2.3). Findings are aligned with current recommendations to increase fibre intake and 
demonstrate a clinically significant risk reduction associated with an achievable increase in 
daily fibre intake. As studies included in meta-analyses mainly calculated fibre using the AOAC 
method, this increment relates to AOAC fibre. To place this in context, an additional 7g of fibre 
(AOAC) is contained within approximately one portion (70g) of wholemeal pasta plus two 
servings of fruit or vegetables (Lunn and Buttriss, 2007). 
For stroke outcomes, studies focusing on cereal, fruit or vegetable sources of fibre were too 
few or too heterogeneous to draw sound conclusions. The summary estimate for soluble fibre 
intake and stroke risk indicates an inverse association but statistical significance was not quite 
reached (Figure 2.3e). CHD risk was significantly and inversely associated with insoluble fibre 
(Figure 2.4a), vegetable fibre (Figure 2.6a) and cereal fibre intake (Figure 2.5a) but not with 
soluble fibre (Figure 2.4b) or fibre from fruit (Figure 2.6c), despite risk estimates being in the 
same direction.  
The findings here relate only to fibre consumed within, rather than extracted from, foods and 
any public health messages must therefore reflect this. It is not clear from these observations 
whether fibre consumed as an extract from certain foods may be beneficial.  
Meta-regression highlighted possible differences with studies using AOAC methods or not, to 
assess fibre intake (Table 2.4). However, the small numbers of studies using non-AOAC 
methods, the notable geographical differences between these studies and the likely 
differences between the main sources of fibre in different cohort populations somewhat limits 
the ability to draw conclusions.  
Grouping cohort results by whether family history of disease was used as an adjustment 
resulted in significant heterogeneity being seen between these studies, indicating that this 
factor influenced final risk estimates. Additionally, grouping studies based on this greatly  
reduced the within subgroup heterogeneity to 0% and 10%, indicating that this factor explains 
a degree of the heterogeneity observed in the main summary estimate for CHD risk.  
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2.5.2 Findings in context, other published reviews 
Although no previous reviews were identified that examined fibre and stroke, one review on 
whole-grains found a similar lack of published data relating to stroke risk (Flight and Clifton, 
2006). The review presented mixed findings in the few studies identified, but concluded there 
was a strong suggestion of a protective effect of whole-grain on stroke risk (Flight and Clifton, 
2006). My findings are aligned with the observation for whole-grain diets, but whole-grains 
contain many other potentially protective components aside from having a high fibre content 
(Slavin, 2004). Other protective components of whole-grains include plant stannols and sterols, 
found in oilseeds, grains, nuts and legumes, which are associated with reducing both biliary 
and dietary cholesterol absorption and also unsaturated fatty-acids, found in whole-grain 
wheat and oats which additionally contribute towards lowering cholesterol levels (Slavin, 
2003). 
The inverse associations for both CVD and CHD with total fibre intake are consistent with those 
of previous reviews (Liu et al., 2002a, Pereira et al., 2004, Mente et al., 2009, Hauner et al., 
2012, Ye et al., 2012), as discussed earlier, in the Background section of this chapter.  
Less consistent associations are apparent when considering previous findings for soluble and 
insoluble fibre or cereal, fruit and vegetable fibre with results from the present meta-analyses. 
The German dietary guidelines published in 2012 were based on a review of literature from 
over 25 years and concluded ‘possible’ evidence of an inverse association for cereal, fruit, 
soluble and insoluble fibre with CHD risk and ‘possible’ evidence of no association for 
vegetable fibre (Hauner et al., 2012). The pooled data presented by Pereira et al., found an 
inverse association for fruit but not vegetable or cereal fibre (Pereira et al., 2004) and the 
recent systematic review by Ye et al., suggests a protective association for cereal fibre but 
vegetable or fruit sources of fibre are not discussed in this publication as the focus was whole-
grain in the diet (Ye et al., 2012).  
The findings from this meta-analysis of systematically sought literature identify possible 
inverse associations for insoluble, cereal and vegetable fibre but not for soluble or fruit fibre. 
The design of this work improves somewhat upon previously published reviews concerning 
sources of fibre, which were not systematic in identifying literature (Pereira et al., 2004), did 
not statistically combine data (Hauner et al., 2012) or selectively reported outcomes (Ye et al., 
2012). 
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Just two previously conducted systematic reviews report exploration of between study 
heterogeneity. No associations were observed when considering the different mean fibre 
intakes in included cohorts in one review (Mente et al., 2009) and no significant change in 
magnitude or direction of estimates was reported in another review that examined studies 
based on sex, study quality, health status, study duration, dietary intake and outcome 
measurement, but combined study subgroup data were not reported (Ye et al., 2012). 
Published results presented in Chapter 5, relating CVD mortality risk to dietary fibre intake in 
the UKWCS (Threapleton et al., 2013b) have been included in updated versions of CVD and 
CHD meta-analyses presented in this chapter (Threapleton et al., 2013e). Extending the 
literature search period and including additional studies in this publication has made possible 
some additional meta-analyses, especially for total CVD risk. Newer risk estimates generated 
for CHD with the various exposures changed only minimally and there was no shift in result 
significance. For CVD risk and total fibre intake there was no change in the risk estimate. New 
meta-analyses for CVD with increased intake of insoluble, fruit, vegetable and cereal fibre were 
significantly associated with risk reduction. However, the combined estimate for soluble fibre 
and CVD risk was non-significant, with CIs spanning the line of no effect despite the estimate 
being in the direction of indicating a protective association (Threapleton et al., 2013e). 
2.5.3 Limitations 
Limitations for this systematic review and meta-analysis include the problem of residual 
confounding which is an issue with observational work and therefore remains a limitation 
when data are statistically combined. Greater intake of dietary fibre is associated with other 
healthy behaviour such as greater physical activity and lower smoking rates (Eshak et al., 2010, 
Kokubo et al., 2011), both of which may independently influence CVD risk. It is difficult to 
estimate the extent to which other behaviours are accurately controlled for when used as 
adjustments in models and therefore we cannot ascribe causality to the associations from 
observational without additional RCT evidence. However, given the lengthy pathogenesis of 
the disease, trials of adequate duration and compliance would be costly and virtually 
impossible to run. Yet, most of the observational studies here did include important 
confounders such as age, sex, education/class and smoking status in their analyses but not all 
adjusted for other potentially important confounders such as physical activity or other dietary 
factors. Exploration of adjustment for factors such as Body Mass Index (BMI) or alcohol intake, 
through meta-regression, did not reveal that adjustment for such confounders sufficiently 
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explained the strength or direction of associations observed, though, this was mainly because 
the majority of studies had included these as adjustments so comparisons were not possible. 
Furthermore, Kaushik et al, Wolk et al and Mozaffarian et al point out that although residual 
confounding may be a limitation for prospective cohorts, it is unlikely in their cases because 
different observations were seen for cereal, fruit and vegetable fibre, despite intakes being 
highly correlated (Wolk et al., 1999, Mozaffarian et al., 2003, Kaushik et al., 2009). In light of 
the differing associations observed, they argue that residual confounding is not likely to be an 
issue of concern since all of the fibre exposures are related to healthier lifestyles (Wolk et al., 
1999, Mozaffarian et al., 2003, Kaushik et al., 2009). Additionally, in the case of the Nurses’ 
Health Study, cereal fibre but not fibre from fruit or vegetables or total fibre was protective 
and this association was not explained by higher intakes of associated micronutrients (vitamin 
E, folate, vitamin B6, magnesium) or by vegetable or fruit intake (Wolk et al., 1999). Similarly, 
in the Cardiovascular Health Study, risk estimates were minimally modified by adjustment for 
social or lifestyle factors (Mozaffarian et al., 2003). 
Another possible limitation is that the majority of dietary data were collected using FFQs which 
may adequately characterise dietary patterns but could be limited in terms of describing 
individual nutrient intakes. One study explored risk of CHD with diet assessed both using FFQs 
and 7-day food diaries and a protective association was seen with fibre assessed from food 
diaries but risk was attenuated with fibre estimated by FFQs (Ward et al., 2012). The authors 
suggest that FFQs may not capture sufficient heterogeneity within a single population but are 
appropriate in pooled analyses where a wider range of intakes are collated.  
Studies assessing fibre intakes using different methods (AOAC or not) were combined. 
Although direct comparisons may not be appropriate between studies using different intake 
estimations, the direction of effect and to some extent the magnitude of the associations may 
be similar and combining results may therefore be informative when summarising data from 
multiple studies.  For example, in the HPFS, the protective association observed between total 
MI and total fibre intake calculated with the Southgate method (RR per 10g/day increase 0.76 
(95% CI: 0.65 to 0.88)) and the Englyst method (RR 0.74 (95% CI: 0.61 to 0.89)) were not 
substantially different from AOAC calculation (RR 0.81 (95% CI: 0.70 to 0.93)) (Rimm et al., 
1996). 
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Inconsistent results between cohorts may also result from different dietary assessment 
methods. For example, the Japanese Collaborative Cohort Study only included 40 food items 
on the FFQ and this limited list may result in difficulty when differentiating between 
consumers of high or low levels of both soluble and insoluble dietary fibre. Although the ATBC 
used a comprehensive 276-item FFQ to assess diet, the inclusion of only smokers in this study 
means findings must be interpreted with caution as results may not apply to wider populations 
since smoking may modify the effect of fibre on CVD risk. 
A further limitation in meta-analysing data is the problem of publication bias, where non-
significant results may be largely unreported, leading to higher chance of false positive 
findings. Publication bias can arise from a number of sources such as a tendency for authors to 
write up and submit positive findings to journals, a tendency for journals to favour acceptance 
of studies showing positive findings and studies with positive findings being more likely to be 
published in English than studies reporting no evidence of associations (Bowers et al., 2006b).  
2.5.4 Strengths 
A major strength of this work is the inclusion of studies from multiple online database 
searches, covering published literature from over two decades. The prospective nature of the 
included studies also avoids issues caused by recall bias.  The included cohorts additionally 
reported on large numbers of participants, had long follow-up durations and therefore many 
case observations. 
The quality of the meta-analyses was strengthened by generating dose-response curves rather 
than comparisons of high and low fibre consumers. Combining studies that examined dietary 
sources of fibre is an additional strength of this work as the physiological consequences of a 
high-fibre diet may depend on the type of fibre and the food source (Rimm et al., 1996).  
2.6 Summary 
Diets high in fibre, specifically from cereal or vegetable sources and rich in insoluble-type fibre 
should be recommended for prevention of cardiovascular diseases. These data provide 
evidence relating to whole-food consumption and therefore do not support consumption of 
foods specifically enriched in cereal or vegetable-derived fibre, however RCT data may provide 
insight into whole food intake compared to fibre derived from these foods on CVD risk factors. 
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The best available research evidence should inform public policy to ensure recommendations 
are rooted in knowledge (CRD, 2008). In due course, the UK SACN will issue their own 
interpretation of findings from this systematic review and will potentially make new 
recommendations or strengthen existing recommendations for England, on the basis of the 
work carried out here.  
Exploring food sources of fibre brings understanding of how different types of fibre or, foods 
containing different ratios of fibre molecules, may influence CVD risk and enables tailoring of 
nutritional recommendations for at-risk populations. In Chapters 5, 6 and 7, I build on findings 
from my systematic review to explore whether fibre intake for a relatively health-conscious 
sample of women (the UKWCS) remains protectively associated with CHD, stroke and total 
CVD risk, as observed in these meta-analyses. The findings reported in these coming chapters 
will additionally contribute to the small group of existing studies that report stroke risk in 
association with total fibre and major food sources of dietary fibre.  
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Chapter 3 Methods, the UK Women’s Cohort Study 
and dietary fibre intake 
3.1 Chapter overview 
Briefly, this chapter gives a detailed background to the UK Women’s Cohort Study. Sampling 
methods and details of dietary and lifestyle data collection are presented in addition to simple 
descriptive statistics. These dietary and lifestyle descriptive statistics are relevant to later 
chapters, where dietary fibre intake is assessed in relation to CVD mortality (Chapter 5) and 
incident CVD events (Chapters 6 and 7). This chapter does not provide details of cardiovascular 
outcome data, which is covered in depth the next chapter (Chapter 4), or details of statistical 
methods as these are presented within the methods sections of each relevant chapter (refer to 
method section of Chapters 5, 6 and 7).    
3.2 Method 
3.2.1 Study population 
Participants were primarily drawn from respondents to the World Cancer Research Fund’s 
(WCRF) direct mailing survey in the early 1990’s. The mailing respondents numbered 
approximately 500,000 (85% female) and had indicated in the survey whether they were 
vegetarian or meat-eaters. This survey had identified about 16,000 vegetarians and non-red 
meat eaters that were between the study inclusion ages (35-69 years) and had also indicated 
that they were willing to participate in further research. 
These 16,000 vegetarian and non-red meat eating women formed the basis for the cohort and 
recruitment was further boosted to include meat-eaters from the same list. Additional 
participants were recruited into the cohort from respondents to the baseline questionnaires 
who were asked to identify friends and relatives of a similar age who were meat-eaters or 
vegetarian (Cade et al., 2004a).  Figure 3.1 details recruitment of participants and the 
proportion of respondents to each of the two contact phases. 
Baseline data were collected between 1995 and 1998 and 35,692 of 61,000 (58%) women 
responded to the questionnaires. Participants completed a self-administered FFQs and also 
provided further dietary, lifestyle and health information at baseline.  
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Figure 3.1 Recruitment of UKWCS participants 
 
Around five years after baseline data were collected, the participants were asked to complete 
a four day food and one day exercise diary and again to provide updated health and lifestyle 
information.  Over 14,000 women responded to this contact and of these, 12,625 returned 
completed food diaries (35% of baseline participants). All women that returned questionnaires 
and diaries were eligible for inclusion in follow-up of the cohort study.  
Women that provided accurate General Practitioner (GP) information or National Health 
Service (NHS) identification numbers at baseline (>98% of the full cohort) were successfully 
flagged through the Office of National Statistics (ONS), now NHS Information Centre (NHSIC) 
for health outcome episodes or death registration. Details of outcome event data are 
presented in Chapter 4. 
The UKWCS population is not representative of British women, nor was it designed to be. The 
inclusion of high proportions of vegetarians and non-red meat eaters was intended to optimise 
power for exploration of foods such as fruit, vegetables and other related nutrients to disease. 
The motivation being that diet within a single, more representative, population may be too 
homogeneous to be able to detect effects of different dietary intakes (Cade et al., 2004a). 
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Participants are generally white (99%), middle class (63% professional or managerial), well 
educated (27% had degree), and married with children (86%) (Cade et al., 2004a). 
3.2.2 Dietary assessment: Food Frequency Questionnaire 
The FFQ sent to participants at study baseline included a list of 217 commonly consumed food 
items. Participants were asked to indicate their intake of each item over the previous 12 
months by ticking an appropriate consumption category (from 10 choices) such as ‘once per 
day’ or ‘2-4 times per week’ (Figure 3.2). 
Figure 3.2 Example section of baseline FFQ form 
The FFQ was developed from that used in the Oxford arm of the EPIC study (Riboli and Kaaks, 
1997) with modifications based on a pilot study, which was undertaken in a sample of 
vegetarian women (Cade et al., 2004a). Additional vegetable-based composite dishes were 
added to the FFQ based on food diaries completed during this pilot study and information 
relating to portion size estimates used for FFQ nutrient calculations were also contributed by 
this pilot. Nutrient intakes were calculated by multiplying each food item by the consumption 
frequency and estimated portion size. Portion sizes were an average calculated from three 
sources where the information was available (Calvert et al., 1997); 1) the pilot study food 
diaries; 2) food portion sizes for women from the NDNS (NDNS, 1994); 3) other published 
values (Crawley, 1993). 
FFQ nutrient values were originally generated using data from McCance & Widdowson’s The 
Composition of Foods (5th edition) (Holland et al., 1991). A mean value was created from 
multiple food items from The Composition of Foods for each FFQ row, to take account of type 
or preparation and cooking methods of different foods and dishes. In the FFQ, a number of 
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fruit items were under the heading ‘seasonal’ and participants were asked to mark the 
consumption of these foods when they were seasonally available. The number of months 
these items were available was taken into account when nutrient intakes were calculated. 
Daily NSP values were generated for the total diet and also from key food sources (detailed 
below). Fibre intake was also calculated using the AOAC method. British nutrient tables do not 
include AOAC values for all foods and so to estimate AOAC fibre intake from the FFQ, AOAC 
estimates were sought from a number of sources. The following order of preference for 
sources of AOAC data was applied, and values in brackets indicate the proportion of data 
ultimately identified from each source: British reference values (7%) (Holland et al., 1991); a 
review article (12%) (Lunn and Buttriss, 2007); European databases (11%) (EuroFIR, 2010); 
United States Department of Agriculture databank (46%) (USDA, 2010); food packaging labels 
(18%); in-house recipe calculation (6%). A similar approach was taken to estimate soluble or 
insoluble dietary fibre intake from the FFQ where these values were missing in The 
Composition of Foods.  
AOAC fibre, soluble and insoluble fibre values were estimated for each FFQ item by another 
doctoral student, Maryam Aldwairji, and values were manually input into the existing 
Microsoft Access nutrient database for the cohort. For accuracy, I cross checked each food 
item and new values to ensure all nutrients and food items were correctly matched to those 
used for FFQ items. 
FFQ calculations for fibre from food sources 
The original FFQ data for participants was converted into a Microsoft Access format and this 
has permitted the derivation of fibre from different food sources. Note that throughout this 
work, the terms, for example, ‘fruit fibre’, ‘fibre from fruit’ and ‘fibre in fruit’ are used 
interchangeably to identify fibre which is contributed to the diet by fruit. Since this work 
focuses on consumption of whole foods rather than extracted constituents, the terms and thus 
any findings relate only to fibre which is consumed within the whole food.  
I grouped FFQ items to generate dietary fibre (NSP) from the following specific food groups 
(see Appendix V for details of which FFQ items were combined to form each food group): 
 Total cereal foods 
 Breakfast cereals 
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 Fruit (excluding juice) 
 Vegetables (excluding potatoes) 
 Legumes 
 Nuts and seeds 
Correlation of baseline FFQ fibre intakes, by type 
Fibre intake assessed as either NSP or using the AOAC method were highly correlated 0.99 
(95% CI: 0.99 to 0.99) (Figure 3.3). Fibre density of the diet (g/1000kcal/day) was generated for 
both NSP and AOAC fibre, using the total energy intake that was estimated from the FFQ. 
Correlation between the density values for both methods of fibre estimation was also high at 
0.97 (Table 3.1).  
Soluble and insoluble fibre intakes were highly correlated with each other (0.91). Fibre from 
the various food sources were generally not so highly correlated, except fibre from breakfast 
cereals and total cereal intake (0.71), which is to be expected since breakfast cereals are 
included within the total cereal category. For example, fruit fibre and fibre from cereal foods 
were not highly correlated, 0.19 (95% CI: 0.18 to 0.20), as can be seen in Figure 3.4. 
Table 3.1 Correlation between fibre types and sources of fibre assessed using FFQ 
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NSP 1            
AOAC 0.99 1           
NSP Density 0.61 0.56 1          
AOAC Density 0.61 0.60 0.97 1         
Soluble fibre 0.95 0.96 0.51 0.56 1        
Insoluble fibre 0.98 0.98 0.62 0.64 0.91 1       
Cereal fibre 0.72 0.68 0.45 0.41 0.51 0.78 1      
Breakfast cereal fibre 0.46 0.44 0.37 0.36 0.34 0.55 0.71 1     
Vegetable fibre 0.64 0.62 0.48 0.47 0.69 0.58 0.17 0.07 1    
Fruit fibre 0.62 0.66 0.46 0.54 0.68 0.60 0.19 0.11 0.37 1   
Legume fibre 0.44 0.45 0.27 0.29 0.48 0.40 0.17 0.05 0.23 0.14 1  
Nuts/Seed fibre 0.25 0.26 0.08 0.09 0.24 0.24 0.06 0.01 0.13 0.16 0.11 1 
Based on 35,262 observations, after excluding energy intake values outside the range 500-
6000 kcal/day. 
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Figure 3.3 Correlation between NSP and AOAC fibre, estimated from FFQ 
 
Figure 3.4 Correlation between NSP intake from fruit and cereal foods, estimated from FFQ 
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Characteristics of low and high fibre consumers as estimated from FFQ 
I divided the sample into 5 equal-sized groups, based on NSP intake and NSP density and 
descriptive characteristics are presented in Table 3.2 and Table 3.3, respectively. Age increases 
and BMI decreases in each increasing NSP or NSP density category. The lowest NSP consumers 
(14.1g/day) had a median age of 50.5 years (interquartile range (IQR) 14.5) compared to the 
highest NSP consumers (38.6g/day) where the median age was 51.3 years (IQR 14.9). 
The proportions of participants reporting history of hypertension or angina at baseline were 
similar across the groups, with 16% reporting history of hypertension and 2% reporting history 
of angina in the total sample.  
The proportion of smokers, women with lower NS-SEC rankings and lower educational 
achievement were greatest in the lowest NSP or NSP density categories compared to the other 
four categories, among which the differences were not so apparent.  
Physical activity levels were greater in women consuming highest levels of NSP, 17.0 vs. 12.2 
Metabolic Equivalent of Task (MET) in the lowest NSP intake category. The large apparent 
difference in activity level is reduced once energy intake is taken into consideration, when 
looking at NSP density quintiles (Table 3.3). However greater activity levels are still reported 
with the highest NSP density intake. 
Across the quintiles of NSP intake, greater intakes of carbohydrate, fat and protein were 
observed, likely due to the greater energy intakes in the higher NSP consumers (Table 3.2). 
When energy intake is accounted for, it becomes clear that those with the higher NSP density 
reportedly consume fewer calories than the lower NSP density groups (Table 3.3). In the higher 
NSP density groups, where total energy intake is lower, it appears that a greater proportion of 
the diet is made up of carbohydrate rather than fat, as compared with lower NSP density 
groups. The greater proportion of vegetarian participants in the higher NSP density group 
(35%) compared to the lowest NSP density group (7%) may explain some of the dietary 
macronutrient differences across groups. 
The proportional contribution of fibre from different food groups to the total NSP intake, in 
the full sample of participants and NSP intake quintiles, is shown in Figure 3.5. Other sources 
of fibre, aside from cereals, fruit, vegetables, legumes and nuts/seeds are likely to include fibre 
from potatoes and also from mixed dishes, where it was not possible to determine the 
84 
 
 
 
contribution of separate foods groups. A notably larger proportion of NSP is provided by 
‘other’ fibre in the lowest NSP quintile (35%), compared to the highest NSP quintile (17%). The 
proportion of NSP from vegetables and legumes is comparable across the groups at around 
21% and 5%, respectively. NSP from fruit and cereal sources contributed less towards the total 
NSP intake in the lowest intake group, compared to the categories of higher NSP intake. 
 Table 3.2 Characteristics of all participants, groups based on total NSP intake (FFQ) 
 Q1 Q2 Q3 Q4 Q5 All 
N 6925 6929 6950 6944 6821 34569 
NSP, g/day 14.1 (3.9) 19.5 (2.3) 24.0 (2.4) 29.3 (3.1) 38.6 (8.5) 23.9 (12.5) 
NSP density, g/1000kcal/day 8.2 (2.9) 9.9 (3.0) 11.0 (3.2) 12.1 (3.4) 13.8 (3.8) 11.0 (4.2) 
AOAC fibre, g/day 21.9 (6.1) 30.1 (3.9) 36.8 (4.3) 44.7 (5.4) 59.1(13.7) 36.8 (18.9) 
AOAC density, g/1000kcal/day 12.8 (4.2) 15.4 (4.4) 16.9 (4.7) 18.6 (4.9) 21.0 (5.7) 16.9 (6.2) 
Fibre 
types or 
sources, 
g/day 
Soluble 6.5 (1.9) 8.8 (1.6) 10.5 (1.9) 12.5 (2.2) 16.3 (4.4) 10.4 (5.1) 
Insoluble  8.4 (2.7) 12.2 (2.0) 15.4 (2.1) 19.1 (2.6) 25.7 (6.1) 15.4 (8.9) 
Cereal 3.4 (2.6) 5.8 (3.70 8.0 (4.5) 10.5 (5.6) 14.3 (7.6) 7.6 (7.1) 
Breakfast cereal 0.4 (1.4) 1.4 (3.0) 2.1 (3.4) 3.2 (5.0) 4.0 (5.9) 1.8 (3.7) 
Fruit 2.1 (2.1) 3.4 (2.5) 4.2 (2.9) 5.3 (3.60 7.6 (5.9) 4.2 (3.9) 
Vegetables 3.0 (2.0) 4.2 (2.4) 5.1 (2.8) 6.0 (3.4) 8.0 (4.9) 4.9 (3.7) 
Legumes 0.6 (0.9) 0.9 (0.9) 1.1 (1.1) 1.3 (1.5) 1.9 (2.6) 1.1 (1.3) 
Nuts/seeds 0.07(0.17) 0.08(0.20) 0.08(0.24) 0.15(0.34) 0.24(0.62) 0.08 (0.29) 
Age, years 50.5(14.5) 50.8(14.8) 51.2(14.8) 51.1(14.9) 51.3(14.9) 51.0 (14.8) 
BMI, kg/m
2
 24.0 (5.2) 23.8 (4.7) 23.7 (4.7) 23.4 (4.6) 23.2 (4.4) 23.7 (4.8) 
Hypertension at 
baseline (%) 
Yes 1165 (17) 1159 (17) 1093 (16) 1122 (16) 1113 (16) 5652 (16) 
No 5760 (83) 5770 (83) 5857(84) 5822 (84) 5708 (84) 28917 (84) 
Angina at 
baseline (%) 
Yes 136 (2) 119 (2) 132 (2) 141 (2) 176 (3) 695 (2) 
No 6789 (98) 6810 (98) 6827 (98) 6803 (98) 6645 (97) 33874 (98) 
Smoking 
status (%) 
Never smoker 3598 (53) 3931 (58) 4100 (60) 4073 (60) 4070 (61) 19772 (59) 
Current smoker 1194 (17) 779 (11) 623 (9) 538 (8) 501 (8) 3635 (11) 
Former smoker 1964 (29) 2068 (31) 2063 (30) 2137 (32) 2059 (31) 10291 (31) 
Diet group 
(%) 
Meat-eaters 5426 (78) 4932 (71) 4634 (67) 4011 (58) 3323 (49) 22326 (65) 
Poultry-eaters 147 (2) 163 (2) 191 (3) 215 (3) 267 (4) 983 (3) 
Fish-eaters 467 (7) 694 (10) 857 (12) 1056 (15) 1308 (19) 4382 (13) 
Vegetarian 885 (13) 1140 (16) 1268 (18) 1662 (24) 1923 (28) 6878 (20) 
Socio-
economic 
status  
NS-SEC (%) 
Professional/ 
managerial 
4092 (61) 4189 (62) 4297 (63) 4371 (64) 4414 (66) 21363 (63) 
Intermediate 1984 (29) 1933 (28) 1903 (28) 1824 (27) 1693 (25) 9337 (28) 
Routine and 
manual 
679 (10) 678 (10) 605 (9) 594 (9) 570 (9) 3126 (9) 
Highest 
educational 
achieve-
ment (%) 
No formal 
record 
1244 (20) 1044 (17) 997 (16) 901 (15) 1001 (16) 5187 (17) 
O-level 2075 (34) 1945 (32) 1968 (32) 1857 (30) 1809 (30) 9654 (31) 
A-level 1371 (22) 1511 (24) 1567 (25) 1630 (26) 1528 (25) 7606 (25) 
Degree 1467 (24) 1672 (27) 1712 (27) 1815 (29) 1746 (29) 8412 (27) 
Menopause 
status (%) 
Post 2436 (37) 2418 (36) 2524 (38) 2494 (38) 2538 (39) 12410 (37) 
Pre 2654 (40) 2771 (41) 2669 (40) 2691 (40) 2562 (39) 13347 (40) 
NA † 1553 (23) 1509 (23) 1500 (22) 1463 (22) 1428 (22) 7453 (22) 
Ethanol, g/day 5.4 (12.9) 5.5 (12.2) 5.6 (11.4) 5.3 (11.0) 4.7 (10.5) 5.3 (11.5) 
Physical activity, MET-hrs/wk 12.2(12.3) 13.7(12.3) 14.4(12.6) 15.2(12.8) 17.0(14.7) 14.5 (13.2) 
Energy intake, kcal/day 1636(578) 1949(581) 2177(631) 2412(679) 2882(878) 2189 (864) 
Carbohydrate intake, g/day 211 (76) 260 (73) 295 (79) 335 (83) 416 (116) 299 (127) 
Protein intake, g/day 68 (26) 79 (26) 87 (29) 94 (30) 110 (36) 86 (34) 
Fat intake, g/day 64 (31) 74 (33) 80 (35) 87 (39) 99 (46) 80 (39) 
Saturated fat intake, g/day 23 (14) 26 (15) 27 (15) 28 (16) 31 (18) 27 (16) 
Values are median (interquartile range) or frequency (percent) 
† Pregnant, taking the contraceptive pill or hormone replacement therapy 
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a: Q1, mean NSP intake 14.1 (SD 3.9) g/day  b: Q2, mean NSP intake 19.5 (SD 2.3) g/day 
  
c: Q3, mean NSP intake 24.1 (SD 2.4) g/day d: Q4, mean NSP intake 29.3 (SD 3.1) g/day 
  
e: Q5, mean NSP intake 38.6 (SD 8.5) g/day f: All participants, mean NSP intake 23.9 (SD 12.5) g/d 
  
 
Figure 3.5 Percent contributions of food groups calculated from FFQ to total NSP intake in all 
participants and NSP intake quintiles (as presented in Table 3.2) 
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Table 3.3 Characteristics of all participants, groups based on NSP density of the diet (FFQ) 
 Q1 Q2 Q3 Q4 Q5 All 
N 6923 6924 6913 6918 6891 34569 
NSP, g/day 16.4 (7.5) 21.0 (8.4) 24.4 (9.3) 27.7(11.0) 32.8(13.5) 23.9(12.5) 
NSP density, g/1000kcal/day 7.4 (1.5) 9.4 (0.8) 11.0 (0.8) 12.7 (1.0) 15.4 (2.3) 11.0 (4.2) 
AOAC fibre, g/day 26.0(12.3) 32.6(13.3) 37.4(14.9) 42.0(16.7) 49.2(20.9) 36.8(18.9) 
AOAC density,  g/1000kcal/day 11.7 (2.2) 14.6 (1.5) 16.9 (1.6) 19.4 (1.8) 23.4 (3.7) 16.9 (6.2) 
Fibre 
types or 
sources, 
g/day 
Soluble 7.8 (3.6) 9.5 (3.8) 10.5 (4.2) 11.6 (4.7) 13.4 (5.9) 10.4 (5.1) 
Insoluble  9.8 (5.1) 13.1 (5.8) 15.7 (6.6) 18.1 (7.5) 21.7 (9.4) 15.4 (8.9) 
Cereal 4.4 (3.5) 6.4 (5.0) 8.1 (6.2) 9.7 (6.9) 11.5 (7.9) 7.6 (7.1) 
Breakfast cereal 0.6 (1.6) 1.6 (3.0) 2.1 (3.5) 3.0 (4.8) 3.6 (6.7) 1.8 (3.7) 
Fruit 2.4 (2.4) 3.6 (2.8) 4.3 (3.3) 5.2 (4.0) 6.6 (5.7) 4.2 (3.9) 
Vegetables 3.4 (2.3) 4.4 (2.9) 5.1 (3.3) 5.7 (3.7) 7.1 (4.9) 4.9 (3.7) 
Legumes 0.8 (0.9) 1.0 (1.0) 1.1 (1.2) 1.2 (1.5) 1.5 (2.5) 1.1 (1.3) 
Nuts/seeds 0.07(0.18) 0.08(0.24) 0.11(0.29) 0.13(0.35) 0.12(0.36) 0.08(0.29) 
Age, years 50.6(15.2) 50.7(15.1) 50.7(14.4) 51.3(14.6) 51.7(14.3) 51.0(14.8) 
BMI, kg/m
2
 24.1 (5.2) 23.8 (4.7) 23.6 (4.7) 23.5 (4.5) 23.2 (4.3) 23.7 (4.8) 
Hypertension at 
baseline (%) 
Yes 1191 (17) 1139 (16) 1097 (16) 1154 (17) 1071 (16) 5652 (16) 
No 5732 (83) 5785 (84) 5816 (84) 5764 (83) 5820 (84) 28917(84) 
Angina at 
baseline (%) 
Yes 118 (2) 141 (2) 142(2) 126 (2) 168 (2) 695 (20) 
No 6805 (98) 6783 (98) 6771 (98) 6792 (98) 6723 (98) 33874(98) 
Smoking 
status (%) 
Never smoker 3761 (56) 4048 (60) 3992 (59) 4024 (60) 3947 (59) 19772(59) 
Current smoker 1185 (18) 740 (11) 672 (10) 544 (8) 494 (7) 3635 (11) 
Former smoker 1805 (27) 1969 (29) 2095 (31) 2175 (32) 2247 (34) 10291(31) 
Diet group 
(%) 
Meat-eaters 6075 (88) 5181 (75) 4527 (65) 3794 (55) 2749 (40) 22326(65) 
Poultry-eaters 90 (1) 164 (2) 183 (3) 224 (3) 322 (5) 983 (3) 
Fish-eaters 289 (4) 642 (9) 886 (13) 1160 (17) 1405 (20) 4382 (13) 
Vegetarian 469 (7) 937 (14) 1317 (19) 1740 (25) 2415 (35) 6878 (20) 
Socio-
economic 
status  
NS-SEC (%) 
Professional/ 
managerial 
3849 (57) 4195 (62) 4415 (65) 4492 (66) 4412 (65) 21363(63) 
Intermediate 2109 (31) 1953 (29) 1752 (26) 1744 (26) 1779 (26) 9337 (28) 
Routine and 
manual 
809 (12) 642 (9) 598 (9) 526 (8) 551 (8) 3126 (9) 
Highest 
educational 
achieve-
ment (%) 
No formal 
record 
1238 (20) 1024 (17) 942 (15) 912 (15) 1071 (17) 5187 (17) 
O-level 2143 (35) 1913 (31) 1850 (30) 1889 (30) 1859 (30) 9654 (31) 
A-level 1387 (23) 1540 (25) 1557 (25) 1583 (26) 1539 (25) 7606 (25) 
Degree 1371 (22) 1722 (28) 1841 (30) 1817 (29) 1661 (27) 8412 (27) 
Menopause 
status (%) 
Post 2462 (37) 2427 (36) 2383 (36) 2491 (37) 2647 (40) 12410(37) 
Pre 2681 (40) 2742 (41) 2804 (42) 2636 (40) 2484 (38) 13347(40) 
NA † 1497 (23) 1488 (22) 1485 (22) 1534 (23) 1449 (22) 7453 (22) 
Ethanol, g/day 5.0 (11.6) 5.9 (12.0) 6.0 (11.8) 5.4 (11.3) 4.0 (10.9) 5.3 (11.5) 
Physical activity, MET-hrs/wk 13.8(13.7) 14.4(13.1) 14.5(13.4) 14.5(13.1) 15.0(13.0) 14.5(13.2) 
Energy intake, kcal/day 2275(951) 2227(867) 2209(848) 2162(847) 2077(817) 2189(864) 
Carbohydrate intake, g/day 288 (131) 293 (121) 300 (122) 303 (126) 311 (131) 299 (127) 
Protein intake, g/day 89 (35) 88 (34) 87 (35) 85 (33) 82 (34) 86 (34) 
Fat intake, g/day 93 (45) 86 (39) 82 (37) 76 (35) 65 (32) 80 (39) 
Saturated fat intake, g/day 35 (19) 31 (16) 28 (14) 24 (12) 19 (11) 27 (16) 
Values are median (interquartile range) or frequency (percent) 
† Pregnant, taking the contraceptive pill or hormone replacement therapy 
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Exploring linear dose-response associations with CVD for each fibre exposure 
Incremental units were derived for each of the various fibre intake exposures to be used for 
modelling linear dose-response associations with CVD risk (full statistical methods are detailed 
in Chapters 5, 6 and 7). The exposure increments to be used were generated to reflect intakes 
reported within the cohort sample (Table 3.4). For each exposure, the sample was divided into 
five approximately equal groups based on intake level and median intakes were calculated 
within each group. The mean difference between these median values was then used in linear 
dose-response models to provide a realistic increment for that exposure. The mean difference 
between the fifths was rounded to the nearest gram, where practical, for ease of 
interpretation.  
Taking total NSP intake as an example, the mean difference between each median value, when 
divided into 5 categories was 6.05g/day. Linear dose-response models using NSP estimates 
from the FFQ will therefore use an increment of 6g/day rather than simply using 1g/day. This 
will reflect a realistic increase in NSP intake within the sample and mean results may be more 
easily interpreted. 
 Table 3.4 Median intakes and mean difference between categories for different dietary 
exposures estimated from the FFQ 
Exposure Median intake in each fifth (Interquartile 
range) 
Mean 
difference 
between Qs 
Continuous 
increment for 
model Q1 Q2 Q3 Q4 Q5 
NSP, g/day 14.1 
(3.9) 
19.4 
(2.3) 
23.8 
(2.3) 
29.1 
(3.1) 
38.3 
(8.6) 
6.05 6 
AOAC, g/day 21.0 
(5.9) 
30.0 
(3.4) 
36.8 
(3.5) 
44.8 
(4.8) 
63.0 
(13.5) 
10.5 11 
NSP density, 
g/1000kcal/day 
7.4 
(1.5) 
9.4 
(0.8) 
11.0 
(0.8) 
12.7 
(1.0) 
15.4 
(2.3) 
2.0 2 
AOAC density, 
g/1000kcal/day 
11.3 
(2.1) 
14.6 
(1.2) 
16.9 
(1.1) 
19.4 
(1.4) 
24.3 
(3.6) 
3.25 3 
Soluble fibre, g/day 6.4 
(1.6) 
8.6 
(0.9) 
10.4 
(0.9) 
12.5 
(1.2) 
16.4 
(3.8) 
2.5 3 
Insoluble fibre, g/day 8.4 
(2.6) 
12.4 
(1.6) 
15.3 
(1.6) 
19.1 
(2.2) 
25.6 
(6.0) 
4.3 4 
Fibre 
from 
food 
sources, 
g/day 
Cereals 2.8 
(1.4) 
5.1 
(1.1) 
7.6 
(1.4) 
10.7 
(1.8) 
15.7 
(4.5) 
3.23 3 
Breakfast 
cereals 
0.05 
(0.14) 
0.5 
(0.4) 
1.8 
(0.7) 
3.5 
(0.7) 
7.6 
(2.6) 
1.89 2 
Fruit 1.4 
(0.9) 
2.9 
(0.7) 
4.2 
(0.7) 
5.8 
(1.1) 
9.5 
(4.1) 
2.03 2 
Vegetables 2.3 
(0.9) 
3.7 
(0.6) 
4.9 
(0.7) 
6.6 
(1.0) 
9.5 
(3.0) 
1.8 2 
Legumes 0.2 
(0.2) 
0.65 
(0.20) 
1.11 
(0.18) 
1.66 
(0.39) 
3.6 
(1.4) 
0.85 1 
Nuts/seeds 0 
(0.01) 
0.06 
(0.01) 
0.08 
(0.05) 
0.27 
(0.13) 
0.85 
(0.91) 
0.21 0.2 
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3.2.3 Dietary assessment: Food Diary 
Four-day weighed food diaries were collected from 12,625 respondents to the follow-up phase 
(1999-2004). Participants were asked to list all food and drinks and estimate the weight of 
items or weigh foods, where possible. Diary nutrient intakes were calculated using an in-house 
package which was developed at the University of Leeds, Nutritional Epidemiology Group. This 
package ‘DANTE’ contains standard nutrient values from McCance & Widdowson’s The 
Composition of Foods (5th edition) (Holland et al., 1991) and also supplemental data from 
manufacturers and recipe information. The software allows coders to search for foods and 
provides information on standard servings or portions sizes, so this can be selected when it is 
absent from the diary. The package also allows coders to examine nutrient information for all 
foods so that closely matching items may be substituted if any foods recorded in the diary do 
not match existing items in the software. All recipe information provided by participants was 
carefully used to calculate the exact serving proportion and coders took care to select the 
appropriate cooking methods for foods, where relevant. 
Because coding diaries is very labour intensive, only a fraction of the 12,625 available diaries 
could be coded within the scope of this project. Diary selection and statistical methods relating 
to analysis of food diary data are presented in depth within Chapter 7, which focuses entirely 
on diet assessed using food diaries and CVD risk in the UKWCS. 
Characteristics of responders to follow-up data collection 
Descriptive characteristics, collected at baseline, for responders and non-responders to the 
second phase of contact are presented in Table 3.5. Responders are classified as those 
providing both valid lifestyle information and a completed four day food diary (n= 12,625).  
Characteristics of responders to the phase 2 contact appear largely similar in comparison to 
non-responders. Responders were marginally older (0.4 years older), had slightly lower BMI 
(0.5 units), higher energy intake (46 kcal/day) and higher physical activity (0.6 MET-
hours/week). A greater proportion of the non-responders were current smokers, meat-eaters 
and had lower educational achievement however these differences in proportions between 
responders and non-responders were not large.   
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Table 3.5 Baseline characteristics of participants that provided complete dietary and lifestyle 
information at phase 2, follow-up. 
 Baseline participant 
not responding at 
phase 2 
Baseline 
participant 
responding at  
phase 2 
All baseline 
participants† 
N 23121 12625 35746 
Age, years 50.9 (15.2) 51.3 (14.0) 51.0 (14.8) 
BMI, kg/m
2
 23.8 (4.9) 23.3 (4.4) 23.7 (4.8) 
Energy intake, kcal/day 2174 (879) 2220 (848) 2191 (870) 
Physical activity, MET-hours/week 14.2 (13.5) 14.8 (12.6) 14.4 (13.2) 
NSP intake g/day 23.4 (12.4) 25.1 (12.7) 24.0 (12.5) 
NSP density g/1000kcal/day 10.8 (4.3) 11.3 (4.2) 11.0 (4.2) 
Smoking status 
(%) 
Never smoked 12232 (57) 7558 (63) 19790 (59) 
Current smoker 2676 (12) 964 (8) 3640 (11) 
Ex-smoker 6725 (31) 3571 (30) 10296 (31) 
Diet group (%) Meat-eaters 15255 (67) 7564 (60) 22819 (65) 
Poultry-eaters 645 (3) 364 (3) 1009 (3) 
Fish-eaters 2774 (12) 1718 (14) 4492 (13) 
Vegetarian 4159 (18) 2894 (23) 7053 (20) 
Socio-economic 
status NS-SEC 
(%) 
Professional/ 
managerial 
13710 (62) 8142 (66) 21852 (63) 
Intermediate 6314 (28) 3201 (26) 9515 (28) 
Routine and manual 2210 (10) 993 (8) 3203 (9) 
Highest 
educational 
achievement 
(%) 
No formal record 3735 (19) 1455 (13) 5190 (17) 
O-level 6298 (32) 3363 (30) 9661 (31) 
A-level 4690 (24) 2921 (26) 7611 (25) 
Degree 5012 (25) 3409 (31) 8421 (27) 
Menopause 
status (%) 
Post 7931 (37) 4496 (38) 12427 (38) 
Pre 8551 (40) 4803 (40) 13354 (40) 
Not applicable‡ 4780 (22) 2677 (22) 7457 (22) 
History of 
hypertension 
(%) 
Yes 3839 (18) 1916 (16) 5755 (17) 
No 17754 (82) 10003 (84) 27577 (83) 
History of 
angina (%) 
Yes 521 (2) 197 (2) 718 (2) 
No 20383 (98) 11489 (98) 31872 (98) 
Values are median (IQR) or frequency (percent) 
† No exclusions were used and this data represents the full sample of baseline participants  
‡Pregnant, taking the contraceptive pill or hormone replacement therapy  
 
Diary data quality and cleaning  
Coders were instructed to enter food items into DANTE in the form eaten (e.g. cooked rice) but 
often participants report weight of foods before cooking. Despite the DANTE data entry 
protocol stating that foods must be entered ‘as eaten’, it is relatively common for coders to 
mistakenly enter this information incorrectly. This is especially an issue for cereals where the 
food mass can multiply four or five-fold during cooking but also concerns other foods such as 
meat where mass is lost during cooking. To help reduce the errors in coding, I designed an 
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Excel spreadsheet with conversion factors programmed in, so coders could easily enter the 
raw weight for foods and this would convert to cooked weights. Cooking conversion 
multiplication factors were sourced from The 5th Edition of The Composition of Foods (Holland 
et al., 1991).  
I was responsible for coordinating and training coders on how to use the DANTE package and 
dealt with issues relating to any food items which were difficult to code. I also implemented a 
program of cross-checking between coders to ensure a high standard of data entry and make 
sure corrections were completed for any errors in food coding. 
Food diary calculations for fibre from food sources 
It was possible to generate values for NSP from various food sources using food diary data. The 
following food sub categories, as defined in The 5th Edition of The Composition of Foods 
(Holland et al., 1991), were combined to produce fibre values for key food sources: 
1) Cereal fibre 
o Biscuits 
o Bread 
o Breakfast cereals 
o Buns and pastries 
o Cakes 
o Flours, grains and starches 
o Pasta 
o Pastry 
o Puddings 
o Rice 
o Rolls 
o Savouries 
2) Breakfast cereal fibre 
o Breakfast cereals 
3) Fruit fibre (excluding fruit juice) 
o Fruit, general 
4) Vegetable fibre (excluding potatoes and potato products) 
o Vegetables, dried 
o Vegetables, general 
o Vegetable dishes 
o Peas 
5) Legume fibre 
o Beans and lentils 
o Peas 
6) Fibre from nuts and seeds 
o Nuts and seeds 
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Correlation of food diary fibre intakes 
As expected, total NSP intake and NSP density correlate highly 0.74 (95% CI: 0.72 to 0.76) 
(Table 3.6, Figure 3.6). However, correlation between the various sources of fibre assessed 
using food diaries was relatively low and ranged from 0.28 for legume and vegetable fibre to 
almost 0 for other comparisons. The highest correlation for legume and vegetables sources of 
fibre likely exists as peas are counted within both categories. The correlation between fruit 
and vegetable fibre as assessed using food diaries was relatively low at 0.19 (95% CI: 0.72 to 
0.24) (Figure 3.7).   
Table 3.6 Correlation between total and sources of fibre assessed using food diaries 
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NSP 1        
NSP density 0.74 1       
Cereal fibre 0.67 0.46 1      
Breakfast cereal fibre 0.45 0.38 0.72 1     
Fruit fibre 0.60 0.50 0.14 0.11 1    
Vegetable fibre 0.53 0.48 0.04 -0.01 0.20 1   
Legume fibre 0.31 0.27 -0.02 -0.03 0.08 0.28 1  
Nut/ seed fibre 0.30 0.15 0.04 -0.04 0.21 0.14 0.04 1 
Based on 1,878 observations, after excluding diaries with fewer than 3 full days. 
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Figure 3.6 Correlation between NSP intake and NSP density estimated from food diaries 
 
Figure 3.7 Correlation between fruit and vegetable fibre estimated from food diaries 
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Characteristics of low and high fibre consumers as estimated from food diaries 
Of the 12,625 available food diaries, nutrients for 1,844 have so far been processed. Some 
descriptive statistics using the 1,844 diaries are presented below in addition to descriptive 
statistics for the 451 diaries which were selected and used in Chapter 7 (refer to Chapter 7 
method selection for diary selection procedure and statistical methods used to analyse data). 
Characteristics were explored in women who met the UK dietary recommendation to consume 
a minimum 18 g/day of NSP and those who did not (Table 3.7). The median NSP intake in the 
total sample of case and non-case diaries (n=451) was just under the recommended level, at 
16.9g/day (IQR 8.3). Of these 451 women, 43% reached the 18 g/day recommendation, having 
average fibre intakes of 21.6g/day (IQR 5.6) compared to the 57% that did not reach the 
recommended intake, where the median intake was 13.3g/day (IQR 4.8). 
Median BMI was marginally greater in the lower consumers 23.8 Kg/m2 (IQR 4.4) compared to 
23.4 Kg/m2 (IQR 3.9) in high NSP consumers. Markedly lower energy intake was reported in 
lower fibre consumers 1679 kcal/day (IQR 557) compared to higher consumers 1904 kcal/day 
(IQR 456), though this may simply reflect under-reporting. Differing activity levels may also 
explain the BMI and energy intake differences as higher NSP consumers reported greater levels 
of vigorous activity and lower levels of moderate activity.  
Age was also only marginally different in the two groups with the lower fibre intake group 
being slightly older (53.8 years) than the high fibre group (53.2 years). As expected, a greater 
proportion of the high fibre group were vegetarian. 
Education and socio-economic profiles and saturated fatty acid intake were not widely 
different between the two groups and the relative proportion of women in each group with 
history of hypertension was similar. 
The relative proportion of NSP intake from various food groups to the total intake is presented 
in Figure 3.8. Cereal foods make the largest contribution to NSP intake (35%), followed by 
other foods, which includes potatoes and mixed dishes (22%), vegetables (20%) and fruit 
(17%). These proportion contributions are remarkably similar to diet assessed using FFQs, 
where the relative contribution of each food group was: cereals 32%, fruit 18%, vegetables 
21%, legumes 5%, nuts/seeds 0.4% and other sources 25% (Figure 3.5). 
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Figure 3.8 Percent contributions of food groups calculated from food diary to total NSP 
intake (as presented in Table 3.7) 
 
When the sample was divided into categories based on NSP intake (Table 3.8) or NSP density 
(Table 3.9) patterns of characteristics across increasing intake groups were apparent. Energy 
intake increased with each NSP intake category from a median of 1556kcal/day (IQR 490) in Q1 
to 2050kcal/day (IQR 538) in Q5. With the greater energy intake, ever greater carbohydrate, 
protein and fat intakes were also reported, although the level of saturated fat intake across 
the groups remained relatively constant around the median sample value of 22.3g/day.  
When energy intake was accounted for (Table 3.9), these differences in macronutrient intakes 
were less apparent with protein and carbohydrate intakes being similar, although intake of 
total fat and saturated fat were lower in the greater NSP density groups. Energy intakes were 
similar across the NSP density categories except the highest group where the median energy 
intake was 1531 (IQR 656) compared to the sample median 1778 (IQR 563). 
In contrast to the categories which were made for NSP assessed from FFQs, there was little 
difference in median age or BMI in the NSP or NSP density categories calculated from food 
diaries.  
Fewer women reported high activity levels, high educational achievement and a higher 
proportion of women were classed in the lower NS-SEC category in women with lower NSP 
intakes as compared to women with greater NSP intakes.  
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Table 3.7 Characteristics of all case and sub-cohort participants who meet the UK dietary NSP 
recommended intake level, as assessed using food diaries  
 NSP intake 
under 18g/day 
NSP intake ≥ 
18g/day 
All diaries 
N 258 193 451 
Food and 
nutrient 
intake from 
phase 2 
diary, g/day 
NSP  13.3 (4.8) 21.6 (5.6) 16.9 (8.3) 
NSP density g/1000kcal/day 7.9 (3.1) 11.7 (3.7) 9.5 (4.5) 
Ethanol  5.7 (15.8) 4.2 (13.5) 4.8 (14.9) 
Protein  65.3 (21.2) 72.8 (23.5) 69.1 (21.6) 
Total fat  61.1 (33.3) 68.6 (30.8) 63.9 (33.1) 
Carbohydrate  201.4 (70.1) 249.6 (65.3) 223.1 (79.4) 
Saturated fat  22.5 (14.6) 22.0 (12.2) 22.3 (13.6) 
Cereal NSP 4.7 (3.6) 8.7 (5.7) 5.9 (5.1) 
Breakfast cereal NSP 0.5 (1.9) 2.3 (5.1) 1 (3.3) 
Fruit NSP 2.2 (2.2) 4.2 (2.5) 2.9 (2.8) 
Vegetable NSP 2.7 (2.3) 4.2 (2.9) 3.3 (2.7) 
Legume NSP 1.6 (0.4) 1.3 (1.9) 0.8 (1.9) 
Nut/Seed NSP [mean (SD)] 0.5 (1.4) 0.4 (1.0) 0.3 (0.7) 
Age at phase 2, years 53.8 (15.9) 53.2 (15.8) 53.5 (16.0) 
BMI at phase 2, kg/m
2
 23.8 (4.4) 23.4 (3.9) 23.5 (4.4) 
Energy intake at phase 2 from diary, kcal/day 1679 (557) 1904 (456) 1778 (563) 
Smoking status 
at phase 2 (%) 
Not a current smoker 229 (89) 182 (94) 411 (91) 
Current smoker 29 (11) 11 (6) 40 (9) 
Diet group at 
baseline (%) 
Meat-eaters 171 (66) 95 (49) 266 (59) 
Poultry-eaters 8 (3) 6 (3) 14 (3) 
Fish-eaters 35 (14) 28 (15) 63 (14) 
Vegetarian 44 (17) 64 (33) 108 (24) 
Socio-economic 
status NS-SEC at 
baseline (%) 
Professional/ managerial 160 (64) 136 (71) 296 (67) 
Intermediate 72 (29) 50 (26) 122 (28) 
Routine and manual 19 (8) 6 (3) 25 (6) 
Highest 
educational 
achievement at 
baseline (%) 
No formal record 40 (17) 22 (12) 62 (15) 
O-level 60 (26) 45 (25) 105 (25) 
A-level 65 (28) 46 (25) 111 (27) 
Degree 70 (30) 69 (38) 139 (33) 
Menopause 
status p2 (%) 
Post 194 (75) 131 (68) 325 (72) 
Pre 66 (25) 62 (32) 128 (28) 
History of 
hypertension at 
phase 2 (%) 
Yes 61 (25) 42 (23) 103 (24) 
No 181 (75) 139 (77) 320 (75) 
Physical 
activity at 
phase 2 
(%) 
No weekly activity 27 (11) 9 (5) 36 (9) 
Light/moderate activity 122 (51) 86 (47) 208 (49) 
Vigorous activity 1-2 
times/week 
59 (25) 46 (25) 105 (25) 
Vigorous activity ≥3 times/week 31 (13) 41 (23) 72 (17) 
Values are median (IQR) or frequency (percent) unless otherwise stated
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 Table 3.8 Characteristics of all case and sub-cohort participants, grouped based on total NSP intake, as assessed using food diaries 
 Q1 Q2 Q3 Q4 Q5 All diaries 
N 90 90 90 90 91 451 
NSP at phase 2 from diary, g/day 9.8 (2.4) 13.5 (1.7) 16.9 (1.7) 20.1 (1.8) 25.5 (5.3) 16.9 (8.3) 
NSP density at phase 2 from diary, g/1000kcal/day 5.9 (2.0) 8.4 (2.6) 9.0 (2.8) 11.0 (2.5) 12.5 (3.8) 9.5 (4.5) 
Frequency of incident MI/ acute coronary syndrome cases* 12/ 18 8/ 17 12/ 20 10/ 18 11/15 53/ 88 
Frequency of fatal IHD / stroke cases* 6/ 12 2/ 8 5/ 10 4/ 8 8/ 4 25/ 42 
Frequency of random sub-cohort diaries 59 64 60 64 67 314 
Age at phase 2, years 53.7 (17.9) 53.4 (13.7) 54.6 (17.4) 51.8 (15.2) 54.8 (17.5) 53.5 (16.0) 
BMI at phase 2, kg/m
2
 24.1 (4.1) 23.0 (3.9) 24.1 (5.0) 23.5 (4.3) 23.0 (3.6) 23.5 (4.4) 
Current smoker at phase 2 (%) 14 (16) 12 (13) 3 (3) 5 (6) 6 (7) 40 (9) 
Diet group at baseline (%) Meat-eaters 70 (78) 58 (64) 54 (60) 49 (54) 49 (54) 280 (62) 
Fish-eaters 10 (11) 13 (14) 15 (17) 10 (11) 15 (16) 63 (14) 
Vegetarian 10 (11) 19 (21) 21 (23) 31 (34) 27 (30) 108 (24) 
Socio-economic status  
NS-SEC at baseline (%) 
Professional/ managerial 48 (55) 60 (69) 62 (70) 65 (72) 61 (68) 296 (67) 
Intermediate 34 (39) 23 (26) 17 (19) 22 (24) 26 (29) 122 (28) 
Routine and manual 5 (6) 4 (5) 10 (11) 3 (3) 3 (3) 25 (6) 
Highest educational 
achievement at baseline (%) 
No formal record 19 (22) 13 (16) 9 (12) 7 (9) 14 (16) 62 (15) 
O-level 30 (35) 15 (18) 18 (23) 24 (30) 18 (20) 105 (25) 
A-level 19 (22) 24 (29) 24 (31) 20 (25) 24 (27) 111 (27) 
Degree 18 (21) 31 (38) 27 (35) 30 (37) 33 (37) 139 (33) 
Menopause status phase 2 
(%) 
Post 64 (71) 73 (80) 63 (70) 56 (62) 69 (76) 325 (72) 
Pre 26 (29) 18 (20) 27 (30) 35 (38) 22 (24) 128 (28) 
History of hypertension at 
phase 2 (%) 
Yes 26 (30) 19 (23) 20 (24) 20 (24) 18 (21) 103 (24) 
No 60 (70) 65 (77) 64 (76) 62 (76) 69 (79) 320 (75) 
Physical activity at phase 2 
(%) 
No weekly activity 13 (15) 6 (7) 9 (11) 3 (3) 5 (6) 36 (9) 
Light/moderate activity 50 (60) 41 (50) 33 (40) 43 (49) 41 (49) 208 (49) 
Vigorous activity 1-2 /week 14 (17) 22 (27) 27 (33) 21 (24) 21 (25) 105 (25) 
Vigorous 3 or more/week 7 (8) 13 (16) 14 (17) 21 (24) 17 (20) 72 (17) 
Ethanol at phase 2 from diary, g/day  7.4 (16.7) 7.3 (17.3) 4.4 (10.9) 5.0 (13.5) 2.8 (14.0) 4.8 (14.9) 
Energy intake at phase 2 from diary, kcal/day 1556 (490) 1645 (544) 1817 (517) 1844 (381) 2050 (538) 1778 (563) 
Protein intake from food diary, g/day 64.2 (23.0) 62.0 (21.3) 69.8 (21.0) 69.9 (20.3) 76.3 (22.8) 69.1 (21.6) 
Total fat intake from food diary, g/day 59.1 (31.3) 58.2 (30.4) 66.7 (35.9) 62.8 (28.4) 72.9 (27.1) 63.9 (33.1) 
Carbohydrate intake from food diary, g/day 179.1 (62.0) 197.4 (63.8) 231.1 (58.5) 235.2 (56.1) 268.6 (94.3) 223.1 (79.4) 
Saturated fat intake at phase 2 from diary, g/day 22.4 (16.1) 22.4 (13.7) 22.8 (13.6) 21.4 (12.8) 22.1 (13.6) 22.3 (13.6) 
*Case definitions are detailed in Chapter 4; Values are median (IQR) or frequency (percent), unless otherwise stated   
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Table 3.9 Characteristics of all case and sub-cohort participants, grouped based on NSP density of the diet, as assessed using food diaries 
 Q1 Q2 Q3 Q4 Q5 All diaries 
N 90 90 90 90 91 451 
NSP density at phase 2 from diary, g/1000kcal/day 5.8 (1.2) 7.8 (1.0) 9.5 (0.9) 11.2 (1.0) 14.4 (3.1) 9.5 (4.5) 
NSP at phase 2 from diary, g/day 10.3 (3.9) 15.1 (5.1) 16.3 (4.7) 20.7 (4.3) 22.3 (7.5) 16.9 (8.3) 
Frequency of incident MI/ acute coronary syndrome cases* 10/ 16 11/ 20 8/ 14 9/ 17 15/ 21 53/ 88 
Frequency of fatal IHD/ stroke cases* 5/ 10 4/ 11 2/ 9 5/ 5 9/ 7 25/ 42 
Frequency of random sub-cohort diaries 64 57 68 67 58 314 
Age at phase 2, years 53.7 (13.7) 53.6 (14.7) 52.7 (16.8) 52.2 (15.4) 53.5 (16.0) 53.5 (16.0) 
BMI at phase 2, kg/m
2
 24.1 (4.0) 24.1 (4.5) 23.6 (4.3) 23.1 (4.4) 23.2 (4.4) 23.5 (4.4) 
Current smoker at phase 2 (%) 14 (16) 10 (11) 5 (6) 5 (6) 6 (7) 40 (9) 
Diet group at baseline (%) Meat-eaters 74 (82) 62 (69) 55 (61) 45 (50) 44 (49) 280 (62) 
Fish-eaters 8 (9) 11 (120 16 (18) 17 (19) 11 (12) 63 (14) 
Vegetarian 8 (9) 17 (19) 19 (21) 28 (31) 36 (40) 108 (24) 
Socio-economic status  
NS-SEC at baseline (%) 
Professional/ managerial 46 (53) 67 (74) 61 (70) 62 (70) 60 (67) 296 (67) 
Intermediate 34 (39) 19 (21) 21 (24) 21 (24) 25 (28) 122 (28) 
Routine and manual 7 (8) 4 (4) 3 (3) 6 (7) 5 (6) 25 (6) 
Highest educational 
achievement at baseline (%) 
No formal record 19 (23) 7 (9) 9 (11) 11 (13) 16 (19) 62 (15) 
O-level 26 (31) 21 (26) 18 (21) 15 (18) 25 (29) 105 (25) 
A-level 19 (23) 20 (25) 28 (33) 20 (24) 24 (28) 111 (27) 
Degree 19 (23) 32 (40) 29 (35) 38 (45) 21 (24) 139 (33) 
Menopause status phase 2 
(%) 
Post 65 (72) 70 (77) 62 (69) 57 (63) 71 (78) 325 (72) 
Pre 25 (28) 21 (23) 28 (31) 34 (37) 20 (22) 128 (28) 
History of hypertension at 
phase 2 (%) 
Yes 23 (27) 23 (27) 15 (18) 22 (26) 20 (24) 103 (24) 
No 62 (73) 61 (73) 69 (82) 64 (74) 64 (76) 320 (75) 
Physical activity at phase 2 
(%) 
No weekly activity 10 (12) 9 (11) 8 (9) 4 (5) 5 (6) 36 (9) 
Light/moderate activity 49 (60) 39 (47) 39 (46) 39 (46) 42 (49) 208 (49) 
Vigorous activity 1-2 /wk 16 (20) 22 (27) 30 (35) 21 (25) 16 (19) 105 (25) 
Vigorous 3 or more/week 7 (9) 13 (16) 8 (9) 21 (25) 23 (27) 72 (17) 
Ethanol at phase 2 from diary, g/day  8.2 (20.3) 7.4 (16.0) 6.2 (15.7) 5.5 (15.3) 0 (4.6) 4.8 (14.9) 
Energy intake at phase 2 from diary, kcal/day 1841 (501) 1927 (627) 1748 (488) 1856 (396) 1531 (656) 1778 (563) 
Protein intake from food diary, g/day 71.7 (18.0) 69.7 (26.5) 67.8 (19.2) 70.0 (21.8) 63.5 (20.1) 69.1 (21.6) 
Total fat intake from food diary, g/day 73.9 (32.2) 73.9 (33.0) 62.9 (26.2) 61.5 (28.9) 47.1 (30.1) 63.9 (33.1) 
Carbohydrate intake from food diary, g/day 211.3 (80.1) 236.1 (82.6) 222.2 (65.0) 236.0 (55.1) 209.3 (76.3) 223.1 (79.4) 
Saturated fat intake at phase 2 from diary, g/day 28.0 (14.0) 24.9 (13.9) 23.5 (9.7) 21.0 (10.0) 16.4 (9.6) 22.3 (13.6) 
*Case definitions are detailed in Chapter 4; Values are median (IQR) or frequency (percent), unless otherwise stated
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Exploring linear dose-response associations with CVD, for each fibre exposure 
Incremental units for exploring linear, dose-response, associations between fibre exposures 
and CVD were generated using the same approach as for fibre estimated from the FFQ (Table 
3.4). In order to reflect the trajectory of intakes reported within the cohort sample, the mean 
differences between quintile median intakes were calculated. These calculations were carried 
out using all case and non-case diaries (n=451) with the only exclusion being of diaries where 
fewer than 3 full days had been completed (Table 3.10). 
Table 3.10 Median intakes and mean difference between categories for different dietary 
exposures estimated from food diaries 
Exposure Median intake in each fifth (Interquartile 
range) 
Mean 
difference 
between Qs 
Continuous 
increment 
for model Q1 Q2 Q3 Q4 Q5 
NSP, g/day 9.8 
(2.4) 
13.5 
(1.7) 
16.9 
(1.7) 
20.1 
(1.8) 
25.5 
(5.3) 
3.9 4 
NSP density, 
g/1000kcal/day 
5.8 
(1.2) 
7.8 
(1.0) 
9.5 
(0.9) 
11.2 
(1.0) 
14.4 
(3.1) 
2.2 2 
Fibre 
from 
food 
sources, 
g/day 
Cereal 2.4 
(1.3) 
4.2 
(0.9) 
5.9 
(1.20 
8.0 
(1.2) 
12.1 
(5.3) 
2.9 3 
Breakfast 
cereals† 
/ 0 
(1.1) 
1.0 
(0.5) 
2.7 
(1.2) 
6.2 
(4.7) 
2.1 2 
Fruit 0.7 
(0.8) 
1.9 
(0.4) 
2.8 
(0.6) 
4.1 
(0.6) 
6.0 
(2.0) 
1.3 1 
Vegetables 1.2 
(0.8) 
2.4 
(0.6) 
3.3 
(0.4) 
4.4 
(0.6) 
6.6 
(2.7) 
1.4 1 
Legumes† / 0 
(0.2) 
0.8 
(0.3) 
1.7 
(0.5) 
3.0 
(1.6) 
1.0 1 
Nuts/seeds
† 
/ / / 0 (0) 0.9 
(0.9) 
0.9 1 
† Categories 1, 2 and 3 include a high proportion of non-consumers so means are derived using 
comparison between fewer categories, for consumers of the specific source of fibre. 
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3.3 FFQ values compared to food diaries 
To approximately estimate the degree of difference between the average energy and fibre 
intakes as calculated by the two dietary assessment methods, intakes were compared using all 
available FFQ data plus all coded diaries to date (n=1,844). Participants with extreme calorie 
intakes (<500kcal/day or >6000kcal/day), as estimated by the FFQ, were excluded as were food 
diaries that had not been completed for at least 3 days. 
There were 35,260 participants with valid FFQ data and for the whole cohort to date and 1,844 
food diaries have so far been processed.  
Using just those women with available data from both FFQs and food diaries, the mean NSP 
intake, as estimated by food diaries, was on average 8.9g/day (SD 9.9) lower than assessed by 
FFQs (Table 3.11). The mean NSP intake from FFQs was 25.5g/day (SD 10.3) and was 17.4g/day 
(SD 6.3) from food diaries. Energy intakes were 530kcal/day (SD 739) higher with FFQs 
compared to mean energy intake estimated from food diaries. Although both fibre and energy 
values were far greater when estimated using the FFQ, the fibre density values were closer 
when methods were compared, there was a difference of 1.8 (SD 3.2) g/1000kcal/day. The 
mean fibre intake calculated as AOAC was 13.7g/day (SD 6.0) higher than mean NSP intake. 
Table 3.11 Energy and fibre intakes estimated from FFQs and food diaries 
 N Mean (SD) Min Max 
FFQ Energy intake from FFQ, kcal/day 35260 2342 (713) 510 5997 
NSP intake from FFQ, g/day 35260 25.5 (10.3) 1.8 151.9 
NSP density from FFQ, g/1000kcal/day 35260 11.3 (3.2) 1.9 32.8 
AOAC intake from FFQ, g/day 35260 39.2 (15.9) 3.7 216.6 
AOAC density from FFQ, g/1000kcal/day 35260 17.3 (4.7) 3.4 56.8 
AOAC intake minus NSP intake, g/day 35260 13.7 (6.0) -0.4 81.1 
AOAC density minus NSP density, 
g/1000kcal/day 
35260 6.1 (1.8) -0.2 28.5 
      
Diary Energy intake, kcal/day 1844 1811 (422) 607 4043 
NSP intake, g/day 1844 17.4 (6.3) 0.2 57.9 
NSP density, g/1000kcal/day 1844 9.8 (3.4) 0.3 34.7 
      
FFQ-Diary 
comparison 
NSP, FFQ minus Diary, g/day 1844 8.9 (9.9) -22.4 62.9 
NSP density, FFQ minus Diary, 
g/1000kcal/day 
1844 1.8 (3.2) -18.9 17.5 
Energy intake, FFQ minus Diary, kcal/day 
 
1844 530 (739) -1640 4306 
 
100 
 
 
 
3.4 Discussion 
3.4.1 How FFQs compare to diary methods 
The two different dietary assessment methods employed in the UKWCS have distinct strengths 
and weaknesses. The use of a FFQ has allowed dietary habits to be examined in a large sample 
of women. The tool captures an impression of usual intakes over the previous 12 months and 
so gives an estimation of long-term diet. The diary, by contrast, captures very detailed dietary 
intake and represents more of a ‘snap-shot’ within the normal variation in dietary intakes. 
Despite food diaries giving more precise estimates of intakes, they do not capture long-term 
intake unless multiple diaries are completed throughout the year. Additionally, because of 
limited resources it has not been possible to generate nutrient values for the whole cohort and 
so only a sub-sample of diaries could be processed.    
Energy and NSP intakes estimated here using both methods indicate that FFQs tend to over-
estimate intakes, assuming that food diaries are more precise and not vice versa. Greater 
energy and fibre intakes were also observed from FFQs, compared to food diaries, in other 
British cohort studies (Bingham et al., 1997, Brunner et al., 2001). Dietary assessment 
validation for the UK arm of the EPIC study and the Whitehall II study identified good 
correlation between fibre intakes estimated from FFQs and 16-day weighed records (0.57) 
(Bingham et al., 1997) or between energy adjusted intakes from FFQs and 7-day diaries (0.60) 
(Brunner et al., 2001). Agreement between quartile classification for NSP or Southgate fibre 
intake assessed with FFQs and 16-day or 7-day diaries, respectively, were also assessed and 
reported to be around 40% in both studies (Bingham et al., 1997, Brunner et al., 2001). 
Agreement between FFQs and food diaries was not explored in depth here as the two methods 
were used around 5 years apart. Any differences observed between the two methods may well 
be due to actual changes in diet over this time. Additionally, a small validation study was 
carried out in a sub-group of UKWCS participants a few years after baseline dietary assessment 
(Spence et al., 2002). FFQs and food diaries were completed by 303 participants and the 
correlation for key macronutrients assessed with the two methods was not high at around 
0.35.  
3.4.2 Fibre intakes in UKWCS compared to other study populations 
The mean NSP intake, as assessed by food diaries (n=451) was 16.9 g/day (SD 8.3) and of those 
women meeting the UK dietary recommended intake, the mean was 21.6 g/day (SD 5.6) (Table 
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3.7). Even in those participants that did not meet the recommendation, the mean intake was 
13.3 (SD 4.8) g/day, which is still greater than the mean intake in UK women estimated in 
2001, around the same time as diaries were completed for UKWCS participants. In the NDNS 
survey 2001 the mean intake in women was 12.6g/day and was slightly higher in the older 
sample of participants, 50-64 years where the mean NSP intake was 14.0g/day (Henderson et 
al., 2003).   
Average NSP intake in the UKWCS, assessed by FFQ, was around 24g/day, much higher than 
the 18g/day NSP intake found in another UK cohort, where diet was also assessed by FFQ 
(Ward et al., 2012). After accounting for the higher daily energy intake in the UKWCS 
(2342kcal) compared to EPIC Norfolk (2103kcal), the NSP density of the UKWCS, at 
11.3g/1000kcal/day was still greater than EPIC Norfolk, where I estimate NSP density as 
8.8g/1000kcal/day (Ward et al., 2012). A Finnish study of male smokers reported mean NSP 
intake closer to the UKWCS intake, at around 25g/day (Larsson et al., 2009). Mean AOAC fibre 
intake in the Nurses’ Health Study however was drastically lower than the 36g/day AOAC fibre 
intake observed here at around 15g/day (Oh et al., 2005). Focusing on NSP estimated from 
food diaries, the EPIC Norfolk study again reported lower intakes at 15.4g/day (SD 5.5) [NSP 
density 7.6g/1000kcal/day] (Ward et al., 2012) compared to the UKWCS where mean intake 
was 17.4g/day (SD 6.3) [NSP density 9.8g/1000kcal/day]. 
The high fibre intakes in this cohort, by comparison to representative study populations from 
the UK or US, could simply reflect the healthy characteristics of participants here and the large 
proportion of vegetarians in the UKWCS.  Average fibre intake estimated with FFQs in the 
Oxford arm of the EPIC study, which also recruited a large proportion of non-meat eaters, was 
closer to that seen for the UKWCS and in women, mean NSP was 20.4 (SD 7.7) g/day (Davey et 
al., 2003). In addition to the greater proportion of non meat-eaters, it is possible that higher 
NSP intake may result from the large number of individual fruit and vegetable items and the 
inclusion of additional composite vegetable dishes listed on the FFQ, causing participants to 
over-estimate their intake of these foods, leading to inflated fibre values. The issue of 
exaggerated vegetable intake using FFQ methods, compared to other methods of dietary 
assessment, has also been noted in other British studies (Bingham et al., 1997, Brunner et al., 
2001). In the UK arm of the EPIC study, authors ascribe higher nutrient values from the FFQ, as 
compared with weighed diaries completed at four time points throughout the year, partly to 
the 120g/day greater vegetable intake calculated from FFQs (Bingham et al., 1997). In the 
Whitehall II study, reported intake of vegetable foods also appeared to be over-estimated 
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compared to food diaries when biomarkers such as beta-carotene were assessed. The authors 
similarly suggest this may occur because of the large number of vegetables items on their FFQ 
(Brunner et al., 2001).  
Differences observed between study populations may also result not only from actual 
differences but also the method of coding diaries and sources of nutrient information. Data 
from the UKWCS was pooled with six other cohort studies in the UK to investigate diet and 
associations with cancer. All other cohorts assessed diet using ‘DINER’ software but not all 
diaries for the UKWCS were assessed with DINER and some were assessed using DANTE. In an 
investigation into fibre and colorectal cancer risk, Dahm and colleagues performed a 
comparative analysis of the DINER and DANTE methods for 100 randomly selected UKWCS 
diaries and found that the geometric mean difference in energy and carbohydrate intake 
between the methods was 2% (95% CI: 0 to 5%). The geometric mean difference for fibre 
assessed by the two methods was 8% (95% CI: 4 to 12%) which was estimated to be equivalent 
to an arithmetic mean difference of 1.3g/day (Dahm et al., 2010). 
3.4.3 Limitations and strengths of dietary assessment methods 
The effects of systematic bias from FFQs are debated, with some believing that bias does not 
generally hinder the ability to identify important associations in epidemiologic research and is 
lessened through categorising participants into intake fifths (Willett and Stampfer, 1998). 
However, others argue that the substantial measurement error can profoundly influence the 
interpretation of epidemiologic studies and the attenuation could be so severe as to preclude 
useful results (Freedman et al., 2011, Kipnis et al., 2003). Solutions include adjusting for energy 
intake (Freedman et al., 2011) and other confounders. However measurement error in 
assessing confounders is also an issue of concern and this bias can be large and work to inflate 
or attenuate associations (Greenland, 1980, Willett, 2013a). Findings from validation studies 
using biomarkers suggest that measurement error in dietary exposures will often result in 
attenuated estimates (Kipnis et al., 2003, Freedman et al., 2011). Thus, moderate diet-disease 
associations in the order of 2.0 for risk would appear close to 1.3 using FFQ-based energy 
adjusted values (Kipnis et al., 2003). However, the impact of measurement error is less severe 
after adjustment for energy intake (Kipnis et al., 2003, Freedman et al., 2011).  
Energy intake can be accounted for by both dividing nutrients by energy or adjusting for total 
energy intake in models, along with other potential confounders. When energy intake is 
unrelated to disease outcomes, dividing nutrients by energy intake can be beneficial in 
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reducing the variation in nutrient intake that is due to differences in body size or net activity. 
However, if the nutrient correlates with energy intake, as with fibre, dividing by energy intake 
creates a variable that is highly related to the factor we wish to account for i.e. energy intake. 
The correlation between NSP and energy intake assessed using the FFQ was 0.68 and for the 
diary was 0.43. The issue of nutrient density variables being highly related to energy intake 
may be addressed with additional adjustment for energy intake in density analyses (Willett, 
2013b) and so will be applied here in analyses using fibre density values. Models and covariate 
adjustments are described in detail in the method section of Chapter 5.  
Other limitations of assessing diet at one time point using a food diary is the day-to-day or 
week-to-week variation and the changes in diet during the week or weekend. Although 
individual diets may be influenced by day of the week, diaries were issued with staggered 
instructions for the start day so that this issue would be negated somewhat in the UKWCS 
dataset. Additionally, fibre intake is unlike certain micronutrients which may be very heavily 
influenced by seasonally available foods, although intake of fibre from seasonally available 
fruit or vegetables may vary. Since fibre intake is not heavily concentrated in just a few, 
sporadically consumed foods, but is rather a feature of many foods in the diet, using a food 
diary to assess intake of fibre should give a reasonable impression of usual intake (Willett, 
2013c). However, Bingham has estimated that 10 days of diary records are necessary to give 
robust estimates for dietary fibre intake at the individual, rather than group, level in order to 
be ±10% of the average intake (Bingham, 1987). 
To reduce error in dietary estimation that is attributable to daily variation, a greater number of 
recording days would be needed (Willett, 2013c), ideally spaced throughout the year to reduce 
error from seasonal variation. The restricted number of diary days available for the UKWCS is a 
limitation and the introduction of electronic dietary assessment in newer studies is a huge leap 
forward for speeding dietary assessment and reducing errors which may be introduced in 
coding foods. 
While diaries capture detailed intakes, a drawback is the risk of reactivity for participants 
(Baranowski, 2013) as the high burden may cause participants to simplify their intake to make 
recording of their diet easier or they may omit foods or recipes which are difficult to record. 
Additionally self-monitoring may increase the chance of selecting or reporting more socially 
acceptable foods (Baranowski, 2013).  
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A strength of the food diary approach is that it is totally open ended, allowing participants to 
record as much or as little of any foods they consumed. The FFQ, by contrast is limited in terms 
of the items described and the fact that standard, rather than individual portion sizes, must be 
ascribed to the various food items. Diaries also have the benefit of not relying so heavily on 
memory as FFQs since foods can be recorded as they are eaten or in the near past 
(Baranowski, 2013).  
A further source of error with diaries may be the lack of participant or coder motivation to 
accurately record or code diet (Baranowski, 2013). Little may be done to address lack of 
motivation in participants, although the recruitment of self-selecting participants means they 
may be more highly motivated that the general population. However, implementing cross-
checking procedures between coders will go some way towards limiting any bias caused 
through lack of motivation from coders, such as the checking protocol applied for coding 
diaries here. 
3.5 Summary 
This chapter outlines the design and data collection of the UKWCS. Details of the two dietary 
assessment methods are described, along with details for how fibre values were derived for 
the total diet and from key food sources of fibre. Correlation between the different sources of 
fibre are explored within each method and study population characteristics are presented for 
low and high fibre consumers, as assessed using both methods.  
Calculations for fibre and energy from the two methods are briefly compared and the high 
fibre intakes observed in the UKWCS are compared with fibre intakes estimated from other 
cohort study populations. Results from validation studies of other British cohorts are 
additionally discussed here as well as both strengths and limitations of the FFQ and food diary 
approaches to estimate usual intake.  
This chapter has presented a background to the UKWCS and dietary fibre intakes. The next 
chapter (Chapter 4) focuses on cardiovascular outcome data; the different event sources used 
and how data were processed. Detailed methods describing the completeness of event 
reporting, or capture, within these different sources are also presented in the next chapter. 
Subsequent chapters (5, 6 and 7) then utilise the dietary data presented in this chapter along 
with cardiovascular event data presented in Chapter 4 to examine CVD risk in association with 
dietary fibre intake.    
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Chapter 4 Sources of cardiovascular event data and 
case ascertainment rates 
4.1 Chapter overview 
The three different sources of cardiovascular event data obtained for participants of the 
UKWCS are described. Mortality data were obtained in addition to CVD cases from Hospital 
Episode Statistics (HES) and acute coronary events from the Myocardial Ischaemia National 
Audit Project (MINAP). Cases from each dataset were identified and this preparation, in terms 
of the definitions applied for both CHD and stroke cases within each source, is described. The 
ethical approval process and data security arrangements are also detailed in this chapter. 
In this chapter the potential number of missing cases, i.e. CVD cases not identified in any of the 
datasets, and therefore the degree of complete case capture within the three sources has 
been estimated using capture-recapture analysis.  
4.2 Background 
Over recent years there have been initiatives to expand the use of electronic health records for 
research in the UK, such as the Strategic Framework for Health Informatics in Support of 
Research, whose aims include maximising the potential for research through linking patient 
databases in the NHS (MRC, 2010). Unlike recording of cancer incidence, no single or complete 
register exists for CVD outcomes in the UK and so different resources must be combined in 
order to estimate incidence with as much accuracy as possible.  
Combining different sources of outcome data for participants of the UKWCS is challenging 
because the available data cover different geographical areas and sources become ‘complete’ 
over different time frames. At study inception, no clinical register for CVD-related outcomes 
was available. CVD cases may therefore only be obtained from death certificates until the late 
1990’s when hospital records become available. The quality of routinely collected hospital data 
has been improving (Burns et al., 2012) and as a result, these data are becoming increasingly 
useful for research. Additionally, in the past decade a clinical registry for acute coronary 
admissions in English and Welsh hospitals has been established and now reports promising 
levels of data completeness (Herrett et al., 2010). 
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Although no case list can be proven to identify all cases in a given population, through 
combining lists it is possible to estimate the number of missed cases. Capture-recapture 
methods, which have their origins in ecology, can be applied to human populations. Originally, 
wildlife population sizes were estimated through capturing a sample, marking, releasing and 
later recapturing another sample of the same species. Using the numbers of recaptures and 
the number in each sample, it was possible to estimate the number not caught in either 
sample and thus the total population size (IWGDMF, 1995a). In human disease, these methods 
began to catch on in the late 1980s and by the 1990’s epidemiologists were applying log-linear 
modelling methods to capture-recapture analyses (IWGDMF, 1995b). The application of these 
methods in epidemiology presents some difficulties because assumptions which should be met 
include that the population size is closed and lists are independent, rarely the case in 
epidemiological study settings. In epidemiology and public health, capture-recapture 
methodology can be applied to estimate the extent of incomplete case ascertainment using 
lists from different sources with overlapping cases (Hook and Regal, 1995). Log-linear analysis 
essentially compares the observed frequency of cases with the frequency that is expected to 
occur by chance (Cramer, 2003). The approach is deemed to be the method of choice for 
assessing completeness of data from multiple sources (Hook and Regal, 1995) and was 
therefore applied to the observed case frequency data for the UKWCS (details below in Section 
4.3.5).  
4.2.1 Ethical considerations and approval for access to data  
At inception of the UKWCS in 1993, in the absence of a more centralised system, individual 
ethical approval was sought and obtained from 174 local ethics committees within the UK. 
Approval was granted from each local authority for the study to follow participants for cases of 
cancer and other diseases. At this time individual consent forms were not required by the 
ethics committees, therefore those women who returned questionnaires with a completed 
back page were considered to have provided consent for participation. The back page of the 
questionnaire informed participants that the purpose of the study was to examine "the 
occurrence of certain diseases such as cancer which are registered by the National Health 
Service" and participants were asked to provide their NHS number and GP address in order for 
their medical records to be accessed. 
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Obtaining the appropriate approvals for cardiovascular event data linkage with the UKWCS 
was not straightforward and the various processes are detailed below and shown in Figure 4.1:  
1) In January 2011 I applied to the Data Access Advisory Group (DAAG) for access to HES data 
relating to cohort participants.  
2) In May 2011 I received a letter from the DAAG informing me that the application was not 
approved and the group indicated that the return of a questionnaire at study baseline did 
not constitute appropriate consent for a project of this type.  
3) Section 251 approval was therefore sought from the Ethics and Confidentiality Committee 
(ECC) since it was not possible to obtain additional consent, more aligned with current 
standards, directly from participants. ‘Section 251 of the NHS Act 2006 allows the common 
law duty of confidentiality to be set aside in specific circumstances where anonymised 
information is not sufficient and where patient consent is not practicable’ (NIGB, 2011). 
The application for approval was made in June 2011. 
4) The ECC granted Section 251 approval for access to HES data for cohort participants in 
August 2011. This approval was subject to two specific conditions: 
o Data security arrangements had to be in place and confirmed  
o Confirmation was required to show that the original ethics approvals for the 
cohort covered the linkage with HES data or a new favourable research ethics 
committee (REC) opinion was needed for access to HES data. 
5) After consultation with the National Research Ethics Committee (NRES), it was decided 
that a REC local to Leeds should be contacted regarding a Notice of Substantial 
Amendment (NoSA) for the new data linkage as no singular REC had been appointed for 
the cohort since the centralised system for ethical approval was introduced nationally. 
6) I submitted a NoSA to Leeds East REC in November 2011. The NoSA related to access to 
and linkage with cardiovascular event data since this had not previously been accessed for 
or linked to the cohort participants. Leeds East REC considered the NoSA in December 
2011 and approval for the linkage was granted (approval letter in Appendix VI). 
7) The ECC were informed of the favourable ethics outcome and data security arrangements 
and full section 251 approval was granted (approval letter in Appendix VII).  
8) Confirmation of this approval was provided to the DAAG and linked HES data were 
provided for cohort participants. 
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Figure 4.1 Process of obtaining ethical approval for access to and linkage with cardiovascular 
event data 
 
4.2.2 Data security and anonymity  
Data files including HES or MINAP outcome data have been either stored on an encrypted 
laptop or a secure drive, where access to the file was restricted and files were protected 
through secure firewalls.  
Third party record linkage to UKWCS participant identifiers was carried out for both MINAP 
and HES to ensure anonymity for cohort participants. Identifiers (unique identification number, 
name, date of birth, NHS number) were provided to the trusted third parties (NHS information 
centre/MINAP clinical director) so that cohort participants could be identified from within 
these national registries. Relevant event records for participants were then returned with only 
a unique identification number so that records could be matched up with lifestyle information 
for cohort participants. 
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4.3 Methods 
4.3.1 Overview of the three sources of outcome data 
Three main sources of cardiovascular disease case data were available for the UKWCS and 
these span different timeframes (Figure 4.2). Mortality records for participants are available 
from study baseline to present (from the NHS central register/ NHS information centre), in-
patient HES records are available for all English hospitals since 1998 and the MINAP clinical 
registry data became complete in 2003 and records spanning up to 2011 have been obtained. 
Figure 4.2 Time periods covered by different case datasets 
 
Cohort participants were primarily from England but also from Scotland and Wales. MINAP 
covers only English and Welsh hospitals and HES data were only obtained from English 
hospitals as both Scottish and Welsh data are separately generated and stored. In analyses 
where only mortality data are used, all participants are retained in the sample but where 
incidence data, from HES or MINAP are used, the sample has been restricted to just those 
women whose address at baseline was within England. This ensures that datasets are 
comparable and as complete as possible for examining incidence in the largest regional group 
within the cohort. 
In each of the following three sections, the different datasets are discussed including 
preparation of the data and for HES and MINAP, the number of cases whose address was listed 
in Scotland or Wales is presented.  
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4.3.2 Mortality data 
Source summary 
Mortality information has been received since baseline for all participants of the cohort who 
provided sufficient information (name, date of birth, NHS number) to allow record linkage 
through the then ONS, now NHSIC. Ninety eight percent of baseline participants were 
successfully traced to allow record linkage.  
Records have been received regularly since study baseline and from these both fatal CHD and 
stroke cases have been identified.  
Case definitions 
Cases were classified using the ‘original underlying’ field from death certificates and using ICD 
9th edition and 10th edition codes. Fatal cerebrovascular events were identified with ICD9 codes 
430 to 438 or ICD10 codes I60 to I698 and fatal CHD events with ICD9 codes 410 to 4149 and 
ICD10 codes I20 to I259. For analyses using mortality data, total CVD cases were classed as 
those where the cause of death was either ascribed to cerebrovascular or heart disease. Note 
that fatal CHD cases identified here may all be classified as ischaemic heart disease (IHD) cases 
as no participants were identified with main cause of death classified as I46 or I47 (Cardiac 
arrest or Paroxysmal tachycardia).  
Data summary 
For analyses using only mortality outcome data, which are presented in the next chapter 
(Chapter 5), records span from study baseline to February 2011 and include English, Welsh and 
Scottish residents. Cases in later chapters, which examine total (fatal plus non-fatal) CVD risk 
and include cases from MINAP and HES (Chapters 6 and 7), extend up to June 2011 as 
additional mortality data were available. Table 4.1 details the IHD, stroke and CVD case 
numbers used in the different stages of work. 
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Table 4.1 Fatal IHD, stroke and CVD case numbers used in examining associations between 
dietary fibre and CVD mortality and CVD incidence 
 IHD 
mortality 
case 
frequency 
Stroke 
mortality 
case 
frequency 
CVD 
mortality 
case 
frequency 
Chapter 5: mortality cases span to 28th Feb 
2011 for English, Welsh and Scottish residents 
208 175 383 
Chapter 6/7: mortality cases used in incident 
CVD analyses span to 30th June 2011 for English 
residents only 
196 158 354 
Note: case numbers presented here are before any exclusions have been applied to the 
sample 
4.3.3 Myocardial Ischaemia National Audit Project 
Source summary 
MINAP is a clinical database specifically designed to record acute coronary syndromes (ACS) 
within English and Welsh hospitals (Herrett et al., 2010). ACS data are collected prospectively 
at each hospital, electronically encrypted and transferred on-line to a central database. By 
means of many data fields, each patient entry gives details of the patient journey, including 
the method and timing of admission, inpatient investigations, results and treatment, final 
diagnosis and (if applicable) date of death (from linkage to NHSIC). Data entry is subject to 
routine on-line error checking.  
The registry was established in 1998, data collection began in 2000 and by mid-2002 all acute 
hospitals in England and Wales were participating (Herrett et al., 2010). Records for UKWCS 
participants were therefore obtained from 2003 onwards, when the register coverage was 
nationwide. All ACS data relating to participants of the UKWCS were identified in July 2011 
through a third-party record linkage service. Event data therefore span from 1st January 2003 
to 30th June 2011. 
Case definitions 
Within the MINAP dataset there is a ‘final diagnosis’ field which is completed for all 
admissions. Final diagnosis is defined for each participant using standard definitions (MINAP, 
2010), which are detailed Appendix VIII. Each of the seven classifications used are listed in 
Table 4.2 below and were used to determine record inclusion with the help of Dr Chris Gale, a 
senior lecturer in Cardiovascular Health Sciences and Honorary Consultant Cardiologist, who 
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indicated which of the diagnosis types should be included in the definitions for MI and ACS 
(see Table 4.2). 
Table 4.2 Final diagnosis frequency and outcome classification in all MINAP records and for 
English participants only 
Final diagnosis 
classifications used in 
MINAP dataset 
Total 
records 
received 
Number of first 
diagnosis 
records in 
English 
residents* 
Diagnosis type 
included in MI 
classification? 
Diagnosis type 
included in ACS 
classification? 
ST segment elevation MI 67 58 X X 
Threatened infarction 1 1 - X 
ACS troponin +ve 138 114 - X 
ACS troponin –ve 29 23 - X 
Chest pain, cause 
uncertain 
6 5 - - 
Other diagnosis 18 16 - - 
ACS troponin not stated 2 2 - X 
Blank field 8 7 - - 
Total records 269 226 58 198 
X= final diagnosis category included in classification of MI or ACS 
*Subsequent events removed for each participant 
Data cleaning and summary 
In total, 269 event records were received, matching to 236 UKWCS participants (after 
removing any subsequent events for each participant, where multiple records existed). 
Records for 8 Welsh participants (12 event records) were then removed. The earliest event 
record for each participant was identified through manual screening and if a second event was 
listed, the earliest was retained, providing that the ‘final diagnosis’ for the earliest record was 
either MI or ACS. In all cases where more than one record existed, the earliest recorded event 
was either MI or ACS.  
Case frequencies for each of the diagnosis types before and after removal of records for Welsh 
participants and any subsequent events are listed in Table 4.2. In total 58 MI and 198 ACS 
records were identified for English participants within the MINAP dataset.  
Admission dates for MINAP records were examined to check whether a lag-time in event 
recording existed for the more recent events i.e. to check that recent event reporting was not 
incomplete because of recording lag. In general, consistent case frequencies each month 
followed by a reduction in event cases in the most recent month would indicate a lag-time in 
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event recording. However, when examining a histogram of MINAP record frequency reporting 
(Figure 4.3) there was no evidence of a drop-off in event reporting because the number of 
cases each month was small and there was a large degree of variation in case numbers 
between months. All MINAP events were therefore included in analyses. The latest event date 
in MINAP was chosen as the censor date for all outcome data sources. 
Figure 4.3 MINAP case frequency reported each quarter (Q) since 1st January 2003 to 30th 
June 2011, for English residents 
 
4.3.4 Hospital Episode Statistics 
Source summary 
HES records have been routinely collected by all English hospitals since around 1998. These 
data primarily exist for economic purposes and to track service use but diseases or diagnoses 
are also recorded for each admission. The inpatient data for CHD and stroke obtained for the 
UKWCS span from 1998 to 30th December 2011. 
Case definitions 
All records for UKWCS participants with any of the CVD ICD10 codes listed in Table 4.3 were 
identified within the main HES database and were extracted by a trusted third party for data 
linkage with the cohort.  
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Table 4.3 ICD10 codes used to identify relevant HES records 
Disease 
category 
ICD 10 
Code 
General description (sub-category descriptions not 
included here) 
Hypertensive 
diseases 
I10 Essential (primary) hypertension 
I11 Hypertensive heart disease 
I15 Secondary hypertension 
Ischaemic heart 
disease 
I20 Angina pectoris 
I21 Acute myocardial infarction 
I22 Subsequent myocardial infarction 
I23 Certain current complications following acute 
myocardial infarction 
I24 Other ischaemic heart diseases 
I25 Chronic ischaemic heart disease 
Other forms of 
heart disease 
I46 Cardiac arrest 
I47 Paroxysmal tachycardia 
I48 Atrial fibrillation and flutter 
I49 Other cardiac arrhythmias 
I50 Heart failure 
Cerebrovascular 
diseases 
I60 Subarachnoid haemorrhage 
I61 Intracerebral haemorrhage 
I62 Other non-traumatic intracranial haemorrhage 
I63 Cerebral infarction 
I64 Stroke not specified as haemorrhage or infarction 
 
Four CHD event types were identified from HES records using the relevant ICD codes (Table 
4.4) in consultation with Dr Chris Gale (Cardiologist). Separating events by sub-type allows for 
exploration of fibre and risk associations, where sufficient cases exist in each sub-group: 
 Total CHD: All CHD-related events 
 Myocardial Infarction (MI) 
 ACS: includes all acute coronary events 
 Chronic: includes all chronic and not acute events 
 Other: includes other cardiac events suggestive of heart disease. These are mostly due 
to chronic heart disease but these diseases can also have other, non heart disease 
related causes. 
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Table 4.4 Coronary heart disease classification codes and outcome grouping 
ICD10 
Code 
Code description 
Total 
CHD 
MI ACS Chronic Other 
I20 Angina pectoris      
I20.0 Unstable angina X  X   
I20.1 Angina pectoris with documented spasm X   X  
I20.8 Other forms of angina pectoris X   X  
I20.9 Angina pectoris, unspecified X   X  
I21 Acute myocardial infarction      
I21.0 Acute transmural myocardial infarction of 
anterior wall 
X X X   
I21.1 Acute transmural myocardial infarction of 
inferior wall 
X X X   
I21.2 Acute transmural myocardial infarction of 
other sites 
X X X   
I21.3 Acute transmural myocardial infarction of 
unspecified site 
X X X   
I21.4 Acute subendocardial myocardial infarction X X X   
I21.9 Acute myocardial infarction, unspecified X X X   
I22 Subsequent myocardial infarction      
I22.0 Subsequent myocardial infarction of anterior 
wall 
X X X   
I22.1 Subsequent myocardial infarction of inferior 
wall 
X X X   
I22.8 Subsequent myocardial infarction of other sites X X X   
I22.9 Subsequent myocardial infarction of 
unspecified site 
X X X   
I24 Other acute ischaemic heart diseases      
I24.8 Other forms of acute ischaemic heart disease X  X   
I24.9 Acute ischaemic heart disease, unspecified X  X   
I25 Chronic ischaemic heart disease      
I25.0 Atherosclerotic cardiovascular disease, so 
described 
X   X  
I25.1 Atherosclerotic heart disease X   X  
I25.2 Old myocardial infarction X   X  
I25.3 Aneurysm of heart X   X  
I25.5 Ischaemic cardiomyopathy X   X  
I25.6 Silent myocardial ischaemia X   X  
I25.8 Other forms of chronic ischaemic heart disease X   X  
I25.9 Chronic ischaemic heart disease, unspecified X   X  
I46 Cardiac arrest      
I46.0 Cardiac arrest with successful resuscitation X    X 
I46.1 Sudden cardiac death, so described X    X 
I46.9 Cardiac arrest, unspecified X    X 
I47.0 Paroxysmal tachycardia X    X 
I47.2 Ventricular tachycardia X    X 
I49.0 Other cardiac arrhythmias X    X 
Key: MI Myocardial Infarction; ACS Acute Coronary Syndrome 
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Stroke data were similarly grouped into outcome classifications to allow exploration of the 
associations between fibre and different types of stroke (Table 4.5): 
 Total stroke: Any ICD code spanning I60-I64X 
 Subarachnoid haemorrhage (SH) 
 Intracerebral haemorrhage (IBH) 
 Intracranial haemorrhage (ICH) 
 Cerebral infarction (CIF) 
 Other: diagnosis of stroke but no distinction was made between infarction or haemorrhage 
 
Table 4.5 Stroke classification codes and outcome grouping 
ICD10 
Code 
Code description 
Total 
stroke 
SH IBH ICH CIF Other 
I60 Subarachnoid haemorrhage (SH)       
I600 SH from carotid siphon and bifurcation X X     
I601 SH from middle cerebral artery X X     
I602 SH from anterior communicating artery X X     
I603 SH from posterior communicating artery X X     
I604 SH from basilar artery X X     
I605 SH from vertebral artery X X     
I606 SH from other intracranial arteries X X     
I607 SH from intracranial artery, unspecified X X     
I608 Other SH X X     
I609 SH, unspecified X X     
I61 Intracerebral haemorrhage (IBH)       
I610 IBH in hemisphere, subcortical X  X    
I611 IBH in hemisphere, cortical X  X    
I612 IBH in hemisphere, unspecified X  X    
I613 IBH in brain stem X  X    
I614 IBH in cerebellum X  X    
I615 IBH, intraventricular X  X    
I616 IBH, multiple localised X  X    
I618 Other IBH X  X    
I619 IBH, unspecified X  X    
I62 Other nontraumatic intracranial 
haemorrhage (ICH) 
      
I620 Subdural haemorrhage (acute) 
(nontraumatic) 
X   X   
I621 Nontraumatic extradural haemorrhage X   X   
I629 ICH (nontraumatic), unspecified X   X   
I63 Cerebral Infarction (CI)       
I630 CI due to thrombosis of precerebral arteries X    X  
I631 CI due to embolism of precerebral arteries X    X  
I632 CI due to unspecified occlusion or stenosis 
of precerebral arteries 
X    X  
I633 CI due to thrombosis of cerebral arteries X    X  
I634 CI due to embolism of cerebral arteries X    X  
I635 CI due to unspecified occlusion or stenosis 
of cerebral arteries 
X    X  
I636 CI due to cerebral venous thrombosis, 
nonpyogenic 
X    X  
I638 Other CI X    X  
I639 CI, unspecified X    X  
I64X Stroke, not specified as haemorrhage or 
infarction 
X     X 
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Data cleaning and summary 
Within the HES database, for UKWCS participants, 25,787 record rows were identified with the 
disease codes listed in Table 4.3. Each episode in HES or each admission into hospital is 
presented on multiple rows within the dataset.  ICD10 codes are also presented in a ‘main 
diagnosis’ field and in multiple ‘other diagnosis’ fields and so taking only the main field for case 
identification results in the appearance of fewer cases compared to assessing ICD10 codes 
listed in any of the ‘other diagnosis’ fields. 
Removal of non-English residents 
As HES data were only obtained for English hospitals and MINAP covers only England and 
Wales, all participants whose address at baseline was listed outside of England were removed. 
The numbers and proportion of participants not matching to any CVD-related HES records 
within each region of the UK was calculated (Table 4.6). Received HES records were compared 
against the 36,126 UKWCS participants who were listed as successfully traceable via the NHSIC. 
Firstly, missing geographical data (government office region) for participants was filled in 
where this was not already assigned in the dataset. In the existing UKWCS dataset 1,149 
women had no government office region assigned. Region assignment was based on address 
information and so missing data were likely because of incorrect postcode or format of 
address. Addresses for these women were visually scanned and participants were either 
grouped with existing Scottish, Welsh and Northern Ireland participants or grouped as 
‘unassigned English region’. 
In total, 7,841 women of 36,126 (21.7%) had not been identified in any CVD-related HES record 
since 1995, when both the main or other HES diagnosis fields were examined for the relevant 
ICD10 codes listed in Table 4.3.  
For each of the English regions, the proportion of participants not appearing in HES was much 
lower than the average unmatched proportion of 21.7% (discussed above), at around 10% (8.4 
to 11.9%). Despite HES records relating to only English hospitals, a small proportion of women 
whose address at baseline was listed as in Northern Ireland, Wales or Scotland appear in the 
dataset. The relative proportion of Welsh and Northern Ireland residents being unmatched in 
HES was similar, 76.2% and 67.9%, respectively and almost all of the Scottish residents were 
not matched in HES (96.1%). Of those women without an assigned region but not resident in 
Scotland, Wales or NI (n=961), 12.8% (n=123) were not matched to any HES record. 
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Hospital records for Scotland, Wales and Northern Ireland are not centrally held with English 
data and so fewer HES records would be expected for these participants. Examining record 
matching in this way confirmed that records were much less complete for non English 
residents and analyses using incidence data should therefore include only English residents.  
Table 4.6 Proportion of participants with no CVD-related HES records, by region 
Government office 
region (based on 
reported postcode or 
address at baseline) 
Participant 
frequency in 
each region 
Proportion 
of total 
sample in 
each region 
(%)  
Frequency 
of 
unmatched* 
participants 
Proportion 
of each 
region 
unmatched* 
to HES (%) 
Proportion of 
total 7841 
unmatched* 
participants 
from each 
region (%)  
North East 1 102 3.05 93 8.4 1.19 
North West 3 319 9.19 334 10.1 4.26 
Yorkshire and Humber 2 702 7.48 226 8.4 2.88 
East Midlands 2 028 5.61 183 9.0 2.33 
West Midlands 2 739 7.58 327 11.9 4.17 
East of England 2 942 8.14 327 11.1 4.17 
Greater London 4 139 11.46 447 10.8 5.70 
South East 6 939 19.21 812 11.7 10.36 
South West 4 208 11.65 383 9.1 4.88 
Unassigned English 
region 
961 2.66 123 12.8 1.57 
Wales 1 291 3.57 984 76.2 12.55 
Northern Ireland 28 0.08 19 67.9 0.24 
Scotland 3 728 10.32 3 583 96.1 45.70 
 36 126 100 7 841  100 
*Unmatched refers to participants that were not identified from the English HES record 
database for any CVD related record. 
Identifying earliest event dates within HES  
Within HES, multiple rows of data exist for each participant. These detail stages of treatment 
through an in-patient stay and also possible multiple inpatient experiences. The data were 
collapsed into a single row in order to link with cohort variables. New variables were generated 
for each disease diagnosis (detailed in Tables 4.4 and 4.5) and a distinction was also made as to 
whether the relevant diagnosis codes had been recorded in the main or other diagnosis fields. 
This distinction results in narrow and broad criteria for identifying cases from HES.  
Each of the 20 new variables was separately condensed, using participant ID, to identify the 
earliest occurrence of each type of diagnosis, by participant. This allowed multiple diagnosis 
records, occurring at different dates, to exist on a single row for each participant (see example 
dataset in Table 4.7). 
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Table 4.7 Example dataset displaying multiple diagnoses per participant 
ID ACS case 
from 
main 
diagnosis 
ACS 
main 
event 
date 
ACS case 
from any 
diagnosis 
ACS any 
event 
date 
Stroke 
case 
from 
main 
diagnosis 
Stroke 
main 
event 
date 
Stroke 
case 
from any 
diagnosis 
Stroke 
any 
event 
date 
55550 no - yes 05/05/05 yes 01/01/01 yes 01/01/01 
55551 no - no - no - yes 03/03/03 
55552 yes 06/06/06 yes 06/06/03 no - no - 
ACS = acute coronary syndrome 
Cases identified from HES, by diagnosis type 
The numbers of data rows and individual cases for each diagnosis type using both the main 
diagnosis field and all diagnosis fields are displayed in Table 4.8. In total, 1178 CHD events 
were identified using the main and 1937 using all diagnosis fields. For stroke, 494 cases were 
observed using the main and 546 using any diagnosis field. 
Table 4.8 Row and case frequency since study baseline of different CVD outcomes using the 
primary and multiple diagnosis fields from HES 
 Identified using HES primary 
diagnosis field 
Identified using all HES 
diagnosis fields 
Data row 
frequency* 
Case 
frequency# 
Data row 
frequency* 
Case 
frequency# 
Total CHD 2675 1178 8143 1937 
Myocardial Infarction 535 312 698 374 
Acute coronary syndrome 1076 556 1446 666 
Chronic cardiac events 1512 822 7180 1696 
Other cardiac events 87 51 219 150 
Total stroke  1007 494 1126 546 
Subarachnoid haemorrhage 116 58 126 61 
Intracerebral haemorrhage 144 73 170 89 
Intracranial haemorrhage 56 30 78 41 
Cerebral Infarction 492 258 554 283 
Other cerebrovascular events 199 124 227 144 
*Multiple rows/events per participant  
# Subsequent events per participant removed.  
Note numbers for total stroke and total CHD are not equal to the sum of each sub-type 
because first event type was considered where multiple events exist for participants. 
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Incident cases after study follow-up 
To identify the number of incident cases available for analyses including food diary data, which 
was collected at study follow-up, HES data rows were dropped where the event date preceded 
the date of follow-up questionnaire receipt (refer to figure 4.2). The number of data rows and 
individual cases for each diagnosis type occurring after follow-up questionnaire receipt are 
displayed in Table 4.9. There were 332 incident CHD cases and 173 incident stroke cases from 
follow-up questionnaire receipt. Note that case frequencies for CHD or stroke cases identified 
using all HES diagnosis codes are not presented as this follow-up incidence data will only be 
used in time-to-event analyses (Chapter 7). As the secondary diagnosis fields in HES may 
represent historical events, it is not appropriate to use the admission date for a potentially 
unrelated condition in calculating survival times for modelling disease risk. 
Table 4.9 Row and case frequency since study follow-up for each CVD outcome, calculated 
using the primary HES diagnosis field 
 Frequency of 
data rows in 
HES records* 
Case 
frequency# 
Total CHD   788 332 
Myocardial Infarction 151 86 
Acute coronary syndrome 309 161 
Chronic cardiac events 458 267 
Other cardiac events 21 12 
Total stroke  405 173 
Subarachnoid haemorrhage 46 16 
Intracerebral haemorrhage 48 25 
Intracranial haemorrhage 34 16 
Cerebral Infarction 206 95 
Other cerebrovascular events 71 41 
*Includes multiple rows/events per participant  
#Subsequent events per participant removed, no duplicate IDs 
 
HES data for comparison with MINAP 
In order to suitably compare the ‘quality’ of HES and MINAP and establish if both sources have 
identified the same cases, ACS cases from HES were restricted to the same time-frame as 
MINAP. In total there were 1,007 data rows relating to 462 English individuals, with event 
dates inside the date range 1st January 2003 to 30th June 2011. HES ACS cases were defined 
both using the main or any diagnosis fields. 
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4.3.5 Capture-recapture methodology 
It is not necessary to count every case in a population because the recapture or source overlap 
information can be used to estimate this (Chao et al., 2003). The capture-recapture method 
attempts to estimate the total number of disease cases in a population and thus the 
completeness of different data sources can be calculated (Hook and Regal, 1995).  
Log-linear modelling is typically used to model count data when there are three or more 
variables of interest and can be applied, among other uses, to capture-recapture count data. 
The expected cell counts are estimated in a similar way to the application of the Chi-squared 
method when there are two variables of interest. The method essentially compares the 
observed number of cases in each cell with the number that is expected to occur by chance 
(Cramer, 2003). “The log-linear approach models the logarithm of the expected value of each 
observable category” (Chao et al., 2003) and the dependant variable in this analysis is the 
difference between the observed and expected case frequency, expressed as a likelihood ratio 
chi-square (Cramer, 2003). Log-linear models are the method of choice for assessing capture-
recapture count data (Hook and Regal, 1995) and have been extensively used to handle 
dependence among samples (Chao et al., 2003).  
Using the log-linear approach, various models are fitted to observed cells. The fit of the various 
models can be assessed to identify which model includes the simplest or most parsimonious 
explanation of the case distribution (Chao et al., 2003, Cramer, 2003). The ‘best’ model can 
then be applied to predict the expected number of cases missing from all lists (Chao et al., 
2003).  
Three-source approach 
Using the numbers of observed cases from each source individually and from all combinations 
of sources, log-linear analysis was used to calculate the number of expected incident cases not 
captured on any of the three lists. The number of cases not identified with any list is 
represented by ‘h’ in Table 4.10.  
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Table 4.10 Three-way cross over table illustrating all potential combinations of case 
reporting from the three event data sources 
 
Case in mortality records? 
YES NO 
Case in HES? Case in HES? 
YES NO YES NO 
Case in 
MINAP? 
YES a b c d 
NO e f g h 
 
In comparing mortality data and cases from HES and MINAP, the cases considered were IHD 
mortality cases received from NHSIC and ACS cases identified through both HES and in MINAP.  
Lists may not be independent in the way cases are identified, for example, the characteristics 
that lead to being recorded in one list may mean cases are more likely to be identified in other 
lists. This list dependency was explored using eight (23) models, to identify the most 
parsimonious model for calculating the completeness of datasets and therefore estimate the 
number of missed cases. 
Models with increasing dependency are presented in Table 4.11. The first model assumes all 
sources to be independent with no interactions between lists, three models include one two-
way interaction, three include two pair-wise interactions and one model was saturated, with 
three pair-wise interactions. It is not possible to model a three way interaction as the number 
of missed cases is unknown so it is assumed that no three way interaction exists, in order to 
estimate the number of cases missed from all lists.  
Table 4.11 Eight models fitted for three-source data, from independent to dependant lists 
  Source interactions in each model 
i Unsaturated model, assumes independent lists ONS, MINAP, HES 
ii  ONS*MINAP, HES 
iii ONS*HES, MINAP 
iv MINAP*HES, ONS 
v ONS*MINAP, HES*ONS 
vi ONS*MINAP, MINAP*HES 
vii MINAP*HES, ONS*HES 
viii Saturated model, assumes dependent lists ONS*MINAP, ONS*HES, MINAP*HES 
*= interaction between sources 
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Models were reviewed for goodness-of-fit to identify whether the inclusion of interactions 
between sources improved estimates. Using the most appropriate model, completeness of 
each data source was estimated followed by the completeness of the three overlapped 
sources, calculated as the proportion of cases observed to the number expected. 
As the MINAP dataset covered a shorter time-frame (1st January 2003 to 30th June 2011) than 
both HES and the mortality data, cases occurring outside these dates were excluded from 
analyses to ensure comparability with MINAP. Estimates of missing cases were generated 
twice, once including a diagnosis of ACS from the main HES field and again using any of the 
diagnosis fields within HES records. 
The ‘poisson’ command was used in Stata which produces estimates comparable to the Stata 
user-written program ‘recap’ (an der Heiden, 2009). In order that symmetric behaviour of the 
likelihood function was not assumed, 95% CIs around the maximum likelihood ratio value were 
generated according to the goodness-of-fit method suggested by Regal and Hook (Regal and 
Hook, 1984). The Stata command for goodness-of-fit based 95% CIs was kindly provided by Dr 
Darren Greenwood.  
Two-source approach 
Stroke data 
The completeness of stroke case capture was assessed using HES and mortality data spanning 
from 1st January 2003 to 30th June 2011. This analysis was conducted twice, once including a 
diagnosis of stroke in the main HES diagnosis field and again using any of the diagnosis fields 
within HES records.  
HES vs. MINAP 
HES and MINAP should essentially capture the same participants who are admitted into 
hospitals with ACS. The successful capture of cases in HES and MINAP has been examined over 
a comparable time frame for both datasets, 1st January 2003 to 30th June 2011. As with stroke 
analyses, both the main and all diagnoses fields within HES were separately considered in this 
comparison. Additionally, as the quality of data recording is likely to have improved over time, 
since MINAP has become fully established, the analysis was repeated looking at cases reported 
between 1st January 2003 to 31st December 2006 and from 1st January 2007 to 30th June 2011.  
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4.4 Results 
4.4.1 Case cross-matches 
Spanning from 1st January 2003 to 30th June 2011, 149 IHD mortality cases were observed, 198 
ACS cases from the MINAP dataset and 339 or 419 ACS cases were identified within the HES 
dataset, using either the main or all diagnosis fields, respectively (Table 4.12). When the three 
sources were combined, and so including case overlap, a total of 516 cases were identified 
using the main HES diagnosis field and this increased to 573 coronary cases identified using 
any diagnosis field within HES. The degree of overlap between the three sources, using both 
the main or using all diagnosis fields within HES, is also displayed in Figures 4.4 and 4.5, 
respectively.  
Table 4.12 CHD case capture and overlap within 3 sources 
IHD 
mortality 
case 
MINAP ACS 
case 
HES ACS case 
Source overlap 
frequency 
using main 
HES diagnosis 
field 
Source overlap 
frequency using all 
HES diagnosis fields 
- - - ? ? 
- -  181 238 
-  - 51 37 
-   135 149 
 - - 123 115 
 -  14 22 
  - 3 2 
   9 10 
n=149 n=198 
Main diagnosis 339 
Any diagnosis 419 
Total n=516 Total n=573 
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Spanning from 1st January 2003 to 30th June 2011, 145 stroke mortality cases were observed 
and 368 or 406 stroke cases were identified within the HES dataset, using either the main or all 
diagnosis fields respectively (Table 4.13). When both sources were combined, and so including 
case overlap, a total of 433 cases were identified using the main field and this increased to 467 
stroke cases identified with any diagnosis field in HES.   
Table 4.13 Stroke case capture and overlap within 2 sources 
Stroke mortality 
case 
HES stroke case 
Source overlap 
frequency using main 
HES diagnosis field 
Source overlap 
frequency using all 
HES diagnosis fields 
- - ? ? 
-  288 322 
 - 65 61 
  80 84 
n=145 
Main diagnosis field=368 
All diagnosis fields=406 
Total n=433 Total n=467 
 
ACS cases from both HES and MINAP records were assessed spanning from 1st January 2003 to 
30th June 2011 and also split by event date. Using the primary diagnosis field within HES, 393 
ACS cases were observed in HES and MINAP and using all diagnosis fields this increased to 458 
(Table 4.14).  
  
 
Figure 4.4 Source overlap including only the 
main HES diagnosis field 
 
Figure 4.5 Source overlap including all HES 
diagnosis fields 
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Table 4.14 ACS case capture and overlap within HES and MINAP over different timeframes 
ACS case 
observed 
in MINAP 
ACS case 
observed 
in HES 
Case frequency observed using 
main HES diagnosis field 
Case frequency observed using all 
HES diagnosis fields 
01/01/03 
to 
30/06/11 
01/01/03 
to 
31/12/06 
01/01/07 
to 
30/06/11 
01/01/03 
to 
30/06/11 
01/01/03 
to 
31/12/06 
01/01/07 
to 
30/06/11 
- - ? ? ? ? ? ? 
-  195 85 112 260 100 162 
 - 54 16 40 39 12 29 
  144 56 86 159 60 97 
  n=393 n=157 n=238 n=458 n=172 n=288 
 
4.4.2 Estimation of total CHD cases 
Each of the eight list dependency models (Table 4.11) was applied to the CHD case data to 
identify the best fit. Estimates for expected missing cases, total case estimation and CHD 
ascertainment rates using the three combined sources in each of eight models which account 
for different source interactions, are displayed in Tables 4.15 and 4.16.  
The model without source interaction terms (i) fit the data least well (refer to Table 4.11), 
having the highest values for goodness-of-fit and Akaike’s Information Criterion (AIC), which is 
a measure of goodness-of-fit corrected for the number of parameters in the model. Of the 
models that included just one, two-way interaction between sources (models ii, iii and iv), 
models ii and iii which had an interaction term between mortality information and MINAP or 
HES, do not fit the data as well as model iv with an interaction between HES and MINAP 
sources. Models vi, vii and viii that include two and three interaction terms between sources 
also have comparably low goodness-of-fit and AIC values as model iv but are more complex 
with additional interactions and therefore do not represent the most parsimonious 
explanation of list dependence. Model iv was selected as the best or most parsimonious of the 
eight, having acceptable goodness-of-fit and AIC values. 
Using model iv, the best model, the estimated number of CHD cases missed by all three 
sources is 1736 (95% CI: 1138 to 2741) when cases were identified with the primary field in 
HES (Table 4.17). This gives an estimate for total CHD cases of 2252 (95% CI: 1654 to 3257) and 
indicates that just 23% (95% CI: 16 to 31%) of cases were captured in total. Estimates are 
127 
 
 
 
similar when cases were identified using the broader HES definition (all diagnosis fields). The 
number of missing cases is estimated as slightly lower at 1434 (95% CI: 973 to 2162) and so in 
total, 2007 (95% CI: 1546 to 2734) cases are estimated. The total ascertainment rate for CHD 
events using death records, MINAP and all diagnoses codes in HES is 29% (95% CI: 21 to 37%). 
The estimated proportion of total cases identified through death records was just 7% (95% CI: 
5 to 9%), through MINAP was 9% (95% CI: 6 to 12%) and 15% (95% CI: 10 to 20%) of total cases 
were observed in HES. Numbers were similar when all HES diagnosis fields were included in 
the definition of ACS, but the proportion of total cases identified through HES increased to 21% 
(95% CI: 15 to 27%) (Table 4.17). 
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Table 4.15 Assessing best model fit for list dependency: Estimation of expected missing cases and total cases estimated from each of eight interaction models, 
using ACS cases identified from the main HES diagnosis field 
Model Terms and interactions in 
each model 
Pearson 
goodness
-of-fit 
AIC Expected missing  
(95% CI)* 
Estimated total 
cases  
(95% CI)* 
Total 
ascertainment 
rate (%)(95% CI)  
Death 
ascertainment 
rate (%)(95% CI)  
MINAP 
ascertainment 
rate (%)(95% CI) 
HES 
ascertainment 
rate (%)(95% CI) 
i) D , M, H 182 173.2 275 (209, 357) 791 (725, 873) 65 (59, 71) 19 (17, 21) 25 (23, 27) 43 (39, 47) 
ii) D , M, H, D*M 127 136.94 203 (150, 270) 719 (666, 786) 72 (66, 77) 21 (19, 22) 28 (25, 30) 47 (43, 51) 
iii) D , M, H, D*H 68 85.75 110 (73, 159) 626 (589, 675) 82 (76, 87) 24 (22, 25) 32 (29, 34) 54 (50, 58) 
iv)  D , M, H, M*H 0.23 -3.77 1736 (1138, 2741) 2252 (1654, 3257) 23 (16, 31) 7 (5, 9) 9 (6, 12) 15 (10, 20) 
v) D , M, H, D*M, D*H 35 22.32 68 (43, 102) 584 (559, 618) 88 (83, 92) 26 (24, 27) 34 (32, 35) 58 (55, 61) 
vi) D , M, H, D*M, M*H 0.03 -1.97 1590 (925, 2941) 2106 (1441, 3457) 25 (15, 36) 7 (4, 10) 9 (6, 14) 16 (10, 24) 
vii) D , M, H, D*H, M*H 0.11 -1.89 2091 (754, 8663) 2607 (1270, 9179) 20 (6, 41) 6 (2, 12) 8 (2, 16) 13 (4, 27) 
viii) D , M, H, D*M, D*H, M*H 0 0 1802 (453, 9184) 2318 (969, 9700) 22 (5, 53) 6 (2, 15) 9 (2, 20) 15 (3, 35) 
Key as below 
Table 4.16 Assessing best model fit for list dependency: Estimation of expected missing cases and total cases estimated from each of eight interaction models, 
using ACS cases identified from all HES diagnosis fields 
Model Terms and interactions 
in each model 
Pearson 
goodness
-of-fit 
AIC Expected missing  
(95% CI)* 
Estimated total 
cases  
(95% CI)* 
Total 
ascertainment 
rate (%)(95% CI)  
Death 
ascertainment 
rate (%)(95% CI)  
MINAP 
ascertainment 
rate (%)(95% CI) 
HES 
ascertainment 
rate (%)(95% CI) 
i) D , M, H 181 171.87 256 (194, 332) 829 (767, 905) 69 (63, 75) 18 (16, 19) 24 (22, 26) 51 (46, 55) 
ii) D , M, H, D*M 135 141.09 202 (151, 267) 776 (724, 840) 74 (68, 79) 19 (18, 21) 26 (24, 27) 54 (50, 58) 
iii) D , M, H, D*H 58 75.35 86 (54, 129) 659 (627, 702) 87 (82, 91) 23 (21, 24) 30 (28, 32) 64 (60, 67) 
iv)  D , M, H, M*H 1 -2.96 1434 (973, 2161) 2007 (1546, 2734) 29 (21, 37) 7 (5, 10) 10 (7, 13) 21 (15, 27) 
v) D , M, H, D*M, D*H 30 21.47 59 (36, 91) 632 (609, 664) 91 (86, 94) 24 (22, 24) 31 (30, 33) 66 (63, 69) 
vi) D , M, H, D*M, M*H 0.07 -1.92 1244 (786, 2049) 1817 (1359, 2622) 32 (22, 42) 8 (6, 11) 11 (8, 15) 23 (16, 31) 
vii) D , M, H, D*H, M*H 0.66 -1.32 2128 (639 13164) 2701 (1212, 13737) 32 (4, 47) 6 (1, 12) 7 (1, 16) 16 (3, 35) 
viii) D , M, H, D*M, D*H,M*H 1.14 0 1545 (354 10848) 2118 (927, 11421) 27 (5, 62) 7 (1, 16) 9 (2, 21) 20 (4, 45) 
AIC Akaike Information Criterion; CI confidence intervals; D IHD death; H HES ACS case; M MINAP ACS case. *95% CIs calculated using goodness-of-fit based 
method (Regal and Hook, 1984) 
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4.4.3 Estimation of total stroke cases 
Stroke cases identified from death records and through HES were combined to estimate 
missing cases. A total of 433 and 467 cases were observed using either the main or all HES 
diagnosis fields, respectively (Table 4.18). The total number of cases expected, using the main 
HES field, was 667 (95% CI: 593 to 769) and 701 (95% CI: 627 to 803) when all diagnosis codes 
were considered. 
The total case ascertainment rate for mortality records was 22% (95% CI: 19 to 24%) or 21% 
(95% CI: 18 to 23%) and for HES was 55% (95% CI: 48 to 62%) or 58% (95% CI: 51 to 65%), using 
the main or all HES diagnosis fields, respectively. 
4.4.4 Estimation of total ACS cases from HES and MINAP 
ACS cases identified through MINAP and HES were combined and 393 or 458 cases were 
identified using the main or all HES diagnosis fields, respectively. An estimated 73 cases (95% 
CI: 47 to 108) were missed when just the primary HES diagnosis field was used and this 
reduced to 64 cases missed (95% CI: 39 to 97) with all diagnosis fields (Table 4.19).   
The total ascertainment rate and separately, MINAP and HES ascertainment rates, appear to 
have improved from the early time period to the latter when considering ACS cases estimated 
from the main HES diagnosis field. The total ascertainment rate rose from 87% between 2003 
and 2006 to 95% between 2007 and 2011. However, when considering the broader ACS 
definition within HES data (cases identified using all diagnosis fields), the total case 
ascertainment rate dropped slightly from 90% to 86% whilst the MINAP rate remained 
constant at 38% and HES ascertainment increased from 83% to 95%.
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Table 4.17 Observed and expected cell counts and case ascertainment rates for CHD events reported by mortality records, MINAP and HES 
 Total 
observed 
cases 
Expected missing  
(95% CI) 
Estimated total cases  
(95% CI) 
Total 
ascertainment rate 
(%) (95% CI)  
Death record 
ascertainment rate 
(%) (95% CI)  
MINAP 
ascertainment rate 
(%) (95% CI) 
HES 
ascertainment 
rate (%) (95% CI) 
Comparison using 
main HES 
diagnosis field 
516 1736 (1138 to 2741) 2252 (1654 to 3257) 23 (16 to 31) 7 (5 to 9) 9 (6 to 12) 15 (10 to 20) 
Comparison using 
all HES diagnosis 
fields 
573 1434 (973 to 2161) 2007 (1546 to 2734) 29 (21 to 37) 7 (5 to 10) 10 (7 to 13) 21 (15 to 27) 
95% CIs calculated using the goodness-of-fit based method (Regal and Hook, 1984).  
 
Table 4.18 Observed and expected cell counts and case ascertainment rates for stroke events reported by mortality records and from the primary and all HES 
diagnosis fields 
Stroke death vs. 
HES stroke 
Stroke 
deaths 
observed n 
HES strokes 
observed n 
Total 
observed 
strokes  n 
Expected 
missing  
(95% CIs)  
Total expected  
(95% CIs)  
Total 
ascertainment 
rate (%) (95% CIs) 
Death records 
ascertainment 
rate (%) (95% CIs) 
HES ascertainment 
rate (%) (95% CIs) 
Comparison 
using main HES 
diagnosis field 
145 368 433 234 (160 to 336) 667 (593 to 769) 65 (56 to 73) 22 (19 to 24) 55 (48 to 62) 
Comparison 
using all HES 
diagnosis fields 
145 406 467 234 (160 to 336) 701 (627 to 803) 67 (58 to 74) 21 (18 to 23) 58 (51 to 65) 
95% CIs calculated using the goodness-of-fit based method (Regal and Hook, 1984). 
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Table 4.19 Observed and expected cell counts and case ascertainment rates for ACS in HES and MINAP 
MINAP vs. HES Comparison 
timeframe 
MINAP 
observed 
n 
HES 
observed 
n 
Total 
observed 
n 
Expected 
missing  
(95% CIs)  
Total expected  
(95% CIs)  
Total 
ascertainment 
rate (95% CIs) 
MINAP 
ascertainment 
rate (95% CIs) 
HES 
ascertainment 
rate (95% CIs) 
Comparison 
using main HES 
diagnosis field 
01/01/03 to 
30/06/11 
198 339 393 73 (47 to 108) 466 (440 to 501) 84 (78 to 89) 42 (40 to 45) 76 (68 to 77) 
01/01/03 to 
31/12/06 
72 141 157 24 (11 to 46) 181 (168 to 203) 87 (77 to 93) 40 (35 to 43) 78 (69 to 84) 
01/01/07 to 
30/06/11 
126 198 238 40 (22 to 65) 251 (233 to 276) 95 (86 to 102) 50 (46 to 54) 79 (72 to 85) 
Comparison 
using all HES 
diagnosis fields 
01/01/03 to 
30/06/11 
198 419 458 64 (39 to 97) 522 (497 to 555) 88 (83 to 92) 38 (36 to 40) 80 (75 to 84) 
01/01/03 to 
31/12/06 
72 160 172 20 (8 to 40) 192 (180 to 212) 90 (81 to 96) 38 (34 to 40) 83 (75 to 89) 
01/01/07 to 
30/06/11 
126 319 288 48 (27 to 79) 336 (215 to 367) 86 (78 to 134) 38 (34 to 59) 95 (87 to 148) 
95% CIs calculated using the goodness-of-fit based method (Regal and Hook, 1984).
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4.5 Discussion 
4.5.1 Summary of findings 
The most suitable model to explain the three source dependency included an interaction term 
between HES and MINAP. Dependency between these two sources is unsurprising as both 
record hospital inpatient events. Using this best model, an estimated 1736 (95% CI: 1138 to 
2741) cases were missed from all three sources of CHD event data. The CIs are relatively wide 
and it is possible that this estimate for total case capture is not truly reflective of the number 
of cases. This estimate could be unreliable because of relatively small numbers of cases and 
the fact that for each interaction, there are even fewer cases available on which to base the 
estimate. This creates greater uncertainty around the estimates.  
With the high estimate for total CHD cases, the total ascertainment rate is relatively low at just 
23% with the death, MINAP and HES records respectively observing just 7%, 9% and 15% of 
cases. These findings suggest that there may be a substantial number of events occurring 
within the community which do not result in hospitalisation or death and thus are not 
recorded in the data sources used here. A recent study that included 4 sources of MI case data 
from English HES, MINAP, death registry and primary care datasets found that when just non-
fatal events were considered from HES, MINAP and primary care data, 52.5% of all events 
were observed in MINAP, 67.9% in HES and 74.5% in the primary care dataset (Herrett et al., 
2013). This study, published after the comparison of case data for the UKWCS was completed, 
supports the necessity of obtaining case data from multiple sources and in terms of MI 
demonstrates that primary care data have a valuable role to play (Herrett et al., 2013). A 
limitation of this study however was that no estimation of missing numbers of cases was made 
using a log-linear approach despite having large numbers of cases and comparable datasets in 
terms of outcomes and timeframes. The study, by contrast to the work presented in this 
chapter, assumes that no cases are missed when calculating the proportion of cases from each 
dataset. This may somewhat explain why the proportion of MI cases captured from HES and 
MINAP exceed the values identified here for the UKWCS case data. Additionally, the narrower 
outcome classification (MI) used by Herrett and colleagues may also account for the greater 
estimates of case capture. Some sensitivity may have been lost through comparing all CHD 
events, as was done in this chapter.  
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List dependency could not be modelled for estimating the number of missing and therefore 
total number of stroke cases because only two sources of event data were available. There 
were an estimated 234 (95% CI: 160 to 336) stroke cases for the UKWCS participants that were 
not captured either with HES or death records. The total ascertainment rate for both sources 
was estimated as 65%, with death records capturing 22% and the main HES diagnosis field 
capturing 55% of cases. 
When just HES and MINAP cases were considered together, an estimated 73 (95% CI: 47 to 
108) cases were missed over the study time period, with 24 (95% CI: 11 to 46) being missed 
between 2003 and 2006 and 40 (95% CI: 22 to 65) cases being missed between 2007 and 2011. 
The models estimate that a greater proportion of total ACS cases were recorded in the latter 
time period, even when taking into consideration that the later period is 6 months longer than 
the early period. Total ACS cases expected during 2003-2006 was 181 (95% CI: 168 to 203) and 
was considerably higher for the period 2007-2011, at 251 (95% CI: 233 to 276). During the 
years 1999 to 2007 it has been demonstrated that ACS admission rates decreased in women 
across all age groups (Pearson-Stuttard et al., 2012). The greater observed and total expected 
case numbers in this later period may therefore indicate more complete ACS capture and 
recording within HES and MINAP systems or could simply reflect the ageing profile of the 
UKWCS participants and greater risk of events with increasing age. 
Participants who died were unlikely to appear in HES or MINAP, just 8% of death cases 
appeared in MINAP and 15% or 21% of death cases were listed in HES, using the main or all 
diagnosis fields, respectively. Similar observations were also made in the recent evaluation of 
the completeness and diagnostic validity of MI recording in four health record sources within 
England, discussed above. A total of 21,482 acute MI cases were observed and 36.7% of fatal 
MI cases were recorded in HES whilst just 17.1% were observed in MINAP. A far greater 
proportion of fatal MI cases, 55.9%, were however observed in primary care records (Herrett 
et al., 2013). 
The three source case estimation results are informative but the application may somewhat 
over-estimate the degree of under-capture and therefore provide overly large estimates of the 
number of missed cases. This may occur because it is not possible to include the three-way 
source interaction in models, for this the number of missed cases would be needed and it is 
this that the model tries to estimate. Additionally, the two-way interactions are not estimated 
very precisely when applied to the case data for the UKWCS. Firstly, the model assumes there 
134 
 
 
 
is an equal chance of being captured by lists but fatalities that are not admitted to hospital 
would never be recorded in HES or MINAP. Secondly, there are relatively small numbers of 
cases available over the matching time periods and even fewer cases available to be used in 
source dependency models, where the number of overlapping cases is used. Thirdly, different 
case types are captured in the lists with only fatal events from one source, clinically confirmed 
ACS from MINAP and potentially unverified cases being recorded in HES. Additionally, less 
critical cases or silent MI cases are missed from all three sources. The recent work by Herrett 
and colleagues explores the less critical and retrospective case diagnosis within primary care 
settings in England and identified that many more cases can be identified with the use of this 
data (Herrett et al., 2013). 
4.5.2 Strengths and limitations 
Model assumptions 
Principle assumptions should be met when applying capture-recapture methods for multiple 
lists. The first assumption, that individual identifiers are not lost, is not an issue where 
participants have unique identifiers. However, the second assumption, that lists are 
independent, is problematic in health applications (IWGDMF, 1995b). List or source 
dependency occurs because the nature of being on one list means participants are more likely 
to appear on others. In the context of the data available for the UKWCS, lists are likely to be 
dependent, simply being admitted to hospital and therefore appearing in HES means that 
participants are then available for entry in the MINAP system. Women who die before 
reaching hospital will not be identified in HES or MINAP and these records may therefore not 
be independent from HES or MINAP but partly mutually exclusive. Conversely, those women 
who die of cardiovascular disease whilst in hospital may be more likely to have accurate 
mortality records than those who die outside of hospital and therefore will appear in all three 
sources. 
The assumption that homogeneity of capture probability should exist within lists is often 
violated in human populations (IWGDMF, 1995b). However the application of log-linear 
analysis permits modelling of this list dependency and can be appropriately applied to produce 
total case estimates where it is not possible to ensure list independence. Capture-recapture 
methods are widely used and are generally accepted as a practical way to estimate the degree 
of under-capture and to calculate the actual number of cases (Reintjes et al., 2007).  
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A further assumption made with capture-recapture methods is that the study population is 
closed (Hook and Regal, 1995), which essentially means that there are no additions or losses 
during a study period (Chao et al., 2003). Whilst there is a fixed list of participants for the 
UKWCS there is no guarantee that all cases would be captured, for example any non-fatal 
events outside of English hospitals would not be identified. However assuming that net 
migration between England and Wales or Scotland is roughly reciprocal, and given the small 
proportion of HES records received for Scottish or Welsh residents (Table 4.6), only a small 
proportion of events would be missed this way.   
Sources of data 
A major limitation is that there is no national register for all cardiovascular events in the UK 
and so sources must be combined for maximum case identification. Additionally, neither HES 
nor MINAP include cases spanning back to study inception and so any non-fatal events 
occurring before HES and MINAP began reliably collecting data cannot be identified.   
HES data are principally collected for administrative purposes and so an obvious concern is 
regarding the accuracy of diagnostic code reporting and the validity of applying these for 
epidemiological research. Some authors caution careful interpretation of hospital activity data 
as it may not accurately reflect the underlying prevalence of disease (Hansell et al., 2001). 
Causes of data quality issues in HES include poor recording in patient notes or coding into the 
database system, failure to meet submission deadlines, leading to gaps in coverage and the 
fact that local systems vary greatly, which can lead to differences in data quality (HES, 2013). 
Although HES data quality has improved since the early 1990s, there is still reportedly wide 
variation between some health authority data especially for diagnostic codes (Hansell et al., 
2001).  
A comprehensive comparison study between HES records and GP records in England was 
carried out for random samples of participants from the Million Women Study (Wright et al., 
2012). The reporting of vascular diseases between 1997 and 2005 was the main aim of the 
work to assess whether the reporting in HES is sufficiently reliable for epidemiological 
research. GPs were contacted for women presenting in HES with diagnoses of IHD, venous 
thromboembolism and cerebrovascular disease and also for a sample of women with no HES 
record of these diagnoses. For a diagnosis of IHD in HES, 92% of GP records had a matching 
diagnosis or for a closely related IHD diagnosis and for cerebrovascular disease this was 94%. 
The authors also identified that agreement was highest for the more severe outcomes which 
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are likely to be of greater epidemiological interest. By examining GP records for those women 
without vascular disease diagnosis in HES and finding very few contradicting diagnoses, the 
study found that recording of admissions for vascular disease in HES was virtually complete. 
The authors indicate that the Million Women Study is likely to be representative of middle-
aged women in the general population. This validation work is therefore very informative and 
reassures that the likely quality of the data collected for UKWCS participants is acceptable for 
research, despite population differences between UKWCS participants and those in the Million 
Women Study or in the general population.  
Furthermore, a recently published systematic review assessing the accuracy of routinely 
collected data from 25 British studies, published over two decades, where the comparison was 
against case notes found that 80% of diagnoses in routine data were confirmed in case notes 
(Burns et al., 2012). Over the time period assessed, coding practice has greatly changed with 
the introduction of payment by results and also changes to ICD classification (Burns et al., 
2012). The studies were however heterogeneous with varying outcomes and methods and the 
historical nature of the data limits contemporary applicability somewhat (Burns et al., 2012). 
Despite this, and a lack of consensus on what level of data accuracy is acceptable, the authors 
identify that accuracy rates have improved and continue to do so (Burns et al., 2012). 
Because of the limitations of using HES data, it was not relied on alone but used in conjunction 
with MINAP. The completeness of key fields in MINAP, including main discharge diagnosis, is 
closely monitored and has been found to be generally above 95%. Validation exercises using 
randomly selected MINAP records also indicate the median level of agreement between re-
entered data and original has risen from 72% in 2003 to 89.5% in 2008 (Herrett et al., 2010). 
The scale of MINAP and the representativeness of MINAP data are also cited as key strengths 
which underpin its use as a research tool (Herrett et al., 2010).  
4.6 Summary 
This chapter has outlined the different sources of event data available for the UKWCS and how 
each dataset was prepared for use, with details of case definitions and exclusion of non-English 
participants.  
Estimation of the validity of these datasets has been undertaken using both three and two 
source comparisons, as appropriate. It is likely that the three source comparisons, although 
informative, provide inflated estimates for total cases. The comparison of the matching case 
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type (ACS) through using MINAP and HES data may provide closer estimates of missing case 
numbers but list dependence cannot be accounted for in these two-source models. This 
validation exercise does however provide useful estimates for expected missing CHD, stroke or 
ACS cases for the UKWCS population despite limitations in either having only two sources of 
event data or limitations with case types not being exactly comparable in the three source 
estimations. The validation work indicates that none of the lists are complete and this finding 
supports the use of multiple sources of event data, as has been applied in Chapters 5, 6 and 7.  
The next chapter utilises the mortality data, detailed above, and examines risk of IHD, stroke 
and total CVD mortality in association with dietary fibre intake. For this work all mortality cases 
since study baseline are utilised and not just those which were used in the validation exercise. 
Subsequent chapters then build upon this work by assessing risk of total (fatal plus non-fatal) 
CVD risk in relation to fibre intake assessed using, firstly FFQs (Chapter 6), then food diaries 
(Chapter 7).  
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Chapter 5 Dietary fibre and fatal ischaemic heart 
disease, stroke and cardiovascular disease 
5.1 Chapter overview 
The current chapter explores dietary fibre and risk of fatal IHD, stroke and CVD. Fibre intakes 
assessed using FFQs contribute data on total fibre intakes, both soluble and insoluble fibre and 
also fibre from key food sources. Participants were followed from baseline for just over 14 
years on average.  Figure 5.1 details dietary and outcome data sources, as described in earlier 
chapters that have been used in the current chapter: diet assessed by FFQ and mortality data 
only. 
This chapter details how potential confounders in the relationship between fibre and CVD risk 
were identified and handled in models. Survival analysis has been used to model the 
relationship between fibre and CVD and the approach described in the method section of this 
chapter applies to chapters 6 and 7 also. 
Using survival analysis methods to explore exposures and outcomes, there was no evidence of 
an association between fibre intakes of any kind and IHD, stroke or CVD mortality risk in the 
full sample of women, after adjustments were applied. There was some evidence that greater 
cereal fibre intake may confer protection for stroke mortality in women who were classed as 
overweight or obese using their BMI at baseline. Greater fibre density of the diet was also 
protectively associated with fatal stroke risk in women who were free of hypertension or 
angina at study baseline. 
An article was published from the work in this chapter (Threapleton et al., 2013b), in addition 
to two abstracts presented to the 2012 Meeting of the Society of Social Medicine (Threapleton 
et al., 2012b) and the winter meeting of the Nutrition Society 2012 (Threapleton et al., 2012a). 
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Figure 5.1 Data sources used in this chapter: Dietary data from FFQs and mortality (CHD, 
stroke and CVD) data spanning from study baseline 
 
5.2 Background 
CVD accounts for almost half of all deaths across Europe and is the main cause of disease 
burden (Allender et al., 2008). Although women typically experience CVD events later in life 
than men (Vaidya et al., 2011, Worrall-Carter et al., 2011), the annual mortality burden for 
CHD and stroke in women is estimated to be greater than that in men, at around 597,000 
compared to 548,000 cases within the European Union (EU) (Nichols et al., 2012). In the UK 
specifically, around one in three deaths is attributed to CVD and for the year 2010 that is 
approximately 180,000 deaths. CHD was responsible for around 45% of the total CVD deaths 
and stroke for 28%, the rest being caused by a range of other circulatory diseases (Townsend 
et al., 2012). Rates of CVD are in decline in many developed European countries (Allender et 
al., 2008) and incidence rates are also declining in the UK, (Allender et al., 2008, Gale et al., 
2012) a fall that has been attributed to improvements in risk factors for CVD, by means of 
lifestyle improvements (Unal et al., 2004).  
A UK national target set in 1999 to reduce the death rate from CHD and stroke, among other 
diseases, by at least two fifths by 2010 was reached in 2009. In addition there has been 
progress towards reducing CVD inequalities for death rates in England between the population 
as a whole and the most deprived areas (Townsend et al., 2012). Although death from CVD 
related causes is likely to always be one of the primary causes of death in any population, key 
aims must include improving rates in premature mortality, typically classed as death under 75 
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years. Over the past 10 years premature mortality from CVD in the UK has fallen by 44% and in 
2010 an estimated 28% of premature deaths in men and 19% in women were from CVD 
(Townsend et al., 2012). 
Trends in CVD incidence reflect trends in mortality in that they have been declining over the 
past few decades. In England, over 10% of men and 15% of women who are admitted to 
hospital for MI die within 30 days and for stroke the figures are higher but are measured over 
a 60 day period. In England, an estimated 17% of men and 25% of women admitted to hospital 
with strokes die within 60 days but these mortality rates are substantially lower in individuals 
under 75 years (Townsend et al., 2012).  
Gender differences in CVD mortality rates or life course disease trends exist (Nichols et al., 
2012, Vaidya et al., 2011), indicating the importance in exploring preventative strategies 
separately between the sexes. Social inequalities in CVD mortality rates persist and are more 
striking in women than men. In the most recently available data from 2001/03 it was 
estimated that female workers with routine jobs had CHD death rates five times higher than 
their professional/managerial counterparts (Townsend et al., 2012). Given that ‘most CVD in 
women is preventable’ (Mosca et al., 2007, Worrall-Carter et al., 2011), the current work 
utilises dietary data from middle-aged women and explores fatal CVD risk in relation to total 
fibre intake as well as exploring major food sources of fibre, in order to characterise potentially 
beneficial dietary behaviour.  
5.3 Method 
5.3.1 Dietary data 
A validated 217-item FFQ was used at baseline to assess typical intake over the previous 12 
months (Calvert et al., 1997, Cade et al., 2004a). NSP intake values were estimated using data 
from McCance & Widdowson’s The Composition of Foods (5th edition) (Holland et al., 1991) 
Fibre calculated using the AOAC method, in addition to soluble and insoluble fibre intakes 
were also used.  
NSP estimates from specific food sources were also generated and include fibre from the 
following food groups: total cereal foods, breakfast cereals, vegetables (excluding potatoes), 
fruit (excluding juice), legumes and nuts/seeds. 
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Refer back to the ‘Dietary assessment’ section of Chapter 3 for additional details on dietary 
data collection or generation of exposure variables.  
5.3.2 Mortality data 
Mortality data were available from baseline for participants who provided sufficient 
information for their records to be traced through the NHSIC (98% of baseline participants 
were traced to allow linkage). Deaths were classified using ICD 9th edition and 10th edition 
codes. Fatal cerebrovascular events were identified with codes 430 to 438 or I60 to I698 and 
fatal IHD events with codes 410 to 4149 or I20 to I259. CVD cases were classed as either a 
cerebrovascular or heart disease case. Refer back to the ‘Mortality Data’ section of Chapter 4 
for additional information. 
5.3.3 Exclusions 
Participants were excluded from analyses where the following criteria were met:  
1) Not successfully tracked through the NHSIC (generally because NHS number or date of 
birth were incorrect) (n=695) 
2) Tracked through national registers but did not provide both lifestyle and dietary 
information (n=318) 
3) Daily calorie intake from the FFQ was outside a plausible range (500-6000 kcal/day) 
(n=405) 
4) Reported personal history of cancer (n=2445), stroke (n=264), diabetes (n=646) or heart 
attack (n=498) at study baseline  
5) Died within one year of returning FFQ (removed to limit reverse causality for any latent 
disease that may have caused diet to change) (n=98) 
6) Requested their data not to be used in future studies (n=1) 
5.3.4 Testing dose-response and non-linear associations 
For full sample analyses (not subgroups), fibre intake was explored as a categorical exposure 
(fifths of intake) where each subsequent category was compared to the lowest intake category 
or where low and high consumers were compared to the middle intake group, in order to 
observe the shape of any associations. Models with continuous exposure variables were also 
used to determine whether any associations were linear, thus meeting one of the established 
criteria for causality (Hill, 1965).  
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Subgroup analyses were carried out only with the continuous exposure to minimise the effects 
of multiple testing and because case numbers were diminished, so splitting the samples into 
fifths would have resulted in small case numbers in each group.  
5.3.5 Descriptive statistics 
After exclusions, characteristics of high and low fibre consumers were explored when the 
sample was split into five categories based on NSP intake. The same dietary and lifestyle 
characteristics were also explored separately for women who reported personal history of 
stroke or heart attacks at baseline and were therefore excluded from analyses, those not 
classified as cases by the censor date (either died of other causes or were alive until study 
censor date) and those who became cases (study censor dates are discussed in Chapter 4). 
Stata version 11 (Statacorp, 2009) was used for all data manipulation and analyses in this 
chapter.  
5.3.6 Survival analyses 
Survival analyses were conducted using Cox regression (Cox and Oakes, 1984). The time 
variable used in survival analyses was time in the study (person years), calculated as the time 
from the date the questionnaire was completed until either a report of death or the censor 
date of the analysis, whichever comes first. Note that the censor date for those who died of 
other causes was their date of death. Censor date for surviving participants was set at 
February 2011, approximately the latest date of death received to that point for the cohort. 
Models were weighted by the inverse of the probability of being sampled to take into account 
the large proportion of vegetarians in the cohort and give less weight in models to data from 
vegetarian participants. The weighting variable had been generated by Dr Darren Greenwood 
for a previous study (Cade et al., 2007). 
5.3.7 Checking proportional hazards 
In order to ensure variables in the model were associated with proportional hazards over time, 
each variable was examined using log-log survival curves for each of the three outcomes (IHD, 
stroke, CVD) to ensure the survival function was constant over time and hazards were 
proportional in different groups. Here, the survival function [–ln(-ln(S))] was plotted over 
ln(time). Categorical variables were plotted with two or three categories and continuous 
variables were divided into two equal weight groups to explore whether risks were 
proportional in the high vs. low fibre consumers or younger vs. older women etc. Roughly 
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parallel lines on these plots indicate that hazards are proportional over time among different 
intake or lifestyle groups, thus meeting the requirement for the models.  
Figure 5.2 displays smoothed (log-log) survival curves for IHD mortality in higher compared to 
lower NSP consumers. The closely parallel lines display how the hazards in low and high 
consumers are similar over the time frame of the study. This gives confidence that generating 
one hazard ratio for the association between NSP and risk is therefore sufficient to explain the 
association over the whole study duration because the risk association is constant in high 
compared to low level consumers.  
This condition was met and hazard ratios were proportional in the case of each exposure and 
for all covariates used in models. 
 
Figure 5.2 Survival function for IHD mortality in those consuming lower and higher NSP 
density diets  
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5.3.8 Confounder adjustment 
Confounders are generally considered to be causal determinants of outcomes and are also 
associated with exposure (Wang, 2002). The concept of using causal diagrams to explore 
confounders has been formalised with the use of directed acyclic graphs (DAGs) and 
arguments supporting this approach are detailed by Greenland et al. (Greenland et al., 1999). 
DAGs allow the user to identify which potential confounders to adjust for in models to help 
limit over- or under-adjustment (Greenland et al., 1999).  
Selection of confounding variables to adjust for in models was undertaken in the first instance 
using a DAG to identify the minimal number of adjustments needed, to avoid issues of over 
adjustment. Firstly, a diagram was drawn for all causal paths between exposure, confounders 
and outcome, then arrows originating from the exposure (fibre) were removed. Unblocked 
backdoor paths were then identified. These ‘unblocked’ paths are defined as routes between 
fibre and CVD using arrows of any direction that do not incorporate ‘colliders’. Colliders are 
considered to ‘block’ a path and exist where the arrows of a certain path both point towards 
each other at a variable on the path. 
These principles are detailed using the simplified DAG example below (Figure 5.3), unblocked 
backdoor paths exists between CVD and fibre via two confounder paths [CVDCBFibre] 
[CVDCAFibre], but not another [CVD EDBFibre], as arrows collide at ‘D’ on this 
path. Using this example, A, B and C would be adjusted for in the model but D and E would not. 
 
Figure 5.3 Example of simplified directed acyclic graph 
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A causal diagram for fibre, CVD and associated potential confounders has been generated for 
the UKWCS so the method of using DAGs can be applied here (Figure 5.4). In principle, it may 
only be necessary to adjust for a few confounders in a system or for one variable within an 
unblocked backdoor path because confounders on one path are causally related and 
adjustment for just one represents the minimal sufficiency set (Greenland et al., 1999). 
However, applying this principle here would mean adjusting only for SES, family history and 
age as all paths run via these three confounders. A problem with categorising participants into 
just three groups based on SES is that this simple classification is not likely to accurately 
capture the complexity of the relationship between many lifestyle characteristics and fibre or 
CVD and other confounding variables were therefore also used as adjustments as they existed 
on separate backdoor paths.   
 
Figure 5.4 Causal diagram for the variables associated with fibre and CVD 
 
Correlations between different potential confounders (continuous variables) were explored in 
order to identify collinear associations and avoid over-adjustment in models (Table 5.1). These 
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tests revealed that the selected variables were not so closely associated to preclude them 
from being used as adjustments in the same model.  
Table 5.1 Correlation between continuous variables 
 Age Saturated 
fat 
BMI Physical 
activity 
Ethanol Fibre 
Energy 0.00  0.76 -0.01 0.17 -0.03 0.68 
Age  0.01 0.14 -0.04 -0.10 0.02 
Saturated Fat   0.01 0.12 0.02 0.22 
BMI    -0.04 -0.06 -0.08 
Physical 
activity 
    -0.01 0.15 
Ethanol      -0.06 
 
Notes on selection of potential confounders: 
 Vegetarian status was not included as a confounder since models had been weighted on 
this factor.  
 An ANOVA test revealed significant differences (p<0.001) in the distribution of participants 
across categories for SES and education. As education data were less complete for this 
sample, SES was selected as the adjustment within in the model.  
 Saturated fat intake correlated highly with energy intake (0.76) and this was therefore not 
included in models to avoid collinearity.  
 Menopausal status was not included as an adjustment as it is functionally related to age.   
 Ethnicity was not considered for adjustment because 99% of the cohort was classified as 
white and ethnicity did not appear to be related to fibre intake in the sample, likely 
because of the relatively small number of non-white participants. 
 History of hypertension or angina was not used as an adjustment in models as both sit on 
the causal pathway for the development of CVD. 
 BMI is considered both as a potential confounder and effect modifier in Figure 4.4 because 
of the many potential mechanisms through which fibre may affect CVD risk. If protective 
effects of fibre are mediated through body weight changes then this exists on the causal 
pathway and need not be adjusted for. If another mechanism is in play then BMI should be 
included as a potential confounder as BMI will dictate energy intake (and thus fibre) and is 
also causally related to CVD risk. It is also known that BMI is independently related to CVD 
risk and it may therefore modify any effect of fibre on CVD risk.  
 Family history of disease data were not available for use. 
147 
 
 
 
The following three levels of adjustment were applied: 
1) Age (years)  
2) Age (years), alcohol (ethanol g/day), smoking status (non-smoker, current-smoker, ex-
smoker), physical activity-metabolic equivalents (MET-hours/week) and SES 
(professional/managerial, intermediate or routine/manual). 
3) As model 2 with the addition of energy intake (kcal/day)* and BMI (kg/m2). 
* By way of sensitivity analysis, when modelling CVD risk associated with fibre density of the 
diet, energy intake was additionally excluded in separate models, as suggested for nutrient 
density analyses by Willett (2013b). Results were not appreciably different with or without 
adjustment for energy intake in fibre density analyses (data not shown) and the results 
presented here are without adjustment for energy intake. 
The intermediate model adjusted for potential confounders except for energy intake and BMI 
as the action of fibre on satiety, energy intake and ultimately BMI is one plausible mechanism 
for the action of fibre and adjustment for this could therefore mask potential effects. The 
inclusion of BMI and energy intake as adjustments did not greatly alter risk estimates. For 
brevity, results from model 2 are therefore not included in tables, as they offer little extra 
information but are discussed where relevant. 
5.3.9 Subgroup analyses 
Subgroup analyses were conducted for potential effect modifiers, where a biologically 
plausible mechanism exists for the different effect of fibre on CVD within these subgroups.  
1) Menopausal status was explored through subgroup analyses because of its proposed 
independent association with CVD risk, possibly via influencing lipid changes (Matthews et 
al., 2009). Too few cases existed in the pre-menopausal women to allow analysis with this 
sub-group. Menopausal status groups were derived in a previous study (Cade et al., 2007) 
and briefly, women were classified as either pre-menopausal, post-menopausal or ‘not 
applicable’, which included women who were pregnant, taking contraceptive pills or using 
hormone replacement therapy.  
2) BMI was explored through subgroup analyses since greater BMI has been independently 
associated with CHD risk (Nordestgaard et al., 2012, Logue et al., 2011) and may modify 
the effect of fibre. World Health Organisation cut-points were applied to group 
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participants on BMI; underweight BMI <18.5, healthy weight BMI 18.5-24.9, overweight 
BMI 25.0-29.9, obese BMI ≥30 kg/m2. Overweight and obese participants (BMI ≥25kg/m2) 
were grouped due to insufficient case numbers in either group separately. Subgroup 
analyses were therefore conducted in women who reported a healthy BMI at baseline and 
those who were classed as overweight or obese. 
3) Personal history of hypertension or angina (cardiovascular event risk factors) were also 
considered potential effect modifiers as they may interact with any protective association 
of fibre on cardiovascular health. Analyses were conducted only on those not reporting 
history of angina or hypertension at baseline as there were insufficient event cases to run 
models for those with a history of these conditions. 
5.3.10 Statistical significance 
For primary analyses (full sample) a 2-sided p-value ≤0.05 was considered statistically 
significant but to acknowledge issues with multiple testing, for subgroup analyses the accepted 
p-value was reduced to ≤0.01, thus reducing the probability of observing false positive results.  
5.4 Results 
5.4.1 Descriptive statistics 
After applying exclusions, 31,036 women remained from 35,690. Table 5.2 shows the 
characteristics and cardiovascular risk factors for those women who at baseline had reported a 
personal history of stroke or heart attacks, and therefore were excluded from the analysis and 
data for those women who subsequently developed CVD during the study period. As expected, 
the non-cases were younger, with a median age of 50 years (IQR 14), compared to 67 years 
(IQR 11) and 66 years (IQR 11) for the stroke and IHD cases, respectively (p<0.001 for 
comparisons of cases to non-cases). Unsurprisingly, menopausal status also was significantly 
different for cases and non-cases with 78% of cases being classified as postmenopausal 
compared to 35% of non-cases (p<0.001); a reflection of greater age in the case group.  
BMI was lower in the non-cases compared to IHD cases (23.6 vs. 24.6 kg/m2, p<0.001) but BMI 
was not significantly different for stroke cases and non-cases (24.1 vs. 23.6 kg/m2, p=0.98).  
The proportion of women grouped by each SES category was also not different when 
comparing stroke cases and non-cases but differed significantly for IHD and CVD cases 
compared to non-cases. Educational achievement was significantly different for cases and non-
cases for all disease comparisons, with a greater proportion of women grouped in the lower 
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educational achievement groups for stroke and IHD cases (36 and 37%) compared to non-cases 
(15%).   
Ethanol intake was markedly lower for the IHD cases, 1.2g/day (IQR 7.2) compared to stroke 
cases, 5.0g/day (IQR 12.2) and the non-cases 5.5g/day (IQR 11.6). Smoking status classification 
was also different among cases and non-cases. Many other lifestyle characteristics however 
did not differ among cases and non-cases. Physical activity was 14.3 MET-hours/week (IQR 
13.9) for IHD cases and 12.3 (IQR 12.6) in stroke cases and was similar in non-cases, 14.5 (IQR 
13.2). Dietary characteristics such as energy intake, saturated fat intake and total dietary fibre 
also did not differ among cases and non-cases. The exceptions to this were fibre from 
breakfast cereals for IHD cases (2.1g/day) vs. non-cases (1.8g/day) (p=0.05) and fibre from 
legumes which was significantly different in IHD cases (0.8g/day) and stroke cases (0.9g/day) 
compared to non-cases (1.1g/day), p<0.001. 
Table 5.3 shows how characteristics differ across increasing categories of fibre (NSP) intake. 
Age appears to vary little with increasing fibre intake but an ANOVA test indicated significant 
age differences among fibre quintiles (p<0.01). BMI clearly decreases across increasing 
categories (p<0.001), whilst physical activity and energy intake both increase across increasing 
fibre intake categories (p<0.001). 
Unsurprisingly, fewer meat-eaters and more vegetarians were categorised in the higher fibre 
intake groups and a Chi2 test revealed significant differences among groups (p<0.001).  More 
smokers were classed within the lower intake groups, a difference that was also significant 
among the categories (p<0.001). Additionally, the education and socio-economic profile 
improved with increased levels of fibre intake.  
Saturated fat intake was not significantly different in cases or non-cases but did increase with 
increasing fibre intake quintiles, the difference between quintiles was statistically significant 
(p<0.001). The increasing saturated fat intake level seen with increasing fibre intake, likely 
reflects greater overall consumption of food across increasing fibre intake groups.  
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Table 5.2 Baseline cross-sectional characteristics in those excluded because of history of 
stroke and heart-attacks, those subsequently suffering a fatal stoke or IHD and those women 
still alive at censor date or whose cause of death was not attributed to CVD 
 History of 
stroke or 
IHD 
(excluded 
from 
analysis) 
Fatal 
Stroke 
Fatal IHD Non-cases 
(No fatal 
stroke or 
IHD) 
P-value 
stroke 
vs. non 
stroke 
cases† 
P-value 
IHD vs. 
non IHD 
cases† 
P-value 
CVD vs. 
non CVD 
cases† 
N 565 130 128 30778    
Age, years 62.6(12.4) 67.3(11.4) 65.8(10.5) 50.3 (14.1) <0.001 <0.001 <0.001 
BMI, kg/m
2
 25.5 (5.7) 24.1 (5.1) 24.6 (6.2) 23.6 (4.7) 0.98 <0.001 0.01 
Smoking 
status (%) 
Current  68 (13) 22 (18) 24 (20) 3228 (11) 
0.01 <0.01 <0.01 Former 222 (40) 27 (22) 43 (35) 9123 (30) 
Never smoked 274 (47) 76 (60) 56 (45) 17545 (59) 
Diet group 
(%) 
Meat-eaters 437 (77) 99 (76) 98 (77) 20478 (67) 
0.10 0.07 <0.01 Fish-eaters 61 (11) 12 (9) 13 (10) 3938 (13) 
Vegetarian 67 (12) 19 (14) 17 (13) 6363 (21) 
Socio-
economic 
status NS-
SEC (%) 
Professional/ 
managerial 
316 (58) 71 (58) 63 (52) 19214 (64) 
0.45 0.01 0.01 Intermediate 161 (30) 38 (31) 48 (40) 8198 (27) 
Routine and 
manual 
66 (12) 13 (11) 10 (8) 2722 (9) 
Highest 
educational 
achieve-
ment (%) 
No formal 
record 
166 (33) 37 (36) 38 (37) 4469 (15) 
<0.001 <0.001 <0.001 O-level 122 (25) 20 (20) 25 (24) 8909 (32) 
A-level 115 (23) 22 (22) 17 (16) 7039 (25) 
Degree 93 (19) 23 (22) 24 (23) 7834 (28) 
Menopause 
status (%) 
Postmenopause 384 (70) 100 (78) 94 (78) 10657 (35) 
<0.001 <0.001 <0.001 Premenopause 64 (12) 9 (7) 6 (5) 12808 (42) 
Not applicable‡ 99 (18) 19 (15) 21(17) 6838 (23) 
History of angina at 
baseline (%) 
Yes 162 (37) 6 (5) 11 (10) 374 (1) <0.001 <0.001 <0.001 
No 277 (63) 104 (95) 99 (90) 28421 (99)    
History of 
hypertension at 
baseline (%) 
Yes 245 (52) 48 (41) 46 (39) 4596 (16) <0.001 <0.001 <0.001 
No 
226 (48) 69 (59) 73 (61) 24768 (84)    
Ethanol g/day 2.1 (10.0) 5.0 (12.2) 1.2 (7.2) 5.5 (11.6) 0.39 <0.001 <0.01 
Physical activity, MET-hrs/wk 14.4(14.3) 14.3(13.9) 12.3(12.6) 14.5 (13.2) 0.54 0.27 0.22 
Energy intake, kcal/day 2202 
(952) 
2175 
(1010) 
2215 
(864) 
2187  
(863) 
0.52 0.40 0.29 
Saturated fat intake g/day 26.9(16.3) 28.2(15.7) 26.7(16.4) 27.0 (16.0) 0.66 0.72 0.57 
NSP, g/day 24.3(13.3) 23.0(14.5) 23.3(12.1) 23.8 (12.4) 0.30 0.39 0.18 
NSP density, g/1000kcal/day 11.1 (4.3) 11.1 (4.6) 11.0 (5.0) 11.0 (4.2) 0.64 0.86 0.65 
AOAC fibre, g/day 37.6(20.4) 36.1(22.0) 34.8(17.1) 36.7 (18.9) 0.36 0.37 0.20 
AOAC fibre density, 
g/1000kcal/day 
17.2 (6.6) 17.1 (6.9) 16.3 (6.9) 16.9 (6.2) 0.68 0.79 0.63 
Soluble fibre, g/day 10.6 (5.7) 9.6 (5.6) 9.6 (4.7) 10.4 (5.0) 0.28 0.14 0.07 
Insoluble fibre, g/day 15.6 (9.5) 14.9(10.7) 14.4 (9.0) 15.3 (8.9) 0.36 0.55 0.28 
NSP 
within  
Foods, 
g/day 
 
Total fruit 4.5 (4.4) 4.2 (4.8) 3.9 (3.5) 4.2 (3.9) 0.17 0.60 0.55 
Vegetables 5.2 (4.7) 4.5 (3.6) 5.0 (4.2) 4.9 (3.7) 0.40 0.77 0.42 
Total cereal foods 7.8 (7.3) 7.2 (7.0) 7.5 (7.3) 7.6 (7.0) 0.82 0.38 0.65 
Breakfast cereals 1.9 (4.5) 2.1 (3.3) 1.7 (3.8) 1.8 (3.6) 0.84 0.0 0.12 
Nuts & Seeds 0.07(0.26) 0.07(0.17) 0.06(0.22) 0.08 (0.29) 0.12 0.20 0.05 
Legumes 1.1 (1.2) 0.8 (1.0) 0.9 (0.9) 1.1 (1.3) 0.01 0.01 <0.001 
Values are median (interquartile range) or frequency (percent) 
† p values were generated using χ
2
 for categorical variables and t-tests for continuous variables and the 
comparisons are between specific case types and all other participants except those with history of 
stroke or IHD  
‡ Pregnant, taking the contraceptive pill or hormone replacement therapy 
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Table 5.3 Dietary and lifestyle characteristics across increasing NSP quintiles, after applying 
exclusions to the sample 
 1
st
 fifth 2
nd
 fifth 3
rd
 fifth 4
th
 fifth 5
th
 fifth p-value† 
N 6207 6207 6207 6207 6208  
NSP g/day 14.2 (3.9) 19.5 (2.3) 23.8 (2.3) 29.1 (3.1) 38.3 (8.6)  
NSP density g/1000kcal/day 8.2 (2.9) 10.0 (3.0) 11.0 (3.2) 12.1 (3.4) 13.8 (3.8)  
AOAC fibre g/day 21.9 (6.0) 30.1 (3.9) 36.7 (4.2) 44.6 (5.3) 58.8 (13.8)  
Soluble fibre g/day 6.5 (1.9) 8.8 (1.6) 10.5 (1.9) 12.5 (2.2) 16.3 (4.3)  
Insoluble fibre g/day 8.4 (2.7) 12.2 (2.0) 15.3(14.3) 19.0 (2.6) 25.6 (6.2)  
Age, years 50.0(13.8) 50.2(14.1) 50.6(14.0) 50.1(14.4) 50.7 (14.5) 0.005 
BMI, kg/m
2
 24.0 (5.1) 23.8 (4.8) 23.6 (4.5) 23.3 (4.5) 23.1 (4.3) <0.001 
Hypertension at baseline % 19 18  17 18 18 0.356 
Angina at baseline % 1.3 1.1 1.1 1.3 1.5 0.266 
Frequency 
of deaths 
Stroke 37 21 21 22 24 0.156 
IHD 26 30 20 26 17 0.566 
CVD (stroke+IHD) 63 51 41 48 41 0.250 
Smoking 
status (%) 
Current smoker  1075 (18) 701 (12) 545 (9) 489 (8) 464 (8) <0.001 
Former smoker 1751 (29) 1831 (30) 1843 (30) 1904 (31) 1864 (31) 
Never smoker 3189 (53) 3507 (58) 3658 (61) 3652 (61) 3671 (61) 
Diet group 
(%) 
Meat-eaters 4959 (80) 4525 (73) 4281 (69) 3718 (60) 3192 (51) <0.001 
Fish-eaters 429 (7) 629 (10) 760 (12) 949 (15) 1196 (19) 
Vegetarian 819 (13) 1053 (17) 1167 (19) 1540 (25) 1820 (29) 
Socio-
economic 
status 
NSSEC % 
Professional/ 
managerial 
3711 (61) 3784 (62) 3889 (64) 3945 (65) 4019 (66) 
<0.001 
Intermediate 1759 (29) 1708 (28) 1672 (27) 1607 (27) 1538 (25) 
Routine and manual 589 (10) 597 (10) 525 (9) 514 (8) 520 (9) 
Highest 
educational 
achieve-
ment % 
No formal record 1096 (19) 911 (16) 862 (15) 791 (14) 884 (16) <0.001 
O-level 1925 (34) 1788 (31) 1821 (32) 1715 (30) 1705 (30) 
A-level 1283 (23) 1397 (25) 1436 (25) 1516 (27) 1446 (25) 
Degree 1367 (24) 1566 (28) 1602 (28) 1690 (29) 1656 (29) 
Menopause 
status % 
Postmenopausal 2123 (35) 2094 (34) 2198 (36) 2172 (36) 2264 (37) 0.019 
Premenopausal 2543 (42) 2653 (43) 2534 (41) 2598 (42) 2495 (41) 
Not-applicable‡ 1432 (23) 1375 (23) 1391 (23) 1338 (22) 1342 (22) 
Ethanol g/day 5.7 (13.1) 5.6 (12.2) 5.8 (11.6) 5.4 (11.0) 4.8 (10.7) <0.001 
Physical activity, MET-hrs/wk 12.3(12.2) 13.6(12.2) 14.4(12.6) 15.2(12.8) 17.0 (14.8) <0.001 
Energy intake, kcal/day 1642(573) 1946(578) 2173(623) 2407(682) 2877 (873) <0.001 
Saturated fat intake g/day 23.2(13.7) 25.5(14.8) 27.3(15.4) 28.5(16.1) 30.9 (18.1) <0.001 
Values are median (interquartile range) or frequency (percent) 
† p values were generated using χ2 for categorical variables and t-tests for continuous variables  
‡ Pregnant, taking the contraceptive pill or hormone replacement therapy 
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Case numbers 
At follow up, a total of 258 deaths attributable to CVD were observed. Nine of the 128 IHD 
cases and five of the 130 stroke cases had missing BMI data and SES data were missing from an 
additional 6 IHD and 8 stroke cases. Fully adjusted models therefore included 113 IHD and 117 
stroke cases. Subgroup analyses included fewer cases and the numbers included in fully-
adjusted models are listed in Table 5.4. 
Table 5.4 IHD, stroke and CVD case numbers in full sample and subgroup analyses 
 Sample 
number 
IHD cases in 
fully-
adjusted 
model 
Stroke cases 
in fully-
adjusted 
model 
CVD cases 
in fully-
adjusted 
model 
Full sample 31036 113 117 230 
Postmenopausal women 10851 85 89 174 
No history of hypertension or angina 26143 67 69 136 
BMI 18.5-24.9kg/m2 19042 55 65 120 
BMI ≥25kg/m2 11331 55 45 100 
 
5.4.2 Survival analysis  
In total, 31,036 women free from personal history of stroke or heart attacks were followed for 
a median of 14.3 years (IQR 1.4). The cause of death was attributed to stroke in 130 
participants and 128 fatal IHD cases were observed.  
HRs and 95% CIs for IHD, stroke and CVD mortality in relation to increasing fifths of the various 
fibre exposures are presented along with HRs for the linear dose-response associations in age-
adjusted and fully adjusted models (Table 5.5). Results from intermediate models (without 
adjustment for BMI and energy intake) have not been presented as they did not appreciably 
differ from age or fully-adjusted models. For example, HRs for the age-adjusted, intermediate 
and fully-adjusted models for fatal CVD risk and each 6g/day higher total fibre intake were 
respectively, 0.93 (95% CI: 0.85 to 1.02) p=0.13, 0.96 (95% CI: 0.88 to 1.06) p=0.45 and 0.92 
(95% CI: 0.80 to 1.05) p=0.20.  
Comparisons were also made between lower or higher intake groups using a middle reference 
category, rather than comparing all levels to the lowest intake category, as the lowest 
consumers may differ in other characteristics not accounted for through adjustments (results 
not displayed in tables). 
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Full sample results-overview 
For analyses including the full sample, no statistically significant results were observed for 
models using the continuous exposures, indicating that there is no evidence of a linear dose-
response relationship between the fibre exposures and risk of fatal IHD, stroke or CVD (Table 
5.5). The risk estimates are all less than 1, which would indicate an inverse association, but CIs 
span 1 in each model.  
The models examining quintiles of fibre intake and risk did indicate inverse relationships but 
only for one or two quintiles compared to the lowest intake group. In most cases, statistical 
significance in age-adjusted models was attenuated in the multivariate models. In multivariate 
models displaying some statistically significant results, significance was often seen in just one 
or two of the four intake comparisons with the lowest quintile, despite HRs all being indicative 
of a protective association (lower than 1). The results for stroke risk and fibre from nuts and 
seeds depict this well, HRs and 95% CIs for comparisons with Q1 were as follows: Q2 0.86 (0.52 
to 1.43) p=0.57; Q3 0.63 (0.35 to 1.13) p=0.12; Q4 0.50 (0.26 to 0.95) p=0.03; Q5 0.45 (0.23 to 
0.85) p=0.01. Here, risk estimates decrease with greater intake levels, but statistical 
significance was reached in only two of the four comparisons. This likely explains the close but 
non-significant result for the continuous exposure risk estimate: risk of fatal stroke was 
reduced by 8% per 0.2g/day increase in fibre from nuts and seeds but this was not statistically 
significant 0.92 (0.83 to 1.02) p=0.13 (Table 5.5).  
Modelling risk in high and low intakes compared to the mid-intake group 
Modelling risk in quintile 1, 2, 4 and 5 compared to the middle category (Q3) on the whole 
provided little extra insight into the association between fibre from different sources as none 
of the results proved statistically significant. For fatal IHD risk and total fibre intake, no 
associations were seen in those consuming high or low intakes compared to the middle-intake 
category.  
Stroke risk was greater in low fibre (NSP or AOAC) consumers compared to the middle intake 
group, for the lowest NSP group, HR 2.10 (95% CI: 1.08 to 4.11) p=0.03 and lowest AOAC group 
HR 2.11 (95% CI: 1.11 to 3.99) p=0.02, compared to Q3. 
Risk of fatal CVD was 62% higher in comparisons for both the lowest intake groups for AOAC 
fibre density and insoluble fibre compared to the middle intake group, AOAC density HR 1.62 
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(95% CI: 1.02 to 2.56) p=0.04; Insoluble fibre HR 1.62 (95% CI: 1.02 to 2.58) p=0.04 and also for 
Q2 vs. Q3 of insoluble fibre intake HR 1.60 (95% CI: 1.01 to 2.53) p=0.05.  
Taken together, these findings indicate lower fibre density or insoluble fibre are associated 
with greater fatal CVD risk and lower total fibre is associated with stroke risk increase. 
However, there did not appear to be a clear risk trend across increasing quintiles of fibre 
intakes except for this greater risk in the lowest intake level.  
Total NSP and AOAC fibre intake and fibre density  
No apparent association was seen for total dietary fibre, assessed either as NSP or AOAC and 
IHD risk. For stroke events, estimates indicated roughly 50% reduction in risk across many of 
the intake categories compared to the lowest intake level. Those consuming approximately 
45g/day AOAC fibre compared to 21g/day saw a 53% risk reduction HR 0.47 (95% CI: 0.25 to 
0.90) p=0.02. This association was not observed in Q2 or Q5 compared to Q1, which likely 
explains why the examination of continuous fibre intake did not indicate a protective 
association. 
As noted above, stroke risk was significantly increased in the lowest total fibre intake 
categories compared to mid-intake levels. 
There did not appear to be an association between fibre density (assessed either as NSP or 
AOAC) and risk of fatal IHD, stroke or CVD. 
Soluble and insoluble fibre 
Although the majority of risk estimates were on the side of indicating a protective association, 
CIs were generally wide and no significant associations were observed for soluble or insoluble 
fibre intake and risk of fatal IHD, stroke or CVD, in the full sample.  
Fibre from food sources 
Similar to total fibre intake, no specific food sources of fibre were significantly associated with 
fatal IHD, stroke or CVD risk in fully adjusted models using the full sample. One or two quintile 
comparisons were statistically significant, but this did not carry through to the linear dose-
response test. Stroke risk was reduced by 55% for the highest group compared to the lowest 
intake of fibre from nuts and seeds HR 0.45 (95% CI: 0.23 to 0.85) p=0.01, but for every 
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0.2g/day increase in intake, the association was not statistically significant HR 0.92 (95% CI: 
0.83 to 1.02) p=0.13. 
Subgroup analyses 
No significant associations were observed with any of the fibre exposures and risk of IHD, 
stroke or CVD in the sample of postmenopausal women or those with BMI within the healthy 
range at baseline (Table 5.6 and 5.7).  
In women whose baseline BMI was ≥25kg/m2 (n=11,331) 45 stroke cases were observed. Risk 
of fatal stroke appeared to be significantly reduced with greater intake of fibre from nuts and 
seeds (Table 5.8). With every 0.2g/day increase, risk was reduced by 32%, HR 0.68 (95% CI: 
0.48 to 0.98) p=0.04, but this result did not reach the 1% pre-specified significance criterion. 
However, stroke risk was significantly reduced with greater cereal fibre intake in women 
whose baseline BMI was ≥25kg/m2 HR 0.80 (95% CI: 0.65 to 0.93) p<0.01. No other notable 
associations were seen in this subgroup for risk of IHD or CVD. 
In a healthy sub-sample of women, who were free of hypertension or angina at baseline 
(n=26,143) 69 stroke cases were observed and a protective association was seen for both NSP 
and AOAC fibre density and stroke risk (Table 5.9). For every 2g/1000kcal/day increase in NSP 
fibre, risk was reduced by 17%, HR 0.83 (95% CI: 0.70 to 0.99) p=0.04 and by 18% for every 
3g/1000kcal/day increase in AOAC fibre, HR 0.82 (95% CI: 0.68 to 0.99) p=0.04. However, these 
results did not reach the pre-specified 1% significance level and so must be interpreted with 
caution because of the greater chance for type I error or false positive findings. Surprisingly, in 
this sub-group, greater risk of fatal IHD was associated with increasing fibre from total cereal 
foods, although this 15% risk increase was not significant at the 1% level; risk was 1.15 (95% CI: 
1.00 to 1.31) p=0.05, for each 3g/day increase in fibre from cereal foods. 
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Table 5.5 Cardiovascular mortality risk assessed using both categorised fibre intake and by fitting a linear dose-response trend, using fibre as a continuous 
variable 
 Median 
intake (IQR) 
CHD HR (95% CI) p-value Stroke HR (95% CI) p-value Total CVD HR (95% CI) p-value 
Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 
NSP 
(g/day) 
Q1 14.1 (3.9) 24 1 1 34 1 1 58 1 1 
Q2 19.4 (2.3) 28 0.99 (0.58, 1.68) 1.30 (0.76, 2.24) 21 0.61 (0.35, 1.04)  0.63 (0.35, 1.12) 49 0.78 (0.54, 1.14) 0.90 (0.61, 1.34) 
Q3 23.8 (2.3) 18 0.75 (0.42, 1.33) 0.93 (0.48, 1.82) 19 0.48 (0.27, 0.86) 0.48 (0.24, 0.93) 37 0.60 (0.40, 0.90) 0.66 (0.41, 1.06) 
Q4 29.1 (3.1) 26 0.84 (0.49, 1.45) 1.15 (0.61, 2.17) 21 0.57 (0.33, 0.99) 0.55 (0.39, 1.04) 47 0.69 (0.47, 1.02) 0.79 (0.51, 1.24)  
Q5 38.3 (8.6) 17 0.63 (0.34, 1.15) 0.89 (0.38, 2.08) 22 0.74 (0.44, 1.25) 0.61 (0.27, 1.36) 39 0.69 (0.47, 1.03) 0.74 (0.41, 1.33) 
Per 6g/day  
pTrend 
 113 0.92 (0.80, 1.05) 
0.22 
0.96 (0.79, 1.17) 
0.69 
117 0.95 (0.84, 1.07) 
0.37 
0.87 (0.73, 1.04) 
0.13 
230 0.93 (0.85, 1.02)  
0.13 
0.92 (0.80, 1.05) 
0.20 
AOAC 
(g/day) 
Q1 21.0 (5.9) 27 1 1 35 1 1 62 1 1 
Q2 30.0 (3.4) 26 0.89 (0.52, 1.50) 1.18 (0.68, 2.03) 20 0.57 (0.33, 0.99) 0.59 (0.32, 1.06) 46 0.72 (0.49, 1.05) 0.84 (0.56, 1.25) 
Q3 36.8 (3.5) 18 0.72 (0.42, 1.26) 0.82 (0.43, 1.58) 20 0.50 (0.28, 0.87) 0.47 (0.25, 0.90) 38 0.60 (0.41, 0.89) 0.62 (0.39, 0.98) 
Q4 44.8 (4.8) 26 0.76 (0.44, 1.29) 0.99 (0.52, 1.86) 21 0.58 (0.34, 1.00) 0.54 (0.29, 1.00) 47 0.66 (0.45, 0.97) 0.72 (0.46, 1.13) 
Q5 63.0 (13.5) 16 0.56 (0.30, 1.02) 0.72 (0.28, 1.83) 21 0.69 (0.40, 1.16) 0.51 (0.21, 1.26) 37 0.63 (0.42, 0.93) 0.61 (0.32, 1.17) 
Per 11g/day  
pTrend 
 113 0.90 (0.76, 1.07) 
0.23 
0.96 (0.73, 1.26) 
0.76 
117 0.94 (0.81, 1.09) 
0.42 
0.86 (0.68, 1.08) 
0.19 
230 0.92 (0.82, 1.03)  
0.15 
0.91 (0.76, 1.08) 
0.28 
NSP 
density  
g/1000 
kcal/day 
Q1 7.4 (1.5) 29 1 1 27 1 1 56 1 1 
Q2 9.4 (0.8) 20 0.66 (0.38, 1.16) 0.85 (0.47, 1.52) 23 0.75 (0.43, 1.30) 0.81 (0.46, 1.44)  43 0.70 (0.47, 1.04) 0.83 (0.55, 1.24)  
Q3 11.0 (0.8) 22 0.72 (0.41, 1.25) 0.91 (0.51, 1.63) 19 0.64 (0.36, 1.15)  0.71 (0.39, 1.29)  41 0.68 (0.46, 1.02)  0.80 (0.53, 1.22)  
Q4 12.7 (1.0) 19 0.70 (0.40, 1.22)  0.74 (0.40, 1.38)  23 0.80 (0.46, 1.39) 0.79 (0.44, 1.44)  42 0.75 (0.51, 1.11)  0.77 (0.50, 1.19)  
Q5 15.4 (2.3) 23 0.84 (0.49, 1.43) 0.99 (0.55, 1.76)  25 0.82 (0.47, 1.43)  0.89 (0.49, 1.62) 48 0.83 (0.57, 1.22) 0.94 (0.62, 1.42)  
Per 2g/1000 kcal/day  
pTrend 
113 0.98 (0.85, 1.14) 
0.81 
0.95 (0.86, 1.06) 
0.89 
117 0.92 (0.81, 1.04) 
0.17 
0.92 (0.80, 1.05) 
0.21 
230 0.95 (0.86, 1.05)  
0.30 
0.95 (0.86, 1.06) 
0.37 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.3 (2.1) 31 1 1 28 1 1 59 1 1 
Q2 14.6 (1.2) 22 0.63 (0.37, 1.09) 0.76 (0.43, 1.33) 20 0.62 (0.25, 1.09) 0.65 (0.36, 1.16) 42 0.62 (0.42, 0.92) 0.70 (0.47, 1.05)  
Q3 16.9 (1.1) 21 0.70 (0.41, 1.19) 0.81 (0.46, 1.44) 21 0.64 (0.36, 1.12) 0.68 (0.38, 1.21) 42 0.67 (0.45, 0.99) 0.74 (0.49, 1.11) 
Q4 19.4 (1.4) 18 0.59 (0.33, 1.03) 0.68 (0.37, 1.25) 25 0.76 (0.44, 1.31) 0.84 (0.47, 1.49) 43 0.67 (0.45, 0.99) 0.76 (0.50, 1.15)  
Q5 24.3 (3.6) 21 0.73 (0.42, 1.25) 0.81 (0.45, 1.47) 23 0.75 (0.43, 1.31) 0.76 (0.42, 1.40) 44 0.74 (0.50, 1.09)  0.79 (0.52, 1.21)  
Per 3g/1000 kcal/day  
pTrend 
113 0.98 (0.84, 1.15) 
0.81 
0.99 (0.84, 1.17) 
0.92 
117 0.92 (0.80, 1.05) 
0.20 
0.92 (0.80, 1.06) 
0.24 
230 0.95 (0.86, 1.05)  
0.32 
0.96 (0.86, 1.07) 
0.42 
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 Median 
intake (IQR) 
CHD HR (95% CI) p-value Stroke HR (95% CI) p-value Total CVD HR (95% CI) p-value 
Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 29 1 1 31 1 1 60 1 1 
Q2 8.6 (0.9) 24 0.88 (0.52, 1.47) 0.91 (0.52, 1.61) 27 0.80 (0.47, 1.36) 0.89 (0.50, 1.60) 51 0.84 (0.58, 1.22) 0.90 (0.60, 1.35)  
Q3 10.4 (0.9) 20 0.65 (0.37, 1.14) 0.88 (0.47, 1.62) 15 0.56 (0.31, 1.01) 0.52 (0.26, 1.03) 35 0.60 (0.40, 0.91) 0.68 (0.43, 1.08)  
Q4 12.5 (1.2) 21 0.64 (0.37, 1.11) 0.74 (0.37, 1.49) 26 0.85 (0.50, 1.43) 0.78 (0.40, 1.51)  47 0.74 (0.51, 1.08) 0.76 (0.47, 1.23)  
Q5 16.4 (3.8) 19 0.62 (0.35, 1.10) 0.76 (0.32, 1.80) 18 0.70 (0.40, 1.24)  0.60 (0.25, 1.43)  37 0.66 (0.44, 0.99) 0.68 (0.37, 1.25)  
Per 3g/day  
pTrend 
 113 0.87 (0.74, 1.03) 
0.12 
0.91 (0.69, 1.19) 
0.47 
117 0.95 (0.83, 1.10) 
0.52 
0.88 (0.70, 1.11) 
0.29 
230 0.91 (0.82, 1.02)  
0.11 
0.89 (0.75, 1.07) 
0.22 
Insoluble 
fibre 
(g/day) 
Q1 8.4 (2.6) 26 1 1 32 1 1 58 1 1 
Q2 12.4 (1.6) 29 1.00 (0.60, 1.68)  1.29 (0.76, 2.19) 21 0.68 (0.39, 1.17)  0.73 (0.41, 1.32)  50 0.83 (0.57, 1.21) 0.98 (0.66, 1.46) 
Q3 15.3 (1.6) 15 0.64 (0.36, 1.14)  0.67 (0.35, 1.31) 19 0.56 (0.32, 1.00) 0.57 (0.30, 1.07) 34 0.60 (0.40, 0.90) 0.62 (0.39, 0.98) 
Q4 19.1 (2.2) 27 0.80 (0.47, 1.36)  1.09 (0.58, 2.06)  22 0.63 (0.36, 1.10)  0.69 (0.37, 1.28)  49 0.71 (0.49, 1.04)  0.87 (0.56, 1.36)  
Q5 25.6 (6.0) 16 0.57 (0.31, 1.05) 0.75 (0.33, 1.71) 23 0.83 (0.49, 1.41) 0.78 (0.37, 1.67) 39 0.71 (0.48, 1.05)  0.78 (0.45, 1.36) 
Per 4g/day  
pTrend 
 113 0.94 (0.82, 1.08) 
0.38 
1.00 (0.82, 1.20) 
0.96 
117 0.95 (0.85, 1.07) 
0.40 
 
0.90 (0.78, 1.05) 
0.20 
230 0.95 (0.87, 1.03)  
0.23 
0.95 (0.84, 1.07) 
0.41 
Total 
cereal fibre 
(g/day) 
 
Q1 2.8 (1.4) 25 1 1 27 1 1 52 1 1 
Q2 5.1 (1.1) 18 0.70 (0.39,1.26) 0.87 (0.46, 1.65)  21 0.86 (0.49, 1.53)  0.88 (0.48, 1.62)  39 0.78 (0.52, 1.17)  0.88 (0.56, 1.36)  
Q3 7.6 (1.4) 27 0.98 (0.58, 1.65)  1.11 (0.61, 2.04)  26 0.92 (0.53, 1.59)  0.95 (0.53, 1.71)  53 0.95 (0.65, 1.39)  1.04 (0.68, 1.58)  
Q4 10.7 (1.8) 19 0.59 (0.33, 1.06)  0.72 (0.36, 1.45) 21 0.72 (0.41, 1.28)  0.69 (0.37, 1.26)  40 0.65 (0.43, 0.98) 0.71 (0.44, 1.12)  
Q5 15.7 (4.5) 24 0.75 (0.43, 1.29)  1.06 (0.52, 2.15)  22 0.81 (0.46, 1.41)  0.77 (0.40, 1.50)  46 0.78 (0.52, 1.15) 0.91 (0.56, 1.48)  
Per 3g/day  
pTrend 
 113 1.00 (0.88, 1.14) 
0.99 
1.03 (0.89, 1.19) 
0.71 
117 0.96 (0.87, 1.07) 
0.48 
0.94 (0.83, 1.07) 
0.34 
230 0.98 (0.90, 1.07)  
0.67 
0.99 (0.89, 1.09) 
0.77 
Fibre from 
breakfast 
cereals 
(g/day) 
Q1 0.05 (0.14) 23 1 1 20 1 1 43 1 1 
Q2 0.5 (0.4) 25 1.20 (0.68, 2.09)  1.11 (0.61, 2.03)  21 1.17 (0.63, 2.17) 1.24 (0.65, 2.35) 46 1.18 (0.78, 1.79) 1.16 (0.75, 1.80)  
Q3 1.8 (0.7) 16 0.75 (0.41, 1.40)  0.82 (0.42, 1.62)  23 1.04 (0.57, 1.92) 1.06 (0.56, 2.02) 39 0.89 (0.57, 1.36) 0.93 (0.80, 1.48)  
Q4 3.5 (0.7) 23 0.93 (0.52, 1.64)  1.04 (0.55, 1.69)  30 1.41 (0.80, 2.50) 1.45 (0.79, 2.68) 53 1.15 (0.77, 1.71) 1.22 (0.79, 1.90) 
Q5 7.6 (2.6) 26 0.91 (0.52, 1.59)  1.09 (0.58, 2.02) 23 1.06 (0.59, 1.91) 1.11 (0.59, 2.10) 49 0.98 (0.65, 1.46) 1.09 (0.70, 1.71) 
Per 2g/day  
pTrend 
 113 1.04 (0.93, 1.16) 
0.52 
1.04 (0.93, 1.17) 
0.46 
117 0.98 (0.89, 1.07) 
0.58 
0.97 (0.88, 1.07) 
0.52 
230 1.01 (0.93, 1.09)  
0.81 
1.01 (0.93, 1.09) 
0.83 
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 Median 
intake (IQR) 
CHD HR (95% CI) p-value Stroke HR (95% CI) p-value Total CVD HR (95% CI) p-value 
Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 Cases1 Age-adjusted Fully-adjusted2 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 26 1 1 27 1 1 53 1 1 
Q2 2.9 (0.7) 24 0.64 (0.38, 1.08)  0.83 (0.47, 1.47)  21 0.56 (0.32, 1.00) 0.69 (0.39, 1.23) 45 0.60 (0.41, 0.89) 0.76 (0.50, 1.14) 
Q3 4.2 (0.7) 23 0.55 (0.32, 0.95) 0.76 (0.42, 1.38) 25 0.69 (0.40, 1.17) 0.73 (0.41, 1.31) 48 0.61 (0.42, 0.90) 0.74 (0.49, 1.13) 
Q4 5.8 (1.1) 23 0.53 (0.31, 0.90) 0.74 (0.40, 1.36)  18 0.43 (0.23, 0.78) 0.50 (0.25, 0.97) 41 0.48 (0.32, 0.72) 0.61 (0.39, 0.96) 
Q5 9.5 (4.1) 17 0.38 (0.21, 0.69) 0.55 (0.28, 1.06) 26 0.72 (0.43, 1.22) 0.79 (0.42, 1.48)  43 0.54 (0.37, 0.80) 0.68 (0.43, 1.06)  
Per 2g/day  
pTrend 
 113 0.91 (0.75, 1.10) 
0.32 
0.98 (0.83, 1.17) 
0.85 
117 1.00 (0.90, 1.12) 
0.98 
1.02 (0.90, 1.15) 
0.78 
230 0.96 (0.87, 1.06)  
0.42 
1.00 (0.90, 1.11) 
0.97 
Vegetable 
fibre 
(g/day) 
Q1 2.3 (0.9) 27 1 1 27 1 1 54 1 1 
Q2 3.7 (0.6) 23 0.79 (0.46, 1.36) 0.92 (0.52, 1.62) 25 1.11 (0.65, 1.90) 1.10 (0.63, 1.93) 48 0.94 (0.64, 1.37)  1.00 (0.67, 1.50)  
Q3 4.9 (0.7) 20 0.73 (0.42, 1.27) 0.82 (0.45, 1.50) 21 0.68 (0.37, 1.23) 0.76 (0.41, 1.41)  41 0.71 (0.47, 1.06)  0.78 (0.51, 1.20)  
Q4 6.6 (1.0) 17 0.57 (0.32, 1.03)  0.64 (0.35, 1.18) 27 0.90 (0.53, 1.55) 1.00 (0.57, 1.75)  44 0.73 (0.49, 1.08)  0.82 (0.54, 1.23)  
Q5 9.5 (3.0) 26 0.74 (0.44, 1.26) 0.95 (0.52, 1.74) 17 0.69 (0.39, 1.22) 0.58 (0.30, 1.11)  43 0.72 (0.49, 1.06)  0.75 (0.49, 1.17)  
Per 2g/day  
pTrend 
 113 0.92 (0.81, 1.05) 
0.21 
0.95 (0.83, 1.09) 
0.50 
117 0.94 (0.83, 1.06) 
0.30 
0.90 (0.79, 1.03) 
0.11 
230 0.93 (0.85, 1.01)  
0.10 
0.93 (0.84, 1.02) 
0.21 
Legume 
fibre 
(g/day) 
Q1 0.2 (0.2) 25 1 1 31 1 1 56 1 1 
Q2 0.65 (0.20) 29 1.08 (0.65, 1.79)  1.35 (0.77, 2.37) 30 1.06 (0.64, 1.74)  1.11 (0.65, 1.89)  59 1.07 (0.75, 1.52)  1.22 (0.83, 1.79)  
Q3 1.11 (0.18) 28 1.12 (0.66, 1.89)  1.58 (0.90, 2.79)  23 0.93 (0.54, 1.61) 1.08 (0.62, 1.90) 51 1.02 (0.71, 1.49) 1.30 (0.87, 1.94)  
Q4 1.66 (0.39) 14 0.84 (0.46, 1.56)  1.09 (0.54, 2.21)  19 0.89 (0.50, 1.61)  1.05 (0.58, 1.90)  33 0.87 (0.57, 1.33)  1.07 (0.68, 1.69)  
Q5 3.6 (1.4) 17 1.01 (0.55, 1.85)  1.33 (0.65, 2.71)  14 1.01 (0.55, 1.86)  0.79 (0.37, 1.67) 31 1.01 (0.66, 1.55) 1.03 (0.62, 1.72)  
Per 1g/day  
pTrend 
 113 0.95 (0.82, 1.10) 
0.47 
1.01 (0.87, 1.17) 
0.92 
117 0.97 (0.82, 1.14) 
0.73 
0.87 (0.74, 1.04) 
0.12 
230 0.96 (0.86, 1.07)  
0.46 
0.94 (0.84, 1.06) 
0.32 
Fibre from 
nuts and 
seeds 
(g/day) 
Q1 0 (0.01) 38 1 1 45 1 1 83 1 1 
Q2 0.06 (0.01) 25 0.83 (0.51, 1.36)  0.86 (0.51, 1.45) 26 0.96 (0.60, 1.53) 0.86 (0.52, 1.43) 51 0.89 (0.64, 1.26) 0.86 (0.60, 1.23)  
Q3 0.08 (0.05) 16 0.74 (0.42, 1.30)  0.84 (0.50, 1.53) 18 0.67 (0.38, 1.17)  0.63 (0.35, 1.13) 34 0.70 (0.47, 1.05) 0.72 (0.47, 1.10) 
Q4 0.27 (0.13) 17 0.67 (0.38, 1.21) 0.87 (0.47, 1.61) 14 0.49 (0.29, 0.94) 0.50 (0.26, 0.95) 31 0.58 (0.38, 0.90) 0.66 (0.42, 1.03) 
Q5 0.85 (0.91) 17 0.65 (0.37, 1.15)  0.84 (0.44, 1.59) 14 0.52 (0.29, 0.96) 0.45 (0.23, 0.85) 31 0.58 (0.39, 0.88) 0.61 (0.39, 0.96) 
Per 0.2g/day  
pTrend 
 113 0.97 (0.89, 1.06) 
0.51 
0.99 (0.90, 1.08) 
0.76 
117 0.93 (0.85, 1.02) 
0.13 
0.92 (0.83, 1.02) 
0.13 
230 0.95 (0.89, 1.02)  
0.16 
0.96 (0.89, 1.03) 
0.25 
1Case numbers apply to fully-adjusted models. 2Adjustments include Age (years), BMI (kg/m2), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not 
current smoker), socio-economic status (professional or managerial/ intermediate/ routine or manual). Note, adjustment for energy intake was not included in fibre density models. Shading for CIs that do not span 1 in fully 
adjusted models.
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Table 5.6 Risk of fatal IHD, stroke and CVD in postmenopausal women, using continuous fibre variables 
 Fibre exposure 
model increment 
IHD  HR (95% CI) p-value Stroke  HR (95% CI) p-value CVD  HR (95% CI) p-value 
 Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model 
Case number  94 85 100 89 194 174 
NSP  6 g/day 0.92 (0.80, 1.06) 0.25 1.06 (0.85, 1.31) 0.60 0.98 (0.87, 1.10) 0.73 0.88 (0.73, 1.07) 0.20 0.95 (0.87, 1.04) 0.27 0.96 (0.83, 1.12) 0.63 
NSP density  2 g/1000kcal/day 0.97 (0.84, 1.13) 0.70 1.06 (0.90, 1.24) 0.49 0.94 (0.83, 1.07) 0.34 0.92 (0.79, 1.07) 0.26 0.96 (0.87, 1.06) 0.37 0.99 (0.88, 1.11) 0.84 
AOAC  11 g/day 0.91 (0.77, 1.07) 0.26 1.09 (0.81, 1.47) 0.58 0.98 (0.85, 1.13) 0.78 0.87 (0.67, 1.14) 0.32 0.94 (0.84, 1.05) 0.30 0.98 (0.80, 1.19) 0.81 
AOAC density  3 g/1000kcal/day 0.97 (0.83, 1.14) 0.70 1.06 (0.89, 1.27) 0.49 0.94 (0.82, 1.07) 0.37 0.93 (0.79, 1.09) 0.35 0.96 (0.86, 1.06) 0.39 1.00 (0.88, 1.13) 0.95 
Soluble fibre  3 g/day 0.87 (0.74, 1.04) 0.12 0.99 (0.73, 1.36) 0.97 0.99 (0.86, 1.14) 0.89 0.93 (0.72, 1.21) 0.60 0.93 (0.83, 1.04) 0.21 0.96 (0.78, 1.18) 0.70 
Insoluble fibre 4 g/day 0.95 (0.83, 1.08) 0.42 1.10 (0.90, 1.34) 0.35 0.98 (0.88, 1.10) 0.75 0.91 (0.76, 1.07) 0.25 0.96 (0.88, 1.05) 0.41 1.00 (0.87, 1.14) 0.99 
Fibre from total cereals 3 g/day 1.01 (0.88, 1.14) 0.93 1.10 (0.96, 1.27) 0.18 0.98 (0.88, 1.09) 0.70 0.88 (0.77, 1.01) 0.08 0.99 (0.91, 1.08) 0.87 1.00 (0.89, 1.11) 0.93 
Fibre from breakfast cereals 2 g/day 1.04 (0.93, 1.16) 0.51 1.09 (0.99, 1.20) 0.07 0.98 (0.90, 1.07) 0.68 0.94 (0.83, 1.06) 0.32 1.01 (0.94, 1.10) 0.75 1.03 (0.94, 1.13) 0.51 
Fibre from fruit 2 g/day 0.91 (0.75, 1.10) 0.35 1.00 (0.81, 1.24) 1.00 1.02 (0.92, 1.13) 0.67 1.06 (0.95, 1.19) 0.31 0.97 (0.88, 1.07) 0.58 1.04 (0.93, 1.16) 0.53 
Fibre from vegetables 2 g/day 0.92 (0.81, 1.04) 0.19 0.94 (0.79, 1.12) 0.49 0.96 (0.86, 1.08) 0.53 0.91 (0.78, 1.06) 0.23 0.94 (0.86, 1.03) 0.16 0.92 (0.82, 1.04) 0.18 
Fibre from legumes 1 g/day 0.97 (0.84, 1.12) 0.66 1.09 (0.95, 1.26) 0.23 0.98 (0.82, 1.17) 0.82 0.94 (0.78, 1.12) 0.47 0.97 (0.87, 1.09) 0.64 1.02 (0.91, 1.14) 0.75 
Fibre from nuts and seeds 0.2 g/day 0.97 (0.89, 1.06) 0.56 1.00 (0.91, 1.09) 0.92 0.94 (0.86, 1.03) 0.18 0.94 (0.85, 1.04) 0.25 0.96 (0.90, 1.02) 0.22 0.97 (0.90, 1.05) 0.43 
 
Table 5.7 Risk of fatal IHD, stroke and CVD in those with healthy BMI at baseline (18.5-24.9kg/m2), using continuous fibre variables 
 Fibre exposure 
model increment 
IHD  HR (95% CI) p-value Stroke  HR (95% CI) p-value CVD  HR (95% CI) p-value 
 Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model 
Case number  58 55 71 65 129 120 
NSP  6 g/day 0.98 (0.85, 1.13) 0.81 1.04 (0.84, 1.29) 0.71 0.98 (0.84, 1.15) 0.80 0.98 (0.80, 1.20) 0.83 0.98 (0.88, 1.09) 0.73 1.01 (0.87, 1.17) 0.93 
NSP density  2 g/1000kcal/day 1.01 (0.83, 1.22) 0.94 1.07 (0.89, 1.29) 0.46 0.96 (0.81, 1.13) 0.61 0.99 (0.84, 1.17) 0.92 0.98 (0.86, 1.11) 0.75 1.03 (0.91, 1.17) 0.65 
AOAC  11 g/day 0.97 (0.82, 1.15) 0.75 1.03 (0.78, 1.36) 0.85 0.98 (0.81, 1.18) 0.80 0.98 (0.75, 1.29) 0.89 0.97 (0.86, 1.11) 0.70 1.00 (0.82, 1.22) 0.98 
AOAC density  3 g/1000kcal/day 1.00 (0.81, 1.22) 0.97 1.06 (0.87, 1.29) 0.58 0.95 (0.80, 1.13) 0.59 1.00 (0.84, 1.19) 0.98 0.97 (0.85, 1.11) 0.67 1.03 (0.90, 1.17) 0.71 
Soluble fibre  3 g/day 0.96 (0.81, 1.15) 0.67 0.99 (0.73, 1.34) 0.96 0.96 (0.79, 1.17) 0.69 0.94 (0.70, 1.26) 0.68 0.96 (0.84, 1.10) 0.57 0.96 (0.78, 1.19) 0.73 
Insoluble fibre 4 g/day 0.99 (0.87, 1.12) 0.84 1.05 (0.87, 1.25) 0.63 0.99 (0.86, 1.14) 0.91 1.01 (0.85, 1.20) 0.94 0.99 (0.90, 1.09) 0.84 1.02 (0.90, 1.16) 0.71 
Fibre from total cereals 3 g/day 1.03 (0.93, 1.15) 0.57 1.07 (0.95, 1.20) 0.27 1.01 (0.91, 1.13) 0.80 1.03 (0.91, 1.15) 0.67 1.02 (0.95, 1.11) 0.58 1.05 (0.96, 1.14) 0.30 
Fibre from breakfast cereals 2 g/day 0.99 (0.89, 1.11) 0.87 1.02 (0.92, 1.13) 0.77 1.00 (0.91, 1.10) 0.96 1.01 (0.93, 1.10) 0.82 1.00 (0.93, 1.07) 0.94 1.01 (0.95, 1.08) 0.71 
Fibre from fruit 2 g/day 0.87 (0.71, 1.06) 0.16 0.91 (0.76, 1.09) 0.30 1.02 (0.89, 1.18) 0.75 1.05 (0.91, 1.21) 0.50 0.97 (0.85, 1.10) 0.62 1.00 (0.88, 1.13) 0.99 
Fibre from vegetables 2 g/day 1.02 (0.88, 1.17) 0.84 1.04 (0.90, 1.20) 0.59 0.95 (0.80, 1.13) 0.53 0.93 (0.79, 1.10) 0.40 0.98 (0.87, 1.10) 0.71 0.98 (0.87, 1.11) 0.78 
Fibre from legumes 1 g/day 1.05 (0.89, 1.23) 0.57 1.07 (0.91, 1.27) 0.40 0.86 (0.69, 1.09) 0.22 0.85 (0.66, 1.08) 0.18 0.95 (0.83, 1.10) 0.52 0.96 (0.83, 1.12) 0.64 
Fibre from nuts and seeds 0.2 g/day 0.97 (0.84, 1.12) 0.66 0.97 (0.85, 1.12) 0.69 0.96 (0.88, 1.05) 0.36 0.96 (0.88, 1.05) 0.36 0.96 (0.89, 1.04) 0.37 0.97 (0.89, 1.05) 0.39 
Adjustments: Age (years), BMI (kg/m
2
), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not current smoker), socio-
economic status (professional or managerial/ intermediate/ routine or manual). Energy intake was not included in fibre density models. 
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Table 5.8 Risk of fatal IHD, stroke and CVD in those with BMI classed as overweight or obese at baseline (≥25kg/m2), using continuous fibre variables 
 Fibre exposure 
model increment 
IHD  HR (95% CI) p-value Stroke  HR (95% CI) p-value CVD  HR (95% CI) p-value 
 Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model 
Case number  67 55 50 45 117 100 
NSP  6 g/day 0.88 (0.70, 1.12) 0.30 0.90 (0.63, 1.28) 0.56 0.95 (0.78, 1.14) 0.57 0.80 (0.62, 1.04) 0.10 0.91 (0.78, 1.06) 0.23 0.86 (0.68, 1.08) 0.19 
NSP density  2 g/1000kcal/day 1.00 (0.80, 1.24) 1.00 0.94 (0.74, 1.19) 0.60 0.91 (0.75, 1.11) 0.35 0.89 (0.72, 1.09) 0.25 0.96 (0.83, 1.12) 0.63 0.92 (0.78, 1.08) 0.34 
AOAC  11 g/day 0.87 (0.65, 1.16) 0.33 0.93 (0.58, 1.50) 0.76 0.93 (0.75, 1.17) 0.56 0.76 (0.53, 1.09) 0.14 0.89 (0.74, 1.08) 0.25 0.86 (0.62, 1.17) 0.33 
AOAC density  3 g/1000kcal/day 1.01 (0.80, 1.28) 0.94 0.96 (0.74, 1.24) 0.75 0.90 (0.73, 1.11) 0.34 0.88 (0.70, 1.10) 0.26 0.97 (0.82, 1.14) 0.68 0.93 (0.78, 1.11) 0.40 
Soluble fibre  3 g/day 0.82 (0.62, 1.09) 0.18 0.88 (0.56, 1.37) 0.57 1.00 (0.82, 1.22) 1.00 0.90 (0.63, 1.27) 0.54 0.90 (0.75, 1.07) 0.24 0.89 (0.67, 1.18) 0.42 
Insoluble fibre 4 g/day 0.92 (0.73, 1.17) 0.50 0.96 (0.67, 1.35) 0.80 0.92 (0.76, 1.11) 0.38 0.79 (0.62, 1.01) 0.07 0.92 (0.78, 1.08) 0.31 0.88 (0.70, 1.11) 0.29 
Fibre from total cereals 3 g/day 0.97 (0.75, 1.26) 0.83 0.95 (0.69, 1.29) 0.72 0.87 (0.74, 1.03) 0.10 0.80 (0.65, 0.93) <0.01 0.93 (0.78, 1.11) 0.43 0.87 (0.71, 1.07) 0.19 
Fibre from breakfast cereals 2 g/day 1.10 (0.90, 1.34) 0.34 1.07 (0.85, 1.35) 0.57 0.91 (0.77, 1.08) 0.29 0.85 (0.69, 1.04) 0.11 1.04 (0.87, 1.24) 0.67 0.99 (0.81, 1.20) 0.90 
Fibre from fruit 2 g/day 0.96 (0.74, 1.25) 0.77 1.06 (0.86, 1.31) 0.57 1.00 (0.87, 1.14) 0.95 1.02 (0.88, 1.18) 0.84 0.98 (0.83, 1.14) 0.76 1.04 (0.91, 1.20) 0.55 
Fibre from vegetables 2 g/day 0.86 (0.72, 1.04) 0.12 0.90 (0.74, 1.09) 0.28 0.99 (0.84, 1.15) 0.87 0.91 (0.76, 1.11) 0.35 0.92 (0.81, 1.04) 0.18 0,90 (0.79, 1.04) 0.15 
Fibre from legumes 1 g/day 0.85 (0.66, 1.10) 0.22 0.94 (0.72, 1.21) 0.62 1.09 (0.89, 1.35) 0.40 0.94 (0.74, 1.20) 0.63 0.97 (0.82, 1.15) 0.72 0.94 (0.79, 1.12) 0.50 
Fibre from nuts and seeds 0.2 g/day 1.00 (0.92, 1.08) 1.00 1.01 (0.91, 1.11) 0.91 0.81 (0.59, 1.09) 0.17 0.68 (0.48, 0.98) 0.04 0.96 (0.86, 1.06) 0.41 0.93 (0.81, 1.07) 0.29 
 
Table 5.9 Risk of fatal IHD, stroke and CVD in those without history of hypertension or angina at baseline, using continuous fibre variables 
 Fibre exposure 
model increment 
IHD  HR (95% CI) p-value Stroke  HR (95% CI) p-value CVD  HR (95% CI) p-value 
 Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model Age-adjusted model Fully-adjusted model 
Case number  75 67 81 69 156 136 
NSP  6 g/day 0.91 (0.77, 1.07) 0.25 1.03 (0.81, 1.32) 0.79 0.94 (0.80, 1.10) 0.44 0.81 (0.65, 1.01) 0.07 0.92 (0.82, 1.04) 0.18 0.91 (0.77, 1.07) 0.27 
NSP density  2 g/1000kcal/day 1.04 (0.87, 1.25) 0.64 1.07 (0.89, 1.30) 0.47 0.85 (0.72, 0.99) 0.04 0.83 (0.70, 0.99) 0.04 0.94 (0.83, 1.06) 0.31 0.95 (0.83, 1.08) 0.41 
AOAC  11 g/day 0.86 (0.71, 1.05) 0.15 1.01 (0.73, 1.38) 0.98 0.92 (0.76, 1.12) 0.42 0.76 (0.56, 1.02) 0.07 0.89 (0.78, 1.03) 0.12 0.86 (0.70, 1.08) 0.19 
AOAC density  3 g/1000kcal/day 1.03 (0.85, 1.24) 0.78 1.06 (0.87, 1.29) 0.58 0.83 (0.70, 0.99) 0.04 0.82 (0.68, 0.99) 0.04 0.92 (0.81, 1.05) 0.24 0.93 (0.81, 1.07) 0.34 
Soluble fibre  3 g/day 0.82 (0.67, 1.01) 0.06 0.87 (0.64, 1.20) 0.40 0.93 (0.77, 1.13) 0.48 0.80 (0.57, 1.06) 0.11 0.88 (0.77, 1.02) 0.08 0.82 (0.66, 1.02) 0.08 
Insoluble fibre 4 g/day 0.93 (0.79, 1.09) 0.36 0.99 (0.97, 1.02) 0.68 0.93 (0.80, 1.09) 0.38 0.83 (0.69, 1.01) 0.06 0.93 (0.83, 1.04) 0.21 0.94 (0.81, 1.10) 0.45 
Fibre from total cereals 3 g/day 1.02 (0.89, 1.17) 0.75 1.15 (1.00, 1.31) 0.05 0.97 (0.86, 1.11) 0.69 0.93 (0.80, 1.09) 0.39 1.00 (0.91, 1.10) 0.96 1.04 (0.93, 1.16) 0.49 
Fibre from breakfast cereals 2 g/day 1,04 (0.92, 1.17) 0.51 1.09 (0.98, 1.23) 0.12 1.00 (0.90, 1.10) 0.98 0.98 (0.88, 1.10) 0.78 1.02 (0.94, 1.11) 0.63 1.04 (0.95, 1.14) 0.36 
Fibre from fruit 2 g/day 0.79 (0.65, 0.94) 0.01 0.86 (0.73, 1.02) 0.08 0.92 (0.74, 1.13) 0.42 0.92 (0.72, 1.18) 0.52 0.86 (0.74, 1.00) 0.05 0.89 (0.76, 1.06) 0.19 
Fibre from vegetables 2 g/day 0.87 (0.73, 1.05) 0.15 0.88 (0.72, 1.09) 0.24 0.94 (0.79, 1.10) 0.43 0.87 (0.73, 1.04) 0.13 0.91 (0.80, 1.03) 0.12 0.88 (0.77, 1.01) 0.06 
Fibre from legumes 1 g/day 0.97 (0.82, 1.13) 0.66 1.02 (0.87, 1.20) 0.76 0.97 (0.77, 1.21) 0.77 0.83 (0.65, 1.05) 0.12 0.97 (0.84, 1.11) 0.63 0.93 (0.81, 1.06) 0.28 
Fibre from nuts and seeds 0.2 g/day 0.98 (0.86, 1.11) 0.71 1.00 (0.88, 1.13) 0.97 0.97 (0.89, 1.05) 0.44 0.96 (0.87, 1.06) 0.40 0.97 (0.90, 1.05) 0.46 0.98 (0.90, 1.06) 0.60 
Adjustments: Age (years), BMI (kg/m
2
), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not current smoker), socio-
economic status (professional or managerial/ intermediate/ routine or manual). Energy intake was not included in fibre density models. Shading in fully adjusted models where CIs do not span 1.
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5.5 Discussion 
5.5.1 Result summary 
In this prospective study of healthy females, there was no evidence of any statistically 
significant associations between total fibre intake or fibre from certain food sources and risk of 
fatal IHD, stroke or CVD in analyses of the full sample. Results suggest that greater intake of 
cereal sources of fibre in those with higher BMI may be associated with reduced fatal stroke 
risk. Risk was reduced by 20% for every 3g/day increase in cereal fibre, this is roughly 
equivalent to fibre contained within a standard portion of brown rice or two slices of 
wholemeal bread (Holland et al., 1991). This specific observation relating to cereal fibre intake 
may be indicative of the greater insoluble fibre content of cereals compared to fruit and 
vegetables and is concordant with the protective associations observed for insoluble fibre, but 
not soluble fibre intake with CHD risk in Chapter 2 (Figure 2.4) and lower stroke risk with 
greater insoluble but not soluble fibre (Threapleton et al., 2013d). Cereal fibre may also be a 
surrogate for total cereal intake and the protective association observed in overweight women 
may reflect other beneficial components of cereal grains. Compounds within grains such as  
antioxidants, hormonally-active lignans, phytosterols, amylase inhibitors and saponins have all 
been shown to influence risk factors for CHD and it is likely that this combination of 
compounds within grains is responsible for their protective effect (Slavin, 2004). It has also 
been noted in this and other cohort studies that FFQs tend to overestimate intake of some 
foods such as vegetables (refer to Chapter 3, discussion) and the protective association evident 
only for cereal fibre may be because of fewer issues with measurement error in assessing 
cereal intake compared to other foods, especially vegetables.  
For both fatal stroke and CVD HRs decreased with greater intake of fibre from nuts and seeds 
and for both outcomes, risk was significantly reduced in the highest group compared to the 
lowest consumers. However, the evidence for a linear dose-response relationship was lacking, 
perhaps because fibre intake from nut and seed sources was relatively low and protective 
associations may only become apparent with intakes at sufficiently high levels. 
In the healthy subgroup of participants, that is those free of hypertension and angina, there 
appeared to be a protective association with fibre density and fatal stroke risk. This had not 
been observed when those with hypertension or angina were combined in the full sample, 
suggesting greater fibre density may prevent CVD development in those who are healthy, 
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rather than halt or reverse disease development in those already displaying risk factors. This 
result however did not reach the pre-specified 1% level of statistical significance that was set 
for subgroup analyses. The risk of Type I error, or false positive findings, is even greater in 
subgroup analyses, where sample sizes are diminished (Bowers et al., 2006a). The possible 
protective effect of fibre density in those without key CVD risk factors should be further 
explored in cohorts with larger case numbers.  
The attenuation of associations between the age or mid-adjusted models and fully-adjusted 
models indicates that the variables identified as potential confounders explain some of the 
variation in risk and are associated with fibre intake. Differing results by BMI classification 
indicate that BMI may modify the effect of fibre on CVD risk despite no different risk estimates 
being observed between models with and without adjustment for BMI. 
5.5.2 Comparison with other published studies 
A recent pan-European EPIC study observed contrasting results to the findings in this chapter 
and report a protective association between total fibre intake and total CVD mortality (Chuang 
et al., 2012). However, the definition for CVD mortality differed from the UKWCS and included 
all cardiovascular-related death rather than coronary plus stroke events (this study is included 
in meta-analyses and has been discussed in Chapter 2). Another observation from this EPIC 
study was for cereal fibre intake; greater intake was associated with risk reduction, as was 
seen for the UKWCS in obese women. Similarly, both the EPIC study and the work in this 
chapter indicate no evidence of protective associations for fruit or vegetable fibre intake 
(Chuang et al., 2012). Fatal CHD risk within EPIC was explored in a separate publication and a 
significant risk reduction was also reported with greater intake of total fibre (Crowe et al., 
2012). However, as discussed in Chapter 2, one study focusing on just the UK data from the 
pooled EPIC study found that fibre assessed using food diaries was protectively associated with 
risk, but this was not the case for fibre calculated from FFQs (Ward et al., 2012), mirroring the 
non significant results observed here. As discussed in Chapter 3, the limitations in assessing 
diet using FFQ are potentially greater than with food diaries and this observation from Ward 
and colleagues may be attributed to this.   
Systematic reviews and data pooling projects for dietary fibre and CVD or CHD report 
protective associations for dietary fibre intake (Pereira et al., 2004, Mente et al., 2009, Ye et 
al., 2012) as was seen in the systematic review and meta-analyses reported in Chapter 2. These 
reviews examined both incidence and mortality data together but it is possible the underlying 
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pathology for non-fatal events differs from fatal events. However, other prospective studies 
reporting just on fatal CVD or CHD  events also tend to observe protective associations both in 
men and women (Eshak et al., 2010, Park et al., 2011, Pietinen et al., 1996, Rimm et al., 1996, 
Streppel et al., 2008, Wolk et al., 1999) unlike the results observed here. One exception to this 
trend is the Australian Blue Mountain Eye study, which did not report a protective association 
for total fibre and fatal CVD (Buyken et al., 2010). 
The picture for total (fatal plus non-fatal) stroke risk is less consistent than CHD and CVD, 
whereby some studies report no evidence of protective associations with increased fibre 
intake (Oh et al., 2005, Bazzano et al., 2003) and several observe protective associations 
(Kokubo et al., 2011, Larsson et al., 2009, Ascherio et al., 1998). Few studies report fatal stroke 
events and total fibre intake but a lack of association was reported in one Japanese cohort for 
both men and women (Eshak et al., 2010) and a cohort from the US (Bazzano et al., 2003). 
Additionally fatal stroke risk was not associated with greater cereal fibre intake in an Australian 
cohort (Kaushik et al., 2009). 
Considering the existing evidence from observational studies and meta-analyses together, 
there appears to be an inverse association between total dietary fibre and both total (fatal plus 
non-fatal) and fatal CVD or CHD risk, contrasting observations in the UKWCS which were not 
statistically significant despite being in the same direction. The general lack of evidence for a 
protective association of total fibre and stoke mortality risk does mirror observations from 
some other cohorts (discussed above) but does not elucidate possible reasons for the 
protective associations which were observed for stroke risk in some subgroup analyses. 
5.5.3 Strengths and limitations 
Strengths of this work include that data are from a large prospective cohort that has been 
followed up for a relatively long period of time. The cohort was designed to allow exploration 
of disease in relation to healthy dietary characteristics by recruiting a large proportion of 
health conscious individuals. Diet was also assessed using a tool that had been validated for 
use in the sample. 
Results were weighted to reduce the impact of data from vegetarian participants as a much 
greater proportion exist in this sample than the general population, meaning risk estimates are 
more applicable to the general population. The inclusion of this weighting factor actually had 
relatively little impact on the estimates but does account somewhat for the oversampling of 
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vegetarians. However, the sample does include women who are generally well-educated, 
middle-class and are reasonably healthy and therefore, the generalisablility of findings to other 
populations is unknown.  
One limitation in dietary assessment here is that diets may change over time but only diet 
assessed at baseline was considered in this analysis. However, some work using a sub-sample 
of cohort participants assessed 5-years after baseline indicated moderate stability in dietary 
pattern classification (Greenwood et al., 2003). Other shortcomings in dietary assessment 
using FFQs are issues such as measurement error and the tendency to over-estimate 
consumption of certain foods like fruit and vegetables (Cade et al., 2002). Refer to Chapter 3 
where strengths and limitation of dietary assessment methods are discussed.  
Uncontrolled confounding is a limitation with observational work (Willett, 1998a), meaning 
some other lifestyle or dietary factor, not adequately controlled for or accounted for in 
models, could explain observations. Evidence from RCTs would be required to confirm 
associations as causal but given the long progression of CVD, trials are unlikely to be feasible. 
Another problem with observational work of this kind is the inability to distinguish single 
nutrient specific end-points from other nutrients that are highly correlated (Bingham et al., 
1994). Here it is not possible to identify whether fibre from a specific food is related to end-
points or whether intake of the whole food, with associated nutrients, is responsible. 
Further limitations include the imperfect measurement of confounding variables, BMI was 
derived from self-reported weight and height, SES in the model was based on three broad 
groupings and physical activity expenditure was calculated from a series of questions which 
asked participants to estimate the time spent on usual activities, all of which introduce error 
into calculations. The use of only mortality data is a limitation as non-fatal cases are 
unidentified and are therefore misclassified as non-cases. Case numbers are also limited by 
using only mortality data, especially for sensitivity analyses. However, given that different 
associations have been reported in some studies for mortality or non-fatal CVD outcomes and 
fibre intake (Bazzano et al., 2003, Pietinen et al., 1996), it is plausible that the underlying 
pathology for the two outcomes is distinct and combining events may cloud rather than 
elucidate associations. The lack of consideration for the time-frame of exposure and disease 
development in prospective work has also been criticised (Willett, 1998a) but case numbers 
here were too few to explore this.  
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There are reported inconsistencies in the coding of the ‘original underlying cause’ of death in 
the UK, with 78% of cases reportedly matching to the fourth ICD code level and 90% matching 
to the ICD10 chapter, in a sample of 7,914 deaths which were coded in duplicate. The national 
death data are however routinely checked and pass through a series of validation checks and 
processes to highlight potential errors (ONS, 2013). Mortality data have been recorded in a 
consistent way through national registry services for decades in the UK and registers were well 
established before the start of the UKWCS.  
5.6 Summary 
Greater total dietary fibre intake may confer no additional cardiovascular benefit in already 
health-conscious women but may contribute to lower fatal stroke risk in those free of 
cardiovascular risk factors (hypertension/angina). Cereal fibre may contribute to lower fatal 
stroke risk specifically in women with higher BMI and there are suggestions that fibre from 
nuts and seeds may contribute to lower stroke mortality risk in women free of CVD risk factors. 
There was no suggestion of protective associations for other sources of fibre for fatal stroke 
risk reduction or for any food source of fibre with fatal CHD or CVD. 
Further observational work will ideally include incidence data to boost statistical power. 
Experimental studies should contribute towards explaining observations from this and other 
cohort studies through exploring possible mechanisms underlying the relationship between 
CVD risk factors, BMI and the different types of fibre or sources of fibre. 
The principles used to explore CVD mortality and fibre intake, assessed with FFQs, in this 
chapter are extended in the next chapter (Chapter 6) to explore fatal plus non-fatal CVD risk in 
relation to fibre intake. Risk of specific types of CHD and stroke subtypes in relation to fibre 
intake are also explored in Chapter 6.  
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Chapter 6 Dietary fibre intake and risk of total 
CVD, non-fatal CVD and CVD subtypes  
6.1 Chapter overview 
The current chapter explores dietary fibre assessed with FFQs and risk of non-fatal or total 
CHD, stroke and CVD. As in the last chapter, FFQs provide data on total fibre intake, both 
soluble and insoluble fibre and also fibre from key food sources.  Mortality event data are 
combined with HES and MINAP cases to estimate total CVD incidence. For non-fatal events, 
data from HES and MINAP were combined. Figure 6.1 highlights the sources of dietary and 
outcome data that are used and presented in this chapter. 
The previous chapter detailed the methods used to select confounding variables and survival 
analysis methods. These methods are also applied in this chapter and are therefore only 
described here briefly, with additional detail to highlight any differences from the work in the 
previous chapter.  
Few of the fibre exposures were associated with risk of non-fatal or total incident CHD in this 
chapter but protective associations were observed for fibre density and total fibre assessed as 
AOAC and insoluble fibre intake when MI was assessed separately from other CHD outcomes. 
Each 11g/day greater AOAC fibre intake was associated with lower MI risk, HR 0.86 (95% CI: 
0.73 to 1.00) p=0.04. Higher fibre intake was also protectively associated with risk of total 
stroke (fatal plus non-fatal) but this association only extended to cereal fibre when non-fatal 
strokes were assessed. The associations observed with fibre intake and stroke risk were 
apparent for ischaemic, rather than haemorrhagic strokes but there were comparatively fewer 
haemorrhagic stroke cases observed over the 14 year follow up. Lower overall CVD risk was 
associated with greater fibre density, with every 2g/1000kcal/day higher NSP density, risk was 
0.95 (95% CI: 0.91 to 1.00) p=0.03. 
Two abstracts presenting results from work in this chapter were accepted for presentation at 
the European Congress of Epidemiology 2013 (Threapleton et al., 2013a) and the UK Society 
for Social Medicine annual meeting 2013 (Threapleton et al., 2013c) and have now been 
published. 
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Figure 6.1 Data sources used in this chapter: Dietary data from FFQs, mortality data 
spanning from study baseline, HES data since 1998 and MINAP since 2003 
6.2 Background 
There are an estimated 103,000 heart attacks in the UK each year, with approximately 50,000 
of these in English men and 32,000 in English women (Townsend et al., 2012). Although 
incidence rates for CHD and strokes are declining, CVD remains an enormous social and 
financial burden for the UK, as noted in Chapter 1.  
Reductions in MI over the past few decades have been driven by improvements in risk factors 
(Unal et al., 2004) and the incidence rate in England has decreased by a third between 2002 
and 2010. Generally, MI incidence increases with age and it is this characteristic that means 
women experience more events in total than men, because they are living longer (Townsend 
et al., 2012). 
Stroke incidence has also decreased over the past few decades but there remains a greater 
number of stroke events in women, again, because they live longer in general (Townsend et 
al., 2012). In England there are an estimated 68,000 strokes in women annually and 57,000 in 
men. For the whole UK, there are an estimated 152,000 strokes annually (Townsend et al., 
2012). 
Unlike mortality, which is a clearly defined outcome and where the style of recording events 
on death certificates has been largely consistent over many decades, non-fatal CVD events 
were unrecorded, or recorded in a non centralised system, during the early phase of the 
UKWCS. Still today, unlike cancer events, there is no national database from which to draw 
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complete CVD event data. In addition, the severity of non-fatal events will differ meaning that 
only the most severe types lead to hospitalisation, clear diagnosis and event recording 
whereas many minor events or risk factors for CVD may go unrecorded. Despite limitations in 
the availability of historical CVD event data for the participants of the UKWCS, compiling cases 
from multiple available sources, even though they span different timeframes, has much 
potential benefit. This approach allows not only case numbers to be increased for improved 
statistical power but also provides sufficient case numbers to allow exploration of stroke and 
coronary event sub-types as the aetiology of the different event types may differ. 
As noted in Chapter 2 (systematic review of literature) other cohorts studies have separately 
assessed fibre intake in relation to risk of fatal, non-fatal or total CVD events and found 
different observations. Two of the identified studies explored fatal events in addition to total 
(fatal plus non-fatal events combined) and found contrasting results (Bazzano et al., 2003, 
Pietinen et al., 1996). In the NHANES I study, a significant protective association was seen for 
fibre intake and total CVD or CHD risk but the association was not apparent when examining 
only risk of fatal CVD or CHD, possibly because of fewer events being available (Bazzano et al., 
2003). The Finnish ATBC study observed the opposite, with a protective association between 
total fibre intake and fatal CHD but there was no evidence of an association when non-fatal MI 
events were combined with fatal CHD (Pietinen et al., 1996).  
The US Health Professionals’ Follow-up Study (HPFS) and Nurses’ Health Study assessed risk of 
fatal, non-fatal or total CHD (Rimm et al., 1996, Wolk et al., 1999). The HPFS found protective 
associations for risk with total fibre intake in all three outcomes but protective associations for 
both fatal and non-fatal CHD were seen in the Nurses’ Health Study but not when the two 
events combined (Wolk et al., 1999). The relatively small number of other studies which have 
assessed risk of non-fatal events in addition to fatal and total, only one of which reported 
stroke events (Bazzano et al., 2003), and the inconsistent results observed in these studies 
indicates the need for further research in this area. This issue is addressed in this chapter 
where risk of non fatal CVD is explored along with total CVD and CVD subtypes. 
6.3 Method 
6.3.1 Dietary data 
As discussed in previous chapters, FFQs were used to assess typical intake over the previous 12 
months. Fibre calculated as both NSP and using the AOAC method were examined. Fibre 
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density of the diet in addition to soluble and insoluble fibre intakes and NSP from key food 
sources were explored, as in the previous chapter. 
6.3.2 Mortality data 
The same IHD and stroke definitions were applied to mortality records to identify cases, as 
discussed in Chapters 4 and 5. The inclusion of case event dates was however extended, from 
February 2011, to 30th June 2011 to reflect newly available data and to match with the latest 
available case information from the two other sources (HES and MINAP). 
6.3.3 HES records 
CHD cases include those with records listing ICD10 codes I20 to I25.9 and I46 to I59.0 (Table 
4.4). Stroke cases were identified as those with records listing any stroke event ICD10 I60.0 to 
I64X (Table 4.5). 
Stroke or CHD events were identified from HES using only the primary diagnosis field in the 
dataset and not using any of the other diagnosis fields. This approach was taken for survival 
analyses as events listed in secondary diagnosis fields may relate to old conditions, not 
necessarily to the reason for inpatient admission. As it is not clear when events in secondary 
diagnosis fields occurred, accurate survival times could not be generated. 
6.3.4 MINAP records 
Coronary events from MINAP were those where a final diagnosis of MI, threatened MI or ACS 
were identified (refer to Chapter 4 for details).  
6.3.5 Censor date 
MINAP events were examined closely to observe if a lag-time in event reporting and therefore 
drop-off in events was visible. If this was the case, a censor date earlier than the date of the 
latest record would be set, to reflect a month where event reporting appeared complete. No 
lag-time and therefore drop off in MINAP event reporting was observed because the numbers 
of cases each month was small and there was a large degree of variation in case numbers 
between months (refer to Figure 4.3 in Chapter 4). The date of the most recent event in 
MINAP was therefore chosen as the censor date for all outcome sources. Survival times were 
calculated in years from receipt of baseline questionnaire until either, earliest CVD event date, 
date of death for any other cause or until 30th June 2011, whichever came first. The censor 
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date of 30th June 2011 was applied to HES and mortality events, where records extended after 
this time.  
6.3.6 Exclusions 
In addition to the exclusions applied for mortality analyses (detailed below and in Chapter 5), 
participants whose baseline address was in Scotland, Wales or Northern Ireland were 
excluded. This decision was taken because MINAP records relate to English and Welsh 
hospitals but HES data were only obtained for English hospitals. Women were also excluded 
where they reported personal history of angina, unlike in the previous chapter, because this 
was included as an outcome for ACS, chronic and total CHD events. 
For analyses examining risk of non-fatal events, those who died, of any cause, within 1 month 
of the earliest CHD, stroke or CVD event, were excluded. For example, a participant with non-
fatal stroke occurring in one year, followed by a fatal stroke in the next year would remain in 
the analysis but a CHD event followed by death within 30 days, from any cause, would be 
excluded.  
Participants were excluded from analyses where the following criteria were met:  
1) Not successfully tracked through the ONS/ NHSIC for record linkage (n=695) 
2) Tracked through national registers but did not provide both lifestyle and dietary 
information (n=318) 
3) Daily calorie intake from the FFQ was outside a plausible range (500-6000 kcal/day) 
(n=405) 
4) Reported personal history of cancer (n=2445), stroke (n=264), diabetes (n=646), angina 
(n=718) or heart attack (n=498) at study baseline  
5) Died (any cause) or experienced CVD event within one year of returning FFQ  (n=129) 
6) Requested their data not to be used in future studies (n=1) 
7) Address not in England (n=3874) 
8) Died within 30 days of CHD (n=107), stroke (n=99) or CVD (n=192) event [this criteria was 
applied separately in each analysis using non-fatal data] 
6.3.7 Testing dose-response and non-linear associations 
CVD risk was assessed with fibre as both a categorical exposure (fifths of intake) where each 
subsequent category was compared to the lowest intake category and as a continuous 
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exposure to explore potential dose-response associations. Exposure increments used in dose-
response models were the same as those detailed in Chapter 3. Categorical exposures were re-
generated specifically for this sample of women, where only English participants were included 
and are not identical to those in the previous chapter. 
6.3.8 Survival analyses 
Survival analyses were conducted using Cox proportional hazard regression (Cox and Oakes, 
1984) and again models were weighted by the inverse of the probability of being sampled, to 
take into account the large proportion of vegetarians in the cohort (as noted in Chapter 5, 
methods). 
Assumptions for proportional hazards were once again checked with the use of log-log survival 
curves for each outcome with all exposure and confounding variables. This condition was met 
for each exposure and with all covariates used in models. 
For primary analyses (full sample) a 2-sided p-value ≤0.05 was considered statistically 
significant and for subgroup analyses, this was reduced to ≤0.01. In later sections of this 
chapter, results from subgroup analyses are presented where CIs indicate an association but 
where the p-value did not reach the 1% level. These associations are of importance but should 
be interpreted with caution because of the greater chance of false positive findings with 
multiple tests. 
Microsoft Access was used for identifying earliest CHD, stroke or CVD events within each 
participant ID, thus condensing data from long (multiple row) format to wide (one row per 
participant) with the help of a database manager. Survival times were then calculated and all 
other data manipulation and analyses were conducted by myself, using Stata version 12 
(StataCorp, 2011). 
A recent study indicates that vegetarians and meat-eaters may possess different intestinal 
bacteria types and that the bacteria present to a larger degree in meat-eaters may contribute 
to increased CVD risk (Koeth et al., 2013). Since fibre is understood to affect gut micro-flora, 
post-hoc analysis of key associations between total fibre intake and CHD or stroke risk in 
vegetarian and non-vegetarian participants was undertaken to explore any potential different 
associations. The same exclusions and adjustments were applied as with other models but the 
factor that weighted on vegetarian status was removed.   
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6.3.9 Confounder adjustment 
Potential confounding variables chosen as adjustments for models were the same as in the 
previous chapter. Please refer back to Chapter 5 for details surrounding the selection of these. 
The following three levels of adjustment were applied: 
1) Age (years)  
2) Age (years), alcohol (ethanol g/day), smoking status (non-smoker, current-smoker, ex-
smoker), physical activity-metabolic equivalents (MET- hours/week) and SES 
(professional/managerial, intermediate or routine/manual). 
3) As model 2 with the addition of energy intake (kcal/day)* and BMI (kg/m2) 
* As noted in the previous chapter, by way of sensitivity analysis, when modelling CVD risk 
associated with fibre density of the diet, energy intake was additionally excluded in separate 
models, as suggested for nutrient density analyses by Willett (2013b). Results were not 
appreciably different with or without adjustment for energy intake in fibre density analyses 
(data not shown) and the results presented here are without adjustment for energy intake. 
In the intermediate model, the absence of BMI and energy intake as adjustments did not 
greatly alter risk estimates compared to model 3. In the interest of brevity, results from model 
2 are therefore not included in tables as they offer little extra information but are discussed 
where relevant. 
6.3.10 Cohort subgroup analyses 
Secondary analyses were conducted using the same subgroups as detailed in Chapter 5; 
menopausal status, BMI classification and self-reported hypertension at baseline. Subgroups 
analysis was only conducted where, for each outcome type, a minimum of 50 cases existed 
within the subgroup (case numbers are detailed in Tables 6.1 to 6.4). Analyses restricted to 
subgroups were only carried out for linear dose-response associations and not where 
exposures were split into 5 intake levels as case numbers tended to be quite small in the 
various categories. 
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6.3.11 Case subtype analyses 
In addition to examining total and non-fatal coronary and stroke events, fibre intake was 
examined in relation to risk of specific classifications of CHD and stroke (refer to Chapter 4, 
Tables 4.4 and 4.5 for details of which ICD10 codes are included in each outcome): 
 Myocardial infarction 
 Acute coronary syndromes (ACS) (including MI and other acute coronary events) 
 Chronic CHD (all chronic and not acute events) 
 Haemorrhagic stroke 
 Ischaemic stroke 
 Stroke, type not specified 
 Ischaemic and unspecified stroke 
Stroke events were initially grouped as haemorrhagic, ischaemic or those cases where event 
type was not reported (unspecified). Because of strongly protective risk associations observed 
only for the unspecified stroke cases, ischaemic and unspecified strokes were grouped 
together to represent ‘mostly ischaemic’ type stroke, for post-hoc exploration. As the majority 
of first stroke events are ischaemic, grouping the ischaemic and unspecified will approximately 
represent ischaemic strokes. Estimates from other studies of the proportion of first stroke 
events that are ischaemic in type varies from 78% in a collaborative study including 22 
countries around the world (O'Donnell et al., 2010) to 90% of first stroke events being 
recorded as ischaemic in a Danish study (Andersen et al., 2009). Grouping cases in this way 
provides a larger sample of ischaemic type strokes, despite the possibility of including a small 
proportion of haemorrhagic stroke cases.  
6.4 Results 
6.4.1 Sample and case numbers 
After applying exclusions to the sample, 27,400 women remained from 35,692. Up to 30th June 
2011, a total of 821 incident CHD and 388 incident stroke cases were observed. For each 
participant, the first CHD or stroke event was identified, disregarding later events. When 
combined and either the first CHD or stroke event was identified, a total of 1162 incident CVD 
cases were observed (Table 6.1). After removal of participants with missing data for any of the 
selected covariates, 760 incident CHD, 347 incident stroke and 1067 incident CVD cases were 
available in the fully-adjusted model analyses. 
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In fully adjusted models, 125 haemorrhagic, 160 ischaemic and 125 unspecified stroke cases 
were available (Table 6.2) and 217 MI, 361 ACS and 535 chronic heart disease cases were 
available (Table 6.3). For non-fatal CHD, stroke and CVD analyses, 668, 258 and 914 cases were 
available in fully-adjusted models, respectively (Table 6.4).  
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Table 6.1 Cohort participant and total (fatal plus non-fatal) CHD, stroke and CVD case frequency (%) included in unadjusted and fully adjusted models 
 UKWCS participant numbers † Total CHD case 
frequency 
Total stroke case 
frequency 
Total CVD case 
frequency 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Full sample 27400 25810 821 760 388 347 1162 1067 
Premenopausal  11447 (42) 10908 (42) 118 (14) 111 (15) 48 (12) 38 (11) 163 (14) 146 (14) 
Postmenopausal 9475 (35) 8816 (34) 476 (58) 440 (58) 248 (64) 225 (65) 692 (60) 638 (60) 
Underweight* 578 (2) 557 (2) 11 (1) 10 (1) 16 (4) 14 (4) 27 (2) 24 (2) 
Healthy weight* 16965 (62) 16589 (64) 428 (52) 412 (54) 211 (54) 203 (59) 614 (53) 592 (55) 
Overweight* 6457 (24) 6318 (24) 234 (29) 223 (29) 97 (25) 92 (27) 320 (28) 305 (29) 
Obese* 3371 (12) 2318 (9) 148 (18) 115 (15) 64 (16) 38 (11) 201 (17) 146 (14) 
Hypertension 4011 (15) 3745 (15) 242 (29) 224 (29) 117 (30) 108 (31) 347 (30) 323 (30) 
No hypertension 23389 (85) 22065 (85) 579 (71) 536 (71) 271 (70) 239 (69) 815 (70) 744 (70) 
Key as below. Note there are fewer CVD cases than CHD plus stroke numbers combined as CVD represents the first occurrence of either a CHD or stroke event for each participant 
 
Table 6.2 Cohort participant and stroke sub-type case frequency (%) included in unadjusted and fully adjusted models 
 UKWCS participant numbers † Haemorrhagic stroke 
case frequency 
Ischaemic stroke case 
frequency 
Unspecified stroke case 
frequency 
Ischaemic/ unspecified 
stroke case frequency 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Full sample 27400 25810 135 125 184 160 138 125 284 251 
Premenopausal  11447 (42) 10908 (42) 30 (22) 25 (20) 22 (12) 17 (11) 6 (4) 6 (5) 23 (8) 18 (7) 
Postmenopausal 9475 (35) 8816 (34) 66 (49) 62 (50) 119 (65) 106 (66) 106 (77) 96 (77) 199 (70) 179 (71) 
Underweight* 578 (2) 557 (2) 6 (4) 6 (5) 3 (2) 2 (1) 8 (6) 7 (6) 11 (4) 9 (4) 
Healthy weight* 16965 (62) 16589 (64) 74 (55) 71 (57) 98 (53) 95 (59) 76 (55) 72 (58) 154 (54) 149 (59) 
Overweight* 6457 (24) 6318 (24) 33 (24) 11 (9) 53 (29) 49 (31) 32 (23) 31 (25) 71 (25) 66 (26) 
Obese* 3371 (12) 2318 (9) 22 (16) 15 (12) 30 (16) 14 (9) 22 (16) 15 (12) 48 (17) 27 (11) 
Hypertension 4011 (15) 3745 (15) 37 (27) 36 (29) 50 (27) 43 (27) 51 (37) 48 (38) 91 (32) 82 (33) 
No hypertension 23389 (85) 22065 (85) 98 (73) 89 (71) 134 (73) 117 (73) 87 (63) 77 (62) 193 (68) 169 (67) 
Unadjusted: sample/case frequency (%) available in unadjusted models; Adjusted: sample/case frequency (%) available in fully adjusted models  
*using WHO cut-points for BMI <18.5, 18.5-24.9, 25.0-29.9, ≥30 kg/m
2 
† Numbers include cases 
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Table 6.3 Participant and CHD sub-type case frequency (%) included in unadjusted and fully adjusted models 
 UKWCS participant numbers † MI case frequency ACS case frequency Chronic heart disease 
case frequency 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Full sample 27400 25810 236 217 392 361 573 535 
Premenopausal  11447 (42) 10908 (42) 28 (12) 27 (12) 49 (13) 46 (13) 77 (13) 74 (14) 
Postmenopausal 9475 (35) 8816 (34) 156 (66) 142 (65) 241 (61) 222 (61) 328 (57) 302 (56) 
Underweight* 578 (2) 557 (2) 5 (2) 4 (2) 6 (2) 5 (1) 6 (1) 5 (1) 
Healthy weight* 16965 (62) 16589 (64) 134 (57) 127 (59) 214 (55) 202 (56) 291 (51) 283 (53) 
Overweight* 6457 (24) 6318 (24) 54 (23) 51 (24) 107 (27) 99 (27) 173 (30) 167 (31) 
Obese* 3371 (12) 2318 (9) 43 (18) 35 (16) 65 (17) 55 (15) 103 (18) 80 (15) 
Hypertension 4011 (15) 3745 (15) 70 (30) 66 (30) 116 (30) 106 (29) 180 (31) 171 (32) 
No hypertension 23389 (85) 22065 (85) 166 (70) 151 (70) 276 (70) 255 (71) 393 (69) 364 (68) 
Key as below.  
Table 6.4 Participant and non-fatal CHD, stroke and CVD case frequency (%) included in unadjusted and fully adjusted models 
 UKWCS participant 
numbers † 
Non-fatal CHD case 
frequency 
UKWCS participant 
numbers 
Non-fatal stroke case 
frequency 
UKWCS participant 
numbers 
Non-fatal CVD case 
frequency 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Full sample 27287 25606 714 668 27302 25721 290 258 27287 25609 990 914 
Premenopausal  11444 (42) 10893 (43) 112 (16) 107 (16) 11439 (42) 10901 (42) 40 (14) 31 (12) 11435 (42) 10893 (43) 151 (15) 137 (15) 
Postmenopausal 9394 (34) 8674 (34) 399 (56) 372 (56) 9406 (34) 8754 (34) 179 (62) 163 (63) 9337 (34) 8677 (34) 569 (57) 527 (58) 
Underweight* 575 (2) 548 (2) 8 (1) 7 (1) 570 (2) 551 (2) 8 (3) 8 (3) 567 (2) 548 (2) 16 (2) 15 (2) 
Healthy weight* 16898 (62) 16483 (64)  380 (53) 368 (55) 16914 (62) 16541 (64) 160 (55) 155 (60) 16855 (62) 16484 (64) 535 (54) 518 (57) 
Overweight* 6415 (24) 6257 (24)  202 (28) 192 (29) 6435 (24) 6296 (24) 75 (26) 70 (27) 6395 (23) 6258 (24) 272 (27) 257 (28) 
Obese* 3370 (12) 2290 (9)  124 (17) 101 (15) 3354 (12) 2305 (9) 47 (16) 25 (10) 3356 (12) 2291 (9) 167 (17) 124 ()14 
Hypertension 3960 (15) 3669 (14)  205 (29) 192 (29) 3976 (15) 3711 (14) 82 (28) 74 (29) 3929 (14) 3670 (14) 283 (29) 263 (29) 
No hypertension 23327 (85) 21937 (86)  509 (71) 476 (71) 23326 (85) 22010 (86) 208 (72) 184 (71) 23273 (85) 21939 (86) 707 (71) 651 (71) 
Unadjusted: sample/case frequency (%) available in unadjusted models; Adjusted: sample/case frequency (%) available in fully adjusted models  
*using WHO cut-points for BMI <18.5, 18.5-24.9, 25.0-29.9, ≥30 kg/m
2 
† Numbers include cases.  
Note there are fewer CVD cases than CHD plus stroke numbers combined as CVD represents the first occurrence of either a CHD or stroke event for each participant 
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6.4.2 Descriptive statistics 
Stroke cases were unsurprisingly older than non-cases, median age was 62.7 (IQR 13.7) years 
compared to 50.1 (IQR 13.9) years (Table 6.5). Stroke cases also reported slightly higher BMI 
24.0 kg/m2 (IQR 4.9) compared to non-cases 23.4 kg/m2 (IQR 4.6). A greater proportion of 
stroke cases were also meat eaters 74% compared to non-cases 66% and educational 
achievement levels were lower in cases. Haemorrhagic stroke cases tended to be younger than 
other stroke types, median age was 58.4 years (IQR 17.3) for haemorrhagic stroke and was 
63.1 years (IQR 13.5) and 65.9 years (IQR 9.3) for ischaemic and unspecified stroke, 
respectively. Haemorrhagic stroke cases also reported slightly greater fibre intake levels than 
other cases, although this may relate to the marginally higher energy intake reported for the 
haemorrhagic compared to other cases. Stroke cases were also much more likely to report 
history of hypertension compared to non-cases 30% vs. 14%. Intake levels for total fibre and 
fibre from different sources were roughly comparable for different stroke cases types and non-
cases. 
Similar to stroke, CHD cases were almost 10 years older than non-cases. At baseline, median 
age was 59.4 years (IQR 13.5) vs. 50.0 years (IQR 13.9) and median BMI was over one point 
higher in the cases 24.6 kg/m2 (IQR 5.6) compared to non-cases 23.4 kg/m2 (IQR 4.6) (Table 
6.6). Most characteristics were similar between acute and chronic heart disease cases but 
some differences exist between these and the small number of ‘other’ heart disease cases, 
namely the ‘other CHD’ cases were younger and had BMI closer to the non-cases. Heart 
disease cases also tended to be meat-eaters, smokers and have lower educational 
achievement compared to the non-cases. Personal history of hypertension was higher in CHD 
cases, with 30% of participants reporting this at baseline, compared to the non-cases where 
just 14% had existing hypertension.   
CVD cases were more than 10 years older than non-cases 60.4 years (IQR 13.8) compared to 
49.9 years (IQR 13.7) and BMI was one unit higher 24.4 kg/m2 (IQR 5.1) compared to non-cases 
23.4 kg/m2 (IQR 4.6) (Table 6.7). Similar to the stroke and CHD cases and non-cases, CVD cases 
tended to have a lower education or employment profile and tended to include more meat-
eaters and smokers compared to the non-cases. Physical activity, energy intake and other 
dietary characteristics were however largely comparable in the CVD cases and non-cases. 
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Table 6.5 Baseline cross-sectional characteristics for fatal plus non-fatal stroke and stroke subtype cases, non-fatal stroke cases and non cases 
 Haemorrhagic 
stroke (fatal 
plus non-fatal 
cases)  
Ischaemic 
stroke (fatal 
plus non-fatal 
cases) 
Unspecified 
stroke (fatal 
plus non-fatal 
cases) 
Ischaemic or 
unspecified stroke 
(fatal plus non-
fatal cases) 
Total stroke (all 
fatal plus non-
fatal cases)  
Non-fatal stroke Non stroke 
cases 
N 135 184 138 284 388 355 27012 
Age, years 58.4 (17.3)  63.1 (13.5)  65.9 (9.3)  64.5 (12.1) 62.7 (13.6)  61.9 (13.6)  50.1 (13.9)  
BMI, kg/m
2
 23.7 (4.8) 24.4 (5.2) 24.0 (5.3) 24.1 (5.0) 24.0 (4.9) 24.0 (4.8) 23.4 (4.6) 
Smoking status (%) Current  22 (16) 25 (14) 21 (15) 38 (13) 52 (13) 35 (12) 2848 (11) 
Former 37 (27) 43 (24) 38 (28) 71 (25) 105 (27) 89 (31) 8144 (30) 
Never smoked 76 (56) 115 (63) 79 (57) 174 (61) 230 (60) 165 (57) 15975 (59)  
Diet group (%) Meat-eaters 98 (73) 138 (75) 108 (78) 215 (76) 289 (74) 211 (59) 17836 (66) 
Fish-eaters 20 (15)  17 (9)  10 (7)  25 (9) 41 (11)  31 (11) 3518 (13) 
Vegetarian 17 (13) 29 (16) 20 (14) 44 (15) 58 (15) 48 (17)  5658 (21)  
Socio-economic status 
NS-SEC (%) 
Professional/ managerial 78 (59) 96 (54) 64 (49) 143 (53) 199 (54) 146 (52) 16787 (63) 
Intermediate 38 (29) 61 (35) 51 (39) 100 (37) 132 (35) 103 (37) 7297 (28) 
Routine and manual 16 (12) 18 (10) 16 (12) 27 (10) 41 (11) 30 (11) 2378 (9) 
Highest educational 
achievement (%) 
No formal record 30 (24) 49 (33) 46 (42) 80 (35) 105 (32) 73 (30) 3868 (16)  
O-level 31 (24) 37 (25) 22 (20) 54 (24) 80 (25) 65 (27) 8081 (32) 
A-level 34 (27)  34 (23)  27 (24)  55 (24) 80 (24)  62 (25) 6057 (24) 
Degree 32 (25) 28 (19) 14 (13) 41 (18) 62 (19) 45 (18) 6820 (27) 
Menopause status (%) Post 66 (51) 119 (66) 106 (80) 199 (72) 248 (66) 179 (64) 9227 (35)  
Pre 30 (23)  22 (12)  6 (5)  23 (8) 48 (13)  40 (14)  11399 (43) 
Not applicable* 34 (26) 40 (22) 21 (16) 54 (20) 80 (21) 62 (22) 5986 (22) 
History of hypertension 
at baseline (%) 
Yes 37 (27) 50 (27) 51 (37) 91 (32) 117 (30) 82 (28)  3894 (14) 
No 98 (73) 134 (72) 87 (63) 193 (68) 271 (70) 208 (72) 23118 (86) 
Ethanol g/day 4.9 (10.8) 3.3 (10.7) 3.5 (9.6) 3.3 (10.4) 3.8 (10.5) 3.4 (10.1) 5.6 (11.7) 
Physical activity, MET-hours/week 14.0 (14.4) 14.3 (13.8) 16.8 (14.0) 15.3 (13.5) 14.6 (13.7) 15.0 (14.0) 14.5 (13.1) 
Energy intake, kcal/day 2237 (831)  2176 (935) 2012 (952) 2143 (933) 2153 (896) 2169 (915) 2179 (857)  
Saturated fat intake g/day 28.1 (15.1) 26.9 (20.1) 26.1 (17.1) 27.2 (17.9) 27.5 (17.6) 27.5 (19.2) 26.8 (15.8) 
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 Haemorrhagic 
stroke (fatal 
plus non-fatal 
cases)  
Ischaemic 
stroke (fatal 
plus non-fatal 
cases) 
Unspecified 
stroke (fatal 
plus non-fatal 
cases) 
Ischaemic or 
unspecified stroke 
(fatal plus non-
fatal cases) 
Total stroke (all 
fatal plus non-
fatal cases)  
Non-fatal stroke Non stroke 
cases 
NSP, g/day 24.3 (13.3) 23.1 (13.1) 20.8 (13.1) 23.0 (13.7) 23.1 (13.4) 23.6 (13.3) 23.8 (12.3) 
NSP density, g/1000kcal/day 11.1 (4.2) 10.9 (4.9) 10.1 (4.8) 10.6 (4.9) 10.8 (4.6) 10.9 (4.5) 11.0 (4.2) 
AOAC fibre, g/day 36.6 (20.7)  35.7 (19.5) 32.1 (21.8) 35.7 (21.1) 35.9 (20.8) 36.4 (20.7) 36.6 (18.7)  
AOAC fibre density, g/1000kcal/day 16.3 (6.4) 16.7 (6.7) 16.4 (7.4) 16.6 (7.2) 16.6 (7.0) 16.5 (6.7) 16.9 (6.1) 
Soluble fibre, g/day 10.3 (5.5) 10.1 (4.9) 9.1 (6.2) 10.0 (5.3) 10.1 (5.5) 10.3 (5.5) 10.4 (5.0) 
Insoluble fibre, g/day 15.3 (8.8) 14.6 (9.2) 13.5 (9.4) 14.7 (9.8) 14.7 (9.4) 14.9 (9.3) 15.3 (8.8) 
NSP 
within  
Foods, 
g/day 
 
Total fruit 4.0 (3.5) 3.7 (4.0) 4.0 (4.2) 3.8 (4.4) 4.0 (4.2) 3.9 (3.8)  4.2 (3.9) 
Vegetables 5.5 (3.8) 4.9 (4.4) 4.6 (3.3) 4.8 (3.8) 5.0 (3.8) 5.3 (3.9) 5.0 (3.7) 
Total cereal foods 7.4 (7.3) 6.8 (8.0) 6.8 (6.5) 6.9 (7.4) 7.1 (7.3) 6.8 (7.9) 7.6 (7.0) 
Breakfast cereals 1.7 (3.8) 1.8 (3.8) 2.1 (3.9) 2.0 (3.9) 1.9 (3.8) 1.8 (3.9) 1.8 (3.6) 
Nuts & Seeds 0.07 (0.2) 0.07 (0.3) 0.07 (0.2) 0.07 (0.2) 0.07 (0.2) 0.08 (0.3)  0.09 (0.3) 
Legumes 1.0 (1.1)  1.1(1.0)  0.8 (1.2)  0.9 (1.1) 0.9 (1.0)  1.1 (1.0) 1.1(1.3) 
* Pregnant, taking the contraceptive pill/ hormone replacement therapy.   
Values are median (IQR) or numbers (percentages). 
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Table 6.6 Baseline cross-sectional characteristics for fatal plus non-fatal CHD and CHD subtype cases, non-fatal CHD cases and non cases 
 Total MI (fatal 
plus non-fatal 
cases) 
Total ACS (fatal 
plus non-fatal 
cases) 
Chronic heart 
disease (fatal 
plus non-fatal 
cases) 
Other heart 
disease (fatal plus 
non-fatal cases) 
Total CHD 
incidence†(fatal 
plus non-fatal 
cases) 
Non-fatal CHD Non CHD cases 
N 236 392 573 38 812 714 26573 
Age, years 61.2 (13.2)  60.3 (13.4)  59.2 (13.0)  54.2 (15.2)  59.4 (13.5) 58.6 (13.4) 50.0 (13.9) 
BMI, kg/m
2
 24.1 (5.1) 24.4 (5.4) 24.6 (5.7) 23.6 (5.0) 24.6 (5.6) 24.5 (5.6) 23.4 (4.6) 
Smoking status (%) Current  53 (23) 68 (17) 78 (14) 4 (11) 126 (16) 100 (14) 2773 (10) 
Former 72 (31) 120 (31) 181 (32) 14 (37) 261(32) 227 (23) 7986 (30) 
Never smoked 110 (47) 201 (52) 313 (54) 20 (53) 431 (53) 384 (54) 15771 (59) 
Diet group (%) Meat 184 (78) 297 (76) 433 (76) 24 (63) 607 (75) 530 (74) 17508 (66) 
Fish 26 (11) 45 (11) 66 (12) 6 (16)  100 (12) 86 (12) 3460 (13) 
Vegetarian 26 (11) 50 (13) 74 (13) 8 (21) 114 (14) 98 (14) 5605 (21) 
Socio-economic status  
NS-SEC (%) 
Professional/ managerial 124 (56) 213 (58) 313 (56) 20 (53) 445 (55) 384 (54) 16536 (62) 
Intermediate 79 (35) 126 (34) 179 (32) 4 (11) 264 (33) 231 (32) 7167 (27) 
Routine and manual 20 (9) 31 (8) 64 (12) 14 (37) 80 (10) 74 (10) 2337 (9) 
Highest educational 
achieve-ment (%) 
No formal record 62 (30) 100 (29) 138 (28) 9 (28) 201 (25) 171 (24) 3770 (14) 
O-level 57 (28) 102 (30) 149 (30) 13 (41) 221 (27) 198 (28) 7937 (30) 
A-level 44 (21) 69 (20) 103 (21) 9 (28) 153 (19) 138 (19) 5985 (23) 
Degree 43 (21) 73 (21) 100 (20) 1 (3) 135 (17) 115 (16) 6747(25) 
Menopause status (%) Post 156 (68) 241 (63) 328 (59) 17 (45) 476 (59) 399 (56) 8995 (34) 
Pre 28 (12) 49 (13) 77 (14) 12 (32) 118 (15) 112 (16) 11332 (43) 
NA* 47 (20) 92 (24) 152 (27) 9 (24) 204 (25) 187 (26) 5858 (22) 
History of hypertension 
at baseline (%) 
Yes 70 (30) 116 (30) 180 (31) 9 (24) 242 (30) 205 (29) 3755 (14) 
No 166 (70) 276 (70) 393 (69) 29 (76) 579 (71) 509 (71) 22818 (86) 
Ethanol g/day 1.8 (10.5) 3.5 (10.6) 3.6 (9.8) 3.6 (11.4) 3.6 (10.4) 3.9 (10.9) 5.6 (11.7) 
Physical activity, MET-hours/week 14.0 (13.0) 14.3 (14.0) 14.8 (13.4) 13.3 (11.3) 14.4 (13.2) 14.8 (13.3) 14.5 (13.1) 
Energy intake, kcal/day 2215 (862) 2181 (876) 2202 (856) 2089 (886) 2198 (875) 2200 (881) 2178 (858) 
Saturated fat intake g/day 27.8 (15.8) 26.7 (14.5) 26.9 (16.1) 26.9 (15.6) 26.7 (15.7) 26.6 (15.7) 26.8 (15.9) 
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 Total MI (fatal 
plus non-fatal 
cases) 
Total ACS (fatal 
plus non-fatal 
cases) 
Chronic heart 
disease (fatal 
plus non-fatal 
cases) 
Other heart 
disease (fatal plus 
non-fatal cases) 
Total CHD 
incidence†(fatal 
plus non-fatal 
cases) 
Non-fatal CHD Non CHD cases 
NSP, g/day 21.5 (11.6) 23.1 (11.9) 24.2 (13.2) 23.0 (10.1) 24.0 (12.9) 24.2 (12.9) 23.9 (12.3) 
NSP density, g/1000kcal/day 10.7 (4.6) 11.0 (4.5) 11.1 (4.2) 11.0 (3.5) 11.0 (4.3) 11.1 (4.2) 11.0 (4.2) 
AOAC fibre, g/day 34.0 (17.5) 35.3 (17.9) 37.3 (19.7) 33.9 (13.3) 36.6 (19.2) 37.0 (19.6) 36.6 (18.7) 
AOAC fibre density, g/1000kcal/day 16.3 (6.1) 16.6 (6.1) 16.9 (6.1) 17.0 (5.3) 16.9 (6.0) 17.0 (6.0) 16.9 (6.2) 
Soluble fibre, g/day 9.8 (4.9) 10.2 (4.8) 10.4 (5.3) 10.3 (4.9) 10.4 (5.2) 10.5 (5.3) 10.4 (5.0) 
Insoluble fibre, g/day 13.8 (8.3) 14.9 (9.0) 15.6 (9.2) 14.6 (7.4) 15.3 (9.0) 15.5 (9.1) 15.3 (8.8) 
NSP within  
Foods, g/day 
 
Total fruit 4.3 (3.6) 4.3 (4.1) 4.3 (3.9) 5.6 (4.2)  4.3 (4.2) 4.3 (4.3) 4.2 (3.9) 
Vegetables 5.0 (3.9) 5.1 (3.9) 5.3 (3.9) 5.3 (4.5) 5.2 (3.9) 5.3 (3.9) 4.9 (3.7) 
Total cereal foods 7.1 (6.8) 7.6 (7.4) 7.7 (7.1) 8.7 (4.6) 7.7 (7.1) 8.0 (7.2) 7.6 (7.0) 
Breakfast cereals 1.7 (3.6) 1.9 (4.4) 1.8 (4.4) 3.5 (5.2) 1.9 (4.4) 1.9 (4.4) 1.8 (3.6) 
Nuts & Seeds 0.08 (0.2) 0.08 (0.2) 0.08 (0.2) 0.07 (0.2) 0.08 (0.2) 0.08 (0.2) 0.09 (0.3) 
Legumes 0.9 (1.1) 0.9 (1.1) 0.9 (1.2) 1.2 (1.9) 1.0 (1.2) 1.0 (1.2) 1.1 (1.3) 
Values are median (IQR) or numbers (percentages).  
* Pregnant, taking the contraceptive pill/ hormone replacement therapy.  
†Total CHD incidence includes ACS, Chronic and Other cases. 
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Table 6.7 Baseline cross-sectional characteristics for non-fatal and total CVD (fatal plus non-
fatal) cases in addition to non-cases 
 Non-fatal CVD Total CVD (Fatal plus 
non-fatal events) † 
Non-CVD cases 
N 990 1162 26232 
Age, years 59.3 (13.9) 60.4 (13.8) 49.9 (13.7) 
BMI, kg/m
2
 24.4 (5.1) 24.4 (5.1) 23.4 (4.6) 
Smoking 
status (%) 
Current  133 (13) 168 (14) 2731 (10) 
Former 312 (32) 352 (30) 7895 (30) 
Never smoked 541 (55) 639 (55) 15563 (59) 
Diet group 
(%) 
Meat-eaters 733 (74) 863 (74) 17252 (66) 
Fish-eaters 116 (12) 135 (12) 3425 (13) 
Vegetarian 141 (14) 164 (14) 5555 (21) 
Socio-
economic 
status NS-SEC 
(%) 
Professional/ 
managerial 
522 (53) 622 (54) 16359 (62) 
Intermediate 331 (33) 378 (33) 7053 (27) 
Routine and manual 101 (10) 117 (10) 2300 (9) 
Highest 
educational 
achievement (%) 
No formal record 242 (24) 292 (25) 3679 (14) 
O-level 256 (26) 292 (25) 7866 (30) 
A-level 198 (20) 221 (19) 5917 (23) 
Degree 158 (16) 193 (17) 6689 (25) 
Menopause status 
(%) 
Post 569 (57) 692 (60) 8779 (33) 
Pre 151 (15) 163 (14) 11287 (43) 
Not applicable* 246 (25) 274 (24) 5788 (22) 
History of hypertension at 
baseline (%) 
Yes 283 (29) 347 (30) 3650 (14) 
No 707 (71) 815 (70) 22582 (86) 
Ethanol g/day 3.8 (10.6) 3.6 (10.5) 5.6 (11.7) 
Physical activity, MET-hours/week 14.7 (13.1 ) 14.4 (13.3) 14.5 (13.1) 
Energy intake, kcal/day 2187 (892) 2177 (885) 2178 (857) 
Saturated fat intake g/day 26.8 (16.7) 26.8 (16.5) 26.8 (15.8) 
NSP, g/day 24.0 (13.0) 23.7 (12.9) 23.9 (12.3) 
NSP density, g/1000kcal/day 11.0 (4.4) 11.0 (4.3) 11.0 (4.2) 
AOAC fibre, g/day 36.6 (19.9) 36.2 (19.8) 36.7 (18.7) 
AOAC fibre density, g/1000kcal/day 16.9 (6.2) 16.7 (6.3) 16.9 (6.2) 
Soluble fibre, g/day 10.4 (5.4) 10.2 (5.3) 10.4 (5.0) 
Insoluble fibre, g/day 15.2 (9.3) 15.0 (9.2) 15.3 (8.8) 
NSP within  
Foods, g/day 
 
Total fruit 4.2 (4.2)  4.2 (4.1) 4.2 (3.9) 
Vegetables 5.2 (3.9) 5.2 (3.8) 5.0 (3.7) 
Total cereal foods 7.4 (7.3) 7.4 (7.1) 7.6 (7.0) 
Breakfast cereals 1.9 (4.3) 1.9 (4.1) 1.8 (3.6) 
Nuts & Seeds 0.08 (0.3) 0.08 (0.2) 0.10 (0.3) 
Legumes 1.0 (1.2) 1.0 (1.1) 1.1(1.3) 
Values are median (IQR) or numbers (percentages).  
* Pregnant, taking the contraceptive pill/ hormone replacement therapy. 
† CVD cases include heart disease or stroke cases combined. 
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6.4.3 Survival analysis  
In total, 27,400 English residents, free from personal history of stroke or heart attacks were 
followed for over 14 years. During follow-up, and after excluding non eligible women, 821 
incident (fatal plus non-fatal) CHD and 388 incident stroke cases were observed, with 760 CHD 
and 347 stroke cases available in fully adjusted models. When first stroke and CHD events 
were considered together and after median follow up of 14.3 years, 1162 CVD cases (1067 
available in fully adjusted models) were observed.  
HRs (95% CIs) are presented for categorised exposures and by fitting a linear trend over the 
categories for assessing dose-response trends in both age-adjusted and fully adjusted models. 
Total (fatal plus non-fatal) CHD, stroke or CVD events are presented in Table 6.8 and non-fatal 
events in Table 6.9. Risk estimates for stroke sub-types are presented in Tables 6.10 and 6.11 
and for sub-types of CHD in Table 6.12.  
Total CHD, stroke and CVD incidence (fatal plus non-fatal events) 
All participants 
Greater intake of total dietary fibre, assessed as NSP or using the AOAC method, higher fibre 
density and greater intake of soluble fibre, insoluble fibre and fibre from cereals were all 
associated with significantly lower risk for total stroke (Table 6.8). With each 6g/day increase 
in total NSP fibre, risk of total stroke reduced by 11%: HR 0.89 (95% CI: 0.81 to 0.99) p=0.03. 
For these different fibre exposures, risks tended to decrease with increasing intake categories 
and risk was significantly lower in each increasing intake group compared to the lowest 
consumers. For example with total NSP intake, risk of total stroke compared to the lowest 
consumers in Q2 was 0.65 (95% CI: 0.46 to 0.92), Q3 0.63 (95% CI: 0.44 to 0.90), Q4 0.63 (95% 
CI: 0.44 to 0.91) and in Q5 was 0.54 (95% CI: 0.35 to 0.85). With each 4g/day greater insoluble 
fibre intake the HR for total stroke was 0.90 (95% CI: 0.82 to 0.99) p=0.03 and with each 
3g/day increase in cereal fibre HR 0.92 (95% CI: 0.85 to 1.00) p=0.04.  
For total CVD, only fibre density assessed either using the NSP or AOAC method was associated 
with significantly lower risk: with every 2g/1000kcal/day higher NSP density, risk was 0.95 
(95% CI: 0.91 to 1.00) p=0.03.  
No significant associations were observed for any of the different fibre exposures and risk for 
total CHD.  
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Continuous risk estimates for models just adjusted for age, SES, alcohol, smoking status and 
MET-hours/week, without adjustment for BMI and energy intake, were not appreciably 
different from risk estimates for the fully-adjusted models (BMI and energy intake included). In 
most cases, statistical significance in multivariate models was similar to or slightly 
strengthened compared to the age-adjusted models.  
Subgroups 
In subgroups where a minimum of 50 cases were available for fully adjusted analyses, only one 
significant association, at the pre specified 1% significance level, was observed for stroke. With 
each 1g/day increase in fibre from legumes, there was 40% decreased risk of a total stroke HR 
0.60 (95% CI: 0.41 to 0.87) p<0.01 in women who were classed as obese at baseline. 
In women free of hypertension, legume fibre (per 1g/day) was associated with lower CHD risk 
0.92 (95% CI: 0.85 to 0.99) p=0.02 in the fully adjusted model and this association was also 
apparent in the model without adjustment for energy intake and BMI, 0.93 (95% CI: 0.87 to 
0.99) p=0.03. In the same subgroup, many of the different fibre exposures were inversely 
associated with CVD risk in both the mid and fully adjusted models. In those without 
hypertension, and in the fully adjusted models, CVD risk per 6g/day increase in total NSP was 
0.94 (95% CI: 0.88 to 1.00) p=0.05; per 2g/1000kcal/day greater intake in NSP density 0.94 
(95% CI: 0.89 to 1.00) p=0.02; per 11g/day greater AOAC fibre intake 0.91 (95% CI: 0.84 to 
0.99) p=0.03; per 3g/1000kcal/day increase in AOAC density 0.93 (95% CI: 0.88 to 0.98) p=0.01; 
per 3g/day increase in soluble fibre 0.91 (95% CI: 0.84 to 0.99) p=0.03 and per 1g/day increase 
in legume fibre 0.94 (0.88 to 1.00) p=0.04. 
In 7,723 participants that identified themselves as vegetarian at baseline, risk of total CHD (174 
cases) and total stroke (77 cases) per 6g/day greater NSP intake was 0.96 (95% CI 0.85 to 1.09) 
and 1.08 (95% CI 0.90 to 1.30), respectively. In 18,794 participants that were reported meat-
eaters at baseline, risk of total CHD (612 cases) and total stroke (297 cases) per 6g/day greater 
NSP intake was 0.98 (95% CI 0.91 to 1.05) and 0.88 (95% CI 0.79 to 0.98), respectively. No 
significant model interaction was observed by vegetarian status for CHD outcomes (p=0.56) or 
stroke outcomes (p=0.77) using the likelihood ratio test though power was low for this test of 
interaction. 
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Table 6.8 Dietary fibre intake and associated risk for total CHD, total stroke and total CVD 
 
Median 
intake 
(IQR) 
Total CHD Total stroke Total CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
NSP 
(g/day) 
Q1 14.1 (3.9) 163 1 1 87 1 1 243 1 1 
Q2 19.5 (2.2) 156 0.93 (0.74, 1.16) 0.99 (0.78, 1.25) 63 0.75 (0.55, 1.03) 0.65 (0.46, 0.92) 213 0.87 (0.73, 1.05) 0.87 (0.72, 1.06) 
Q3 23.8 (2.3) 138 0.81 (0.64, 1.01) 0.89 (0.68, 1.14) 63 0.69 (0.50, 0.95) 0.63 (0.44, 0.90) 192 0.75 (0.62, 0.91) 0.77 (0.62, 0.96) 
Q4 29.1 (3.1) 149 0.85 (0.68, 1.06) 0.88 (0.67, 1.14) 69 0.70 (0.51, 0.97) 0.63 (0.44, 0.91) 211 0.80 (0.66, 0.96) 0.79 (0.64, 0.98) 
Q5 38.1 (8.5) 154 0.90 (0.72, 1.13) 0.96 (0.71, 1.29) 65 0.71 (0.52, 0.98) 0.54 (0.35, 0.85) 208 0.82 (0.68, 0.99) 0.79 (0.61, 1.01) 
Per 6g/day  760 0.98 (0.94, 1.03)    0.44 0.98 (0.92, 1.05)   0.59 347 0.94 (0.88, 1.02)    0.13 0.89 (0.81, 0.99)   0.03 1067 0.97 (0.93, 1.01)    0.09 0.95 (0.90, 1.01)     0.09 
AOAC 
(g/day) 
Q1 21.8 (5.9) 166 1 1 90 1 1 250 1 1 
Q2 30.0 (3.4) 154 0.92 (0.74, 1.14) 0.96 (0.76, 1.22) 63 0.72 (0.52, 0.98) 0.64 (0.46, 0.91) 214 0.86 (0.72, 1.03) 0.86 (0.70, 1.04) 
Q3 36.6 (3.5) 131 0.75 (0.60, 0.95) 0.81 (0.62, 1.05) 58 0.57 (0.41, 0.79) 0.50 (0.34, 0.71) 180 0.67 (0.56, 0.82) 0.67 (0.54, 0.84) 
Q4 44.5 (4.7) 156 0.85 (0.68, 1.06) 0.89 (0.68, 1.17) 72 0.75 (0.55, 1.02) 0.66 (0.46, 0.95) 217 0.80 (0.67, 0.96) 0.79 (0.63, 0.99) 
Q5 58.5 (13.2) 153 0.92 (0.73, 1.15) 0.94 (0.69, 1.29) 64 0.65 (0.47, 0.90) 0.46 (0.29, 0.73) 206 0.80 (0.67, 0.97) 0.74 (0.56, 0.96) 
Per 11g/day   760 0.98 (0.93, 1.04)    0.48 0.98 (0.90, 1.06)   0.62 347 0.94 (0.86, 1.03)    0.16 0.87 (0.76, 0.99)   0.03 1067 0.96 (0.91, 1.01)    0.11 0.94 (0.88, 1.01)     0.09 
NSP 
density  
g/1000 
kcal/day 
Q1 7.5 (1.5) 165 1 1 85 1 1 242 1 1 
Q2 9.4 (0.8) 148 0.84 (0.67, 1.05) 0.93 (0.74, 1.17) 75 0.89 (0.66, 1.20) 0.90 (0.66, 1.24) 216 0.86 (0.71, 1.03) 0.92 (0.76, 1.12) 
Q3 11.0 (0.8) 150 0.91 (0.73, 1.13) 0.97 (0.77, 1.23) 53 0.56 (0.40, 0.79) 0.61 (0.43, 0.88) 194 0.78 (0.64, 0.94) 0.84 (0.69, 1.03) 
Q4 12.7 (1.0) 141 0.81 (0.65, 1.01) 0.88 (0.70, 1.13) 58 0.64 (0.46, 0.88) 0.62 (0.43, 0.88) 193 0.76 (0.63, 0.91) 0.80 (0.65, 0.97) 
Q5 15.4 (2.4) 156 0.88 (0.71, 1.10) 0.97 (0.76, 1.24) 76 0.74 (0.54, 1.01) 0.78 (0.56, 1.09) 222 0.82 (0.68, 0.99) 0.90 (0.74, 1.10) 
2g/1000kcal/d  760 0.96 (0.91, 1.01)    0.08 0.98 (0.93, 1.03)   0.35 347 0.91 (0.85, 0.98)    0.01 0.92 (0.85, 0.99)   0.03 1067 0.94 (0.90, 0.98)  <0.01 0.95 (0.91, 1.00)     0.04 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.7 (2.1) 158 1 1 87 1 1 238 1 1 
Q2 14.6 (1.2) 163 0.99 (0.80, 1.24) 1.05 (0.84, 1.31) 69 0.73 (0.54, 1.00) 0.73 (0.53, 1.01) 224 0.89 (0.74, 1.07) 0.93 (0.79, 1.12) 
Q3 16.9 (1.1) 141 0.88 (0.71, 1.11) 0.93 (0.73, 1.17) 54 0.58 (0.42, 0.81) 0.59 (0.42, 0.83) 188 0.76 (0.63, 0.92) 0.79 (0.65, 0.97) 
Q4 19.4 (1.4) 158 0.95 (0.76, 1.19) 1.03 (0.81, 1.30) 64 0.60 (0.43, 0.83) 0.65 (0.46, 0.91) 212 0.82 (0.68, 0.99) 0.88 (0.72, 1.07) 
Q5 23.4 (3.5) 140 0.84 (0.66, 1.06) 0.90 (0.70, 1.16) 73 0.69 (0.50, 0.94) 0.69 (0.49, 0.96) 205 0.77 (0.64, 0.93) 0.82 (0.67, 1.01) 
3g/1000kcal/d  760 0.95 (0.91, 1.00)    0.07 0.97 (0.93, 1.03)   0.35 347 0.91 (0.84, 0.98)    0.01 0.91 (0.84, 0.99)   0.03 1067 0.94 (0.90, 0.98)  <0.01 0.95 (0.91, 1.00)     0.03 
186 
 
 
 
 
Median 
intake 
(IQR) 
Total CHD Total stroke Total CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 168 1 1 88 1 1 250 1 1 
Q2 8.6 (0.9) 141 0.84 (0.67, 1.05) 0.86 (0.67, 1.09) 62 0.71 (0.52, 0.98) 0.67 (0.47, 0.95) 197 0.79 (0.65, 0.95) 0.78 (0.64, 0.95) 
Q3 10.4 (0.9) 142 0.84 (0.67, 1.05) 0.88 (0.69, 1.14) 59 0.73 (0.53, 1.00) 0.62 (0.43, 0.89) 195 0.79 (0.66, 0.95) 0.78 (0.63, 0.97) 
Q4 12.5 (1.2) 143 0.78 (0.62, 0.98) 0.85 (0.65, 1.11) 73 0.75 (0.55, 1.03) 0.68 (0.47, 0.99) 209 0.76 (0.63, 0.92) 0.78 (0.62, 0.97) 
Q5 16.3 (3.8) 166 0.97 (0.78, 1.21) 1.01 (0.75, 1.36) 65 0.71 (0.52, 0.98) 0.57 (0.36, 0.90) 216 0.84 (0.70, 1.01) 0.81 (0.62, 1.04) 
Per 3g/day  760 0.98 (0.93, 1.04)    0.55 0.97 (0.90, 1.05)   0.45 347 0.95 (0.87, 1.03)    0.22 0.88 (0.77, 1.00)   0.05 1067 0.97 (0.92, 1.01)    0.16 0.94 (0.88, 1.01)     0.09 
Insoluble 
fibre 
(g/day) 
Q1 8.4 (2.6) 165 1 1 89 1 1 248 1 1 
Q2 12.2 (1.6) 154 0.92 (0.74, 1.14) 0.96 (0.76, 1.21) 66 0.81 (0.60, 1.11) 0.71 (0.50, 0.99) 214 0.88 (0.74, 1.06) 0.87 (0.72, 1.05) 
Q3 15.3 (1.6) 143 0.82 (0.66, 1.03) 0.90 (0.70, 1.16) 60 0.68 (0.49, 0.94) 0.60 (0.42, 0.85) 197 0.77 (0.64, 0.93) 0.78 (0.64, 0.97) 
Q4 19.0 (2.2) 149 0.87 (0.69, 1.08) 0.90 (0.70, 1.16) 67 0.68 (0.49, 0.94) 0.64 (0.45, 0.91) 206 0.79 (0.66, 0.95) 0.79 (0.64, 0.97) 
Q5 25.5 (5.9) 149 0.88 (0.70, 1.11) 0.92 (0.69, 1.23) 65 0.72 (0.52, 0.98) 0.53 (0.34, 0.81) 202 0.80 (0.66, 0.96) 0.75 (0.59, 0.96) 
Per 4g/day   760 0.99 (0.94, 1.03)    0.51 0.99 (0.94, 1.05)   0.85 347 0.94 (0.88, 1.01)    0.10 0.90 (0.82, 0.99)   0.03 1067 0.97 (0.93, 1.00)    0.08 0.96 (0.91, 1.01)     0.12 
Total 
cereal 
fibre 
(g/day) 
 
Q1 2.8 (1.4) 165 1 1 84 1 1 240 1 1 
Q2 5.1 (1.1) 139 0.85 (0.68, 1.06) 0.90 (0.71, 1.14) 72 0.87 (0.63, 1.19) 0.83 (0.59, 1.16) 207 0.86 (0.71, 1.04) 0.89 (0.73, 1.08) 
Q3 7.6 (1.4) 146 0.85 (0.68, 1.06) 0.86 (0.67, 1.10) 60 0.66 (0.47, 0.92) 0.60 (0.41, 0.87) 200 0.78 (0.65, 0.94) 0.77 (0.62, 0.94) 
Q4 10.6 (1.8) 166 0.92 (0.74, 1.15) 1.01 (0.79, 1.29) 61 0.68 (0.49, 0.94) 0.56 (0.39, 0.81) 217 0.82 (0.68, 0.99) 0.85 (0.69, 1.04) 
Q5 15.6 (4.5) 144 0.84 (0.67, 1.05) 0.89 (0.68, 1.16) 70 0.76 (0.55, 1.04) 0.68 (0.46, 0.99) 203 0.80 (0.66, 0.96) 0.81 (0.65, 1.00) 
Per 3g/day  760 1.00 (0.95, 1.04)    0.84 1.01 (0.96, 1.06)   0.62 347 0.95 (0.89, 1.01)      0.11 0.92 (0.85, 1.00)   0.04 1067 0.98 (0.94, 1.01)    0.18 0.98 (0.94, 1.02)     0.37 
Fibre 
from 
breakfast 
cereals 
(g/day) 
Q1 0.05 (0.1) 152 1 1 71 1 1 219 1 1 
Q2 0.5 (0.4) 157 1.06 (0.85, 1.33) 1.02 (0.81, 1.30) 67 1.19 (0.85, 1.66) 1.11 (0.78, 1.59) 217 1.08 (0.89, 1.31) 1.04 (0.85, 1.27) 
Q3 1.8 (0.7) 132 0.85 (0.67, 1.08) 0.84 (0.65, 1.07) 64 0.96 (0.68, 1.36) 0.94 (0.65, 1.35) 188 0.86 (0.70, 1.05) 0.85 (0.69, 1.05) 
Q4 3.5 (0.7) 140 0.88 (0.70, 1.12) 0.89 (0.70, 1.14) 77 1.10 (0.79, 1.53) 1.06 (0.75, 1.51) 206 0.90 (0.74, 1.10) 0.92 (0.75, 1.12) 
Q5 7.6 (2.6) 179 1.04 (0.83, 1.29) 1.06 (0.84, 1.34) 68 0.93 (0.67, 1.30) 0.84 (0.59, 1.20) 237 0.98 (0.81, 1.18) 0.97 (0.80, 1.19) 
Per 2g/day  760 1.00 (0.96, 1.05)    0.84 1.02 (0.97, 1.06)   0.46 347 0.97 (0.92, 1.03)    0.36 0.96 (0.90, 1.02)   0.19 1067 0.99 (0.95, 1.02)    0.46 0.99 (0.95, 1.03)     0.70 
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Median 
intake 
(IQR) 
Total CHD Total stroke Total CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 157 1 1 77 1 1 228 1 1 
Q2 2.9 (0.7) 149 0.82 (0.65, 1.03) 0.88 (0.70, 1.12) 66 0.69 (0.49, 0.96) 0.75 (0.53, 1.06) 209 0.80 (0.66, 0.97) 0.86 (0.70, 1.04) 
Q3 4.2 (0.7) 146 0.74 (0.58, 0.93) 0.82 (0.64, 1.04) 68 0.79 (0.58, 1.09) 0.76 (0.53, 1.07) 204 0.75 (0.62, 0.90) 0.78 (0.64, 0.96) 
Q4 5.8 (1.1) 143 0.78 (0.62, 0.97) 0.84 (0.65, 1.07) 66 0.63 (0.45, 0.87) 0.67 (0.47, 0.96) 202 0.74 (0.61, 0.89) 0.78 (0.63, 0.96) 
Q5 9.4 (4.0) 168 0.83 (0.67, 1.04) 0.94 (0.73, 1.19) 70 0.62 (0.45, 0.86) 0.65 (0.45, 0.93) 224 0.74 (0.61, 0.90) 0.81 (0.66, 1.00) 
Per 2g/day  760 0.98 (0.94, 1.02)    0.38 0.99 (0.95, 1.04)   0.79 347 0.96 (0.90, 1.04)    0.32 0.97 (0.90, 1.05)   0.47 1067 0.97 (0.94, 1.01)    0.12 0.98 (0.95, 1.02)     0.38 
Vegetable 
fibre 
(g/day) 
Q1 2.3 (0.9) 155 1 1 80 1 1 225 1 1 
Q2 3.7 (0.6) 127 0.78 (0.61, 0.99) 0.82 (0.64, 1.05) 50 0.69 (0.49, 0.97) 0.68 (0.48, 0.99) 173 0.76 (0.62, 0.92) 0.78 (0.63, 0.96) 
Q3 5.0 (0.7) 156 0.93 (0.74, 1.16) 0.99 (0.78, 1.26) 67 0.84 (0.61, 1.15) 0.85 (0.60, 1.20) 217 0.91 (0.75, 1.09) 0.96 (0.78, 1.17) 
Q4 6.6 (1.0) 159 0.89 (0.71, 1.12) 0.96 (0.76, 1.22) 82 0.84 (0.62, 1.15) 0.94 (0.67, 1.30) 234 0.88 (0.73, 1.06) 0.97 (0.79, 1.18) 
Q5 9.6 (3.0) 163 0.92 (0.74, 1.15) 0.94 (0.73, 1.20) 68 0.71 (0.51, 0.97) 0.67 (0.48, 0.95) 218 0.84 (0.70, 1.01) 0.85 (0.69, 1.05) 
Per 2g/day  760 0.99 (0.95, 1.04)    0.78 0.99 (0.94, 1.03)   0.57 347 0.97 (0.90, 1.04)    0.40 0.97 (0.90, 1.04)   0.40 1067 0.98 (0.95, 1.02)    0.35 0.98 (0.94, 1.02)     0.34 
Legume 
fibre 
(g/day) 
Q1 0.2 (0.2) 184 1 1 82 1 1 253 1 1 
Q2 0.7 (0.2) 162 0.90 (0.73, 1.11) 0.86 (0.69, 1.08) 87 1.06 (0.79, 1.43) 1.14 (0.83, 1.56) 242 0.97 (0.81, 1.15) 0.97 (0.81, 1.16) 
Q3 1.1 (0.2) 146 0.88 (0.71, 1.10) 0.87 (0.70, 1.10) 70 1.00 (0.74, 1.37) 1.03 (0.73, 1.44) 213 0.95 (0.79, 1.14) 0.96 (0.79, 1.16) 
Q4 1.6 (0.4) 142 0.98 (0.78, 1.22) 0.96 (0.76, 1.22) 58 0.84 (0.60, 1.19) 0.96 (0.67, 1.39) 188 0.93 (0.76, 1.12) 0.96 (0.78, 1.17) 
Q5 3.6 (1.4) 126 0.91 (0.72, 1.16) 0.87 (0.68, 1.12) 50 1.03 (0.73, 1.45) 0.94 (0.63, 1.41) 171 0.97 (0.79, 1.18) 0.92 (0.74, 1.15) 
Per 1g/day  760 0.97 (0.92, 1.02)    0.22 0.96 (0.91, 1.02)   0.17 347 1.00 (0.92, 1.08)    0.93 0.96 (0.88, 1.06)   0.46 1067 0.98 (0.94, 1.03)    0.39 0.97 (0.92, 1.02)     0.18 
Fibre 
from nuts 
and seeds 
(g/day) 
Q1 0 (0.01) 186 1 1 115 1 1 288 1 1 
Q2 0.06 (0.01) 173 1.07 (0.87, 1.31) 1.09 (0.88, 1.36) 63 0.68 (0.51, 0.92) 0.66 (0.48, 0.92) 226 0.93 (0.78, 1.10) 0.94 (0.78, 1.13) 
Q3 0.08 (0.05) 146 0.98 (0.79, 1.23) 1.05 (0.84, 1.33) 59 0.64 (0.46, 0.88) 0.70 (0.50, 0.99) 200 0.86 (0.72, 1.04) 0.94 (0.78, 1.14) 
Q4 0.28 (0.12) 131 0.95 (0.75, 1.19) 1.01 (0.79, 1.28) 47 0.59 (0.42, 0.83) 0.63 (0.44, 0.91) 174 0.82 (0.68, 1.00) 0.88 (0.72, 1.08) 
Q5 0.87 (0.92) 124 0.79 (0.62, 1.00) 0.87 (0.67, 1.13) 63 0.65 (0.47, 0.89) 0.70 (0.49, 1.00) 179 0.74 (0.61, 0.89) 0.81 (0.65, 1.00) 
Per 0.2g/day   760 0.98 (0.96, 1.01)    0.19 0.99 (0.97, 1.02)   0.46 347 0.96 (0.93, 1.00)    0.06 0.97 (0.94, 1.01)   0.17 1067 0.98 (0.96, 1.00)    0.06 0.99 (0.97, 1.01)     0.24 
1Case numbers apply to fully-adjusted models. 2Adjustments include Age (years), BMI (kg/m2), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not 
current smoker), socio-economic status (professional or managerial/ intermediate/ routine or manual). Note: adjustment for energy intake was not included in fibre density models. Highlight=CIs do not span 1 in fully 
adjusted model.  
188 
 
 
 
Non-fatal CHD, non-fatal stroke and non-fatal CVD 
All participants 
Risk of non-fatal coronary or stroke events in relation to the different fibre exposures in the 
full sample of women are shown in Table 6.9. After median follow up of 14.7 years and 
excluding non-eligible participants, 668 non-fatal CHD cases were available for fully-adjusted 
models. Slightly fewer stroke cases were available for fully adjusted models (258) and when 
CHD and stroke cases were considered together, 914 non-fatal CVD cases were available for 
fully adjusted models.  
For stroke events, estimates indicated roughly 20 to 50% lower risk across many of the intake 
categories compared to the lowest intake level for total fibre, insoluble and soluble fibre. 
However, only total cereal fibre intake appeared significantly associated with lower stroke risk 
in the dose-response model HR 0.93 (95% CI: 0.83 to 0.99) p=0.03 per 3 g/day increase.  
As with total (fatal plus non-fatal) CHD, no apparent association was seen with many 
exposures for CHD risk, the only exception being legume fibre. Non-fatal CHD risk per 1g/day 
greater legume fibre was 0.94 (95% CI: 0.88 to 1.00) p=0.05.  
There was no evidence of an association between fibre intake and non-fatal CVD risk in the 
linear dose-response models and risk was significantly associated with greater fibre intake in 
only a handful of the category comparisons. Non-fatal CVD was significantly associated with 
higher fibre density, both assessed as NSP and AOAC, in the intermediate model (energy intake 
and BMI not included as covariates). With each 2g/1000kcal/day greater NSP density, risk was 
0.95 (95% CI: 0.91 to 1.00) p=0.03 and the risk per 3g/1000kcal/day AOAC fibre density 0.95 
(95% CI: 0.91 to 1.00) p=0.04. 
Subgroups  
In the various subgroups of women few associations existed for risk of non-fatal events in 
dose-response models. No associations were apparent for non-fatal CHD and for non-fatal 
stroke just a few of the risk estimates did not span the line of no effect, suggesting some 
evidence of an association, but did not reach the 1% significance criterion and are described 
below.  
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As in the full sample, total cereal fibre intake remained protectively associated with non-fatal 
stroke in women whose baseline BMI was in the healthy range (18.5-25kg/m2). In women with 
history of hypertension, lower non-fatal stroke risk was associated with greater intake of 
cereal fibre (per 3g/day) 0.81 (95% CI: 0.68 to 0.98) p=0.03. 
Several of the fibre exposures were significantly associated with lower non-fatal CVD risk in 
women with no history of hypertension: NSP (per 6/day) 0.92 (95% CI: 0.85 to 0.98) p=0.01; 
NSP density (per 2g/1000kcal/day) 0.91 (95% CI: 0.87 to 0.97) p<0.01; AOAC (per 11g/day) 0.89 
(95% CI: 0.82 to 0.97) p=0.01; AOAC density (per3g/1000kcal/day) 0.91 (95% CI: 0.86 to 0.96) 
p<0.01; soluble fibre (per 3g/day) 0.91 (95% CI: 0.84 to 0.99) p=0.04; insoluble fibre (per 
4g/day) 0.92 (95% CI: 0.86 to 0.98) p=0.01; legume fibre (per 1g/day) 0.92 (95% CI: 0.86 to 
0.99) p=0.02. 
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Table 6.9 Dietary fibre intake and associated risk for non-fatal CHD, non-fatal stroke and non-fatal CVD 
 
Median 
intake 
(IQR) 
Non-fatal CHD Non-fatal stroke Non fatal CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
NSP 
(g/day) 
Q1 14.1 (3.9) 143 1 1 61 1 1 202 1 1 
Q2 19.5 (2.2) 132 0.91 (0.72, 1.16) 0.94 (0.73, 1.21) 45 0.76 (0.53, 1.11) 0.63 (0.42, 0.95) 176 0.87 (0.71, 1.06) 0.86 (0.69, 1.06) 
Q3 23.8 (2.3) 122 0.83 (0.65, 1.05) 0.86 (0.66, 1.14) 47 0.77 (0.53, 1.12) 0.67 (0.44, 1.00) 162 0.78 (0.63, 0.96) 0.79 (0.62, 0.99) 
Q4 29.1 (3.1) 131 0.88 (0.69, 1.12) 0.86 (0.65, 1.14) 55 0.79 (0.55, 1.15) 0.69 (0.46, 1.04) 185 0.86 (0.70, 1.05) 0.84 (0.66, 1.06) 
Q5 38.1 (8.5) 140 0.94 (0.74, 1.19) 0.94 (0.68, 1.29) 50 0.73 (0.50, 1.06) 0.50 (0.31, 0.83) 189 0.87 (0.71, 1.07) 0.82 (0.63, 1.07) 
Per 6g/day  668 1.00 (0.95, 1.05)     0.90 0.99 (0.93, 1.05)    0.73 184 0.96 (0.88, 1.04)   0.31 0.90 (0.81, 1.01)    0.08 914 0.98 (0.94, 1.03)     0.44 0.97 (0.92, 1.03)   0.30 
AOAC 
(g/day) 
Q1 21.8 (5.9) 143 1 1 64 1 1 207 1 1 
Q2 30.0 (3.4) 131 0.90 (0.71, 1.15) 0.92 (0.71, 1.19) 42 0.68 (0.46, 0.99) 0.58 (0.39, 0.89) 172 0.83 (0.68, 1.02) 0.82 (0.66, 1.02) 
Q3 36.6 (3.5) 119 0.79 (0.62, 1.01) 0.82 (0.62, 1.09) 42 0.60 (0.41, 0.88) 0.49 (0.32, 0.75) 156 0.71 (0.57, 0.87) 0.70 (0.55, 0.88) 
Q4 44.5 (4.7) 135 0.89 (0.70, 1.13) 0.89 (0.66, 1.18) 61 0.89 (0.63, 1.26) 0.76 (0.50, 1.15) 192 0.87 (0.71, 1.06) 0.85 (0.67, 1.08) 
Q5 58.5 (13.2) 140 0.97 (0.76, 1.23) 0.95 (0.68, 1.32) 49 0.65 (0.45, 0.95) 0.43 (0.25, 0.72) 187 0.85 (0.70, 1.05) 0.78 (0.59, 1.03) 
Per 11g/day   668 1.00 (0.94, 1.06)     0.96 0.99 (0.91, 1.07)    0.76 184 0.96 (0.87, 1.06)   0.44 0.89 (0.77, 1.03)    0.12 914 0.98 (0.93, 1.04)     0.52 0.96 (0.90, 1.04)   0.33 
NSP 
density  
g/1000 
kcal/day 
Q1 7.5 (1.5) 139 1 1 63 1 1 199 1 1 
Q2 9.4 (0.8) 134 0.90 (0.71, 1.14) 0.98 (0.76, 1.25) 56 0.95 (0.67, 1.34) 0.95 (0.65, 1.37) 189 0.93 (0.76, 1.13) 0.98 (0.80, 1.20) 
Q3 11.0 (0.8) 131 0.93 (0.73, 1.18) 0.99 (0.77, 1.27) 40 0.39 (0.39, 0.86) 0.63 (0.41, 0.95) 164 0.80 (0.65, 0.99) 0.86 (0.69, 1.07) 
Q4 12.7 (1.0) 126 0.85 (0.67, 1.09) 0.94 (0.72, 1.21) 43 0.45 (0.45, 0.95) 0.63 (0.42, 0.96) 167 0.79 (0.64, 0.97) 0.84 (0.68, 1.05) 
Q5 15.4 (2.4) 138 0.91 (0.72, 1.16) 1.00 (0.77, 1.29) 56 0.49 (0.49, 1.02) 0.73 (0.50, 1.08) 195 0.86 (0.70, 1.06) 0.94 (0.76, 1.17) 
2g/1000kcal/d  668 0.96 (0.91, 1.01)     0.10 0.98 (0.93, 1.03)    0.41 184 0.91 (0.84, 0.99)   0.03 0.92 (0.84, 1.00)    0.06 914 0.95 (0.91,0.99)   0.01 0.96 (0.92, 1.01)   0.12 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.7 (2.1) 131 1 1 63 1 1 193 1 1 
Q2 14.6 (1.2) 147 1.07 (0.85, 1.36) 1.11 (0.87, 1.41) 52 0.79 (0.56, 1.13) 0.77 (0.53, 1.13) 194 0.96 (0.79, 1.16) 0.98 (0.79, 1.20) 
Q3 16.9 (1.1) 121 0.90 (0.70, 1.15) 0.94 (0.73, 1.22) 41 0.63 (0.43, 0.92) 0.64 (0.43, 0.95) 159 0.80 (0.65, 0.98) 0.83 (0.67, 1.03) 
Q4 19.4 (1.4) 146 1.04 (0.82, 1.33) 1.12 (0.87, 1.44) 47 0.61 (0.42, 0.89) 0.64 (0.43, 0.96) 189 0.89 (0.72, 1.08) 0.95 (0.77, 1.18) 
Q5 23.4 (3.5) 123 0.86 (0.67, 1.11) 0.93 (0.71, 1.22) 55 0.68 (0.47, 0.98) 0.67 (0.46, 0.99) 179 0.81 (0.65, 0.99) 0.86 (0.69, 1.08) 
3g/1000kcal/d  668 0.96 (0.91, 1.01)     0.09 0.98 (0.93, 1.03)    0.38 184 0.92 (0.84, 1.00)   0.05 0.92 (0.84, 1.01)    0.09 914 0.94 (0.90, 0.99)    0.01 0.96 (0.92, 1.01)   0.12 
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Median 
intake 
(IQR) 
Non-fatal CHD Non-fatal stroke Non fatal CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 144 1 1 64 1 1 207 1 1 
Q2 8.6 (0.9) 122 0.85 (0.66, 1.08) 0.85 (0.66, 1.10) 38 0.64 (0.43, 0.94) 0.56 (0.37, 0.86) 160 0.78 (0.63, 0.96) 0.76 (0.61, 0.95) 
Q3 10.4 (0.9) 126 0.87 (0.69, 1.11) 0.89 (0.68, 1.16) 46 0.77 (0.53, 1.11) 0.64 (0.42, 0.95) 168 0.82 (0.67, 1.01) 0.80 (0.64, 1.00) 
Q4 12.5 (1.2) 126 0.81 (0.64, 1.04) 0.85 (0.64, 1.13) 58 0.83 (0.58, 1.19) 0.74 (0.49, 1.12) 181 0.80 (0.65, 0.98) 0.81 (0.64, 1.03) 
Q5 16.3 (3.8) 150 1.02 (0.81, 1.29) 1.00 (0.73, 1.37) 52 0.72 (0.50, 1.05) 0.56 (0.34, 0.92) 198 0.90 (0.74, 1.10) 0.85 (0.65, 1.12) 
Per 3g/day  668 1.00 (0.95, 1.06)     0.94 0.98 (0.91, 1.06)    0.68 184 0.97 (0.87, 1.07)   0.50 0.90 (0.78, 1.04)    0.17 914 0.99 (0.94, 1.04)    0.59 0.96 (0.90, 1.03)   0.30 
Insoluble 
fibre 
(g/day) 
Q1 8.4 (2.6) 143 1 1 63 1 1 206 1 1 
Q2 12.2 (1.6) 130 0.90 (0.70, 1.14) 0.92 (0.71, 1.18) 48 0.84 (0.58, 1.20) 0.68 (0.46, 1.01) 175 0.87 (0.71, 1.06) 0.84 (0.68, 1.04) 
Q3 15.3 (1.6) 132 0.88 (0.69, 1.12) 0.94 (0.72, 1.23) 44 0.72 (0.50, 1.06) 0.61 (0.40, 0.92) 172 0.81 (0.66, 0.99) 0.82 (0.66, 1.03) 
Q4 19.0 (2.2) 128 0.90 (0.71, 1.15) 0.89 (0.67, 1.16) 53 0.77 (0.53, 1.12) 0.68 (0.46, 1.02) 177 0.84 (0.69, 1.03) 0.82 (0.65, 1.03) 
Q5 25.5 (5.9) 135 0.92 (0.72, 1.17) 0.91 (0.67, 1.24) 50 0.73 (0.51, 1.07) 0.49 (0.30, 0.79) 184 0.85 (0.70, 1.05) 0.79 (0.61, 1.02) 
Per 4g/day  668 1.00 (0.95, 1.05)     0.97 1.00 (0.94, 1.06)    0.95 184 0.95 (0.88, 1.03)   0.25 0.91 (0.82, 1.02)    0.07 914 0.98 (0.94, 1.02)    0.42 0.98 (0.92, 1.03)   0.36 
Total 
cereal 
fibre 
(g/day) 
 
Q1 2.8 (1.4) 144 1 1 63 1 1 203 1 1 
Q2 5.1 (1.1) 125 0.87 (0.68, 1.11) 0.91 (0.71, 1.18) 58 0.90 (0.63, 1.28) 0.85 (0.58, 1.25) 182 0.88 (0.72, 1.08) 0.91 (0.74, 1.13) 
Q3 7.6 (1.4) 126 0.84 (0.66, 1.07) 0.84 (0.65, 1.09) 37 0.54 (0.36, 0.81) 0.46 (0.29, 0.73) 164 0.76 (0.62, 0.94) 0.74 (0.59, 0.93) 
Q4 10.6 (1.8) 144 0.96 (0.76, 1.21) 1.02 (0.79, 1.32) 45 0.65 (0.44, 0.95) 0.53 (0.34, 0.81) 183 0.84 (0.69, 1.03) 0.85 (0.68, 1.07) 
Q5 15.6 (4.5) 129 0.88 (0.69, 1.12) 0.88 (0.67, 1.17) 55 0.77 (0.54, 1.11) 0.64 (0.41, 0.99)  182 0.85 (0.70, 1.04) 0.83 (0.66, 1.06) 
Per 3g/day  668 1.01 (0.96, 1.05)     0.90 1.01 (0.96, 1.06)     0.77 184 0.94 (0.87, 1.02)   0.13 0.91 (0.83, 0.99)    0.03 914 0.99 (0.95, 1.03)    0.49 0.98 (0.94, 1.03)   0.49 
Fibre 
from 
breakfast 
cereals 
(g/day) 
Q1 0.05 (0.1) 131 1 1 56 1 1 185 1 1 
Q2 0.5 (0.4) 133 1.02 (0.79, 1.30) 1.00 (0.77, 1.29) 51 1.18 (0.80, 1.73) 1.07 (0.71, 1.62) 184 1.07 (0.87, 1.32) 1.03 (0.83, 1.29) 
Q3 1.8 (0.7) 119 0.85 (0.66, 1.10) 0.85 (0.65, 1.11) 46 0.90 (0.60, 1.34) 0.87 (0.57, 1.33) 160 0.85 (0.69, 1.06) 0.85 (0.67, 1.06) 
Q4 3.5 (0.7) 129 0.91 (0.71, 1.16) 0.94 (0.73, 1.22) 54 0.99 (0.67, 1.45) 0.95 (0.63, 1.42) 182 0.93 (0.76, 1.15) 0.95 (0.77, 1.19) 
Q5 7.6 (2.6) 156 1.05 (0.83, 1.33) 1.05 (0.82, 1.35) 51 0.88 (0.60, 1.28) 0.75 (0.50, 1.12) 203 0.99 (0.81, 1.22) 0.97 (0.78, 1.20) 
Per 2g/day  668 1.01 (0.96, 1.05)     0.82 1.01 (0.97, 1.06)     0.62 184 0.97 (0.90, 1.04)   0.34 0.95 (0.87, 1.02)    0.16 914 0.99 (0.96, 1.03)    0.77 1.00 (0.96, 1.04)   0.84 
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Median 
intake 
(IQR) 
Non-fatal CHD Non-fatal stroke Non fatal CVD 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 134 1 1 55 1 1 188 1 1 
Q2 2.9 (0.7) 127 0.89 (0.69, 1.13) 0.90 (0.70, 1.17) 54 0.82 (0.56, 1.19) 0.87 (0.59, 1.31) 179 0.86 (0.70, 1.06) 0.90 (0.72, 1.11) 
Q3 4.2 (0.7) 125 0.76 (0.59, 0.98) 0.82 (0.63, 1.07) 48 0.85 (0.59, 1.23) 0.76 (0.50, 1.14) 170 0.78 (0.63, 0.96) 0.80 (0.64, 0.99) 
Q4 5.8 (1.1) 127 0.86 (0.67, 1.10) 0.88 (0.68, 1.15) 52 0.71 (0.48, 1.04) 0.71 (0.47, 1.07) 178 0.81 (0.66, 1.00) 0.83 (0.67, 1.04) 
Q5 9.4 (4.0) 155 0.95 (0.75, 1.21) 1.01 (0.78, 1.32) 49 0.59 (0.39, 0.87) 0.58 (0.38, 0.90) 199 0.81 (0.66, 1.00) 0.87 (0.69, 1.09) 
Per 2g/day  668 1.00 (0.96, 1.04)    0.90 1.00 (0.96, 1.05)     0.84 184 0.97 (0.89, 1.06)   0.46 0.97 (0.88, 1.06)    0.47 914 0.99 (0.95, 1.02)    0.46 0.99 (0.95, 1.03)   0.76 
Vegetable 
fibre 
(g/day) 
Q1 2.3 (0.9) 132 1 1 56 1 1 188 1 1 
Q2 3.7 (0.6) 190 0.78 (0.61, 1.02) 0.82 (0.62, 1.07) 29 0.56 (0.37, 0.87) 0.57 (0.36, 0.91) 135 0.69 (0.56, 0.87) 0.72 (0.57, 0.91) 
Q3 5.0 (0.7) 140 1.00 (0.78, 1.27) 1.03 (0.80, 1.33) 53 0.99 (0.69, 1.43) 0.99 (0.66, 1.47) 192 0.98 (0.80, 1.20) 1.00 (0.81, 1.24) 
Q4 6.6 (1.0) 142 0.94 (0.74, 1.20) 1.00 (0.77, 1.29) 62 0.90 (0.62, 1.29) 0.99 (0.67, 1.45) 202 0.91 (0.74, 1.11) 0.98 (0.79, 1.21) 
Q5 9.6 (3.0) 145 0.95 (0.75, 1.21) 0.95 (0.73, 1.25) 58 0.82 (0.57, 1.19) 0.82 (0.55, 1.20) 197 0.88 (0.72, 1.08) 0.88 (0.70, 1.02) 
Per 2g/day  668 1.00 (0.96, 1.05)    0.86 0.99 (0.95, 1.04)     0.83 184 1.00 (0.93, 1.08)   0.99 1.01 (0.93, 1.09)    0.85 914 1.00 (0.96, 1.04)    0.94 1.00 (0.96, 1.04)   0.83 
Legume 
fibre 
(g/day) 
Q1 0.2 (0.2) 164 1 1 54 1 1 213 1 1 
Q2 0.7 (0.2) 144 0.90 (0.72, 1.12)  0.84 (0.66, 1.05) 63 1.15 (0.81, 1.63) 1.22 (0.84, 1.79) 205 0.98 (0.81, 1.18) 0.94 (0.77, 1.15) 
Q3 1.1 (0.2) 122 0.84 (0.66, 1.06) 0.78 (0.62, 1.00) 55 1.13 (0.79, 1.63) 1.14 (0.76, 1.71) 176 0.92 (0.75, 1.12) 0.89 (0.72, 1.09) 
Q4 1.6 (0.4) 129 0.96 (0.76, 1.22) 0.91 (0.71, 1.16) 45 0.93 (0.62, 1.39) 1.05 (0.68, 1.62) 169 0.95 (0.77, 1.17) 0.95 (0.76, 1.18) 
Q5 3.6 (1.4) 109 0.87 (0.68, 1.12) 0.79 (0.61, 1.03) 41 1.18 (0.79, 1.75) 1.13 (0.71, 1.81) 151 0.97 (0.79, 1.21) 0.91 (0.72, 1.14) 
Per 1g/day  668 0.96 (0.90, 1.02)    0.15 0.94 (0.88, 1.00)     0.05 184 1.01 (0.93, 1.10)   0.75 1.00 (0.90, 1.10)    0.96 914 0.98 (0.93, 1.03)    0.40 0.97 (0.92, 1.02)   0.19 
Fibre 
from nuts 
and seeds 
(g/day) 
Q1 0 (0.01) 154 1 1 79 1 1 231 1 1 
Q2 0.06 (0.01) 153 1.15 (0.92, 1.44) 1.16 (0.92, 1.47) 45 0.67 (0.47, 0.96) 0.66 (0.45, 0.97) 194 0.97 (0.80, 1.17) 0.98 (0.80, 1.19) 
Q3 0.08 (0.05) 135 1.07 (0.84, 1.35) 1.13 (0.88, 1.45) 46 0.72 (0.50, 1.03) 0.80 (0.54, 1.19) 178 0.93 (0.76, 1.14) 1.01 (0.82, 1.24) 
Q4 0.28 (0.12) 117 1.02 (0.80, 1.31) 1.06 (0.81, 1.37) 36 0.64 (0.43, 0.96) 0.69 (0.45, 1.05) 152 0.88 (0.71, 1.08) 0.93 (0.74, 1.16) 
Q5 0.87 (0.92) 109 0.84 (0.65, 1.09) 0.89 (0.68, 1.19) 52 0.74 (0.51, 1.06) 0.81 (0.54, 1.22) 159 0.80 (0.65, 0.98) 0.86 (0.69, 1.09) 
Per 0.2g/day   668 0.99 (0.96, 1.01)    0.41 0.99 (0.97, 1.02)     0.66 184 0.98 (0.94, 1.02)   0.27 0.99 (0.95, 1.02)    0.46 914 0.99 (0.97, 1.01)    0.22 0.99 (0.97, 1.01)   0.52 
1Case numbers apply to fully-adjusted models. 2Adjustments include Age (years), BMI (kg/m2), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not 
current smoker), socio-economic status (professional or managerial/ intermediate/ routine or manual). Note: adjustment for energy intake was not included in fibre density models. Highlight=CIs do not span 1 in fully 
adjusted model.
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Haemorrhagic, ischaemic and unspecified stroke incidence (fatal plus non-fatal events) 
All participants 
After a median follow up of 14.4 years, 135 haemorrhagic and 184 ischaemic strokes were 
observed. There were 138 cases where the type of stroke was not detailed in records.  
Total fibre intake, insoluble fibre, soluble fibre and vegetable fibre were all significantly 
associated with lower risk of unspecified strokes in the fully-adjusted dose-response models 
(Table 6.10). Each 6g/day increase in NSP was associated with 24% lower risk HR 0.76 (95% CI: 
0.63 to 0.92) p<0.01 and with each 2g/day increase in vegetable fibre HR 0.80 (95% CI: 0.68 to 
0.92) p<0.01.  
The majority of risk estimates for haemorrhagic and ischaemic stroke indicated a protective 
association but CIs were generally wide and no significant associations were observed in the 
fully-adjusted models for dose-response associations except with cereal fibre. For each 3g/day 
increase in cereal fibre, risk of ischaemic stroke was 0.89 (95% CI: 0.80 to 1.00) p=0.05. 
When ischaemic and unspecified strokes were combined 284 cases were observed, with 251 
cases being available for use in the fully adjusted models. Risk estimates for ‘mostly ischaemic’ 
type stroke, where ischaemic and unspecified cases were combined, are presented in Table 
6.11. Risk estimates from the dose-response models in this larger subgroup of stroke cases 
largely reflect those seen for the ‘unspecified type’ stroke. The risk estimates for ‘mostly 
ischaemic’ strokes tended to be slightly weaker compared to those seen for the unspecified 
strokes only, but CIs were narrower on the whole in this larger category. For example, with 
total fibre intake, assessed as AOAC, risk was 0.74 (95% CI: 0.57 to 0.94) with each 11g/day 
greater intake for unspecified stroke and 0.80 (95% CI: 0.68 to 0.95) for ‘mostly ischaemic’ 
strokes.  
There was lower risk for ‘mostly ischaemic’ type stroke of between 12 and 16% with greater 
intake of total fibre (NSP and AOAC), fibre density, soluble and insoluble fibre. A protective 
association was also seen for ‘mostly ischaemic’ stroke risk with greater cereal fibre intake (per 
3g/day) HR 0.88 (95% CI: 0.80 to 0.96) p<0.01. An association was also seen with cereal fibre 
and ischaemic stroke risk, 0.89 (95% CI: 0.80 to 1.00) p=0.05 but with unspecified stroke type 
CIs span just over the line of no effect, 0.89 (95% CI: 0.78 to 1.02) p=0.11.  
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A protective association observed with greater vegetable fibre intake in the unspecified stroke 
cases (per 2g/day) 0.80 (95% CI: 0.68 to 0.92) p<0.01, disappeared when combined with the 
ischaemic cases 0.92 (95% CI: 0.84 to 1.02) p=0.13.  
Subgroups 
In the postmenopausal subgroup, vegetable fibre per 2g/day increase was associated with an 
increased risk of haemorrhagic stroke 1.08 (95% CI: 1.02 to 1.14) p=0.01 but a decreased risk 
of unspecified stroke 0.80 (95% CI: 0.66 to 0.96) p=0.02 in fully adjusted models. Total NSP and 
NSP density were also associated with lower risk of unspecified stroke (per 6g/day) 0.77 (95% 
CI: 0.63 to 0.95) p=0.02 and (per 2g/1000kcal/day) 0.86 (95% CI: 0.73 to 0.99) p=0.04, 
respectively in fully adjusted models. In this subgroup of postmenopausal women, these 
protective associations were not the same with fibre assessed as AOAC but were present for 
both soluble (per 3g/day) 0.76 (95% CI: 0.57 to 1.00) p=0.05 and insoluble fibre (per 4g/day) 
0.82 (95% CI: 0.69 to 0.99) p=0.04.  
Protective associations observed with greater NSP or AOAC fibre, greater insoluble fibre and 
greater cereal fibre with risk for ‘mostly ischaemic’ stroke in the full sample remained 
protective in the postmenopausal group. However, soluble fibre was no longer significantly 
associated with risk of ‘mostly ischaemic’ stroke in this subgroup 0.87 (95% CI: 0.73 to 1.04) 
p=0.14, per 3g/day increase. 
In healthy weight women, protective associations for the various fibre exposures (total fibre, 
fibre density, insoluble fibre, cereal fibre) and risk of ‘mostly ischaemic’ stroke remained, as in 
the full sample of participants. For each 4g/day increase in insoluble fibre, risk was 0.81 (95% 
CI: 0.70 to 0.95) p<0.01, however the protective association observed in the full sample for 
soluble fibre did not remain in this healthy weight subgroup. With each 3g/day increase in 
soluble fibre, risk of ‘mostly ischaemic’ stroke was 0.83 (95% CI: 0.67 to 1.02) p=0.08. 
In healthy weight women, each 1g/day increase in legume fibre was associated with an 
increased risk of haemorrhagic stroke 1.11 (95% CI: 1.00 to 1.24) p=0.05 in the fully adjusted 
models. Additionally in fully adjusted models, total cereal fibre (per 3g/day), fibre from 
breakfast cereals (per 2g/day), AOAC fibre density (per 3g/1000kcal/day) and insoluble fibre 
(per 4g/day) were all associated with ischaemic stroke risk reduction, 0.83 (95% CI: 0.71 to 
0.98) p=0.03; 0.78 (95% CI: 0.66 to 0.92) p<0.01; 0.85 (95% CI: 0.73 to 1.00) p=0.05; 0.82 (95% 
CI: 0.67 to 0.99) p=0.04, respectively. Total fibre (NSP) (per 6g/day), vegetable fibre (per 
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2g/day) and soluble fibre (per 3g/day) were associated with lower risk of unspecified type 
stroke in healthy weight women 0.78 (95% CI: 0.61 to 0.99) p=0.04; 0.80 (95% CI: 0.68 to 0.95) 
p=0.01 and 0.74 (95% CI: 0.55 to 1.00) p=0.05, respectively. 
Those classified as overweight or obese were combined because of small case numbers in the 
two groups separately. Haemorrhagic stroke risk reductions were observed with four 
exposures in this overweight subgroup, total cereal fibre (per 3g/day) 0.85 (95% CI: 0.72 to 
1.00) p=0.05; breakfast cereal fibre (per 2g/day) 0.83 (95% CI: 0.69 to 1.00) p=0.05; AOAC fibre 
(per11g/day) 0.76 (95% CI: 0.59 to 0.97) p=0.03 and insoluble fibre (per 4g/day) 0.81 (95% CI: 
0.69 to 0.97) p=0.02. Fibre from nuts or seeds was additionally associated with lower risk of 
unspecified stroke, for each 0.2g increase in daily intake risk was 0.78 (95% CI: 0.62 to 0.97) 
p=0.03.  
In participant subgroups, there were only sufficient cases to explore associations for ‘mostly 
ischaemic’ stroke risk in those reporting to have hypertension at baseline. In this subgroup, 
only greater cereal fibre intake, per 3g/day increase, was associated with lower risk 0.84 (95% 
CI: 0.70 to 1.00) p=0.05. 
Women without hypertension had lower risk of ischaemic stroke with greater NSP density (per 
2g/1000kcal/day) 0.88 (95% CI: 0.77 to 1.00) p=0.05, AOAC density (per 3g/1000kcal/day) 0.86 
(95% CI: 0.75 to 0.98) p=0.02 and fibre from breakfast cereals (per 2g/day) 0.81 (95% CI: 0.71 
to 0.93) p<0.01. Lower risk for unspecified stroke was observed for NSP (per 6g/day) 0.71 (95% 
CI: 0.56 to 0.90) p<0.01; NSP density (per 2g/1000kcal/day) 0.78 (95% CI: 0.60 to 0.92) p<0.01; 
AOAC (per 11g/day) 0.67 (95% CI: 0.48 to 0.93) p=0.02; AOAC density (per 3g/1000kcal/day) 
0.78 (95% CI: 0.65 to 0.93) p<0.01; soluble fibre (per 3g/day) 0.64 (95% CI: 0.46 to 0.89) 
p<0.01; insoluble fibre (per 4g/day) 0.77 (95% CI: 0.62 to 0.96) p=0.02 and vegetable fibre (per 
2g/day) 0.76 (95% CI: 0.61 to 0.96) 0.02, in fully adjusted models. 
For ‘mostly ischaemic’ stroke in women without hypertension at baseline, the following items 
were protectively associated with risk: NSP (per 6g/day) 0.81 (95% CI: 0.69 to 0.94) p<0.01; 
NSP density (per 2g/1000kcal/day) 0.82 (95% CI: 0.73 to 0.91) p<0.01; AOAC (per 11g/day) 0.76 
(95% CI: 0.63 to 0.92) p<0.01; AOAC density (per 3g/1000kcal/day) 0.81 (95% CI: 0.72 to 0.91) 
p<0.01; insoluble fibre (per 4g/day) 0.81 (95% CI: 0.71 to 0.93) p<0.01; soluble fibre (per 
3g/day) 0.79 (95% CI: 0.65 to 0.97) p=0.02; cereal fibre (per 3g/day) 0.90 (95% CI: 0.80 to 1.00) 
p=0.05 and fibre from breakfast cereals (per 2g/day) 0.89 (95% CI: 0.80 to 0.99) p=0.03.  
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Table 6.10 Dietary fibre intake and associated risk for haemorrhagic, ischaemic and ‘unspecified’ stroke 
 
Median 
intake (IQR) 
 
Total haemorrhagic stroke Total ischaemic stroke Total unspecified stroke 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
NSP 
(g/day) 
Q1 14.1 (3.9) 27 1 1 40 1 1 43 1 1 
Q2 19.5 (2.2) 24 0.74 (0.43, 1.29) 0.74 (0.41, 1.34) 26 0.79 (0.50, 1.24) 0.60 (0.35, 1.01) 24 0.57 (0.35, 0.94) 0.56 (0.33, 0.96) 
Q3 23.8 (2.3) 21 0.66 (0.37, 1.17) 0.68 (0.37, 1.27) 35 0.88 (0.56, 1.38) 0.76 (0.46, 1.26) 19 0.44 (0.26, 0.76) 0.42 (0.23, 0.79) 
Q4 29.1 (3.1) 25 0.82 (0.48, 1.41) 0.81 (0.45, 1.45) 32 0.67 (0.41, 1.07) 0.59 (0.34, 1.03) 19 0.40 (0.29, 0.69) 0.37 (0.20, 0.66) 
Q5 38.1 (8.5) 28 0.88 (0.52, 1.49) 0.86 (0.42, 1.77) 27 0.65 (0.40, 1.05) 0.40 (0.21, 0.74) 20 0.53 (0.32, 0.89) 0.43 (0.20, 0.91) 
Per 6g/day  125 0.95 (0.85, 1.06)     0.37 0.92 (0.79, 1.05)      0.22 160 0.96 (0.85, 1.07)     0.46 0.90 (0.77, 1.06)   0.20 125 0.84 (0.73, 0.98)    0.02 0.76 (0.63, 0.92)  <0.01 
AOAC 
(g/day) 
Q1 21.8 (5.9) 30 1 1 42 1 1 43 1 1 
Q2 30.0 (3.4) 22 0.65 (0.37, 1.12) 0.61 (0.33, 1.10) 25 0.66 (0.41, 1.05) 0.54 (0.32, 0.91) 26 0.66 (0.40, 1.06) 0.67 (0.40, 1.13) 
Q3 36.6 (3.5) 20 0.58 (0.33, 1.02) 0.54 (0.30, 0.99) 33 0.70 (0.45, 1.09) 0.57 (0.34, 0.96) 16 0.34 (0.19, 0.61) 0.32 (0.16, 0.62) 
Q4 44.5 (4.7) 31 0.92 (0.56, 1.52) 0.80 (0.46, 1.41) 31 0.67 (0.42, 1.05) 0.56 (0.32, 0.99) 19 0.42 (0.25, 0.73) 0.42 (0.22, 0.78) 
Q5 58.5 (13.2) 22 0.63 (0.36, 1.09) 0.47 (0.22, 1.02) 29 0.59 (0.37, 0.94) 0.35 (0.18, 0.70) 21 0.59 (0.35, 0.97) 0.45 (0.20, 1.00) 
Per 11g/day  125 0.93 (0.82, 1.07)     0.32 0.87 (0.73, 1.05)      0.15 160 0.96 (0.83, 1.10)     0.52 0.88 (0.72, 1.07)   0.20 125 0.83 (0.70, 0.99)    0.04 0.74 (0.57, 0.94)    0.02 
NSP 
density  
g/1000 
kcal/day 
Q1 7.5 (1.5) 27 1 1 45 1 1 32 1 1 
Q2 9.4 (0.8) 26 0.99 (0.59, 1.68) 1.06 (0.61, 1.84) 28 0.67 (0.43, 1.04) 0.64 (0.39, 1.04) 34 0.99 (0.62, 1.60) 1.08 (0.66, 1.75) 
Q3 11.0 (0.8) 25 0.74 (0.42, 1.29) 0.85 (0.49, 1.50) 26 0.56 (0.35, 0.90) 0.62 (0.37, 1.01) 14 0.46 (0.25, 0.85) 0.50 (0.26, 0.95) 
Q4 12.7 (1.0) 24 0.83 (0.48, 1.43) 0.82 (0.46, 1.48) 25 0.48 (0.30, 0.78) 0.48 (0.28, 0.81) 20 0.55 (0.31, 0.96) 0.56 (0.30, 1.02) 
Q5 15.4 (2.4) 23 0.77 (0.44, 1.36) 0.84 (0.47, 1.51) 36 0.63 (0.41, 0.99) 0.71 (0.44, 1.14) 25 0.70 (0.41, 1.19) 0.69 (0.39, 1.21) 
2g/1000kcal/d  125 0.93 (0.82, 1.04)     0.21 0.94 (0.83, 1.06)      0.31 160 0.89 (0.80, 0.99)     0.03 0.91 (0.81, 1.02)   0.12 125 0.86 (0.76, 0.98)    0.02 0.86 (0.75, 0.98)    0.02 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.7 (2.1) 29 1 1 41 1 1 36 1 1 
Q2 14.6 (1.2) 27 0.93 (0.56, 1.56) 0.97 (0.57, 1.64) 30 0.67 (0.43, 1.05) 0.65 (0.40, 1.06) 23 0.59 (0.35, 0.98) 0.59 (0.35, 1.01) 
Q3 16.9 (1.1) 22 0.65 (0.37, 1.14) 0.71 (0.40, 1.26) 26 0.61 (0.38, 0.97) 0.63 (0.38, 1.04) 18 0.49 (0.28, 0.84) 0.51 (0.29, 0.91) 
Q4 19.4 (1.4) 22 0.63 (0.36, 1.11) 0.64 (0.35, 1.15) 30 0.57 (0.36, 0.92) 0.65 (0.39, 1.07) 22 0.51 (0.30, 0.87) 0.55 (0.31, 0.97) 
Q5 23.4 (3.5) 25 0.76 (0.44, 1.30) 0.81 (0.46, 1.43) 33 0.61 (0.39, 0.96) 0.64 (0.39, 1.04) 26 0.66 (0.40, 1.10) 0.64 (0.37, 1.11) 
3g/1000kcal/d  125 0.91 (0.80, 1.03)     0.15 0.92 (0.81, 1.05)     0.22 160 0.88 (0.79, 0.98)     0.02 0.90 (0.80, 1.01)   0.08 125 0.87 (0.75, 0.99)    0.04 0.86 (0.74, 0.99)    0.04 
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Median 
intake (IQR) 
 
Total haemorrhagic stroke Total ischaemic stroke Total unspecified stroke 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 27 1 1 38 1 1 44 1 1 
Q2 8.6 (0.9) 24 0.85 (0.49, 1.48) 0.90 (0.51, 1.61) 29 0.78 (0.49, 1.25) 0.71 (0.42, 1.20) 25 0.55 (0.33, 0.90) 0.57 (0.33, 0.97) 
Q3 10.4 (0.9) 20 0.70 (0.40, 1.25) 0.67 (0.36, 1.26) 30 0.88 (0.56, 1.39) 0.72 (0.42, 1.23) 15 0.37 (0.21, 0.66) 0.37 (0.20, 0.69) 
Q4 12.5 (1.2) 27 0.93 (0.54, 1.58) 0.86 (0.48, 1.56) 34 0.76 (0.48, 1.22) 0.75 (0.42, 1.31) 22 0.48 (0.29, 0.80) 0.44 (0.23, 0.82) 
Q5 16.3 (3.8) 27 0.85 (0.49, 1.46) 0.83 (0.39, 1.78) 29 0.73 (0.45, 1.18) 0.54 (0.28, 1.05) 19 0.51 (0.30, 0.86) 0.44 (0.22, 0.88) 
Per 3g/day  125 0.94 (0.83, 1.07)     0.37 0.89 (0.74, 1.07)     0.21 160 0.98 (0.86, 1.12)     0.79 0.93 (0.77, 1.13)   0.48 125 0.82 (0.69, 0.98)    0.03 0.72 (0.57, 0.92)  <0.01 
Insoluble 
fibre 
(g/day) 
Q1 8.4 (2.6) 28 1 1 42 1 1 43 1 1 
Q2 12.2 (1.6) 27 0.82 (0.48, 1.40) 0.81 (0.46, 1.42) 26 0.82 (0.52, 1.30) 0.61 (0.37, 1.01) 22 0.62 (0.37, 1.02) 0.59 (0.34, 1.01) 
Q3 15.3 (1.6) 18 0.57 (0.31, 1.02) 0.56 (0.30, 1.04) 32 0.81 (0.52, 1.28) 0.68 (0.41, 1.13) 22 0.55 (0.33, 0.92) 0.51 (0.29, 0.89) 
Q4 19.0 (2.2) 27 0.88 (0.52, 1.49) 0.84 (0.48, 1.45) 31 0.65 (0.40, 1.04) 0.59 (0.34, 1.00) 19 0.40 (0.23, 0.71) 0.44 (0.25, 0.78) 
Q5 25.5 (5.9) 25 0.76 (0.44, 1.31) 0.67 (0.34, 1.34) 29 0.67 (0.42, 1.08) 0.42 (0.22, 0.79) 19 0.56 (0.33, 0.94) 0.43 (0.20, 0.92) 
Per 4g/day  
125 
0.95 (0.85, 1.05)     0.32 0.92 (0.81, 1.04)     0.20 160 0.95 (0.85, 1.06)     0.34 0.90 (0.78, 1.03)   0.13 125 0.86 (0.75, 0.98)    0.03 0.80 (0.68, 0.96)    0.01 
Total 
cereal 
fibre 
(g/day) 
 
Q1 2.8 (1.4) 27 1 1 38 1 1 34 1 1 
Q2 5.1 (1.1) 25 1.01 (0.58, 1.73) 0.93 (0.52, 1.66) 42 1.05 (0.68, 1.62) 1.05 (0.65, 1.71) 24 0.68 (0.40, 1.17) 0.77 (0.44, 1.35) 
Q3 7.6 (1.4) 23 0.78 (0.44, 1.38) 0.75 (0.40, 1.38) 19 0.47 (0.27, 0.79) 0.37 (0.20, 0.70) 30 0.82 (0.50, 1.35) 0.93 (0.54, 1.58) 
Q4 10.6 (1.8) 27 0.81 (0.47, 1.41) 0.75 (0.42, 1.34) 21 0.55 (0.34, 0.92) 0.40 (0.21, 0.73) 19 0.59 (0.34, 1.02) 0.60 (0.33, 1.10) 
Q5 15.6 (4.5) 23 0.81 (0.47, 1.42) 0.74 (0.39, 1.41) 40 0.84 (0.54, 1.30) 0.74 (0.42, 1.30) 18 0.60 (0.35, 1.03) 0.57 (0.29, 1.11) 
Per 3g/day   125 0.96 (0.86, 1.06)     0.40 0.95 (0.84, 1.07)    0.40 160 0.94 (0.86, 1.04)     0.23 0.89 (0.80, 1.00)   0.05 125 0.91 (0.81, 1.03)    0.12 0.89 (0.78, 1.02)    0.11 
Fibre from 
breakfast 
cereals 
(g/day) 
Q1 0.05 (0.1) 24 1 1 37 1 1 27 1 1 
Q2 0.5 (0.4) 26 1.10 (0.62, 1.93) 1.02 (0.57, 1.84) 31 1.05 (0.65, 1.71) 0.97 (0.58, 1.64) 21 1.18 (0.67, 2.09) 1.18 (0.65, 2.14) 
Q3 1.8 (0.7) 22 0.85 (0.47, 1.53) 0.84 (0.45, 1.56) 29 0.94 (0.58, 1.53) 0.89 (0.53, 1.50) 23 0.88 (0.49, 1.59) 0.99 (0.54, 1.80) 
Q4 3.5 (0.7) 29 1.07 (0.61, 1.86) 1.03 (0.57, 1.85) 32 0.93 (0.58, 1.49) 0.85 (0.50, 1.42) 29 1.25 (0.73, 2.14) 1.41 (0.80, 2.50) 
Q5 7.6 (2.6) 24 0.86 (0.49, 1.52) 0.81 (0.45, 1.46) 31 0.81 (0.50, 1.30) 0.66 (0.39, 1.11) 25 1.05 (0.61, 1.80) 1.09 (0.61, 1.96) 
Per 2g/day   125 0.98 (0.88, 1.08)     0.68 0.98 (0.88, 1.09)     0.65 160 0.94 (0.86, 1.02)     0.15 0.89 (0.80, 0.99)   0.03 125 1.00 (0.92, 1.09)    0.97 1.00 (0.91, 1.10)    0.95 
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Median 
intake (IQR) 
 
Total haemorrhagic stroke Total ischaemic stroke Total unspecified stroke 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 26 1 1 39 1 1 37 1 1 
Q2 2.9 (0.7) 23 0.61 (0.34, 1.08) 0.72 (0.40, 1.31) 33 0.74 (0.47, 1.18) 0.77 (0.47, 1.28) 20 0.40 (0.23, 0.70) 0.49 (0.28, 0.86) 
Q3 4.2 (0.7) 29 0.95 (0.57, 1.59) 0.96 (0.55, 1.68) 32 0.81 (0.52, 1.26) 0.74 (0.44, 1.22) 20 0.45 (0.26, 0.76) 0.47 (0.26, 0.84) 
Q4 5.8 (1.1) 26 0.68 (0.40, 1.18) 0.77 (0.42, 1.40) 22 0.43 (0.26, 0.73) 0.48 (0.28, 0.84) 27 0.52 (0.32, 0.86) 0.58 (0.34, 0.98) 
Q5 9.4 (4.0) 21 0.57 (0.32, 1.01) 0.63 (0.33, 1.19) 34 0.59 (0.37, 0.94) 0.59 (0.35, 1.00) 31 0.40 (0.23, 0.68) 0.44 (0.24, 0.78) 
Per 2g/day  125 0.94 (0.84, 1.06)     0.33 0.94 (0.83, 1.08)     0.39 160 0.96 (0.85, 1.07)     0.46 0.97 (0.86, 1.09)   0.62 125 0.92 (0.79, 1.07)    0.29 0.95 (0.80, 1.12)    0.52 
Vegetable 
fibre 
(g/day) 
Q1 2.3 (0.9) 26 1 1 39 1 1 34 1 1 
Q2 3.7 (0.6) 15 0.68 (0.36, 1.27) 0.64 (0.33, 1.25) 24 0.62 (0.38, 1.02) 0.70 (0.41, 1.19) 22 0.71 (0.42, 1.20) 0.71 (0.41, 1.21) 
Q3 5.0 (0.7) 23 0.96 (0.55, 1.70) 0.99 (0.55, 1.77) 28 0.73 (0.46, 1.17) 0.78 (0.46, 1.32) 27 0.73 (0.44, 1.21) 0.74 (0.44, 1.27) 
Q4 6.6 (1.0) 34 1.21 (0.71, 2.05) 1.33 (0.78, 2.27) 34 0.67 (0.42, 1.07) 0.81 (0.49, 1.33) 27 0.70 (0.42, 1.15) 0.69 (0.40, 1.18) 
Q5 9.6 (3.0) 27 1.01 (0.58, 1.74) 0.93 (0.52, 1.66) 35 0.76 (0.49, 1.19) 0.80 (0.50, 1.27) 15 0.36 (0.20, 0.66) 0.33 (0.18, 0.62) 
Per 2g/day  125 1.02 (0.94, 1.11)     0.65 1.02 (0.93, 1.11)     0.71 160 1.00 (0.90, 1.11)     0.97 1.02 (0.92, 1.13)   0.75 125 0.83 (0.72, 0.96)    0.01 0.80 (0.68, 0.92)  <0.01 
Legume 
fibre 
(g/day) 
Q1 0.2 (0.2) 24 1 1 38 1 1 42 1 1 
Q2 0.7 (0.2) 33 1.24 (0.75, 2.09) 1.26 (0.73, 2.20) 37 0.95 (0.62, 1.48) 1.10 (0.68, 1.77) 28 0.75 (0.47, 1.20) 0.81 (0.50, 1.32) 
Q3 1.1 (0.2) 26 1.05 (0.60, 1.83) 1.19 (0.66, 2.12) 32 1.05 (0.67, 1.64) 1.02 (0.61, 1.70) 21 0.60 (0.35, 1.02) 0.68 (0.39, 1.18) 
Q4 1.6 (0.4) 22 0.98 (0.55, 1.73) 1.07 (0.58, 1.97) 26 0.82 (0.49, 1.36) 1.00 (0.57, 1.73) 21 0.65 (0.37, 1.12) 0.79 (0.44, 1.40) 
Q5 3.6 (1.4) 20 1.13 (0.63, 2.04) 1.08 (0.56, 2.08) 27 1.10 (0.67, 1.79) 1.09 (0.60, 1.99) 13 0.70 (0.38, 1.28) 0.62 (0.30, 1.27) 
Per 1g/day   125 1.05 (0.93, 1.18)     0.43 1.05 (0.92, 1.19)     0.50 160 1.00 (0.90, 1.11)     0.99 0.99 (0.87, 1.12)   0.82 125 0.90 (0.73, 1.11)    0.33 0.85 (0.68, 1.06)    0.14 
Fibre from 
nuts and 
seeds 
(g/day) 
Q1 0 (0.01) 38 1 1 59 1 1 46 1 1 
Q2 0.06 (0.01) 26 0.88 (0.53, 1.44) 0.82 (0.49, 1.39) 31 0.63 (0.42, 0.95) 0.60 (0.38, 0.94) 25 0.72 (0.44, 1.16) 0.76 (0.45, 1.27) 
Q3 0.08 (0.05) 23 0.72 (0.42, 1.24) 0.72 (0.41, 1.27) 21 0.44 (0.27, 0.73) 0.47 (0.28, 0.81) 19 0.64 (0.38, 1.09) 0.70 (0.39, 1.23) 
Q4 0.28 (0.12) 16 0.54 (0.29, 1.01) 0.57 (0.31, 1.07) 21 0.48 (0.29, 0.80) 0.50 (0.29, 0.86) 19 0.74 (0.44, 1.26) 0.80 (0.45, 1.42) 
Q5 0.87 (0.92) 22 0.75 (0.43, 1.30) 0.68 (0.38, 1.22) 28 0.53 (0.33, 0.85) 0.60 (0.35, 1.02) 16 0.41 (0.22, 0.76) 0.50 (0.26, 0.95) 
Per 0.2g/day   125 0.98 (0.92, 1.04)     0.44 0.97 (0.91, 1.04)     0.40 160 0.95 (0.89, 1.02)     0.14 0.97 (0.91, 1.03)   0.30 125 0.89 (0.81, 0.99)    0.03 0.92 (0.84, 1.01)    0.08 
1Case numbers apply to fully-adjusted models. 2Adjustments include Age (years), BMI (kg/m2), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not 
current smoker), socio-economic status (professional or managerial/ intermediate/ routine or manual). Note, adjustment for energy intake was not included in fibre density models. Highlight=CIs do not span 1 in fully 
adjusted model.  
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Table 6.11 Dietary fibre intake and associated risk for ‘mostly ischaemic’ type stroke (ischaemic type plus unspecified stroke) 
 Median 
intake (IQR) 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
  
Median 
intake (IQR) 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
NSP 
(g/day) 
Q1 14.1 (3.9) 68 1 1 
Total cereal 
fibre (g/day) 
 
Q1 2.8 (1.4) 64 1 1 
Q2 19.5 (2.2) 43 0.70 (0.49, 1.02) 0.56 (0.38, 0.84) Q2 5.1 (1.1) 54 0.80 (0.56, 1.16) 0.77 (0.52, 1.15) 
Q3 23.8 (2.3) 47 0.68 (0.47, 0.99) 0.56 (0.37, 0.84) Q3 7.6 (1.4) 42 0.60 (0.41, 0.88) 0.52 (0.34, 0.81) 
Q4 29.1 (3.1) 49 0.60 (0.41, 0.87) 0.49 (0.32, 0.75) Q4 10.6 (1.8) 37 0.55 (0.37, 0.81) 0.42 (0.27, 0.66) 
Q5 38.1 (8.5) 44 0.61 (0.42, 0.88) 0.35 (0.20, 0.60) Q5 15.6 (4.5) 54 0.71 (0.50, 1.02) 0.57 (0.36, 0.89) 
Per 6g/day  251 0.92 (0.84, 1.01)    0.08 0.83 (0.73, 0.94)   <0.01 Per 3g/day   251 0.93 (0.86, 1.01)     0.07 0.88 (0.80, 0.96)  <0.01 
AOAC 
(g/day) 
Q1 21.8 (5.9) 69 1 1 
Fibre from 
breakfast 
cereals (g/day) 
Q1 0.05 (0.1) 54 1 1 
Q2 30.0 (3.4) 44 0.69 (0.48, 0.99) 0.60 (0.40, 0.89) Q2 0.5 (0.4) 47 1.19 (0.81, 1.77) 1.11 (0.73, 1.69) 
Q3 36.6 (3.5) 42 0.55 (0.38, 0.81) 0.43 (0.28, 0.67) Q3 1.8 (0.7) 45 0.95 (0.63, 1.42) 0.91 (0.59, 1.39) 
Q4 44.5 (4.7) 49 0.64 (0.44, 0.92) 0.53 (0.34, 0.81) Q4 3.5 (0.7) 55 1.11 (0.76, 1.63) 1.05 (0.69, 1.57) 
Q5 58.5 (13.2) 47 0.61 (0.42, 0.88) 0.35 (0.19, 0.61) Q5 7.6 (2.6) 50 0.91 (0.62, 1.34) 0.79 (0.52, 1.20) 
Per 11g/day  251 0.92 (0.83, 1.03)    0.14 0.80 (0.68, 0.95)   <0.01 Per 2g/day   251 0.96 (0.90, 1.03)     0.25 0.93 (0.86, 1.01)    0.09 
NSP 
density  
g/1000 
kcal/day 
Q1 7.5 (1.5) 68 1 1 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 59 1 1 
Q2 9.4 (0.8) 53 0.77 (0.55, 1.10) 0.77 (0.53, 1.11) Q2 2.9 (0.7) 47 0.65 (0.45, 0.96) 0.70 (0.46, 1.05) 
Q3 11.0 (0.8) 35 0.49 (0.33, 0.72) 0.51 (0.34, 0.78) Q3 4.2 (0.7) 49 0.73 (0.51, 1.05) 0.69 (0.46, 1.04) 
Q4 12.7 (1.0) 38 0.47 (0.32, 0.69) 0.44 (0.29, 0.68) Q4 5.8 (1.1) 42 0.53 (0.36, 0.79) 0.55 (0.36, 0.84) 
Q5 15.4 (2.4) 57 0.58 (0.41, 0.84) 0.61 (0.42, 0.90) Q5 9.0 (4.0) 54 0.57 (0.39, 0.82) 0.57 (0.38, 0.87) 
2g/1000kcal/d  251 0.86 (0.79, 0.94)   <0.01 0.86 (0.79, 0.95)   <0.01 Per 2g/day  251 0.96 (0.88, 1.05)     0.38 0.97 (0.88, 1.07)    0.53 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.7 (2.1) 67 1 1 
Vegetable 
fibre (g/day) 
Q1 2.3 (0.9) 62 1 1 
Q2 14.6 (1.2) 46 0.62 (0.43, 0.89) 0.59 (0.40, 0.87) Q2 3.7 (0.6) 39 0.69 (0.47, 1.02) 0.69 (0.46, 1.05) 
Q3 16.9 (1.1) 38 0.54 (0.37, 0.78) 0.54 (0.36, 0.80) Q3 5.0 (0.7) 49 0.78 (0.54, 1.13) 0.77 (0.51, 1.14) 
Q4 19.4 (1.4) 46 0.52 (0.36, 0.75) 0.55 (0.37, 0.83) Q4 6.6 (1.0) 55 0.72 (0.50, 1.03) 0.74 (0.50, 1.09) 
Q5 23.4 (3.5) 54 0.55 (0.38, 0.80) 0.55 (0.37, 0.81) Q5 9.6 (3.0) 46 0.59 (0.40, 0.86) 0.53 (0.36, 0.79) 
3g/1000kcal/d  251 0.86 (0.79, 0.94)   <0.01 0.86 (0.78, 0.95)   <0.01 Per 2g/day  251 0.94 (0.86, 1.03)     0.19 0.92 (0.84, 1.02)    0.13 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 67 1 1 
Legume fibre 
(g/day) 
Q1 0.2 (0.2) 66 1 1 
Q2 8.6 (0.9) 45 0.69 (0.48, 1.01) 0.63 (0.42, 0.95) Q2 0.7 (0.2) 59 0.98 (0.69, 1.38) 1.05 (0.72, 1.51) 
Q3 10.4 (0.9) 41 0.69 (0.48, 1.00) 0.56 (0.37, 0.85) Q3 1.1 (0.2) 46 0.93 (0.65, 1.33) 0.89 (0.60, 1.34) 
Q4 12.5 (1.2) 53 0.70 (0.48, 1.00) 0.61 (0.39, 0.94) Q4 1.6 (0.4) 42 0.80 (0.53, 1.19) 0.92 (0.60, 1.40) 
Q5 16.3 (3.8) 45 0.66 (0.45, 0.96) 0.46 (0.27, 0.77) Q5 3.6 (1.4) 38 0.98 (0.66, 1.46) 0.89 (0.55, 1.42) 
Per 3g/day  251 0.94 (0.84, 1.04)    0.23 0.84 (0.72, 0.98)    0.03 Per 1g/day   251 0.97 (0.88, 1.08)     0.62 0.93 (0.83, 1.05)    0.23 
Insoluble 
fibre 
(g/day) 
Q1 8.4 (2.6) 70 1 1 
Fibre from 
nuts and seeds 
(g/day) 
Q1 0 (0.01) 87 1 1 
Q2 12.2 (1.6) 42 0.73 (0.50, 1.05) 0.58 (0.39, 0.87) Q2 0.06 (0.01) 47 0.70 (0.50, 0.98) 0.70 (0.48, 1.02) 
Q3 15.3 (1.6) 47 0.69 (0.48, 0.99) 0.55 (0.37, 0.82) Q3 0.08 (0.05) 39 0.60 (0.41, 0.87) 0.66 (0.44, 0.99) 
Q4 19.0 (2.2) 46 0.55 (0.37, 0.81) 0.49 (0.32, 0.75) Q4 0.28 (0.12) 34 0.59 (0.39, 0.87) 0.62 (0.40, 0.95) 
Q5 25.5 (5.9) 46 0.62 (0.43, 0.90) 0.36 (0.22, 0.61) Q5 0.87 (0.92) 44 0.54 (0.37, 0.79) 0.62 (0.41, 0.95) 
Per 4g/day   251 0.92 (0.85, 1.00)    0.06 0.84 (0.75, 0.94)   <0.01 Per 0.2g/day   251 0.94 (0.89, 0.99)     0.03 0.96 (0.91, 1.01)   0.09 
Key as on previous page
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Risk of MI, ACS and chronic heart disease (fatal plus non-fatal events) 
All participants 
After median follow-up of 14.4 years, 236 MI, 392 ACS and 573 chronic heart disease cases 
were observed. Greater total and insoluble fibre intakes were associated with lower risk of MI. 
For each 11g/day increase in fibre (AOAC), there was 14% lower risk: 0.86 (95% CI: 0.73 to 
1.00) p=0.04 and for each 3g/1000kal/day increase in AOAC density of the diet, risk was 0.89 
(95% CI: 0.80 to 0.98) p=0.02. Each 4g/day greater intake of insoluble fibre was associated with 
12% lower risk for MI 0.88 (95% CI: 0.79 to 0.99) p=0.03. These protective associations were 
not evident when total ACS or chronic heart disease cases were considered. Greater legume 
fibre (per 1g/day) however was protectively associated with lower risk of chronic heart 
disease, 0.92 (95% CI: 0.86 to 0.99) p=0.03 but for MI and ACS, risk estimates were close to 1, 
indicating no evidence of any associations with greater legume fibre intake. 
Subgroups 
As with the analysis using the full sample of women, no protective associations were apparent 
in any of the subgroups for ACS and fibre intake. For chronic heart disease risk, legume fibre 
(per 1g/day) remained protectively associated in both the women with healthy BMI at baseline 
0.88 (95% CI: 0.78 to 0.99) p=0.03 and those without hypertension 0.87 (95% CI: 0.79 to 0.96) 
p=0.004. Soluble fibre (per 3g/day) was also associated with 12% lower risk of chronic disease 
risk in women without hypertension, 0.88 (95% CI: 0.78 to 0.99) p=0.04. 
The protective associations observed with total fibre and insoluble fibre for the full sample 
remained in the postmenopausal subgroup: per 6g/day increase in NSP, 0.86 (95% CI: 0.73 to 
1.00) p=0.05, per 2g/1000kcal/day increase in NSP density, 0.87 (95% CI: 0.77 to 0.99) p=0.03, 
per 3g/1000kcal/day increase in AOAC density, 0.88 (95% CI: 0.77 to 0.99) p=0.04 and per 
4g/day increase in insoluble fibre, risk was 0.86 (95% CI: 0.75 to 1.00) p=0.05. Fruit fibre intake, 
per 2g/day increase was also associated with lower MI risk 0.90 (95% CI: 0.81 to 1.00) p=0.05.  
When considering women without hypertension at baseline, the protective associations for MI 
risk seen in the full sample, did not remain. They were however apparent in those with 
hypertension; for each 2g/1000kcal/day increase in NSP fibre density, risk of MI was 0.83 (95% 
CI: 0.69 to 0.99) p=0.04 and for AOAC density per 3g/1000kcal/day risk was 0.81 (95% CI: 0.67 
to 0.98) p=0.03. 
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 Table 6.12 Dietary fibre intake and associated risk for MI, ACS or chronic heart disease 
 
Median 
intake (IQR) 
Incident MI  
(fatal plus non-fatal) 
Incident ACS  
(fatal plus non-fatal) 
Incident chronic heart disease (no acute events)  
(fatal plus non-fatal) 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
NSP 
(g/day) 
Q1 14.1 (3.9) 47 1 1 78 1 1 117 1 1 
Q2 19.5 (2.2) 61 1.27 (0.88, 1.85) 1.33 (0.88, 2.00) 88 1.11 (0.82, 1.51) 1.16 (0.84, 1.60) 105 0.84 (0.65, 1.10) 0.90 (0.68, 1.19) 
Q3 23.8 (2.3) 30 0.63 (0.41, 0.99) 0.63 (0.38, 1.06) 55 0.71 (0.50, 1.00) 0.73 (0.50, 1.08) 91 0.73 (0.55, 0.96) 0.81 (0.59, 1.10) 
Q4 29.1 (3.1) 45 0.79 (0.52, 1.19) 0.79 (0.48, 1.29) 76 0.93 (0.67, 1.27) 0.93 (0.64, 1.37) 108 0.83 (0.64, 1.09) 0.88 (0.65, 1.21) 
Q5 38.1 (8.5) 34 0.70 (0.45, 1.08) 0.55 (0.31, 0.99) 64 0.80 (0.57, 1.12) 0.76 (0.48, 1.19) 114 0.94 (0.72, 1.22) 1.05 (0.74, 1.49) 
Per 6g/day  217 0.93 (0.84, 1.02) 0.14 0.89 (0.79, 1.01) 0.06 361 0.96 (0.90, 1.03) 0.31 0.95 (0.87, 1.05) 0.34 535 0.98 (0.93, 1.04) 0.54 0.99 (0.91, 1.07) 0.73 
AOAC 
(g/day) 
Q1 21.8 (5.9) 46 1 1 76 1 1 118 1 1 
Q2 30.0 (3.4) 58 1.29 (0.88, 1.89) 1.38 (0.91, 2.09) 86 1.16 (0.85, 1.58) 1.24 (0.89, 1.72) 104 0.82 (0.63, 1.07) 0.86 (0.65, 1.15) 
Q3 36.6 (3.5) 36 0.76 (0.49, 1.17) 0.76 (0.46, 1.25) 59 0.78 (0.56, 1.10) 0.83 (0.56, 1.22) 90 0.70 (0.54, 0.93) 0.76 (0.56, 1.04) 
Q4 44.5 (4.7) 45 0.82 (0.54, 1.25) 0.80 (0.48, 1.35) 78 1.01 (0.73, 1.39) 1.01 (0.68, 1.50) 110 0.81 (0.62, 1.05) 0.88 (0.64, 1.21) 
Q5 58.5 (13.2) 32 0.72 (0.46, 1.13) 0.55 (0.30, 1.02) 62 0.82 (0.58, 1.15) 0.78 (0.48, 1.25) 113 0.95 (0.73, 1.23) 1.03 (0.71, 1.49) 
Per 11g/day  217 0.92 (0.82, 1.03) 0.15 0.86 (0.73, 1.00) 0.04 361 0.96 (0.88, 1.04) 0.33 0.94 (0.83, 1.06) 0.30 535 0.98 (0.91, 1.05) 0.53 0.98 (0.89, 1.08) 0.71 
NSP 
density  
g/1000 
kcal/day 
Q1 7.5 (1.5) 57 1 1 85 1 1 116 1 1 
Q2 9.4 (0.8) 41 0.66 (0.44, 0.98) 0.76 (0.50, 1.14) 67 0.76 (0.55, 1.04) 0.82 (0.59, 1.13) 106 0.86 (0.66, 1.12) 0.93 (0.71, 1.22) 
Q3 11.0 (0.8) 46 0.83 (0.57, 1.21) 0.88 (0.59, 1.31) 72 0.88 (0.65, 1.20) 0.91 (0.66, 1.26) 101 0.83 (0.64, 1.09) 0.89 (0.67, 1.18) 
Q4 12.7 (1.0) 36 0.58 (0.38, 0.88) 0.66 (0.43, 1.03) 62 0.66 (0.47, 0.92) 0.74 (0.53, 1.04) 107 0.89 (0.69, 1.16) 0.95 (0.72, 1.26) 
Q5 15.4 (2.4) 37 0.57 (0.37, 0.87) 0.67 (0.42, 1.05) 75 0.83 (0.60, 1.13) 0.90 (0.64, 1.25) 105 0.87 (0.66, 1.14) 0.94 (0.71, 1.24) 
2g/1000kcal/d  217 0.86 (0.78, 0.95) <.01 0.89 (0.81, 0.98) 0.02 361 0.93 (0.87, 1.00) 0.87 0.95 (0.88, 1.02) 0.18 535 0.96 (0.90, 1.01) 0.14 0.97 (0.92, 1.04) 0.40 
AOAC 
density 
g/1000 
kcal/day 
Q1 11.7 (2.1) 54 1 1 78 1 1 113 1 1 
Q2 14.6 (1.2) 53 0.90 (0.62, 1.31) 1.00 (0.68, 1.48) 82 1.00 (0.73, 1.36) 1.06 (0.77, 1.45) 110 0.95 (0.73, 1.23) 0.98 (0.75, 1.28) 
Q3 16.9 (1.1) 37 0.67 (0.45, 1.02) 0.74 (0.48, 1.14) 62 0.82 (0.59, 1.13) 0.85 (0.60, 1.19) 102 0.85 (0.65, 1.11) 0.89 (0.67, 1.17) 
Q4 19.4 (1.4) 44 0.81 (0.55, 1.20) 0.87 (0.57, 1.32) 75 0.92 (0.67, 1.26) 0.97 (0.69, 1.35) 111 0.93 (0.71, 1.22) 1.00 (0.76, 1.32) 
Q5 23.4 (3.5) 29 0.46 (0.28, 0.73) 0.54 (0.33, 0.89) 64 0.76 (0.54, 1.06) 0.83 (0.58, 1.19) 99 0.85 (0.65, 1.12) 0.90 (0.68, 1.21) 
3g/1000kcal/d  217 0.86 (0.78, 0.95) <.01 0.89 (0.80, 0.98) 0.02 361 0.93 (0.87, 1.00) 0.07 0.95 (0.88, 1.03) 0.20 535 0.95 (0.90, 1.01) 0.12 0.97 (0.91, 1.04) 0.38 
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Median 
intake (IQR) 
Incident MI  
(fatal plus non-fatal) 
Incident ACS  
(fatal plus non-fatal) 
Incident chronic heart disease (no acute events)  
(fatal plus non-fatal) 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Soluble 
fibre 
(g/day) 
Q1 6.4 (1.6) 52 1 1 79 1 1 121 1 1 
Q2 8.6 (0.9) 45 0.94 (0.63, 1.39) 0.93 (0.61, 1.42) 72 0.96 (0.70, 1.32) 0.99 (0.70, 1.39) 100 0.78 (0.60, 1.01) 0.80 (0.61, 1.07) 
Q3 10.4 (0.9) 40 0.83 (0.55, 1.25) 0.84 (0.53, 1.35) 68 0.98 (0.71, 1.35) 1.00 (0.69, 1.45) 98 0.75 (0.57, 0.98) 0.78 (0.58, 1.05) 
Q4 12.5 (1.2) 39 0.67 (0.44, 1.03) 0.69 (0.41, 1.15) 71 0.88 (0.63, 1.22) 0.94 (0.63, 1.39) 99 0.72 (0.55, 0.95) 0.78 (0.56, 1.07) 
Q5 16.3 (3.8) 41 0.79 (0.52, 1.19) 0.66 (0.37, 1.17) 71 0.88 (0.64, 1.23) 0.90 (0.57, 1.43) 117 0.95 (0.74, 1.23) 0.97 (0.68, 1.38) 
Per 3g/day  217 0.95 (0.85, 1.07) 0.40 0.90 (0.77, 1.04) 0.16 361 0.97 (0.89, 1.05) 0.40 0.94 (0.84, 1.05) 0.28 535 0.97 (0.91, 1.04) 0.44 0.95 (0.86, 1.05) 0.34 
Insouble 
fibre 
(g/day) 
 
Q1 8.4 (2.6) 50 1 1 82 1 1 118 1 1 
Q2 12.2 (1.6) 56 1.14 (0.78, 1.65) 1.18 (0.79, 1.76) 81 1.01 (0.74, 1.37) 1.05 (0.76, 1.45) 105 0.83 (0.63, 1.08) 0.88 (0.66, 1.16) 
Q3 15.3 (1.6) 34 0.64 (0.42, 1.00) 0.69 (0.42, 1.13) 60 0.72 (0.51, 1.00) 0.77 (0.53, 1.12) 103 0.80 (0.61, 1.04) 0.90 (0.67, 1.20) 
Q4 19.0 (2.2) 45 0.78 (0.52, 1.17) 0.76 (0.47, 1.23) 75 0.91 (0.67, 1.25) 0.91 (0.63, 1.31) 101 0.79 (0.61, 1.03) 0.84 (0.62, 1.14) 
Q5 25.5 (5.9) 32 0.66 (0.43, 1.03) 0.55 (0.31, 0.95) 63 0.78 (0.56, 1.09) 0.75 (0.49, 1.16) 108 0.90 (0.68, 1.16) 0.96 (0.68, 1.35) 
Per 4g/day   217 0.92 (0.84, 1.00) 0.06 0.88 (0.79, 0.99) 0.03 361 0.97 (0.90, 1.03) 0.33 0.96 (0.88, 1.05) 0.40 535 0.99 (0.94, 1.04) 0.65 1.00 (0.93, 1.08) 0.93 
Total 
cereal 
fibre 
(g/day) 
 
Q1 2.8 (1.4) 55 1 1 84 1 1 112 1 1 
Q2 5.1 (1.1) 39 0.78 (0.52, 1.17) 0.83 (0.54, 1.26) 66 0.81 (0.59, 1.12) 0.87 (0.62, 1.21) 100 0.86 (0.65, 1.13) 0.93 (0.70, 1.23) 
Q3 7.6 (1.4) 41 0.73 (0.49, 1.09) 0.72 (0.46, 1.11) 65 0.74 (0.53, 1.02) 0.72 (0.51, 1.03) 103 0.84 (0.64, 1.10) 0.89 (0.66, 1.19) 
Q4 10.6 (1.8) 43 0.70 (0.46, 1.05) 0.78 (0.49, 1.23) 77 0.84 (0.61, 1.15) 0.94 (0.67, 1.33) 115 0.90 (0.69, 1.17) 1.00 (0.75, 1.35) 
Q5 15.6 (4.5) 39 0.65 (0.43, 0.98) 0.68 (0.42, 1.09) 69 0.83 (0.60, 1.13) 0.87 (0.60, 1.25) 105 0.85 (0.65, 1.12) 0.95 (0.69, 1.30) 
Per 3g/day   217 0.93 (0.86, 1.02) 0.11 0.94 (0.86, 1.04) 0.22 361 1.00 (0.93, 1.06) 0.91 1.02 (0.95, 1.09) 0.65 535 0.99 (0.94, 1.05) 0.80 1.01 (0.95, 1.07) 0.67 
Fibre from 
breakfast 
cereals 
(g/day) 
Q1 0.05 (0.1) 51 1 1 76 1 1 108 1 1 
Q2 0.5 (0.4) 50 1.06 (0.71, 1.59) 1.02 (0.67, 1.54) 77 1.03 (0.75, 1.43) 1.02 (0.73, 1.42) 107 1.00 (0.76, 1.31) 0.95 (0.72, 1.27) 
Q3 1.8 (0.7) 39 0.73 (0.48, 1.13) 0.74 (0.47, 1.16) 65 0.85 (0.60, 1.18) 0.82 (0.58, 1.16) 96 0.82 (0.62, 1.09) 0.82 (0.61, 1.09) 
Q4 3.5 (0.7) 33 0.68 (0.44, 1.04) 0.64 (0.40, 1.02) 59 0.75 (0.53, 1.06) 0.74 (0.52, 1.06) 96 0.81 (0.61, 1.07) 0.84 (0.63, 1.13) 
Q5 7.6 (2.6) 44 0.81 (0.54, 1.20) 0.78 (0.50, 1.20) 84 0.98 (0.72, 1.34) 0.98 (0.71, 1.36) 128 0.99 (0.76, 1.29) 1.04 (0.79, 1.38) 
Per 2g/day   217 0.93 (0.85, 1.02) 0.11 0.93 (0.85, 1.02) 0.13 361 1.01 (0.94, 1.07) 0.87 1.02 (0.95, 1.09) 0.62 535 1.00 (0.95, 1.06) 0.96 1.02 (0.97, 1.08) 0.48 
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Median 
intake (IQR) 
Incident MI  
(fatal plus non-fatal) 
Incident ACS  
(fatal plus non-fatal) 
Incident chronic heart disease (no acute events)  
(fatal plus non-fatal) 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Cases1 
Age-adjusted 
HR (95% CI) p-trend 
Fully-adjusted2 
HR (95% CI) p-trend 
Fruit fibre 
(g/day) 
Q1 1.4 (0.9) 44 1 1 71 1 1 111 1 1 
Q2 2.9 (0.7) 46 0.80 (0.53, 1.21) 0.99 (0.64, 1.54) 73 0.92 (0.66, 1.27) 1.02 (0.72, 1.45) 103 0.81 (0.62, 1.06) 0.85 (0.64, 1.13) 
Q3 4.2 (0.7) 40 0.70 (0.46, 1.07) 0.85 (0.54, 1.33) 68 0.81 (0.58, 1.13) 0.93 (0.65, 1.32) 107 0.74 (0.56, 0.97) 0.80 (0.60, 1.06) 
Q4 5.8 (1.1) 48 0.78 (0.52, 1.17) 0.98 (0.62, 1.54) 74 0.85 (0.61, 1.18) 0.98 (0.68, 1.41) 101 0.79 (0.60, 1.03) 0.81 (0.61, 1.09) 
Q5 9.4 (4.0) 39 0.61 (0.39, 0.93) 0.72 (0.45, 1.15) 75 0.81 (0.58, 1.13) 0.93 (0.64, 1.35) 113 0.81 (0.62, 1.06) 0.89 (0.66, 1.19) 
Per 2g/day  217 0.93 (0.86, 1.01) 0.08 0.94 (0.87, 1.01) 0.11 361 0.96 (0.91, 1.02) 0.17 0.97 (0.92, 1.03) 0.36 535 0.99 (0.94, 1.04) 0.62 1.00 (0.95, 1.05) 0.97 
Vegetable 
fibre 
(g/day) 
Q1 2.3 (0.9) 49 1 1 80 1 1 108 1 1 
Q2 3.7 (0.6) 32 0.71 (0.46, 1.09) 0.73 (0.46, 1.17) 55 0.76 (0.54, 1.06) 0.77 (0.53, 1.10) 91 0.74 (0.56, 0.99) 0.80 (0.60, 1.08) 
Q3 5.0 (0.7) 44 0.80 (0.53, 1.20) 0.92 (0.60, 1.43) 74 0.88 (0.64, 1.20) 0.90 (0.63, 1.27) 108 0.87 (0.66, 1.14) 0.93 (0.70, 1.24) 
Q4 6.6 (1.0) 49 0.82 (0.55, 1.22) 0.94 (0.62, 1.45) 79 0.85 (0.62, 1.17) 0.92 (0.66, 1.30) 113 0.89 (0.68, 1.16) 0.96 (0.72, 1.27) 
Q5 9.6 (3.0) 43 0.71 (0.47, 1.06) 0.72 (0.45, 1.15) 73 0.81 (0.59, 1.11) 0.80 (0.55, 1.16) 115 0.95 (0.73, 1.23) 0.97 (0.72, 1.30) 
Per 2g/day  217 0.96 (0.88, 1.05) 0.40 0.95 (0.87, 1.05) 0.32 361 0.97 (0.91, 1.03) 0.31 0.95 (0.89, 1.03) 0.21 535 1.00 (0.96, 1.05) 0.85 1.00 (0.95, 1.05) 0.98 
Legume 
fibre 
(g/day) 
Q1 0.2 (0.2) 52 1 1 87 1 1 133 1 1 
Q2 0.7 (0.2) 47 0.96 (0.65, 1.41) 0.94 (0.62, 1.42) 82 0.98 (0.73, 1.33) 0.94 (0.68, 1.28) 125 0.93 (0.73, 1.19) 0.90 (0.70, 1.16) 
Q3 1.1 (0.2) 42 0.92 (0.61, 1.39) 1.00 (0.65, 1.53) 75 0.95 (0.70, 1.30) 0.97 (0.70, 1.34) 96 0.83 (0.64, 1.07) 0.79 (0.60, 1.04) 
Q4 1.6 (0.4) 43 1.22 (0.82, 1.83) 1.21 (0.78, 1.88) 62 1.06 (0.77, 1.46) 0.99 (0.70, 1.39) 94 0.85 (0.65, 1.12) 0.83 (0.63, 1.11) 
Q5 3.6 (1.4) 33 1.04 (0.66, 1.63) 1.03 (0.64, 1.65) 55 0.94 (0.66, 1.34) 0.92 (0.64, 1.33) 87 0.87 (0.66, 1.15) 0.80 (0.59, 1.08) 
Per 1g/day   217 1.00 (0.91, 1.10) 0.93 1.00 (0.90, 1.10) 0.96 361 0.97 (0.90, 1.05) 0.45 0.97 (0.89, 1.05) 0.43 535 0.94 (0.88, 1.01) 0.07 0.92 (0.86, 0.99) 0.03 
Fibre from 
nuts and 
seeds 
(g/day) 
Q1 0 (0.01) 52 1 1 91 1 1 130 1 1 
Q2 0.06 (0.01) 53 1.17 (0.80, 1.70) 1.21 (0.82, 1.79) 82 1.02 (0.76, 1.37) 1.03 (0.76, 1.41) 130 1.12 (0.88, 1.43) 1.17 (0.91, 1.51) 
Q3 0.08 (0.05) 36 0.92 (0.60, 1.41) 1.04 (0.67, 1.61) 70 0.99 (0.72, 1.35) 1.02 (0.73, 1.42) 104 1.00 (0.77, 1.29) 1.08 (0.82, 1.42) 
Q4 0.28 (0.12) 37 1.03 (0.67, 1.57) 1.10 (0.71, 1.71) 60 0.93 (0.66, 1.30) 0.96 (0.68, 1.36) 87 0.87 (0.66, 1.15) 0.94 (0.70, 1.25) 
Q5 0.87 (0.92) 39 0.92 (0.60, 1.41) 0.98 (0.62, 1.57) 58 0.77 (0.55, 1.08) 0.78 (0.54, 1.15) 84 0.75 (0.56, 0.99) 0.86 (0.63, 1.18) 
Per 0.2g/day   217 1.00 (0.96, 1.04) 0.96 1.01 (0.97, 1.04) 0.76 361 0.99 (0.95, 1.02) 0.52 0.99 (0.95, 1.03) 0.59 535 0.98 (0.94, 1.01) 0.14 0.99 (0.96, 1.02) 0.55 
1Case numbers apply to fully-adjusted models. 2Adjustments include Age (years), BMI (kg/m2), calories from carbohydrate, fat and protein (kcal/day), ethanol intake (g/day), MET (hours/week), smoking status (current vs. not 
current smoker), socio-economic status (professional or managerial/ intermediate/ routine or manual). Note, adjustment for energy intake was not included in fibre density models. Highlight=CIs do not span 1 in fully 
adjusted model.
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6.5 Discussion 
6.5.1 Total CVD, CHD and stroke 
Unlike key findings from the previous chapter which focused on CVD mortality and where only 
cereal fibre intake was significantly associated with fatal stroke risk reduction, many more 
associations were apparent when non-fatal events were combined with these fatal events. 
Reduced risk of total stroke was associated with greater intakes of total fibre, fibre density, 
soluble and insoluble fibre. CHD risk reduction was associated with greater legume fibre intake 
and lower CVD risk with higher fibre density.  
The estimated 13% risk reduction observed here with total stroke (fatal plus non fatal) and 
total dietary fibre intake, assessed as AOAC (per 11g/day increase) 0.87 (95% CI: 0.76 to 0.99) 
p=0.03 is of a similar magnitude to the 7% reduction per 7g/day seen in the recent systematic 
review and meta-analysis of other prospective cohort studies (discussed in Chapter 2) 
(Threapleton et al., 2013d). A clearer association was also observed for soluble fibre intake and 
stroke in the UKWCS, compared to the systematic review and meta-analysis. In the UKWCS, 
stroke risk decreased by 12% for each 3g/day higher soluble fibre intake 0.88 (95% CI: 0.77 to 
1.00) p=0.05 and in the systematic review there was an indication of 6% reduction in risk 0.94 
(0.88 to 1.01) for each 4g/day higher intake but in fact this result did not reach statistical 
significance (Threapleton et al., 2013d). This finding may be attributed to study population 
differences, namely the greater variation in dietary intakes in the UKWCS, compared to other 
studies identified in Chapter 2. This feature may allow associations with soluble fibre to be 
fully explored here, whereas no evidence of an association may be apparent in those studies 
with relatively few participants consuming adequate fibre intakes.    
As seen for fatal stroke risk and cereal fibre intake (Chapter 5) (Threapleton et al., 2013b) 
there was a protective association with total stroke risk in this chapter. The Finnish ATBC Study 
of male smokers, identified during the systematic review, reported no protective associations 
with either insoluble or cereal fibre for stroke risk (Larsson et al., 2009). These findings 
contrast those observed in the UKWCS here and the other studies identified during the 
systematic review, which observed protective associations when examining cereal fibre intake 
(Oh et al., 2005, Kaushik et al., 2009)  or insoluble fibre (Eshak et al., 2010, Kokubo et al., 
2011).   
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The systematic review also identified just two other cohort studies reporting fruit or vegetable 
fibre intake in relation to stroke risk. As observed here for the UKWCS, there were no 
protective associations with either fruit or vegetable fibre intake (Larsson et al., 2009, Oh et 
al., 2005). As discussed in the previous chapter, the protective associations with cereal and not 
fruit or vegetable fibre may reflect protective benefits of cereal grains generally (Slavin, 2003), 
the greater relative proportion of insoluble to soluble type fibre (Lunn and Buttriss, 2007) or 
may simply reflect better measurement of cereal foods compared to fruit and especially 
vegetables as there is some evidence of over-reporting of vegetables in other British cohort 
studies (Bingham et al., 1997, Brunner et al., 2001). Additionally, a systematic review of cohort 
studies examining stroke risk with whole fruit and vegetable intake observed lower risk for 
each portion increase in fruit HR 0.95 (95% CI: 0.92 to 0.97) but not for vegetables HR 0.97 
(95% CI: 0.92 to 1.02) (Dauchet et al., 2005) and another meta-analysis found lower risk of 
stroke with greater combined fruit and vegetable intake (He et al., 2006). These associations 
for reduced stroke with whole fruit and vegetable intake contrast the lack of any association 
observed in this and other studies (Larsson et al., 2009, Oh et al., 2005) suggesting that the 
protective benefits of fruit and vegetables for stroke may not be mediated via fibre intake but 
other micronutrients. Alternatively, the opposing findings may reflect differences in 
measurement error in estimating whole food and nutrient intakes, which may lead to reduced 
effect sizes. 
Again, as in the previous chapter, there were no apparent associations with many fibre 
exposures and CHD risk in analyses of the full sample, the exception being an inverse 
association between total CHD risk and legume fibre. The general lack of associations directly 
contrast the pooled results generated from other cohort studies reported in Chapter 2, where 
lower CHD risk was associated with higher fibre intake. Several possible explanations exist for 
the null association seen with total CHD risk and total fibre intake: insufficient dietary 
variation, where the intakes of the sample only sit within a ‘flat’ portion of the dose-response 
curve may explain the lack of observations (Willett, 2013d). Despite participants here having a 
wide range of intake levels it is possible that associations are stronger in populations with 
lower intakes. The intake levels of the majority of UKWCS participants may be at or greater 
than a threshold level where benefits are seen. Another potential explanation for null 
associations is that the method of measuring diet was insufficiently accurate to measure 
differences that truly existed (Willett, 2013d). While this is possible, it is likely that a great deal 
of variation in fibre intakes do exist in this population and it is accepted that FFQs are able to 
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discriminate between and rank participants well with good agreement with food diaries 
(Brunner et al., 2001, Willett and Lenart, 2013) even though overestimation of nutrients tends 
to occur with FFQs (Bingham et al., 1994, Willett and Lenart, 2013).   
Potential associations may also have been missed because of low statistical power and low 
case numbers (Willett and Lenart, 2013), however this is likely not the culprit as strong 
associations were apparent for stroke risk, where fewer cases existed than for CHD. Other 
explanations include that the assessment of diet did not encompass the true latent period 
where diet influences disease risk. There is also the possibility of an opposing variable, 
whereby another factor is associated with greater intake of fibre but is detrimental and creates 
negative confounding (Willett, 2013d). 
The protective associations observed for greater fibre and stroke risk in the full sample were 
also observed in the obese but not healthy weight or overweight subsamples. Obesity is a well 
established risk factor for stroke (Goldstein et al., 2011) and results in systemic inflammation 
which is thought may work to initiate and mediate the development of vascular damage (Berg 
and Scherer, 2005) (discussed in Chapter 1). Additional fibre intake may confer no additional 
benefit in those who are at lower risk of stroke (i.e. not obese) but could be particularly 
beneficial where risk is greater because of higher BMI and inflammation.  
Hypertension is a strong risk factor for stroke (O'Donnell et al., 2010) and inverse associations 
for stroke risk with greater fruit fibre intake became apparent when women with hypertension 
were excluded from the analysis. Additional fruit fibre intake may have no influence on risk in 
this already higher risk group but when these participants were excluded, general protective 
associations became apparent for the rest of the sample who had no history of hypertension. 
The protective associations observed for fibre density and total CVD may simply be a reflection 
of the protective association with stroke rather than risk reduction for all events per se. The 
risk estimates for CVD tend to be weaker than with stroke and may simply reflect a dilution 
with the addition of CHD cases rather than any protective association separately for CHD. 
However, as with stroke events, inverse association for CVD became apparent when the 
sample was restricted to women without history of hypertension. Again, this finding indicates 
that greater fibre intake may not be additionally beneficial for those with hypertension, a risk 
factor for CVD, but may be helpful in healthy individuals. 
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6.5.2 Non-fatal cardiovascular disease 
Similar to the inverse association for total stroke risk with higher cereal fibre, a 9% lower risk 
for non-fatal stroke with each 3g/day greater intake was observed in the dose-response 
analysis including all participants. Again, there were indications that total fibre, insoluble fibre 
and cereal fibre were protective in many of the category comparisons, primarily for risk of non-
fatal stroke.  
With non-fatal stroke, but not CVD and CHD, there were significant associations for many 
exposure categories compared to the lowest intake group but not for the dose-response 
models. For example for non-fatal stroke risk in each group compared to the lowest intake 
group of soluble fibre, risk in Q2 was 0.56 (95% CI: 0.37 to 0.86), Q3 0.64 (95% CI: 0.42 to 0.95), 
Q4 0.74 (95% CI: 0.49 to 1.12) and Q5 0.56 (95% CI: 0.34 to 0.92) but per 3g/day increase, risk 
was 0.90 (95% CI: 0.78 to 1.04). These results suggest that the association between fibre intake 
and stroke risk may not be linear in nature. Traditionally, the key criteria for identification of 
causal relationships in epidemiology has been the presence of a linear trend (Hill, 1965). 
However it has been suggested that a biological gradient may not be appropriate in 
contemporary epidemiology where diseases have multifactorial pathogenesis and where 
associations may be U-shaped or reach a threshold (Lucas and McMichael, 2005). It may well 
be that high intakes of some specific nutrients or elements are detrimental to health (Willett, 
2013d) and it is unclear whether the association between fibre and CVD risk is likely to be 
linear or not. Certainly it is unlikely that high intakes of fibre would prove detrimental to 
health, as in the case of some other nutrients and it would seem logical that greater 
consumption, at least within plausible population intake ranges would likely have greater 
impact on lowering risk profile, although if associations are causal, beneficial effects may reach 
a threshold. An additional explanation for the protective associations that were more often 
observed in lower intake categories may be residual confounding and it may be some other 
aspect of diet or lifestyle in these lower fibre consumers that is conferring greater risk 
reduction.   
Total fibre, fibre density, soluble, insoluble and fibre from legumes were associated with lower 
risk of non-fatal CVD in women without history of hypertension. As noted above, it may be 
that any beneficial action of fibre can stall disease development in healthier women but not 
offer benefit for those with this cardiovascular risk factors. The inclusion of participants with 
this risk factor in the analysis of the full sample may be clouding any associations and explain 
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why evidence is lacking when all participants were included in analysis together. This 
explanation may also extend to the indication of non-fatal stroke risk reduction seen with 
greater cereal fibre intake only in women with healthy BMI. The beneficial association seen in 
the full sample did not remain for overweight or obese women, who are at increased 
cardiovascular risk, and it may be that greater benefit can be seen in preventing the disease in 
those with fewer risk factors. However the smaller number of cases observed in these smaller 
subgroups may also explain null associations here. Additionally non-fatal stroke risk reduction 
was also observed for greater cereal fibre intake in women with history of hypertension. 
6.5.3 Haemorrhagic vs. ischaemic stroke  
Only one significant association was observed in the full sample analyses for haemorrhagic or 
ischaemic types of stroke; an 11% lower risk for ischaemic stroke was observed for each 
3g/day greater cereal fibre intake. The protective associations observed with total fibre, 
soluble, insoluble and cereal fibre in the unspecified type stroke were also apparent when 
ischaemic cases were combined with the unspecified strokes. Combining cases in this way 
tended to slightly attenuate the protective associations but CIs were generally tighter in this 
larger sample of cases. The narrowing of CIs gives greater certainty to the estimates 
quantifying the degree of risk reduction seen with each specified fibre type. 
Total fibre intake, soluble fibre, insoluble fibre and fibre from cereals were all associated with 
lower risk of ‘mostly ischaemic’ stroke in the full sample analysis. Four other cohorts identified 
during the systematic review of literature (Chapter 2) had also considered the associations 
between fibre and stroke sub-types (Oh et al., 2005, Larsson et al., 2009, Wallstrom et al., 
2012, Kokubo et al., 2011). Findings from these studies do not help to explain observations 
seen for the UKWCS as they are not consistent between the studies. The Malmo Diet and 
Cancer Cohort Study identified an inverse association between fibre intake and ischaemic 
stroke in men but not women (Wallstrom et al., 2012). The Nurses’ Health Study also saw no 
evidence of an association for ischaemic stroke risk with total, cereal, fruit or vegetable fibre 
but did observe a beneficial association for haemorrhagic stroke with cereal fibre intake (Oh et 
al., 2005). A Finnish cohort of male smokers found that only vegetable fibre was associated 
with reduced risk of ischaemic stroke but not haemorrhagic stroke when examining total fibre, 
soluble, insoluble, cereal, fruit and vegetable sources of fibre (Larsson et al., 2009). The fourth 
study, a Japanese cohort reported a protective association for women and not men with total 
fibre and insoluble fibre for both ischaemic and haemorrhagic stroke but there was no 
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evidence of associations with soluble fibre (Kokubo et al., 2011). The different findings mean 
formulating a consensus on risk of different types of stroke in relation to fibre intake is 
challenging. The contrasting observations may result from measurement error in assessing 
fibre intake from different foods in the various assessment tools or reflect the likely large 
variation in diets and variation in sources of fibre between the UK, US, Finland, Japan and 
Sweden. 
In subgroup analyses for the UKWCS, results for the various fibre exposures do not tend to give 
a clear impression of the associations with haemorrhagic, ischaemic, unspecified or ‘mostly 
ischaemic’ stroke type. This issue may result from the greater uncertainty around estimates 
which comes from including fewer cases in these sub-group analyses or issues with multiple 
testing. When conducting multiple tests and using small sample sizes, there is greater chance 
of false positive results (Bowers et al., 2006a). In postmenopausal women, greater vegetable 
fibre was associated with increased risk for haemorrhagic stroke but decreased risk of 
ischaemic stroke. In the same subgroup, fibre intake and fibre density assessed as NSP were 
associated with risk reduction for unspecified type stroke but this was not the case when fibre 
intake or fibre density were assessed using the AOAC method. 
In women without history of hypertension, more of the fibre exposures (total fibre, soluble 
fibre, insoluble fibre, cereal fibre, vegetable fibre, fibre from breakfast cereals) were 
associated with lower risk of ischaemic, unclassified and ‘mostly ischaemic’ strokes compared 
to those with personal history of hypertension. In those with this risk factor, just vegetable 
fibre and fibre from nut and seed sources were associated with risk reductions for either 
unspecified or ‘mostly ischaemic’ strokes. As discussed previously, the action of fibre may have 
greater effect in preventing disease rather than reverse disease progression in those already 
with risk factors. Oddly, greater total fibre and fibre from breakfast cereals were both 
associated with increased risk of ischaemic stroke in this subgroup. As discussed above, these 
results may be ‘false positives’ caused by multiple testing and smaller case numbers. Or, 
alternatively, residual confounding might somewhat explain these observations whereby 
women with knowledge of hypertension are both at greater risk of CVD and are following 
healthier diets. Excluding more cases occurring in the years after dietary assessment may 
resolve the issue of residual confounding and help to investigate this, however there are too 
few cases available to explore this here.  
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Protective associations for haemorrhagic stroke became apparent when examining overweight 
or obese women. For these women, greater intake of cereal fibre, fibre from breakfast cereals, 
insoluble fibre and total fibre, assessed as AOAC, were associated with risk reduction. These 
associations were not seen for haemorrhagic stroke in women with healthy BMI suggesting 
that the effect of fibre on risk is modified with greater BMI. 
6.5.4 Acute vs. chronic heart disease 
Protective associations were only apparent for fibre intake with MI and not the broader acute 
syndrome category. Unstable angina and other ischaemic heart diseases (ICD10 I24) were 
additionally included in the ACS category with MI. It is possible that the conditions included in 
the broader acute category and conditions included in the chronic disease category have 
different pathogenesis to MI. These other conditions may be influenced by different risk 
factors and any beneficial effect of fibre may do little to influence overall disease risk.  
For chronic heart disease, just fibre from legumes was protectively associated with risk. This 
association remained in subgroup analyses for healthy BMI and those without history of 
hypertension. However, this lone observation, without any associations evident for total fibre 
intake, seems more likely a result of residual confounding and may reflect healthy behaviours 
of legume consumers rather than a specific benefit from fibre within legumes. 
6.5.5 Strengths and limitations 
As discussed in the previous chapter, strengths of this work include that there has been a 
relatively long period of follow up from this large prospective study and with the addition of 
non-fatal events here, case numbers are boosted. A benefit of this is that there are sufficient 
cases of each type of stroke or CHD event, allowing exploration of fibre intake in relation to the 
different types of events which is especially important for stroke because risk factors for the 
two main types (ischaemic and haemorrhagic), differ (Andersen et al., 2009). The pathology of 
disease development may be different for the two main stroke types and having sufficient 
cases of each allows exploration of this. While combining ischaemic with the unknown type 
stroke cases increased the number of strokes, which are likely to mostly be ischaemic, some 
sensitivity may be lost through including a small number of unidentified haemorrhagic stroke 
cases into this category.   
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A further unique strength of this cohort study is the use of a validated FFQ in a sample that 
includes diverse dietary intakes and this allows exploration of dose-response associations 
between very different levels of fibre intake with CVD risk. However, despite an early 
validation study with the FFQ (discussed in previous chapters) that indicated relatively stable 
dietary habits in participants for the five years since baseline (Greenwood et al., 2003) there 
are naturally limitations in assessing diet through any method and specific limitations with the 
use of FFQs, (Cade et al., 2002, Willett and Lenart, 2013) as discussed in Chapter 3.   
Although the UKWCS includes women with a range of different education and socioeconomic 
classifications, it is a clear limitation that results from the UKWCS may not directly relate to the 
general population as participants are likely to be better educated and healthier than the UK 
population on the whole. Also, being a cohort of women means that the applicability of results 
to men of similar ages is unclear.  
As highlighted in the previous chapter discussion, a major limitation with analysis of data from 
prospective observational studies is the potential for uncontrolled confounding, either via 
another lifestyle variable not considered in models or via an included confounder that has 
been imperfectly measured. It is conceivable that fibre itself is not directly acting to influence 
CVD risk, despite plausible mechanisms for its action (see Chapter 1), but another closely 
correlated nutrient or food component, or maybe both, may elicit the effect (Bingham et al., 
1994).  
Excluding participants with prevalent disease at baseline (cancer, diabetes, stroke, angina and 
heart attacks) removes those participants where knowledge of disease presence may have 
affected diet, thus allowing examination of disease incidence. However, hypertension is a risk 
factor for CHD and the inclusion of these women in the sample may serve to dilute risk 
estimates as associations are not consistent in those with or without hypertension. Another 
key risk factor for CVD development is being obese. These women were also retained in the 
full sample analysis to ensure sufficient case numbers and were then explored separately 
through sub-group analysis. Examining hypertension and overweight in this way allows more 
specific exploration of the relationship between fibre and these potential effect modifiers.  
A limitation however is that relying on self-reported disease prevalence and BMI may lead to 
mis-classification of women with existing CVD conditions who will remain in analysis of total 
events or who are not included in the correct sub-group analyses. Various cohort studies have 
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attempted to estimate the validity of self-reported disease prevalence through comparison 
with medical records (Colditz et al., 1986, Okura et al., 2004, Britton et al., 2012). MI and 
cerebrovascular disease ascertainment rates in an American study of women, the Nurses’ 
Health Study, were estimated as 68% and 66% respectively, although the authors ascribe these 
low rates to the application of strict criteria for case definitions (Colditz et al., 1986). From a 
cohort study of middle aged, mostly white participants in the US, good rates of reporting 
sensitivity were identified for self-reported hypertension (82%), stroke (78%) and MI (90%) 
when medical records were consulted, and similarly for specificity for the same conditions 
respectively, 92%, 99% and 98% (Okura et al., 2004).  In the British Whitehall II cohort study, 
the validity of self reported stroke events was found to be high with almost 90% being 
validated and confirmed by medical records and just a small number of false positives or false 
negatives being identified (Britton et al., 2012). 
6.6 Summary 
Greater fibre intake, both in the form of soluble or insoluble fibre and particularly from cereal 
sources is associated with reduced CVD risk in the UKWCS. Patterns of association were clearer 
for strokes, especially ischaemic type and in women who did not have hypertension but 
relatively few associations were observed for CHD.  
Exploration of effect modifiers (BMI, hypertension and menopausal status) has revealed some 
key differences in the risk profile for the various exposure and outcome combinations in these 
different groups. 
In this and the previous chapter it has been possible to utilise huge quantities of dietary data, 
available because administering and processing nutrients from FFQs is relatively speedy and 
was carried out many years ago for the UKWCS. In the next chapter a different approach is 
taken and diet is assessed from four-day weighed food diaries. For practical reasons only case 
and control diaries are available for use and the sample numbers for controls are therefore 
greatly reduced. However, weighed food diary assessment of dietary intake is considered to be 
the gold standard in a field where no method is perfect (Willett and Lenart, 2013). The 
comparison of results generated with these two key methods will hopefully provide further 
insight into the association between dietary fibre and CVD risk.  
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Chapter 7 Dietary fibre intake and risk of 
cardiovascular disease, a case-cohort approach  
7.1 Chapter overview 
In this chapter a case-cohort approach is used to assess associations between dietary fibre 
intake, recorded from food diaries, and risk of CVD.  
Risks for different CVD outcomes were estimated in association with higher intake of total 
fibre (NSP) and fibre from food sources. Fatal IHD, fatal stroke and fatal CVD (IHD plus stroke 
events) were explored along with risk of fatal plus non-fatal MI and ACS. The different sources 
of dietary and CVD event data used and presented in this chapter are displayed in Figure 7.1. 
Findings, using the case-cohort method, include an inverse association between ACS and 
cereal fibre intake and between fatal stroke risk and total fibre intake. Positive associations 
were also observed with higher fibre intake and increased risk of fatal IHD and fatal stroke, 
although case numbers for the fatal outcomes were particularly small.  
 
Figure 7.1 Data sources used in this chapter: Dietary data from case and sub-cohort food 
diaries, mortality and HES cases identified after receipt of food diaries plus MINAP cases 
identified since 2003  
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7.2 Background 
The case-cohort approach, a variation on the nested case-control study, was proposed for 
failure time analysis by Prentice in the mid 1980’s to deal with situations where it is not 
possible or practical to assess data from whole cohorts (Prentice, 1986). While it can be 
challenging to find participants willing to record their dietary intake in detail, over several days, 
processing the collected data for whole studies can be extremely time consuming and costly. 
This case-cohort method, as with case-control designs, only uses data for participants who 
become cases plus other members of the full cohort. In case-cohort analysis the controls are 
unmatched, are selected at random from the whole cohort and are known as the ‘sub-cohort’. 
The design has the added advantage that sub-cohorts offer flexibility as they can be shared 
among different outcome classifications and timeframes (Barlow et al., 1999). 
The systematic review of studies published in this area (reported in Chapter 2) (Threapleton et 
al., 2013d, Threapleton et al., 2013e) only identified a handful of studies that had assessed diet 
using measures other than FFQs (details are presented in Chapter 2 and the discussion section 
of the current chapter). Given that no dietary assessment method is without some error, the 
methods employed by studies that allow open ended responses and portion sizes to be 
estimated, undoubtedly capture a greater impression of actual intakes during the period of 
observation, be it 24-hours or 7 days in length (refer the discussion section of Chapter 3 for 
detailed description and comparison of dietary assessment approaches). Just one of these 
publications had explored CVD risk associated with fibre intake estimated using two different 
approaches and found different associations depending on the method used (Ward et al., 
2012). In view of the different observations found in the EPIC Norfolk study and that two 
different diet assessment methods had been used in the UKWCS, associations explored in 
Chapters 5 and 6, using FFQ data, were extended here using the case-cohort approach.  
7.3 Methods 
7.3.1 Dietary data 
As already detailed in Chapter 3, at the second point of data collection for the UKWCS, diet 
was assessed using weighed four-day food diaries. Dietary data from the diaries was analysed 
using our in house nutrient analysis software DANTE. It was only possible to estimate fibre 
intake from the diaries as NSP because British food tables do not include the AOAC values for 
the majority of food items. Similarly, values for soluble and insoluble fibre could not be 
accurately calculated for food diary data as many missing values exist in the food tables 
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(Holland et al., 1991). There are estimated factors for standard conversion between NSP and 
AOAC fibre but these are not useful to apply to total fibre intake in this context because the 
intake value would be similarly inflated for all participants. It is also not appropriate to apply a 
standard conversion factor for fibre assessed from specific food groups, because the 
proportions of lignin and resistant starch, the components not included in NSP values, differ 
from one food to another (Buttriss and Stokes, 2008).  
Fibre density of the diet was calculated using the estimated total daily energy intake from the 
diaries. NSP from key food sources were also calculated to enable better comparison of these 
results with those presented in Chapter 5 (CVD mortality risk) and Chapter 6 (total CVD risk). 
CVD risk is presented in relation to NSP from total cereals, breakfast cereals, fruit (excluding 
juice), vegetables (excluding potatoes), legumes and nuts/seeds and details of which foods are 
grouped in each category are presented in Chapter 3.   
7.3.2 Mortality data 
The same IHD and stroke definitions were applied to mortality records to identify cases here, 
as presented and used in previous chapters (case definitions are presented in Chapter 4; 
mortality data are utilised in Chapters 5 and 6). In order to account for the potential influence 
of any latent disease, cases were only included where food diary information was received at 
least 12 months prior to the date of death. Cases used in this analysis extended from 1 year 
after questionnaire receipt to 3rd October 2012. In analyses where mortality data were 
combined with non-fatal cases, events extend only to 30th June 2011 to be consistent with the 
latest available case information from the two other sources of event data, HES and MINAP. 
7.3.3 HES records 
As detailed in prior chapters, CHD cases were identified using only the primary diagnosis field 
within the HES dataset. Because of limited resources, it was not possible to code dietary data 
for stroke cases or chronic heart disease identified in HES and a narrower CHD class was 
explored. ACS cases were defined using ICD10 codes I20.0 and I21.0-I24.9 and MI cases using 
I21.0 to I22.0 (refer to Chapter 4 for full details of event case classification). 
7.3.4 MINAP records 
Coronary events identified from MINAP were those participants where a final diagnosis of MI, 
threatened MI or ACS were recorded in the MINAP dataset (see Chapter 4 for details). 
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7.3.5 Censor date 
Survival times were calculated, in years, from receipt of the follow-up questionnaire and food 
diary until either, earliest CVD event date, date of death from any other cause or the censor 
date, whichever came first.  
When fatal and non-fatal events were combined, the censor date of 30th June 2011 was 
applied to HES and mortality events. Where only fatal events were included in analyses, the 
censor date was set as 3rd October 2012. 
7.3.6 Exclusions 
Of the 647 participants with follow-up data who were identified either as sub-cohort or case 
subjects, women were excluded where the following criteria were met:  
1) Did not provide accurate NHS number or GP information at study baseline and were 
therefore not successfully traceable via the NHSIC (n=5). 
2) Did not provide both lifestyle and dietary information (n=19). 
3) Reported personal history of cancer, stroke, diabetes, angina or heart attack at study 
baseline or Phase II (n=167). 
4) Died (any cause) or experienced CVD event within one year of receipt of Phase II data 
(n=10). 
5) Food diary recording was less than 3 days (n=2). 
7.3.7 Testing dose-response and non-linear associations 
Unlike previous Chapters (5 and 6), associations between CVD risk and fibre intakes were 
assessed only using linear, dose-response models. Categorical exposures were not explored 
here because the limited case numbers for the different outcomes would result in extremely 
small numbers of cases in each intake category if risk was explored in this way and result in 
unreliable estimates. However, as detailed in Chapter 3 the fibre intake increments used in 
dose-response models were generated by calculating the mean intake difference between the 
five categories. 
7.3.8 Case-cohort analysis and selection of sub-cohort participants 
Cases with completed food diaries were identified from the 12,625 available participants and a 
corresponding number of non-case (sub-cohort or control) diaries were selected to be coded 
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1:1 with the cases. This enabled pairs of diaries, with one case and one control diary to be 
given to coders, guaranteeing coder blinding to the disease status of participants. Ensuring 
each coder had an equal number of both cases and controls also helped to minimise the effect 
of individual coder bias on the case and sub-cohort diaries.  
No restrictions were placed on the sub-cohort random selection so that case diaries were also 
eligible to act within the sub-cohort, thus ensuring the sub-cohort was not artificially free of 
CVD cases. This is a main benefit of the case-cohort method (Prentice, 1986), in that sub-
cohort diaries have been selected without restriction i.e. are not matched to specific cases, 
and may therefore act as controls in any future work. This sampling strategy, whereby some 
cases act as sub-cohort controls is accounted for in statistical analysis so estimates are not 
biased (discussed below). Strengths and weaknesses of the case-cohort design are discussed, 
at length, in the discussion of this chapter.  
7.3.9 Survival analyses using the case-cohort method 
Cox proportional hazards regression (Cox and Oakes, 1984) was used to explore the  
association between fibre intake assessed from diaries and CVD risk, with some modifications 
to allow for the sampling (Barlow et al., 1999). The Cox approach was modified for the case-
cohort design according to the Prentice method (Prentice, 1986). Briefly, applying this method 
involves separating the dataset into participants selected to act as the sub-cohort (including 
any cases) and in a separate dataset, the additional cases. The two sets are separately 
processed using survival time and case information, before being rejoined.  
The usual approach for preparing data for the proportional hazard models involves specifying 
failures (or cases) within the dataset. A modified approach, including probability weighting, 
was therefore taken, to ensure all participants in the sub-cohort set were classed as ‘non-
failures’. Any cases in the sub-cohort set are additionally flagged as ‘failures’. The case and 
sub-cohort overlap in these analyses were n=2 for ACS outcomes and n=6 for CVD mortality. 
Participants in the case dataset were identified as ‘failures’ (Coviello, 2001). The two prepared 
datasets were then appended and case weights were specified to reflect the proportion of the 
total available diaries that had been selected as sub-cohort (i.e. 314 of 12,625) and thus 
attempt to estimate findings that would result from a full cohort analysis (Barlow, 1994, 
Barlow et al., 1999). Proportional hazard models were then run, as in previous chapters, 
though this modified method does not allow the inclusion of weighting factors. However, 
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including the inverse probability weighting for vegetarian status made little difference to risk 
estimates in Chapters 5 and 6.   
Assumptions for proportional hazards were once again checked with the use of log-log survival 
curves for each outcome with all exposure and confounding variables. This condition was met 
for each exposure and with all covariates used in models. 
A two-sided p-value ≤0.05 was considered statistically significant. Analyses were conducted 
using Stata version 12 (StataCorp, 2011). 
7.3.10 Confounder adjustment 
Adjustment for confounding variables was the same as Chapters 5 and 6 and the following 
three levels of adjustment were applied: 
1) Age (years) 
2) Age (years), alcohol (ethanol g/day), smoking status (non-smoker, current-smoker, ex-
smoker), physical activity-metabolic equivalents (MET-hours/week) and socio-
economic status (SES) (professional/managerial, intermediate or routine/manual). 
3) As model 2 with the addition of energy intake from carbohydrate, fat and protein 
(excluding calories from ethanol) (kcal/day)* and BMI (kg/m2). 
* As in Chapters 5 and 6, results presented in here for fibre density models do not include 
adjustment for energy intake. Results were not appreciably different with or without 
adjustment for energy intake in fibre density models (data not shown). 
7.3.11 Cohort subgroup analyses 
Too few cases existed in the sample to explore associations by menopausal status, BMI 
category or history of hypertension. 
7.4 Results 
7.4.1 Sample and case numbers 
There were 12,625 participants who responded to Phase II contact and provided both dietary 
and lifestyle information. Of these women, there were 186 ACS cases (102 MI cases) in English 
participants identified since receipt of Phase II data up to 30th June 2011. There were also 53 
fatal IHD cases, 63 fatal stroke cases and therefore 116 fatal CVD cases identified from 
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questionnaire receipt up to 3rd October 2012. From the total 12,625 diaries, 373 sub-cohort 
diaries were randomly selected as ‘controls’.  
After applying exclusions to the sample of 283 case diaries, 144 were eligible to be used in 
analyses. These included 53 MI cases, 88 ACS cases, 25 fatal IHD cases, 42 fatal stroke cases 
and 67 fatal CVD cases (Table 7.1). After exclusions, 314 of the 373 diaries were eligible for use 
in the sub-cohort. 
 Table 7.1 Frequency of available participants and mean follow-up duration in both sub-
cohort and case groups 
 Available participants after 
exclusions applied to sample 
Median (IQR) 
participant 
follow-up time in 
the study, years 
Unadjusted 
model 
Fully-adjusted 
model 
Sub-cohort (control diaries) 314 291 10.6 (1.5) 
MI case 53 49 6.1 (5.3) 
ACS case 88 77 6.5 (4.5) 
IHD mortality case 25 22 7.0 (6.2) 
Stroke mortality case 42 39 7.8 (4.5) 
CVD mortality case 67 61 7.7 (4.9) 
 
7.4.2 Descriptive statistics 
ACS cases were around 8 years older than sub-cohort participants at baseline, mean age was 
59.9 years (SD 8.2) for ACS cases and 51.9 years (SD 9.1) in the sub-cohort (Table 7.2). 
Mortality cases were 62.4 years (SD 7.8) old at baseline. All case groups, except IHD mortality 
cases (n=25), had BMIs at least half a unit greater than the sub-cohort, where median BMI was 
23.4 kg/m2 (IQR 4.1). 
The greatest proportion of current smokers was in the IHD mortality group (24%) but the case 
groups tended to include more reports of being a current smoker, at follow-up assessment (9 
to 24%) than the sub-cohort, where only 7% of participants had indicated they were current 
smokers. Unsurprisingly, more cases also reported history of hypertension (33 to 48%) 
compared to the sub-cohort (19%). The sub-cohort participants also reported higher activity 
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levels and higher energy intake, which may be a reflection of the age difference between cases 
and the sub-cohort women. 
In terms of social class, the case groups were not dissimilar to the sub-cohort in the proportion 
of women in each group; however the education profile of sub-cohort women was marginally 
better than the various case groups. In the sub-cohort, 37% of women reported being 
educated to degree level but the majority of the case groups had listed their highest 
educational achievement as A-levels. 
Mean daily NSP intake in the sub-cohort was 17.5g (SD 6.3), higher than the ACS cases at 16.7g 
(SD 6.0) or the fatal CVD cases 16.6g (SD 6.3). These differences between the cases and sub-
cohort are less apparent when comparing NSP density. The mean NSP density for the fatal CVD 
cases was 9.9g/1000kcal/day (SD 3.7) and for the ACS cases was 10.1g/1000kcal/day (SD 3.9) 
but this was marginally lower in the sub-cohort participants 9.8g/1000kcal/day (SD 3.2).  
Descriptive characteristics of all participants (cases and sub-cohort) based on fibre intake, as 
assessed from the diaries, are discussed and presented in Chapter 3 (Tables 3.6, 3.7 and 3.8). 
In summary, lower fibre consumers tended to report lower energy intake, marginally higher 
BMI and lower levels of physical activity. In fibre density groups, the differences in energy 
intake were less distinct, with similar reported energy intakes across groups, except the 
highest fibre density group where energy intake was markedly lower. There was also little 
difference in BMI between these fibre density groups.  
Lower fibre consumers tended to report lower levels of academic achievement and a higher 
proportion were grouped in the lower socio-economic class. 
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Table 7.2 Follow-up assessment cross-sectional characteristic for MI, ACS, IHD mortality, stroke mortality cases and randomly selected sub-cohort participants 
 MI case  ACS case IHD mortality 
case 
Stroke 
mortality case 
CVD mortality 
case 
Sub-cohort 
N 53 88 25 42 67 314 
Age at baseline, years 61.1 (12.4) 60.5 (12.6) 65.0 (10.4) 63.9 (12.2) 64.3 (10.9) 50.2 (13.3) 
BMI at Phase II, kg/m
2
 24.0 (4.0) 24.2 (4.3) 23.1 (6.6) 24.1 (3.5) 24.0 (4.2) 23.4 (4.1) 
Smoking status at 
Phase II (%) 
Not a current smoker 58 (91) 79 (90) 19 (76) 37 (88) 56 (84) 291 (93) 
Current smoker 5 (9) 9 (10) 6 (24) 5 (12) 11 (16) 23 (7) 
Diet group at 
baseline (%) 
Meat-eaters 40 (75) 64 (73) 14 (56) 30 (71) 44 (66) 183 (58) 
Fish-eaters 5 (9) 10 (11) 5 (20) 5 (12) 10 (15) 46 (15) 
Vegetarian 8 (15) 14 (16) 6 (24) 7 (17) 13 (19) 85 (27) 
Socio-economic 
status NS-SEC at 
baseline (%) 
Professional/ managerial 33 (63) 57 (66) 17 (68) 25 (63) 42 (65) 207 (67) 
Intermediate 18 (35) 25 (29) 8 (32) 12 (30) 20 (31) 85 (27) 
Routine and manual 1 (2) 4 (5) 0 3 (8) 3 (5) 18 (6) 
Highest 
educational 
achievement at 
baseline (%) 
No formal record 13 (26) 20 (24) 1 (4) 11 (31) 12 (21) 33 (11) 
O-level 10 (20) 17 (20) 8 (35) 4 (11) 12 (21) 82 (28) 
A-level 15 (30) 26 (31) 7 (30) 11 (31) 18 (31) 71 (24) 
Degree 12 (24) 20 (24) 7 (30) 9 (26) 16 (28) 107 (37) 
Menopause status 
Phase II (%) 
Post 51 (96) 84 (95) 25 (96) 38 (90) 63 (93) 195 (62) 
Pre 2 (4) 4 (5) 1 (4) 4 (10) 5 (7) 120 (38) 
History of 
hypertension at 
Phase II (%) 
Yes 20 (43) 26 (34) 8 (33) 20 (48) 28 (42) 55 (19) 
No 27 (57) 51 (66) 16 (67) 22 (52) 38 (58) 241 (81) 
Physical activity at 
Phase II (%) 
No weekly activity 8 (16) 12 (16) 5 (23) 3 (7) 8 (13) 20 (7) 
Light/moderate activity 28 (56) 42 (53) 13 (59) 23 (56) 36 (57) 136 (46) 
Vigorous activity 1-2 times per week 11 (22) 17 (22) 3 (14) 9 (22) 12 (19) 78 (26) 
Vigorous activity 3 or more times per week 3 (6) 8 (10) 1 (5) 6 (15) 7 (11) 61 (21) 
Ethanol at Phase II from diary, g/day mean (SD) 6.4 (12.3) 7.2 (11.0) 5.6 (11.9) 11.3 (15.3) 9.2 (14.3) 10.2 (13.0) 
Energy intake at Phase II from diary, kcal/day 1757 (545) 1715 (68) 1758 (529) 1712 (385) 1758 (626) 1838 (583) 
Protein intake from food diary g/day 68.8 (17.0) 68.8 (17.5) 69.8 (20.2) 65.5 (15.9) 66.0 (17.9) 69.7 (23.6) 
Total fat intake from food diary g/day 62.8 (30.3) 62.1 (27.0) 67.5 (22.7) 57.0 (27.4) 61.9 (32.8) 66.8 (34.6) 
Carbohydrate intake from food diary g/day 217.8 (46.1) 218.1 (62.8) 211.2 (52.3) 226.0 (96.0) 222.0 (79.6) 226.8 (80.7) 
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 MI case  ACS case IHD mortality 
case 
Stroke 
mortality case 
CVD mortality 
case 
Sub-cohort 
Saturated fat intake at Phase II from diary g/day 21.7 (12.8) 22.0 (12.5) 24.5 (14.8) 19.8 (9.1) 21.8 (12.7) 22.5 (13.9) 
NSP at Phase II from diary, g/day 16.7 (8.7) 16.7 (8.4) 18.1 (11.6) 15.3 (7.9) 15.8 (9.7) 17.1 (8.4) 
NSP density at Phase II from diary, g/1000kcal/day 9.5 (5.3) 9.5 (4.9) 11.0 (5.8) 8.7 (3.5) 8.8 (5.0) 9.6 (4.4) 
NSP within  
Foods from food diary, g/day 
 
Cereals 2.0 (1.1) 1.7 (1.6) 2.3 (1.4)  1.9 (1.3) 2.1 (1.3) 2.0 (1.8) 
Breakfast Cereals 0.5 (1.2) 0.4 (1.2) 1.0 (1.9) 0.4 (1.3) 0.5 (1.8) 0.6 (1.8) 
Fruit  2.7 (3.0) 3.1 (3.1) 2.9 (3.2) 2.7 (2.0) 2.7 (2.6) 2.9 (2.7) 
Vegetables 3.3 (3.0) 3.3 (2.6) 3.2 (4.6) 2.7 (2.1) 3.0 (2.9) 3.4 (2.6) 
Legumes 0.9 (1.6) 0.8 (1.9) 0.9 (1.6) 0.7 (1.9) 0.8 (1.7) 0.8 (1.8) 
Nuts/Seeds 0 (0.3) 0 (0.2) 0 (0.4) 0 (0.3) 0 (0.3) 0 (0.2) 
Values are median (IQR) or numbers (percentages) unless otherwise stated. 
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7.4.3 Survival analysis  
In total, 314 participants acted as non-cases and were followed for 10.6 years (IQR 1.5) on 
average (median follow-up length). The median study time between receipt of Phase II diary 
and ACS events (n=88) was 6.5 years (IQR 4.5) and for all CVD mortality cases (n=67) was 7.7 
years (IQR 4.9) (Table 7.1). 
HRs and 95% CIs for each outcome were generated by assessing dose-response trends and are 
presented for age-adjusted, mid adjusted and fully adjusted models (as detailed above) in 
Tables 7.3 to 7.6, for the various dietary fibre exposures. 
Incident MI or ACS 
Higher intake of fibre from cereal foods was associated with lower risk of ACS, with each 
3g/day increase, risk was 0.76 (95% CI: 0.58 to 1.00) in the fully adjusted model. None of the 
other fibre exposures were associated with risk for MI or ACS in any of the models. Risk 
estimates tended to sit below 1, with wide CIs when assessing risk in relation to total fibre 
intake, cereal fibre, fibre from breakfast cereals or fruit. However, for the other fibre 
exposures, risk estimates were close to or just higher than 1, again with wide CIs.  
Fatal IHD, Stroke and CVD 
Higher intake of total fibre was associated with lower fatal stroke risk in the age-adjusted 
model and also Model 2, HR 0.76 (95% CI: 0.58 to 1.00). However, this association was 
attenuated when BMI and energy intake were also included as covariates and the HR was 0.80 
(95% CI: 0.60 to 1.06).  
The risk for fatal stroke was significantly increased with higher intake of fibre from nuts/seeds 
HR 1.43 (95% CI: 1.04 to 1.98), in the fully adjusted model. Additionally, in the fully adjusted 
models higher risk for fatal IHD was associated with higher intake of fibre from vegetable, HR 
1.21 (95% CI: 1.03 to 1.43) and legume sources, HR 1.18 (95% CI: 1.06 to 1.31). 
Fatal CVD risk estimates tended to be lower than 1 for total fibre, cereals, fruit and vegetables 
and of a similar magnitude to observations in previous chapters, around 5-15% risk reduction, 
but CIs remained wide here and ultimately none of the exposures were significantly associated 
with fatal CVD risk.
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 Table 7.3 Total dietary fibre and fibre density of the diet and associated risk of total MI/ACS or fatal IHD, Stroke and CVD 
 Cases in fully 
adjusted 
model 
HR (95% CI) p-value, with each 4g/day higher NSP intake HR (95% CI) p-value, with each 2g/1000kcal/day higher NSP density 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Total MI  49 0.96 (0.77, 1.18) 0.68 0.95 (0.75, 1.21) 0.70 0.98 (0.74, 1.30) 0.90 1.06 (0.87, 1.31) 0.55 1.02 (0.81, 1.27) 0.90 1.00 (0.79, 1.26) 0.98 
Total ACS 77 0.91 (0.77, 1.09) 0.31 0.91 (0.74, 1.11) 0.34 0.95 (0.75, 1.20) 0.66 1.02 (0.86, 1.22) 0.79 0.99 (0.81, 1.21) 0.92 0.96 (0.78, 1.18) 0.71 
Fatal IHD 22 1.11 (0.79, 1.56) 0.54 1.15 (0.82, 1.61) 0.43 1.16 (0.81, 1.66) 0.41 1.17 (0.86, 1.59) 0.30 1.11 (0.85, 1.44) 0.45 1.13 (0.85, 1.52) 0.40 
Fatal Stroke 39 0.75 (0.58, 0.97) 0.03 0.76 (0.58, 1.00) 0.05 0.80 (0.60, 1.06) 0.12 0.84 (0.67, 1.06) 0.15 0.88 (0.69, 1.11) 0.27 0.81 (0.63, 1.05) 0.12 
Fatal CVD 61 0.87 (0.70, 1.10) 0.25 0.91 (0.71, 1.16) 0.43 0.94 (0.72, 1.23) 0.66 0.96 (0.78, 1.18) 0.68 0.98 (0.79, 1.21) 0.85 0.94 (0.75, 1.19) 0.61 
Key as below 
 
Table 7.4 Fibre from cereals and breakfast cereals and associated risk of total MI/ACS or fatal IHD, Stroke and CVD 
 Cases in fully 
adjusted 
model 
HR (95% CI) p-value, with each 3g/day higher total cereal fibre intake HR (95% CI) p-value, with each 2g/day higher breakfast cereal fibre 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Total MI 49 0.82 (0.61, 1.08) 0.16 0.80 (0.58, 1.09) 0.16 0.80 (0.58, 1.11) 0.18 0.90 (0.70, 1.16) 0.43 0.85 (0.63, 1.16) 0.31 0.85 (0.62, 1.16) 0.30 
Total ACS 77 0.77 (0.61, 0.97) 0.03 0.75 (0.58, 0.96) 0.03 0.76 (0.58, 1.00) 0.05 0.87 (0.71, 1.07) 0.19 0.83 (0.65, 1.07) 0.15 0.83 (0.64, 1.07) 0.15 
Fatal IHD 22 0.99 (0.69, 1.42) 0.95 0.91 (0.60, 1.39) 0.67 0.90 (0.59, 1.35) 0.60 1.04 (0.81, 1.33) 0.78 0.98 (0.73, 1.32) 0.89 0.98 (0.72, 1.33) 0.90 
Fatal Stroke 39 0.78 (0.57, 1.05) 0.10 0.77 (0.56, 1.06) 0.11 0.80 (0.58, 1.11) 0.17 0.80 (0.60, 1.06) 0.12 0.79 (0.58, 1.09) 0.15 0.78 (0.57, 1.08) 0.14 
Fatal CVD 61 0.85 (0.66, 1.10) 0.21 0.83 (0.63, 1.10) 0.20 0.85 (0.63, 1.13) 0.25 0.90 (0.73, 1.10) 0.30 0.87 (0.68, 1.11) 0.27 0.85 (0.66, 1.11) 0.23 
Model 1: Adjusted only for age (years). 
Model 2: Adjusted for age (years), socio-economic status (professional or managerial/ intermediate/ routine or manual), smoking (current vs. noncurrent smoker), physical activity level (no weekly 
physical activity/ light or moderate physical activity/ vigorous activity 1-2 times per week/ vigorous activity 3 or more times per week) and alcohol intake (g/day). 
Model 3: As Model 2 and additionally adjusted BMI (kg/m
2
) and energy intake from carbohydrates, fat and protein (kcal/day). 
Shading indicates results where CIs do not span 1.  
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Table 7.5 Fibre from fruit and vegetables and associated risk of total MI/ACS or fatal IHD, Stroke and CVD 
 Cases in fully 
adjusted 
model 
HR (95% CI) p-value, with each 1g/day higher fruit fibre intake HR (95% CI) p-value, with each 1g/day higher vegetable fibre intake 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Total MI 49 0.93 (0.79, 1.10) 0.41 0.94 (0.79, 1.13) 0.53 0.95 (0.79, 1.15) 0.62 1.11 (0.98, 1.26) 0.10 1.09 (0.97, 1.23) 0.16 1.10 (0.97, 1.24) 0.14 
Total ACS 77 0.98 (0.87, 1.11) 0.79 0.99 (0.86, 1.13) 0.86 1.01 (0.87, 1.16) 0.93 1.08 (0.97, 1.20) 0.17 1.06 (0.96, 1.18) 0.26 1.07 (0.96, 1.19) 0.20 
Fatal IHD 22 0.87 (0.69, 1.11) 0.26 0.86 (0.65, 1.12) 0.27 0.83 (0.64, 1.10) 0.19 1.20 (0.99, 1.45) 0.06 1.21 (1.03, 1.43) 0.02 1.21 (1.03, 1.43) 0.02 
Fatal Stroke 39 0.89 (0.70, 1.13) 0.33 0.89 (0.67, 1.18) 0.41 0.91 (0.67, 1.22) 0.52 0.83 (0.67, 1.01) 0.07 0.83 (0.65, 1.04) 0.11 0.84 (0.66, 1.06) 0.15 
Fatal CVD 61 0.88 (0.73, 1.07) 0.20 0.88 (0.70, 1.10) 0.27 0.89 (0.70, 1.13) 0.34 0.98 (0.83, 1.15) 0.79 1.00 (0.85, 1.18) 0.98 1.01 (0.87, 1.19) 0.85 
Key as below 
 
Table 7.6 Fibre from legumes and nuts/seeds and associated risk of MI/ACS or fatal IHD, Stroke and CVD 
 Cases in fully 
adjusted 
model 
HR (95% CI) p-value, with each 1g/day higher legume fibre intake HR (95% CI) p-value, with each 1g/day higher nut/seed fibre intake 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Total MI 49 1.03 (0.84, 1.67) 0.76 1.03 (0.83, 1.27) 0.81 1.04 (0.84, 1.29) 0.71 0.91 (0.55, 1.53) 0.73 1.05 (0.71, 1.58) 0.80 1.11 (0.73, 1.68) 0.63 
Total ACS 77 1.01 (0.85, 1.21) 0.91 0.99 (0.81, 1.20) 0.88 1.01 (0.83, 1.22) 0.95 0.82 (0.50, 1.34) 0.43 0.91 (0.58, 1.42) 0.67 1.01 (0.66, 1.54) 0.97 
Fatal IHD 22 1.23 (1.07, 1.42) 0.01 1.17 (1.03, 1.33) 0.02 1.18(1.06, 1.31)<0.01 0.87 (0.44, 1.71) 0.69 1.06 (0.58, 1.93) 0.85 1.05 (0.47, 2.36) 0.91 
Fatal Stroke 39 0.96 (0.75, 1.23) 0.73 0.93 (0.72, 1.20) 0.58 0.96 (0.74, 1.25) 0.77 1.16 (0.73, 1.84) 0.53 1.31 (0.90, 1.90) 0.16 1.43 (1.04, 1.98) 0.03  
Fatal CVD 61 1.10 (0.87, 1.40) 0.43 1.08 (0.89, 1.31) 0.42 1.11 (0.92, 1.33) 0.27 1.08 (0.68, 1.74) 0.74 1.25 (0.87, 1.80) 0.22 1.36 (0.99, 1.87) 0.06 
Model 1: Adjusted only for age (years). 
Model 2: Adjusted for age (years), socio-economic status (professional or managerial/ intermediate/ routine or manual), smoking (current vs. noncurrent smoker), physical activity level (no weekly 
physical activity/ light or moderate physical activity/ vigorous activity 1-2 times per week/ vigorous activity 3 or more times per week) and alcohol intake (g/day). 
Model 3: As Model 2 and additionally adjusted BMI (kg/m
2
) and energy intake from carbohydrates, fat and protein (kcal/day). 
Shading indicates results where CIs do not span 1. 
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7.5 Discussion 
7.5.1 Result summary 
A protective association was observed between cereal fibre intake and ACS, where 77 cases 
were available in fully-adjusted models but no associations were observed for MI, where 49 
cases were included in fully adjusted models. Since MI cases make up the majority of the ACS 
cases, with other acute coronary events being included here, the different observations could 
indicate that cereal fibre has specific associations with ACS events that are not classified as MI. 
However, a clear limitation in this work is the small number of available cases that may 
account for the wide CIs seen with many of the risk estimates, such as with MI. For this reason, 
it would be unwise to place too great an emphasis on the precise risk estimates or indeed the 
specific lack of association with MI, as this may well be related to the wider CIs that come with 
fewer cases in analyses. However, given the small number of cases, many of the risk estimate 
CIs were not extremely wide and were similar in width to results in Chapters 5 and 6. The food 
diary approach, a potentially better assessment tool and the efficient case-cohort design may 
be mitigating the otherwise very wide CIs which could result from having few cases for some 
outcomes. 
Higher intake of total fibre was associated with lower risk of fatal stroke in the age-adjusted 
and mid-adjusted model, but this association became non-significant, with wider CIs when BMI 
and energy intake were included as covariates. The attenuation may reflect the influence of 
BMI or energy intake on the association; the protective association may be mediated via an 
influence of fibre on energy intake and ultimately BMI. However the widened CIs for the fully-
adjusted model may reflect the greater uncertainty around the estimate that comes from 
fewer cases being available to contribute data in the fully-adjusted model (n=39) than the age 
adjusted model (n=42). Two cases had missing information on socioeconomic classification and 
one for physical activity level.   
In contrast to the protective association observed between fatal stroke risk and total fibre 
intake, an increased risk of fatal stroke was also associated with higher intake of fibre from 
nuts and seeds. It is worth bearing in mind that fibre from nuts and seeds contribute only a 
small fraction to the total intake of fibre. Additionally, unlike the FFQ which gives an 
impression of long-term intake, the diary may not be as good at assessing intake of fibre from 
nuts and seeds as they may be more sporadically consumed than other general foods like 
cereals, fruit and vegetables. This positive association, as with any other negative associations, 
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may be the result of residual confounding or indeed reverse causality, where participants at 
greater risk of stroke, for example with a family history, have consumed higher levels of nuts 
and seeds and also experience higher mortality rates. 
The other positive associations between fatal IHD with higher intake of fibre from legumes or 
vegetables were unexpected but because of the even smaller number of cases in this case 
group (n=22), results may be particularly unreliable.  An additional issue is the far greater 
proportion of case participants with hypertension (33-48% for the various outcomes), 
compared to the sub-cohort participants (19%). Because of the small case numbers available 
here, it was not possible to explore subgroup associations, as in Chapters 5 and 6. It is 
therefore not possible to know whether the inclusion of participants with hypertension is 
attenuating associations in the same manner as was seen in Chapter 5; associations between 
fatal stroke and fibre density became apparent only when hypertensive participants were 
removed. The positive associations here could be the result of reverse causality, where women 
with hypertension are adhering to healthier dietary practices whilst also being at greater risk 
for fatal IHD. 
7.5.2 Findings compared with previous chapters 
In Chapter 5, no associations were observed in the full sample when exploring fatal CVD risk 
and fibre estimated from the FFQs but protective associations were apparent in different 
subgroups. For example in overweight women, fatal stroke risk was reduced with higher intake 
of fibre from total cereals and nuts/seeds but there were no associations in the full sample. 
Conceivably, any protective effect of fibre on CVD development and risk may well be 
moderated by personal history of hypertension or BMI and the inability to explore these 
associations in this chapter is certainly a limitation since associations may not be visible when 
all participants are considered together. 
As few protective associations were observed between coronary events and fibre in the 
previous chapter it is difficult to draw conclusions in light of the one positive association for 
ACS and cereal fibre seen in this chapter. In Chapter 6, lower MI risk was associated with 
higher fibre density and insoluble fibre intake but with too few MI cases available here, again it 
is challenging to draw meaningful conclusions.  
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7.5.3 Results compared to other studies 
Few other cohort studies report fibre intake calculated using methods other than FFQs, in 
relation to risk of CVD. The systematic review and update searches (reported in Chapter 2) 
(Threapleton et al., 2013d, Threapleton et al., 2013e) indentified 4 studies, reported in 6 
publications that used methods other than FFQs to assess diet (Bazzano et al., 2003, Streppel 
et al., 2008, Wallstrom et al., 2012, Ward et al., 2012, Crowe et al., 2012, Chuang et al., 2012). 
Diet was assessed using 24 hour recalls, diet histories or interviews in three of the studies 
(Bazzano et al., 2003, Streppel et al., 2008, Wallstrom et al., 2012), with 7 day weighed food 
diaries and FFQs in the Norfolk branch of the EPIC study (Ward et al., 2012) and by various 
methods in the pan-European EPIC studies (Crowe et al., 2012, Chuang et al., 2012). Of the 
identified studies, the most closely related in terms of population and assessment method was 
the work of Ward and colleagues using data from the Norfolk arm of the EPIC study. The 
authors report protective associations between fibre and CVD risk when using fibre estimated 
from food diaries and not with FFQs. The authors suggest that the additional information 
collected with the diary, in terms of the important contributors to fibre intake such as detail on 
the fibre source and portion size, may explain their differing observations by instrument (Ward 
et al., 2012). 
In both UKWCS data and findings from EPIC Norfolk (Ward et al., 2012) limited associations 
were observed for CHD risk with fibre intake assessed using FFQs. In the EPIC study the 
protective association with fibre assessed from diaries contrasts the null association seen in 
this chapter for total fibre intake. Additionally the null associations with FFQ data in both 
studies contrast findings in Chapter 2 from many other cohorts. The different findings in the 
EPIC study with the two assessment tools and also between the two UK studies and pooled 
results in Chapter 2 is somewhat similar to the contrasting results found in studies of breast 
cancer and fat intake in the past decade. Two studies reported increased breast cancer risk 
with fat intake assessed using food diaries (Bingham et al., 2003, Freedman et al., 2006), 
where previously no associations had been seen with fat calculated from FFQs (Smith-Warner 
et al., 2001). This prompted a large collaborative pooling study to explore risk of breast cancer 
with fat intake, also assessed using food diaries (Key et al., 2011). The pooling study did not 
confirm the findings of previous work and suggested that lower case numbers in the earlier 
studies may be responsible for the different associations.  
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Applying this principle here, the larger case numbers reported in the EPIC Norfolk study for 
diet assessed using food diaries compared to the limited cases available in this chapter, 
suggests the observed protective association in the larger study is more reliable. Additionally, 
given the weight of data contributed by other studies which did assess diet using FFQs and the 
protective association that was seen for CHD risk with each 7g/day higher fibre intake HR 0.90 
(95% CI: 0.87 to 0.94) (reported in Chapter 2), it seems likely that an association exists. The 
generally null association for total fibre intake and CHD risk in the UKWCS may therefore be 
explained by fewer cases or different population characteristics. As noted in earlier chapters, 
participants may be generally healthier than other study populations and may consume 
sufficiently high intakes of fibre, and may experience little additive benefit of greater intakes. 
Dietary data from the UKWCS was incorporated into the pooling project (discussed above) but 
was identified as being most different from the other studies (Key et al., 2011). Differences 
between the studies  were attributed to possible real differences, due to chance or were 
related to the different dietary coding methods employed in this cohort, compared to others 
(Key et al., 2011). These explanations of different results for the UKWCS are valid in this 
context and the contrasting results observed in this chapter, compared to those reported for 
Ward and colleagues (Ward et al., 2012) and in the meta-analyses of studies (reported in 
Chapter 2) (Threapleton et al., 2013d, Threapleton et al., 2013e). Opposing findings may 
therefore be due to real differences between the sample populations, chance, or variation in 
dietary assessment.  
UKWCS participants consume higher levels of fibre than the general population (discussed and 
presented in Chapter 3). Since the FFQ was not so dissimilar to those used in other studies, it 
suggests that the different observations may be due to actual differences in fibre intakes 
rather than the tool used. The beneficial effect of fibre may have greater influence at lower 
fibre intakes and therefore associations may be less apparent in a sample such as the UKWCS, 
where many participants meet current recommended intake levels.  
It is fair to consider that the null associations observed here may, in fact, be true and the 
influence of fibre on CVD risk is negligible. If this is the case, residual confounding of other 
dietary or lifestyle factors may be responsible for apparent associations in other study 
populations where there are relatively fewer well educated or health-conscious individuals. 
However, given the wealth of contrasting observations (Threapleton et al., 2013d, Threapleton 
et al., 2013e), this is unlikely to be the case. 
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7.5.4 Strengths and limitations of the case-cohort approach 
The case-cohort design for failure time analysis was proposed by Prentice as a means of 
efficiently assessing exposure-disease associations in large studies (Prentice, 1986). Because of 
the usually low disease occurrence in large studies, much of the covariate data in the disease 
free subjects is redundant and would be costly and time-consuming to process (Prentice, 
1986). The practical solution is therefore to process data for only a proportion of the disease-
free participants, as is done in nested case-control or case-cohort designs.  
The unique design of the case-cohort approach has key strengths and weaknesses. The fact 
that cases and controls are drawn from the same population, including disease-free 
participants at baseline, is a real strength. This attribute ensures the ‘study base principle’ and 
‘comparable accuracy principle’ are not violated. These principles, outlined by Wacholder and 
colleagues concern the selection bias that may be introduced by selecting control subjects 
from a different population as cases and a form of exposure information bias that may be 
introduced when the assessment of exposures, in cases or controls, differs in accuracy 
(Wacholder et al., 1992a).  
A significant benefit of the case-cohort method is the flexibility that comes from having 
unrestricted or randomly selected controls. This efficiency means that the sub-cohort may be 
shared among different outcome groups as no diagnosis restriction was used to identify the 
control participants (Self and Prentice, 1988, Barlow et al., 1999). The availability of a larger 
number of controls serves to improve the precision of risk estimates (Wacholder et al., 1992c). 
However, this method of control selection can lead to an issue with time comparability 
(Wacholder et al., 1992c) as cases contribute fewer study years than the sub-cohort, who likely 
remain in the study until censor date. This is especially a concern when exposures vary over 
time (Wacholder et al., 1992b). However this issue may not be such a concern for fibre intake 
in the UKWCS since reasonable stability was identified in dietary habits during a validation 
study (discussed in Chapter 5) (Greenwood et al., 2003).  
Barlow and colleagues discuss the relative strengths and weaknesses of applying case-control 
and case-cohort methods within an example dataset (Barlow et al., 1999). They identify that 
the case-cohort method, while having some distinct advantages over case-control designs, is 
used infrequently in practice. The authors cite reasons such as perceived analytic complexity, 
perceived difficulty in variance computation and lack of appropriate software for case-cohort 
231 
 
 
 
methods as possible explanations for the infrequent use but recommend the design to be used 
in situations where flexibility is desired (Barlow et al., 1999).  
In applying this method to assess CVD in the UKWCS, a major advantage has been the ability to 
use the larger set of sub-cohort diary information in analysing each of the different 
cardiovascular outcomes. Aside from the advantages brought with using a larger control 
dataset irrespective of the number of cases, a limitation is the relatively small numbers of case 
participants for some of the outcomes. The small numbers of cases may be responsible for 
greater uncertainty around estimates and therefore lack of clear associations. This makes it 
challenging to determine if associations do exist but are masked by the wider CIs resulting 
from limited case numbers. 
7.5.5 Strengths and limitations of dietary and covariate assessment 
Measurement error related to dietary assessment is a persistent problem when exploring 
relationships between diet and diseases. This error is a real concern and can have large effects 
on risk estimates. For example, the day to day variation in diet could mean that assessing 
intake over just a few days gives greater chance that people are misclassified because the true 
long term intake could be misreported in a short time-frame (Willett, 2013c). This within-
person variation or random fluctuation above and below the true long term intake average 
could substantially distort RRs in epidemiologic associations. In general, the effect would be to 
reduce the strength of associations rather than exaggerate them; findings from a validation 
study of dietary assessment methods, using biomarkers, suggests that measurement error in 
FFQs can severely attenuate risk estimates (Kipnis et al., 2003). In this validation study and 
using protein intake as an example, it was found that a true association of 2 would appear as 
1.1 or lower. This study compared 24 hour recalls with FFQs but given that diaries are 
considered the gold standard in terms of dietary assessment (Willett and Lenart, 2013) this 
problem of measurement error may be substantially lower for findings from food diaries. 
However in general, readers should place less emphasis on precise risk estimates and rather, 
should consider the general direction and relative magnitude of associations.  
In addition to dietary measurement error, error and bias in assessing covariates is also a 
concern. For example, energy expenditure varies greatly between persons and fidgeting may 
contribute to energy expenditure of hundreds of calories per day and conventional assessment 
methods may not pick up this detail (Willett, 2013b). Where errors exist in the measurement 
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of confounders such as energy expenditure, the bias may be in either direction, not just to 
dilute the effect (Kipnis and Freedman, 2008, Freedman et al., 2011).  
With diet diaries, the ability for participants to record diet in such an open-ended method and 
specify or estimate portion sizes is a significant advantage, over other methods like FFQs 
where food items and portion sizes are pre-specified. The strengths and limitations of different 
dietary assessment methods are discussed in depth in the discussion section of Chapter 3.   
Dietary intake in the UKWCS has a wide range and is reflective of the recruitment of many 
health-conscious and vegetarian women. The wide variation allows assessment of potentially 
beneficial nutrients, such as fibre, since there is a greater proportion of the sample meeting 
dietary recommendations, than would be seen in a sample of the general population 
(discussed in Chapter 3). Although the recruitment here offers advantages, findings may be 
generally biased with respect to the general population. It is possible that protective 
associations observed in these women or, conversely, the lack of associations may not apply to 
other groups. For example, most of the influence of fibre on CVD risk may occur at lower 
intake levels and therefore be best displayed in populations where participants consume lower 
levels of fibre. This particular hypothesis may explain why findings here, especially for coronary 
outcomes do not reflect those generally observed in other studies (Threapleton et al., 2013d, 
Threapleton et al., 2013e) (reported in Chapter 2).      
7.6 Summary 
The case-cohort method was applied to assess associations between fibre and CVD risk, with 
fibre estimated using diaries in cases and a random sample of cohort participants. This method 
offers the primary benefit that all sub-cohort data can be used with each different outcome 
type. 
Few associations were seen here and protective associations were observed for risk of ACS and 
higher intake of cereal fibre and for fatal stroke risk and total fibre intake. However, increased 
risks were also observed for fatal IHD and fatal stroke with higher intake of some of the other 
fibre exposures. Low case numbers are a major limitation here and contribute to the greater 
uncertainty around risk estimates. 
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It is possible that due to the many potential types of measurement error with quantifying diet 
and other confounders (discussed in Chapter 3 and above), true associations are attenuated 
and may even appear non-significant where they were weak. 
With the exception of the significant association seen in the largest case group (88 ACS cases) 
with only cereal fibre, findings here do not reflect those seen in another, larger British study 
which used similar dietary assessment methods (Ward et al., 2012) or the combined findings of 
other prospective studies (Threapleton et al., 2013e, Threapleton et al., 2013d) (reported in 
Chapter 2). 
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Chapter 8 Summary and Conclusions 
8.1 What was already known about fibre and CVD risk? 
 Numerous observational studies have suggested that greater fibre intake is associated 
with lower risk of CVD, but many also report no evidence of any associations 
(Threapleton et al., 2013e). 
 Previous literature reviews have been unsystematic, have only explored total dietary 
fibre rather than major food sources of fibre, or have not quantified the dose-response 
association between fibre and risk of CVD (Threapleton et al., 2013e) 
 Meta-analyses of RCTs have identified links between intake of soluble fibre or barley 
and lower circulating lipid levels (Brown et al., 1999, Talati et al., 2009) and between 
greater fibre intake and lower blood pressure (Whelton et al., 2005, Streppel et al., 
2005) (refer to Chapter 1).  
 In the UK, just three previous studies have reported fibre intake and CHD risk (Appleby 
et al., 1999, Todd et al., 1999, Ward et al., 2012) with only one of these reporting on 
types of fibre (Ward et al., 2012). One existing UK study has previously reported fibre 
intake and total CVD risk (Akbaraly et al., 2011). These studies report inconsistent 
associations between CHD or CVD risk and fibre. 
8.2 What this work has added 
 The comprehensive systematic review and meta-analysis for CHD and CVD outcomes 
suggests that greater intake of total dietary fibre; insoluble type fibre; and fibre from 
cereal, fruit, or vegetable sources are associated with a lower risk of cardiovascular 
disease and coronary heart disease in healthy populations (Threapleton et al., 2013e). 
 The systematic review and meta-analysis for stroke outcomes indicates that greater 
intake of total fibre is associated with lower stroke risk in healthy populations. Soluble 
fibre was not associated with lower stroke risk but only three studies were available to 
contribute data on this (Threapleton et al., 2013d). 
 A limited study base and therefore gap in current knowledge about the association 
between total fibre and ischaemic or haemorrhagic stroke or key types of fibre and 
stroke risk has been identified.     
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 Work in Chapter 4 indicates that many important CVD events are not identified 
through one or two case sources and as many resources as are available should be 
recruited in order to fully ascertain case numbers in similar UK studies. 
 Results from the UKWCS relating fibre intake and CHD or CVD risk add to the currently 
limited data on this topic in the UK. 
 The results presented on fibre intake and stroke risk are the first of this type to be 
reported in a UK population. 
 Examining fibre intake and CVD risk using two dietary assessment methods has only 
been reported by one other study (Ward et al., 2012). These results for the UKWCS 
therefore add to the limited existing evidence.  
8.3 Thesis result summary 
The analyses presented in this thesis have used data from the UKWCS and have combined 
previously assessed dietary information with CVD event records, for the first time in this 
cohort. 
The objectives stated in Chapter 1 have been met and the association of dietary fibre intake in 
relation to CVD risk has been thoroughly examined using data from the UKWCS: 
1) A systematic literature review was conducted to identify literature from observational 
studies reporting dietary fibre intake and risk of CHD, stroke and CVD (Chapter 2). 
o This work, which combines data from over 24 studies published over two decades, 
identified that each 7g/day greater total dietary fibre intake was associated with 
lower risk for CHD HR 0.90 (95% CI: 0.87to 0.94), stroke HR 0.93 (95% CI: 0.88 to 
0.98) and also for total CVD HR 0.91 (95% CI: 0.88 to 0.94).  
2) Characteristics of high and low fibre consumers, as estimated using FFQs and four day 
food diaries are presented in Chapter 3. 
3) Section 251 approval and ethical approval was obtained specifically to permit linkage 
of CVD event data with the existing data held for the UKWCS (described in Chapter 4). 
The event records received from HES and MINAP were processed in order to reflect 
comparable timeframes, locations and outcomes and the quality, or completeness, of 
the CVD event data was explored using a capture-recapture approach and log-linear 
modelling. 
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o The work presented in Chapter 4 indicates the completeness of CVD event data for 
assessing acute events but other researchers have shown that primary care data 
may also be an important source of case information. 
4) Associations between fatal CVD risk and fibre intake estimated using FFQs are assessed 
using survival analysis and presented in Chapter 5.  
o In total, 258 fatal CVD cases were reported since baseline and only cereal fibre 
intake was associated with significantly lower risk (at the 1% level) for fatal stroke 
in models including overweight and obese women. Subgroup analyses indicated 
greater fibre density is associated with lower risk of fatal stroke in women who 
were free of angina and hypertension at baseline. 
5) The work in Chapter 5 is extended in Chapter 6 and incorporates non-fatal event data 
obtained from HES and MINAP. Dietary fibre intake, as assessed using FFQs, is 
explored in relation to risk of total CVD (fatal plus non-fatal events), non-fatal CVD and 
subtypes of CHD (MI, ACS, chronic events) and stroke (haemorrhage, ischaemia or 
unclassified stroke events). 
o A total of 821 CHD and 388 stroke fatal and non-fatal cases were reported for 
cohort participants. Total dietary fibre and insoluble fibre were associated with 
lower MI risk in the full sample of women. Lower total and non-fatal CVD risk was 
observed with many of the fibre exposures in women without history of 
hypertension. Protective associations were also seen with fibre intakes from 
different sources and stroke events, particularly ischaemic-type stroke. 
6) Finally, detailed dietary information collected from four-day food diaries was 
processed for CVD cases and a random selection of non-case diaries. Risk of fatal 
stroke, fatal CHD and fatal CVD in addition to total MI and total ACS was explored 
using fibre assessed from these food diaries by applying a case-cohort approach and 
findings are presented in Chapter 7. 
o A total of 88 ACS cases and 67 fatal CVD cases, occurring after the follow-up 
dietary assessment, had completed and returned food diaries. Greater cereal fibre 
intake was associated with lower risk for ACS and greater intake of total fibre was 
also associated with lower fatal stroke risk. However, some positive associations 
were observed with some of the exposures for fatal IHD and fatal stroke risk, 
where case numbers were especially small. 
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8.4 Summary discussion 
Drawing together the available evidence, fibre intake appears to be associated with CVD risk 
but the associations tended to stronger with stroke and total CVD rather than coronary 
outcomes alone. Also, cereal type fibre stood out among the different sources as being more 
consistently associated with lower CVD event risk in this cohort.  The differential associations 
between fibre intake and the three main CVD outcomes supports the notion mentioned in 
Chapter 1 that the pathology of these conditions may differ and fibre may exert different 
influences on disease development processes. 
As mentioned in the discussion sections of Chapters 5, 6 and 7 there are many explanations for 
the inverse associations observed between risk and fibre intake. The plausible mechanisms for 
the action of fibre (discussed in Chapter 1) may act to influence vascular health over the life 
course and ultimately lower risk. Alternatively, fibre intake may be a surrogate marker for 
other healthy lifestyle or dietary practices that were not measured or accounted for in models. 
For example, there are other beneficial components of cereal grain foods which may confer 
protection or it may be the combination of these compounds which serve to reduce risk of 
CVD (Slavin, 2004) (Section 5.5.1). In addition to the other beneficial components of cereals, 
the clearer associations with this source of fibre may reflect lower measurement error in 
assessing cereals, as compared with fruit and vegetables (discussed in section 5.5.1 and 6.5.1). 
Other explanations for the associations include that dietary fibre is a marker of available 
carbohydrate within foods and this has been associated with insulin and lipid profiles in clinical 
studies (Liu et al., 2000). Lower glycaemic load diets are also associated with improved levels 
of C-reactive protein, a risk factor for heart disease, and for CHD risk (Liu et al., 2000, Liu et al., 
2002b). 
Cereal fibre stood out as being more consistently associated with lower CVD risk compared to 
fruit or vegetables sources of fibre (Chapter 6). This observation is supported by findings from 
the Nurses' Health Study (discussed in Chapter 2), which were particularly similar to the 
UKWCS, with lower stroke risk associated with greater cereal fibre intake but not fruit or 
vegetable fibre (Oh et al., 2005). When breakfast cereal fibre was considered in the UKWCS, 
some of the same significant associations were observed as for cereal fibre for ischemic stroke 
risk (Table 6.10). Similarly, risk estimates and 95% CIs for both cereal fibre and breakfast cereal 
fibre were alike and were not associated with reduced risk of total CHD, non-fatal CHD or CHD 
sub-types (Tables 6.8, 6.9 and 6.12). In other analyses for total stroke, non-fatal stroke and 
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ischaemic plus unspecified stroke, the risk estimates for breakfast cereal-derived fibre were 
weaker than for total cereal fibre, with CIs that spanned the line of no effect despite risk 
estimates being in the same direction. For example with total stroke, the risk per 3g/day cereal 
fibre was 0.92 (95% CI 0.85 to 1.00) and per 1g/day greater intake of fibre from breakfast 
cereals 0.96 (95% CI 0.90 to 1.02) (Table 6.8). The few weaker associations may be indicative of 
the protective effects of different types of fibre, in that breakfast cereals generally contain 
added bran, which is principally insoluble in type. The composition of fibre types in many 
processed breakfast cereals, which contain greater insoluble fibre, may be less beneficial than 
whole cereal intake. However, these weaker associations with breakfast cereal fibre in some 
stroke analyses may reflect the greater measurement error that comes from assessing smaller 
nutrient intakes. In addition, as noted in Chapter 6, both soluble and insoluble fibres were 
associated with lower stroke risk (Table 6.8).  
Given the current limitations in assessing self-reported diet in nutritional epidemiology studies 
it is rare when we can regard findings from single studies as definitive and associations are 
considered persuasive when data from many studies, including varied populations is combined 
(Kipnis and Freedman, 2008). The work in this thesis has allowed important examination of 
different sources and types of fibre and the associated risk with sub-types of CVD events in this 
sample of women. However, the combined study risk estimates reported in Chapter 2 may be 
more reliable when considering total fibre intake and CVD risk across a wide range of 
populations. The lack of many statistically significant associations seen for total fibre intake 
and CHD risk in the UKWCS may be explained by fewer cases or differences in study 
populations. Participants in this study may be generally healthier and consume sufficiently high 
intakes of fibre, and may experience lower additive benefit of greater intakes. Furthermore, 
the majority of studies included in Chapter 2 meta-analyses included men and it could be this 
principle difference that explains the somewhat weaker associations for some CHD outcomes 
in the UKWCS. However, when participant gender was explored through meta-regression of 
the separate study results, similar observations were seen for CHD outcomes for male and 
female study results (Table 2.4). Similarly for stroke outcomes, the estimated association with 
fibre intake was similar between the studies including men only and the one study including 
women only (Table 2.4). 
Although many of the estimates observed for various exposures in this cohort were not 
statistically significant, they were all in the same direction as previous studies, and the 
confidence intervals often included the pooled estimates from the meta-analyses reported in 
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Chapter 2 (Threapleton et al., 2013e). So, in the context of the other work, results from the 
UKWCS are not entirely inconsistent. Furthermore, when study results for the UKWCS were 
included in the updated meta-analysis, the overall estimates and confidence intervals changed 
little from those reported in Chapter 2 (Threapleton et al., 2013e). 
The several potential explanations for null or weaker observations in this study by comparison 
to other study populations identified during the systematic review are discussed in Section 
6.5.1. Issues include insufficient dietary variation, insufficient accuracy to measure dietary 
differences, low case numbers, assessment not encompassing the true latent period of disease 
or an opposing variable in this study population that may create negative confounding (Willett, 
2013d, Willett and Lenart, 2013). Imprecision in event reporting (discussed in Chapter 4) may 
also contribute towards apparent null associations in this study by comparison to others. The 
quality of MINAP data is well established (Herrett et al., 2010) but the lack of clinical case 
confirmation of events recorded in HES may contribute to error in case classification.  
The quality of outcome reporting and type of event recorded by each data source is an 
important factor to consider. Mortality outcomes were examined in Chapter 5, separately from 
non-fatal or total incident events in Chapters 6 and 7. Whilst both approaches attempt to 
measure the burden of CVD, I have presented them separately for several reasons. Firstly, 
other cohort studies identified through the systematic review had reported different 
associations between fibre intake and risk for fatal or total CVD events and the findings were 
not consistent between studies (Bazzano et al., 2003, Pietinen et al., 1996). Secondly, analyses 
using HES and MINAP data (Chapter 6 and 7) had been restricted to English participants and a 
greater number of fatal events could therefore be examined by looking separately at mortality 
data. Additionally, the mortality event data represent a more complete outcome for this 
cohort in that the data span from baseline, whereas HES are available from 1998 and MINAP 
from 2003. As discussed in Chapter 4, the quality of mortality event reporting has been 
consistent for many years while the other datasets have been improving over recent years and 
examining mortality events separately allows different features of event reporting to be 
considered.  
Understanding the quality of event data is a foundation for interpreting results and there are 
many potential reasons why CHD and stroke cases for cohort participants may be unidentified 
or not captured using the mortality, HES and MINAP datasets obtained. Only the mortality 
events span to study baseline so any non-fatal events would be unidentified during the early 
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phase of study follow-up. Also, any events in participants living in England at baseline who 
have moved to Scotland or overseas would not be identified. Recent work from other studies 
comparing dataset completeness indicates many CHD events are recorded in primary care data 
but not in hospital records (Herrett et al., 2013). Many less serious CHD events for cohort 
participants are likely to exist in these primary care records and these cases have not been 
identified during this study.  
The potential for missing cases has been explored through the work in Chapter 4, the cross-
comparisons using log-linear analysis provided estimates of the missing number of cases and 
capture quality for each dataset. The work was limited in that the different datasets had not 
captured the same type of case events and so the estimates of potential missing cases are 
inflated. For example, one dataset identifies only fatal cases. The model assumes that all of the 
non-fatal cases identified by the other sources are missed by this source, so over-estimating 
the estimate of total missing cases. However, excluding this source could lead to an under-
estimate of the number missing, because some cases are only identified through death 
certificates, and missed by the other sources. Additionally, having case data contributed by 
three sources allowed for list dependency to be modelled, which is not possible with just two 
sources of case information, and list dependency is an important consideration in capture-
recapture work (discussed in detail in Chapter 4). 
8.5 Strengths and limitations 
The challenges faced in epidemiology, to accurately assess exposure to various factors is 
possibly greatest in nutritional epidemiology where diet is a daily ‘exposure’, may be so varied 
and reporting or recording of diet may be influenced by so many factors. Assessing diet using 
multiple methods makes best use of imprecise and biased estimates and contributes better to 
our understanding of the relationship between diet and disease. Addressing the question of 
how fibre intake may influence CVD risk using two dietary assessment methods is therefore a 
key strength in this work. 
As noted in a recent editorial, in order to gain better understanding of what mechanisms and 
which components of fibre might underlie protective associations, studies should investigate 
specific fibres and food sources (Landberg, 2012). This is a key strength of the work 
undertaken here, with a view to identifying the most beneficial sources of fibre. Additionally, 
the use of a validated FFQ in such a large sample of women is a real strength. Utilising CVD 
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event data from different sources has also made best use of available case information, given 
the lack of a standard clinical register for CVD events in the UK. This approach has allowed a 
greater number of cases to be identified, thus allowing exploration of CVD sub-types in view of 
potentially different pathology. Given the inconsistency in international definitions of fibre and 
the potential challenges in comparing findings from studies which have used different 
methods (discussed in Chapter 1 and below),  an additional strength of analyses presented 
here is that risk has been presented in relation to fibre estimated both as NSP and AOAC.  
Strengths and limitations of the systematic review and meta-analyses are discussed in depth in 
earlier sections (2.6.3, 2.6.4). A key limitation in the work reported in Chapter 2, meta-analyses 
using observational study data, concerns the correction of confounding. It is challenging to 
judge whether confounding has been adequately dealt with in each individual study although 
the majority of studies had included adjustment for the most relevant confounders, which 
were explored in turn through meta-regression (Table 2.4). Hypothesised causal links between 
fibre and CVD risk cannot be proven using observational studies but owing to the likely long 
pathogenesis of CVD, it is unlikely that trials of adequate duration and adherence would be 
feasible (Threapleton et al., 2013e). If the individual participant data for all the included 
cohorts were available, then this would provide a better means of deriving a pooled estimate. 
Firstly, because additional confounding could be adjusted for, if they had been collected by the 
cohort, and secondly because there could be consistency in how confounding was addressed 
thus reducing potential heterogeneity. The most suitable approach for answering this question 
appears to be via observational data such as that presented in this thesis in conjunction with 
clearly defined RCTs that examine specific types of fibre in relation with known risk factors for 
CHD and stroke. 
An important limitation with this work is that the applicability of findings to other UK 
populations is unknown. However, it seems evident that greater fibre intake is associated with 
lower risk, especially with stroke and this information is relevant to other British women. Many 
study populations are limited in terms of dietary variation in intakes and results therefore 
depend more on accurate assessment of dietary exposures (Kipnis and Freedman, 2008). The 
unique strength of the UKWCS sample recruitment was the large proportion of vegetarian 
participants and thus a sample with a good range in terms of fibre intake. As noted in Chapter 
3 discussion, the cohort participants on average consume a greater level of fibre than the 
general UK population. It is this characteristic that adds to limited evidence from cohorts based 
in the UK and lends itself to exploring healthy diets, while still having large numbers of 
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participants that have diets and fibre intakes similar to the national average. The unique 
characteristics of the cohort such as high proportion of vegetarians and high mean fibre 
intakes, while lending strength to examining a range of fibre intakes with CVD risk, also make 
this study distinct from others reported in Chapter 2. As noted in the discussion of Chapter 7 
this population heterogeneity may somewhat explain weaker risk estimates observed for the 
UKWCS although most risk estimates here do lie on the protective side and CIs encompass a 
wide range of realistic risk reductions for this cohort.  
To account for the oversampling of vegetarian participants, inverse probability weighting was 
used in models to address potential lack of generalisability of results. This method gives less 
weight to data from vegetarian participants while still benefitting from the full range of data 
provided by this large sub-sample. So, whilst the UKWCS is strengthened by including a large 
proportion of participants with high fibre intakes, estimates are still comparable to other 
population cohorts. In addition, the sensitivity analyses undertaken when this weighting factor 
was removed from the models indicated that it had relatively little impact on relative risk 
estimates, as noted in methods sections of Chapters 5 and 6. 
8.6 Recommendations 
8.6.1 In the cohort  
Further work could focus on exploring food groups rather than specific nutrients in terms of 
CVD risk. Examining total cereal, fruit or vegetable intake might throw light on potential 
mechanisms and indicate whether any associations with these foods relate to the fibre 
content, other micronutrients or other associated behaviour. 
As family history is a strong risk factor for CVD, this could be explored in those with and 
without family history of the disease to indicate whether fibre intake has a differential 
association on risk. 
Participants were excluded from analyses where death or any CVD event was recorded within 
1 year of dietary assessment to account for the influence of CVD and associated ill health that 
may have influenced dietary intake and thus bias associations through reverse causality. Whilst 
valuable cases may be missed from analyses, it is quite possible that many of these would have 
been latent, pre-existing cases, whose inclusion could lead to substantial bias in estimates. In 
addition, after other exclusions were applied to the sample, 59 participants were excluded 
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because of death or CVD event within 1 year of baseline assessment. Of the 1,193 total CVD 
cases, just 31 were removed in this process.  Given the long pathogenesis of CVD discussed in 
Chapter 1, sensitivity analysis could be conducted to exclude CVD cases occurring within 
several years of baseline assessment, rather than one year. This longer exclusion time would 
account for any latent disease which may have influenced dietary choices during the 
assessment period.  
Cardiovascular events examined in this work were principally ischaemic, with smaller 
proportions of the total cases classified as cardiac arrest or haemorrhagic stroke (Tables 4.4 
and 4.5). Other CVD types could also be examined to explore whether the associations, or lack 
of associations in some comparisons, extend to other forms of CVD such as hypertensive CVD 
(see Figure 1.1). Additionally, the approach could be taken to examine all CVD by using all 
ICD10 codes in group ‘I’, such as was done in the recent EPIC study (Chuang et al., 2012).  
It may also be beneficial to further explore stroke risk by accessing hospital records to 
determine if the type of stroke had been recorded. Identifying whether the unclassified strokes 
were ischaemic or haemorrhagic in nature may clarify why associations were seen in the 
unclassified strokes and if they are, as suspected, mainly ischaemic. 
8.6.2 Other studies 
As seen in Chapter 2, there are many existing studies that have assessed the association 
between total fibre intake and CVD, with fewer focusing on sources of fibre and CVD subtypes. 
The majority of these are conducted in the US and Europe with some work been done in 
Australia and Japan. Data from other population groups would therefore be a welcome 
addition to this body of work.  
The question of whether total dietary fibre intake is associated with CVD risk seems largely 
resolved (Chapter 2) with greater intake being associated with lower risk in a dose-response 
fashion. As already noted, it is not possible to definitively distinguish whether these 
associations result from fibre per se or other associated nutrients or dietary and lifestyle 
habits. However, as discussed in Chapter 1, different types of fibre are demonstrated to have 
different physiological effects but fewer studies have examined this issue. Exploring sources of 
fibre in future studies, particularly for stroke outcomes, where this has been examined less, 
may elucidate the specific mechanisms by which fibre affects long-term vascular health. A 
further issue surrounds the inconsistency in definition and measurement of the fibre content 
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of foods, which this serves to limit the emphasis of fibre in labelling schemes (Buttriss and 
Stokes, 2008). International consensus is needed on fibre definitions and the categorisation of 
the various components of fibre and this especially important within research so findings may 
be comparable. 
A recent systematic review identified a risk reduction for CVD of around 20% for high fibre 
consumers and separately for high whole-grain consumers, compared to the lowest consumers 
of each (Ye et al., 2012). Given that fibre and whole-grain consumption are likely to correlate 
highly, it remains a challenge to identify whether fibre intake is a surrogate marker for whole-
grain intake and the potential beneficial compounds within grains or whether it is the fibre 
component of whole-grains which confers the protective associations seen with greater intake. 
Well conducted clinical trials may be useful to illuminate the many potential mechanisms 
through which both whole-grains and fibre from different foods may act. 
Results from clinical trials, mentioned in Chapter 1 give the overall impression that the 
multiple risk factors for CVD may be influenced by fibre intake and it is the cross-linking 
between all these risk factors that makes pinpointing one key mechanism of action 
challenging. For example, one challenge with dietary intervention studies to explore potential 
mechanisms of action is that body weight is often not maintained and since this is related to 
other risk factors such as hypertension, dyslipidaemia, poor glucose control and inflammation 
it is not possible to distinguish the mechanism of action. Intervention studies should therefore 
address issues such as the interrelated nature of risk factors by attempting to maintain body 
weight changes equitably between intervention groups. 
Measurement error is a major threat in nutritional epidemiology, a problem compounded by 
the fact that it is impossible to know whether the misclassification is random or differential 
and thus whether the precision or the validity of the study is affected (Michels, 2001). This 
issue is therefore crucial to address and with the advent of electronically collected data, error, 
cost and participant burden will reduce and this technology should be widely taken up 
(Baranowski, 2013). As noted in Chapter 3, it is well recognised that FFQs tend to universally 
inflate intake values as was seen for both fibre and energy intakes in the UKWCS. This 
imprecision means FFQs are not be ideal for assessing individual diet-disease risk associations 
be but FFQs are practical when ranking individuals and exploring trends in associations across 
specific populations (Cade et al., 2004b).   
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The unique feature of having such a large proportion of non meat-eaters in the UKWCS is ideal 
for exploring, in an observational setting, newly identified potential mechanisms behind CVD 
risk identified through metabolomic, animal and human studies. Recent work proposes CVD 
risk is linked to L-carnitine consumption, principally from red meat in the diet. The hypothesis 
set out by Koeth and colleagues suggests that gut microbiota are responsible for the digestion 
of L-carnitine that ultimately produces trimethylamine-N-oxide, a proatherogenic compound 
(Koeth et al., 2013). The weaker associations observed for the UKWCS compared to others in 
Chapter 2 could suggest a differential effect or interaction between the detrimental effects of 
L-carnitine digestion by the gut microflora of meat-eaters and the potential protective effects 
that high fibre intake may elicit on the proliferation of beneficial gut flora.  
With this hypothesis in mind, that meat-eaters would experience greater beneficial effects of 
fibre through mitigating L-carnitine damage, key analyses from Chapter 6 were repeated 
separately for meat-eaters and vegetarians (Section 6.4.3-Subgroups). Whilst there was a 
suggestion that the association between NSP intake and stroke was slightly more protective in 
meat-eaters than in vegetarians, potentially supporting this hypothesis, there was no evidence 
to support this when formally tested by including an interaction in the model. The test 
indicated that the subgroup differences could easily be just due to chance. Neither was there 
any evidence to support this hypothesis for CHD, and with no reason to suggest that CHD and 
stroke would be influenced differently, these findings collectively do not support the 
hypothesis that meat-eaters have differential risk or that this is because of the presence of L-
carnitine metabolites generated through their diet (Koeth et al., 2013). However, findings are 
inevitably inconclusive because subgroup numbers were small (e.g. 77 stroke cases in the 
vegetarian sub-group) and therefore power for the tests of interaction was low. Further 
observational study work to explore CVD risk by vegetarian status would therefore be useful to 
explore this novel hypothesis. 
8.6.3 Public health messages 
The various components or types of fibre are thought to have distinct effects and in order to 
maximise the health benefits from fibre in the diet it is thought important to come from a 
range of sources (Lunn and Buttriss, 2007). Having said that, cereal sources of fibre seem 
particularly beneficial for lowering risk and are widely consumed in the UK so 
recommendations based on cereal fibre intake may be well accepted.  
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Because of the different methods used to estimate dietary fibre content of foods, 
recommendations differ between countries (discussed in Chapter 1). The findings here indicate 
that increasing fibre intake in especially low consumers may have the most benefit as fewer 
associations were observed in this cohort compared to other studies. Messages should 
continue to promote higher fibre intake in the population but an issue may surround the fact 
that NSP is used for the recommendation, whilst back-of-pack values in the UK present AOAC 
values, potentially leading consumers to overestimate their fibre intake.  In the very least, high 
intakes of fibre are unlikely to produce substantial deleterious effects and any potential 
negative effects of high fibre intake are much outweighed by the potential beneficial effects on 
risk for ill health (Lunn and Buttriss, 2007). Additionally, eating fibre-rich whole foods have the 
added benefit of being rich sources of micronutrients and other beneficial compounds and 
many are lower in energy (Slavin, 2003).  
Messages to increase fibre intake have been in place for some time but fibre intake in the UK is 
well below the recommendation (18g/day) (COMA, 1991) and has only marginally increased 
over the past decade. Using data from adults in the NDNS, in 2000/1 women (19-64 years) 
were consuming 12.6 (SD 5.4) g/day (7.7 g/1000kcal/day) and in 2008/9 the mean intake was 
12.8 (SD 4.5) g/day (7.8 g/1000kcal/day). Reported daily intakes in men were higher than the 
women but in terms of relative consumption, fibre density of the diet was lower. In 2000/1 
men (19-64 years) were consuming 15.5 (SD 6.6) g/day (6.7 g/1000kcal/day) and in 2008/9 the 
mean intake was 14.9 (SD 5.6) g/day (6.8 g/1000kcal/day) (NDNS, 2011). 
A key strategy for increasing intake must therefore address some of the important barriers.  A 
recent qualitative study explored perceived barriers to whole-grain intake in the UK and found 
that the most prominent barriers were negative perception of sensory qualities, lack of 
knowledge about what whole-grains are, where to locate them and how to incorporate them 
into meals. Higher whole-grain consumers identified similar factors as facilitators for their 
consumption and preferred the taste, had good level of knowledge about whole-grains and 
good understanding of the health benefits (McMackin et al., 2013). Further education, 
specifically for low fibre consumers, of the health benefits, types and preparation methods of 
whole-grains could be very useful to increase intake of this rich source of fibre. 
Lecturing individuals has little effect on behaviour change but bigger gains can potentially 
come from structural policy and legislative changes at regional, national and international 
levels (Capewell et al., 2008). The last decade has seen significant efforts by the food industry 
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to assist in consumer choice of whole-grains and increase the availability of whole-grain foods 
(McMackin et al., 2013). Components of foods that resist digestion may be one way to 
increase fibre intake ‘by stealth’ since the key barrier to whole-grain uptake is negative 
perception of sensory qualities (Buttriss and Stokes, 2008) and as noted in Chapter 1, resistant 
starch is fermented in the colon in the same way as soluble and some insoluble fibres and thus 
confers protective benefit. Using resistant starch in foods does not typically change the taste 
or texture of foods and these may therefore be accepted by consumers (Buttriss and Stokes, 
2008). Manufacturers could also modify preparations for existing products by adding bran and 
this may be more acceptable for consumers as is less disruptive than whole dietary changes 
and also adds little by way of energy intake (Nicklas et al., 2011).  
Fibre content of foods must be clearly displayed on pack labels if we hope or expect the 
general population to have an interest in or some knowledge of their own consumption. In 
1999 the Food Standards Agency issued food back-of-pack labelling guidelines and it was 
recommended that fibre intake should be listed on the nutritional composition of foods, 
although this was only on a voluntary basis. The recommendation was initially to include NSP 
but in 2000, this was amended to AOAC fibre, in an effort to harmonise labels across Europe 
(FSA, 1999). Current recommendations still include listing the fibre composition of foods only 
on a voluntary basis (DEFRA, 2012). Since it is likely that most consumers are unaware of more 
recent research linking the properties of resistant carbohydrates to health benefits, a targeted 
education campaign with unambiguous public health messages is long overdue (Buttriss and 
Stokes, 2008). 
8.7 Conclusions 
 Total dietary fibre intake, in addition to insoluble fibre and from cereals and 
vegetables, are inversely associated with CHD, stroke and CVD risk when examining 
findings from many developed countries. 
 Few studies report different stroke types in association with total fibre or fibre from 
key food sources. 
 In a sample of health-conscious, middle-aged, English women, higher fibre intakes 
were associated with lower stroke risk and this association was particularly apparent 
with ischaemic stroke and with cereal fibre intake. 
 Fewer associations were apparent between fibre intake and CHD risk, as compared to 
stroke and this finding, which is different to meta-analyses although in the same 
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direction, may be attributed to the relatively high fibre intake in the UKWCS by 
comparison to other studies and the general UK population.  
 In women without hypertension greater fibre intake was associated with lower overall 
CVD risk indicating potential protective actions of fibre for those without existing risk 
factors for CVD. 
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Appendices 
Appendix I: Medline search strategy 
1. exp cohort studies/ 
2. case control study/ 
3. cohort$.tw. 
4. epidemiologic methods/ 
5. or/1-4 
6. (animals not (humans and animals)).sh. 
7. 5 not 6 
8. oligosaccharide$.tw. 
9. (resistant adj3 starch).tw. 
10. cellulose/ 
11. lignin/ 
12. methylcellulose/ 
13. carboxymethylcellulose/ 
14. inulin/ 
15. alginates/ 
16. exp oligosaccharides/ 
17. mannans/ 
18. pectins/ 
19. plant gums/ 
20. gum arabic/ 
21. tragacanth/ 
22. karaya gum/ 
23. dietary fibre/ 
24. fibre$.tw. 
25. fibre$.tw. 
26. "guar gum".tw. 
27. psyllium/ 
28. psyllium$.tw. 
29. "beta glucan$".tw. 
30. beta-glucans/ 
31. or/8-30 
32. exp cardiovascular diseases/ 
33. stroke.ab,ti. 
34. "acute coronary syndrome".tw. 
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35. stemi.tw. 
36. nstemi.tw. 
37. (transient isch$emic adj3 (accident or incident)).tw. 
38. exp coronary diseases/ 
39. exp heart diseases/ 
40. exp heart diseases/ 
41. (CHD or CVD).tw. 
42. (myocardial adj3 infarction).tw. 
43. exp myocardial infarction/ 
44. exp myocardial ischemia/ 
45. or/32-44 
46. 7 and 31 and 45 
47. limit 46 to english language 
48. limit 47 to yr="2009 -current" 
49. limit 48 to (addresses or bibliography or biography or case reports of clinical conference or comment 
or congresses or consensus development conference or dictionary or directory or editorial or interview 
or letter) 
50. 48 not 49 
51. limit 50 to (cats or cattle or chick embryo or dogs or goats or guinea pigs or hamsters or horses or 
mice or rabbits or rats or sheep or swine) 
52. 50 not 51 
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Appendix II: Structured guidelines for article screening 
 
Article Relevancy Criteria 
 
MARK AS: ‘article not relevant’ / Reject if you can determine:  
 Study published before 1990 
 Study is not published in English 
 Participants outside age range 5-70 years 
 Study includes animals only 
 The reference is not an original research article (e.g. news, letter, review) 
 The study is not a cohort or an RCT (e.g. case study, cross-sectional study) 
 The study does not relate to Carbohydrate intake at all (e.g. Meat, Soy etc) 
 All participants have a health condition, are pregnant or have an eating disorder (e.g. 
Polycystic Ovary Syndrome/Cancer Patients/ Type1Diabetes/ Type2Diaberes/ 
Hypertension/ CVD/ Angina etc) 
 The study does not relate carbohydrate intake to a clinical outcome 
 The study relates to exercise and dietary components cannot be separated from the 
exercise.   
 The study is clearly not relevant to our scope (e.g. cancer treatment studies or surgical 
operations) 
 It does not cover satiety outcomes and intervention duration is 1 day or less 
 
MARK AS: ‘population not relevant’ / Reject if you can determine: 
 Participants are Oriental, African or Asian 
 Participants are exclusively a native subgroup in an otherwise included country (e.g. 
native sub-groups in USA, Australia, New Zealand etc) 
 
MARK AS: ‘potentially relevant’ / Allow if you cannot reject on the above criteria: 
 Anything which appears to be relevant or where insufficient information is available to 
make a decision that it is ‘article not relevant’ or ‘population not relevant’  
 Studies which appear to be relevant even if the duration is too short to be formally 
included at a later stage. 
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Appendix III: Structured flow chart for article inclusion 
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Appendix IV: Individual study results for studies included in Chapter 2 systematic literature review and meta-
analyses 
Table IV.i: Results from cohort studies identified in the systematic review: Total dietary fibre and CVD, CHD and stroke events  
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
*(Akbaraly et 
al., 2011) 
Whitehall II 
141/7319 17.7y 
Total fibre intake 
(Englyst) 
Total CVD [fatal] 
 
Per decile of fibre 
intake based on 
recommendation of 
24g/day  
$ 0.87 (0.71, 1.05) 
 
0.15 
Sex, age, ethnicity, occupation, 
marital status, smoking, energy 
intake, physical activity, BMI, 
prevalent CVD, diabetes, 
hypertension, dyslipidaemia, 
metabolic syndrome, inflammatory 
markers 
(Appleby et al., 
1999) Oxford 
Vegetarian 
Study 
(525) 
/11140 
13.3 y 
Dietary Fibre 
(Englyst) 
Ischaemic heart 
disease   [fatal] 
  Q3 vs Q1 2.25 (0.92, 5.53)  
 
NS Age, SES/class, sex, smoking        
(Ascherio et al., 
1998)  
 HPFS 
(328) 
/51529 
8 y 
Dietary Fibre 
(AOAC) 
Total stroke [fatal + 
non-fatal]  
(28.9) vs (12.4) g/d ‡ 0.70 (0.48, 1.0) 
  
 0.028 
Age, alcohol, BMI, energy intake,  
smoking    hypercholesterolaemia, 
hypertension, occupation, parental 
MI, physical activity,  
 
(Bazzano et al., 
2003)  
NHANES I 
(1198) 
/14407 
19 y (4) 
Dietary Fibre 
(Assessment by 
Englyst and 
Southgate) 
Total CVD [fatal] 
 
10 g/ 1735 kcal/d 0.96 (0.9, 1.03) 0.29  
Age, alcohol, BMI, total cholesterol 
intake, smoking, education, 
ethnicity, diabetes, physical 
activity, saturated fatty acid intake, 
sex, systolic blood pressure    
(3762) 
 
Total CVD [fatal + 
non-fatal]   
$ 0.93 (0.89, 0.97) <0.001  
(668) 
 
Fibre Density CHD events [fatal]   
 
0.91 (0.83, 1.0) 0.06 
 
(1843) 
  
CHD events  [fatal + 
non-fatal] 
  
 
# 0.92 (0.86, 0.98) 0.01   
(233) 
  
Total stroke [fatal] 
  
1.02 (0.85, 1.24) 0.8 
 
(928) 
  
Total stroke [fatal + 
non-fatal]   
‡ 0.94 (0.87, 
1.02)  
0.12 
 
*(Buyken et al., 
2010) Blue 
(109)/1490 13y Dietary fibre (AOAC) Total CVD[fatal] Women 36.2 vs 19.7 g/d $ 0.88 (0.53, 1.46) 0.67 
 
Age, energy intake, glyacemic index 
residuals, alcohol, smoking, 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
Mountains Eye 
Study 
diabetes 
(151)/1245 
   
Men 36.4 vs 18.4 g/d $ 0.84 (0.53, 1.34) 0.55 
 
Age, energy, glycaemic index 
residuals, total fat, underweight, 
smoking, use of corticosteroids 
*(Chuang et al., 
2012) EPIC-
Heart 
2489/ 
322153 
12.7y 
Dietary fibre 
assessed as AOAC in 
most countries and 
values were then 
calibrated across 
Europe 
Total circulatory 
disease [Fatal] 
Women 
Per 10g/d 
$ 0.88 (0.81, 0.97)  <0.001 
Stratified by recruitment age, sex 
and centre. Adjusted for education, 
smoking, alcohol, BMI, physical 
activity, total energy intake 
2115/ 
130564 
Men $ 0.90 (0.84, 0.97)  0.032 
*(Crowe et al., 
2012) 
EPIC-Heart 
2381/3063
31 
11.5y 
Dietary fibre 
assessed as AOAC in 
most countries and 
values were then 
calibrated across 
Europe 
IHD mortality 
 
Per 10g/d # 0.85 (0.73, 0.99)  0.031 
Age, alcohol, BMI, physical activity, 
marital status, education, 
employment, hypertension, 
hyperlipidaemia, angina pectoris, 
diabetes, PUFA:SFA, energy intake 
1596 
  
Men 
 
0.89 (0.76, 1.05)  0.156 
785 
  
Women 
 
0.74 (0.57, 0.95)  0.017 
909 
  
Age<60 at 
recruitment  
0.81 (0.67, 0.97)  0.022 
1472 
  
Age >=60 at 
recruitment  
0.89 (0.75, 1.05)  0.177 
747 
  
Never smoker 
 
0.80 (0.63, 1.01)  0.055 
834 
  
Former smoker 
 
0.89 (0.72, 1.09)  0.254 
156 
  
Current smoker 
<10/d  
0.84 (0.51, 1.37)  0.475 
272 
  
Current smoker 
10-19/d  
0.85 (0.61, 1.20)  0.362 
372 
  
Current smoker 
>=20/d  
0.86 (0.65, 1.15)  0.320 
*(Eshak et al., 
2010) Japanese 
Collaborative 
cohort study 
(1063)/ 
110792 
13.4y 
Dietary fibre (similar 
to AOAC values) 
Total CVD[fatal] Men >12.6 vs. <7.8 g/d $ 0.83 (0.63, 1.09) 
 
0.054 
Age, BMI, hypertension, diabetes, 
alcohol, smoking, education, 
exercise, walking, stress, sleep, fish, 
saturated fatty acid intake, n3 fatty 
acid, sodium intake, folate, vitamin 
Energy intake 
(1017) 
  
Total CVD[fatal] Women >12.7 vs. <8.5 g/d $ 0.82 (0.57, 0.97) 
 
0.044 
(231) 
  
CHD[fatal] Men >12.6 vs. <7.8 g/d # 0.81 (0.61, 1.09) 
 
0.022  
(191) 
  
CHD[fatal] Women >12.7 vs. <8.5 g/d # 0.80 (0.57, 0.97) 
 
0.014 
(499) 
  
Stroke[fatal] Men >12.6 vs. <7.8 g/d ‡1.09 (0.75, 1.58)  0.555 
(484) 
  
Stroke[fatal] Women >12.7 vs. <8.5 g/d ‡1.05 (0.73, 1.51)  0.775 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
(333) 
  
Other CVD[fatal] Men >12.6 vs. <7.8 g/d 0.78 (0.54, 1.13) 
 
0.313 
(342) 
  
Other CVD[fatal] Women >12.7 vs. <8.5 g/d 1.06 (0.74, 1.51) 
 
0.212 
*(Kokubo et al., 
2011)  
Japan public 
health centre-
based cohort 
1984 
/40046 
10.4 
Energy-adjusted 
intake of total fibre 
(similar to AOAC) 
Total CVD [fatal + 
non-fatal] 
Men 19.9 vs. 6.0 g/d $ 0.94 (0.74, 1.20)  0.649 
Age, sex, smoking, alcohol, BMI, 
history of diabetes, medication for 
hypertension or hyper-
cholesterolaemia, exercise, fruit, 
vegetables, fish, sodium, 
isoflavone, energy, public health 
centre 
1253 
/46341   
Women 
 
$ 0.65 (0.48, 0.87)  0.002 
1499 
/40046   All stroke [fatal + 
non-fatal] 
Men 
 ‡1.00 (0.76, 1.32)  0.976 
1054 
/46341   
Women 
 ‡0.64 (0.46, 0.88)  0.005 
910 /40046 
  
Cerebral infarction 
[fatal + non-fatal] 
Men 
 
0.94 (0.66, 1.34)  0.540 
518 /46341 
  
Women 
 
0.73 (0.55, 0.97)  0.029 
456 /40046 
  
Intracerebral 
haemorrhage [fatal 
+ non-fatal] 
Men 
 
1.08 (0.66, 1.78)  0.588 
310 /46341 
  
Women 
 
0.53 (0.28, 0.97)  0.100 
133 /40046 
  
Subarachnoid 
haemorrhage [fatal 
+ non-fatal] 
Men 
 
1.02 (0.45, 2.54)  0.672 
226 /46341 
  
Women 
 
0.72 (0.37, 1.43)  0.419 
485 /40046 
  
CHD [fatal + non-
fatal] 
Men 
 
# 0.76 (0.47, 1.25)  0.327 
199 /46341 
  
Women 
 
# 0.68 (0.32, 1.42)  0.149 
712 
/unknown  
Total fibre intake 
(similar to AOAC) 
Total CVD [fatal + 
non-fatal] 
Male non-
smokers 
Q5 vs. Q1 0.59 (0.38, 0.90)  0.045 
Age, sex, smoking, alcohol, BMI, 
history of diabetes or hypertension, 
medication for hyper-
cholesterolaemia, exercise, fruit, 
vegetables, fish, sodium, 
isoflavone, energy, public health 
centre 
1424 
/unknown   
Male smokers 
 
1.05 (0.79, 1.40)  0.862 
1152 
/unknown   
Female non-
smokers  
0.61 (0.45, 0.83)  0.001 
218 
/unknown   
Female smokers 
 
0.58 (0.24, 1.39)  0.158 
(Larsson et al., 
2009)  ATBC 
Study 
(196) 
/29133 
13.6y 
Dietary Fibre 
(Englyst) 
Stroke, 
haemorrhage 
Subarachnoid  [fatal 
+ non-fatal] 
 
(35.8) vs (16.1) g/d ‡0.86 (0.47, 1.59)    0.49 
Age, alcohol, BMI, total cholesterol 
intake, diastolic and systolic blood 
pressure, energy intake, folate, 
HDL-C, CHD, diabetes, physical 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
(383) 
/29133   
Stroke, 
haemorrhage 
Intracerebral  [fatal 
+ non-fatal] 
  
‡0.97 (0.61, 1.54)    0.63 
activity, magnesium Intake, 
smoking, group allocation 
(2702) 
/29133   
Stroke, ischaemic  
[fatal + non-fatal]   
‡1.01 (0.85, 1.19)    0.83 
(Liu et al., 
2002a)   
The Women's 
Health Study 
  
(570) 
/39876 
6 y 
Dietary Fibre 
(AOAC) 
Total CVD  [fatal + 
non-fatal] 
   
26.3 vs. 12.5 g/d $ 0.79 (0.58, 1.09) 
 
0.17 
Age, alcohol, BMI, energy intake, 
familial MI, fat intake, folate, 
diabetes,  Hypercholesterol-aemia, 
hypertension, physical activity  
protein intake, smoking, group 
allocation, supplements, 
postmenopausal HRT 
(177) 
/39876 
6 y 
Dietary Fibre 
(AOAC) 
MI  [fatal + non-
fatal]  
  
  (26.3) vs (12.5) g/d # 0.68 (0.39, 1.22)  
 
0.13 
(Mozaffarian et 
al., 2003)  
Cardiovascular 
Health Study 
(811) /5201 8.6 y 
Dietary Fibre 
(AOAC) 
CHD events  [fatal + 
non-fatal] 
  Q5 vs Q1  g/d # 0.84 (0.66, 1.07)  
 
0.23 
Age, alcohol, cereal fibre, 
education, fibre from fruit, fibre 
from vegetables, diabetes, physical 
activity, sex, smoking  
(Oh et al., 
2005)  Nurses’ 
Health Study 
(1020) 
/121700 
18 y 
Dietary Fibre 
(AOAC) 
Total stroke [fatal + 
non-fatal]  
(21) vs (10) g/d ‡0.83 (0.66, 1.04)  0.07 
Age, alcohol, aspirin, BMI, 
carbohydrate intake, energy intake, 
familial: diabetes, 
hypertriglyceride-aemia, 
hypertension or MI, menopausal 
status, physical activity, smoking, 
vitamin intake, postmenopausal 
HRT 
(279)  
  
Stroke, 
haemorrhagic    
[fatal + non-fatal]   
0.84 (0.54, 1.3)   0.34 
(515)  
  
Stroke, ischaemic 
[fatal + non-fatal]   
0.78 (0.56, 1.09)   0.09 
*(Park et al., 
2011) 
NIH-AARP Diet 
and Health 
Study 
5248 
/388122 
9y 
Dietary Fibre 
(AOAC) 
Total CVD [fatal] Male 10 g/d $ 0.88 (0.86, 0.91) 
 
<0.001 
Age, race, education, marital 
status, health status, BMI, physical 
activity, smoking, alcohol, red 
meat, fruit, vegetables, total energy 
2417 
/388122    
Female 10 g/d $ 0.76 (0.69, 0.84) 
 
<0.001 
1134 
/388122    
Male never 
smokers 
Q5 vs. Q1 0.95 (0.74, 1.21) 
 
0.81 
729 
/388122    
Female never 
smokers 
Q5 vs. Q1 0.69 (0.50, 0.95) 
 
0.02 
(Pietinen et al., 
1996)   
ATBC Study 
(1399) 
/29133 
6.1 y 
Dietary Fibre 
(Englyst) 
Fatal CHD, MI 
 
(34.8) vs (16.1) g/d # 0.87 (0.73, 1.04)  0.8 
Age, alcohol, beta-carotene, BMI, 
diastolic and systolic blood 
pressure, education, saturated fatty 
acid, energy intake, physical 
(635)  
  
CHD events   [fatal]   
 
 0.73 (0.56, 0.95)  
 
0.004 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
activity, smoking, group allocation, 
vitamin C and E  
(Rimm et al., 
1996)  HPFS 
(232) 
/51529 
6 y 
Dietary Fibre 
(AOAC) 
CHD events  [fatal]   (28.9) vs (12.4) g/d # 0.45 (0.28, 0.72)  
 
<0.001 
Age, alcohol, BMI, saturated fatty 
acid intake, familial MI, smoking, 
vitamin E,  hypercholesterolaemia, 
occupation, physical activity, 
hypertension  
(734)  
  
MI [fatal + non-
fatal] 
  
 
0.59 (0.46, 0.76)  
 
<0.001 
(511) 
  
MI [non-fatal]   
 
# 0.65 (0.49, 0.88)   0.02 
(Streppel et al., 
2008)  Zutphen 
Elderly Study 
(348) / 
1373 
40 y (0.2) 
Dietary Fibre 
(Energy adjusted, 
recent intake) 
CHD events  [fatal]   10 g/d # 0.83 (0.70, 0.98) 
 
 Fatty acid intake (Trans, cis-PUFA 
and saturated), BMI, smoking, 
energy intake, fish, prescribed diet, 
SES/Class, alcohol 
  
Dietary Fibre (Intake 
during middle age. 
Energy adjusted, 
long term intake) 
CHD events  [fatal]   10 g/d 0.87 (0.71, 1.07) 
 
 
(Todd et al., 
1999)  Scottish 
Heart Health 
Study 
(296) 
/11629 
9 y (0.1) Fibre density 
(Inclusive of NSP 
resistant starch and 
lignin) 
CHD events  [fatal + 
non-fatal] 
Men Q4 vs Q1  0.64 (0.45, 0.9)  
 
 
Age, alcohol, BMI, total cholesterol 
intake, energy intake, fibrinogen, 
HDL-C, diabetes, personality score, 
physical activity, smoking, systolic 
blood pressure, blood triglycerides 
(97)  
 
  Women Q4 vs Q1  0.56 (0.29, 1.08)  
 
  
*(Wallstrom et 
al., 2012)  
Malmo Diet 
and Cancer 
Cohort 
(1,077)/ 
8038 
13.2y 
Fibre density (non-
starch 
polysaccharide) 
Fatal and non-fatal 
ischaemic coronary 
and cerebrovascular 
events 
Men 
11.4 vs. 5.8 
g/1000kcal 
$ 0.85 (0.70, 1.04) 
 
0.30 Age, diet assessment method 
version, energy intake, season, 
BMI, Smoking, education, alcohol, 
SBP, antihypertensive medication, 
antihyperlipidaemic medication, 
leasure physical activity, quintiles 
of energy-adjusted dietary fibre 
[Note adjustment for fibre was 
listed in the publication although 
actual adjustment for this is 
unlikely in models dealing with 
dietary fibre intake] 
(687)/ 
12,535 
13.6y 
 
Women 
12.9 vs. 6.5 
g/1000kcal 
$ 0.76 (0.59, 0.97) 
 
0.022 
(680)/ 8038 13.2y 
 
MI and death from 
ischaemic heart 
disease 
Men 
11.4 vs. 5.8 
g/1000kcal 
# 0.97 (0.75, 1.25) 
 
0.85 
(330)/ 
12,402 
13.6y 
 
Women 
12.9 vs. 6.5 
g/1000kcal 
# 0.78 (0.55, 1.11) 
 
0.067 
(397)/ 
8,038 
13.2y 
 
Ischaemic stroke 
Men  
11.4 vs. 5.8 
g/1000kcal ‡0.69 (0.49, 0.96) 
 
0.050 
(346)/ 
12,402 
13.6y 
 
Women 
12.9 vs. 6.5 
g/1000kcal ‡0.73 (0.52, 1.04) 
 
0.18 
*(Ward et al., 
2012)  
EPIC-Norfolk 
(1294) / 
4347 
11y Dietary fibre g/d 
(Englyst) assessed 
with FFQ 
Fatal and non-fatal 
CHD 
Men 
Risk per 6g/d 
increase 
0.98 (0.89, 1.08) 
 
0.68 
Age, BMI, physical activity, 
smoking, family history of MI, class, 
diabetes, antihypertensive 
medication use, lipid-lowering 
(712) / 
2728  
Women 
 
0.90 (0.80, 1.01) 
 
0.072 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
Detail 
Exposure Contrast 
and units 
RR (CI) / Mean 
exposure (SD) 
p p trend Adjustments 
(1294) / 
4347  
Dietary fibre g/d 
(Englyst) assessed 
with food diary 
Men 
 
0.86 (0.79, 0.95) 
 
0.001 
medication use, aspirin use, energy 
from total fat, energy from non-fat, 
alcohol, saturated fat intake, serum 
cholesterol 
(712) / 
2728  
Women 
 
0.86 (0.74, 0.99) 
 
0.036 
(Wolk et al., 
1999)  Nurses’ 
Health Study 
(429) 
/121700 
10 y (20) 
Dietary Fibre (Long-
term intake over 6 
years.  (AOAC)) 
Non-fatal MI     22.9 vs 11.5 g/d 0.57 (0.42, 0.77)  
 
 <0.001 
Age, alcohol, aspirin, BMI, 
carbohydrate intake, saturated 
fatty acid intake, energy intake, 
hypertension, menopausal status, 
parental MI, period of exposure, 
physical activity, smoking, 
postmenopausal HRT, vitamin 
intake 
(162)  
 
CHD events  [fatal]   
 
0.41 (0.23, 0.7)   0.002 
(591)  
 
Non-fatal MI, fatal 
CHD 
  
 
# 0.77 (0.57, 1.04)  
 
0.07 
*Identified during update search; # Result was used in total fibre and CHD meta-analysis; ‡ Result was used in total fibre and stroke meta-analysis; $ Result was used in total fibre and CVD meta-analysis  
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Table IV.ii: Results from cohort studies identified in the systematic review: Soluble and insoluble fibre and CVD, CHD and stroke events  
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup Contrast (mean) RR (CI) p p trend Adjustments 
(Bazzano et 
al., 2003)   
NHANES I 
(1198) 
/14407 
19 y (4) 
Soluble fibre Density 
((Multiple 
assessment 
methods) of 
assessment, 
including Englyst and 
Southgate) 
Total CVD  [fatal]  5g/1735 kcal 0.98 (0.93, 1.04)  0.48   
Age, alcohol, BMI, total cholesterol 
intake, smoking, education, ethnicity, 
diabetes, physical activity, saturated 
fat intake, sex, systolic blood 
pressure   
(3762) 
 
Total CVD  [fatal + non-
fatal] 
 
 
0.94 (0.9, 0.99) 0.01   
(928) 
 
Total stroke  [fatal]  
 
1.03 (0.83, 1.28) 0.78 
 
(928) 
 
Total stroke  [fatal + non-
fatal] 
 
 
‡0.95 (0.88, 1.03) 0.18 
 
(668) 
 
CHD events  [fatal]  
 
0.91 (0.83, 0.99) 0.03 
 
(1843) 
 
CHD events    [fatal + non-
fatal] 
 
 
#0.92 (0.87, 0.97)  0.004 
 
*(Eshak et al., 
2010) 
Japanese 
Collaborative 
cohort study 
(1063)/ 
110792 
13.4y 
Insoluble fibre 
(similar to AOAC) 
Total CVD [fatal] Men >9.2 vs. <5.9 g/d 0.82 (0.65, 0.98) 0.042 
 
Age, BMI, hypertension, diabetes, 
alcohol, smoking, education, 
exercise, walking, stress, sleep, fish, 
saturated fatty acid intake, n3 fatty 
acid, sodium, folate, vitamin E 
(1017) 
  
Women >9.1 vs. <6.2 g/d 0.69 (0.53, 0.91) 0.017 
 (231) 
 
CHD [fatal] Men >9.2 vs. <5.9 g/d #0.48 (0.27, 0.84) <0.001 
 (191) 
  
Women >9.1 vs. <6.2 g/d #0.49 (0.27, 0.86) 0.004 
 (499) 
 
Stroke [fatal] Men >9.2 vs. <5.9 g/d 0.96 (0.64, 1.45) 0.715 
 (484) 
  
Women >9.1 vs. <6.2 g/d 0.90 (0.63, 1.28) 0.128 
 (333) 
 
Other CVD [fatal] Men >9.2 vs. <5.9 g/d 1.15 (0.78, 1.62) 0.798 
 (342) 
  
Women >9.1 vs. <6.2 g/d 0.83 (0.51, 1.33) 0.698 
 (1063) 
 
Soluble fibre (similar 
to AOAC) 
Total CVD [fatal] Men >2.3 vs. <1.3 g/d 0.81 (0.63, 1.04) 0.042 
 (1017) 
  
Women >2.4 vs. <1.5 g/d 0.83 (0.53, 1.02) 0.043 
 (231) 
 
CHD [fatal] Men >2.3 vs. <1.3 g/d #0.71 (0.41, 0.97) 0.043 
 (191) 
  
Women >2.4 vs. <1.5 g/d #0.72 (0.43, 0.99) 0.035 
 
(499) 
 
Stroke [fatal] Men >2.3 vs. <1.3 g/d ‡0.90 (0.61, 1.31) 0.790 
 
(484) 
  
Women >2.4 vs. <1.5 g/d ‡1.02 (0.73, 1.42) 0.643 
 
(333) 
 
Other CVD [fatal] Men >2.3 vs. <1.3 g/d 1.08 (0.75, 1.64) 0.573 
 
(342) 
 
 
 
Women >2.4 vs. <1.5 g/d 0.96 (0.61, 1.50) 0.613 
 
*(Kokubo et 
al., 2011) 
 
Japan public 
1253 
/46341 
10.4 
Soluble fibre (similar 
to AOAC) 
Total CVD [fatal + non-
fatal] 
Women 
Q5 vs. Q1 0.74 (0.56, 0.97) 
 
0.012 Age, sex, smoking, alcohol, BMI, 
history of diabetes, medication for 
hypertension or hyper-
cholesterolaemia, exercise, fruit, 
1054 
  
All stroke [fatal + non-
fatal] 
 
 
0.78 (0.58, 1.06) 
 
0.031 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup Contrast (mean) RR (CI) p p trend Adjustments 
health centre-
based cohort 
518 
  
Cerebral infarction [fatal 
+ non-fatal] 
 
 
0.73 (0.47, 1.14) 
 
0.051 
vegetables, fish, sodium, isoflavone, 
energy, public health centre 
310 
  
Intracerebral 
haemorrhage [fatal + 
non-fatal] 
 
 
0.71 (0.40, 1.26) 
 
0.183 
199 
  
CHD [fatal + non-fatal]  
 
0.60 (0.29, 1.21) 
 
0.252 
1253 
 
Insoluble fibre 
(similar to AOAC) 
Total CVD [fatal + non-
fatal] 
 
 
0.64 (0.47, 0.85) 
 
<0.001 
1054 
  
All stroke [fatal + non-
fatal] 
 
 
0.62 (0.45, 0.85) 
 
0.001 
518 
  
Cerebral infarction [fatal 
+ non-fatal] 
 
 
0.62 (0.40, 0.98) 
 
0.006 
310 
  
Intracerebral 
haemorrhage [fatal + 
non-fatal] 
  
 
0.55 (0.30, 1.00) 
 
0.070 
199 
  
CHD [fatal + non-fatal]  
 
0.78 (0.48, 1.27) 
 
0.396 
(Larsson et 
al., 2009)  
ATBC Study 
 
 
 
 
 
(196) 
/29133 
13.6 years 
Soluble fibre 
(Englyst)  
Stroke, haemorrhage, 
Subarachnoid  [fatal + 
non-fatal] 
 (7.7) vs (3.8) g/d ‡0.95 (0.51, 1.79)  
 
0.86 
Age, alcohol, BMI, total cholesterol 
intake, diastolic blood pressure, 
energy intake, folate, HDL-C, CHD, 
diabetes, physical activity, 
magnesium intake, smoking, group 
allocation, systolic blood pressure 
(383)  
 
 Stroke, haemorrhage-
Intracerebral  [fatal + 
non-fatal] 
 
 
‡0.99 (0.62, 1.59)  
 
0.6 
(2700)  
 
 Stroke, ischaemic  [fatal + 
non-fatal]  
 ‡0.86 (0.73, 1.02)  
 
0.17 
(196)  
 
Insoluble fibre 
(Englyst)  
Stroke, haemorrhage, 
Subarachnoid  [fatal + 
non-fatal] 
 
(28.3) vs (12.2) g/d 
0.89 (0.49, 1.64)  
 
0.58 
(383)  
  
Stroke, haemorrhage, 
Intracerebral  [fatal + 
non-fatal] 
 
 
0.88 (0.56, 1.39)  
 
0.43 
(2702)  
  
Stroke, ischaemic  [fatal + 
non-fatal]  
 1.03 (0.87, 1.21)  
 
0.61 
(Liu et al., 
2002a)   
The Women's 
Health Study 
(570) 
/39876 
6 y Soluble fibre  (AOAC)  
Total CVD [fatal + non-
fatal] 
 (8.6) vs (3.7) g/d 0.90 (0.68, 1.21)    0.5  
Age, alcohol, BMI, energy intake, 
familial MI, fat intake, folate, 
diabetes,  hypercholesterolaemia, 
hypertension, physical activity, 
(570)  
 
Insoluble fibre  
(AOAC)  
Total CVD   [fatal + non-
fatal] 
 (21.8) vs (9.5) g/d 0.78 (0.57, 1.06)  
 
0.09  
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup Contrast (mean) RR (CI) p p trend Adjustments 
 
 
 
(177)  
 
Soluble fibre  MI [fatal + non-fatal]  (8.6) vs (3.7) g/d #0.83 (0.47, 1.48)    0.4 
protein, smoking, group allocation, 
supplements, postmenopausal HRT 
  
Insoluble fibre MI  [fatal + non-fatal]  (21.8) vs (9.5) g/d #0.74 (0.42, 1.3)    0.12 
(Pietinen et 
al., 1996)   
ATBC Study 
(1399) 
/29133 
6.1 y 
Insoluble fibre (based 
on Englyst)  
Fatal CHD & non fatal MI  
(27.7) vs (12.2) g/d 0.87 (0.73, 1.04)  
 
0.13 
Age, alcohol, beta-carotene, BMI, 
systolic and diastolic blood pressure, 
education, saturated fatty acid, 
energy intake, physical activity, 
smoking, group allocation, vitamin C 
and E   
(1399)  
 
Insoluble non 
cellulosic 
polysaccharides 
(based on Englyst)  
Fatal CHD & non fatal MI 
 
(15.9) vs (6.8) g/d 0.86 (0.72, 1.03)  
 
0.13 
(635)  
 
Insoluble fibre (based 
on Englyst)  
CHD events  [fatal] 
  
(27.7) vs (12.2) g/d #0.75 (0.58, 0.98)    0.01 
(635) 
 
Soluble fibre (based 
on Englyst)  
CHD events  [fatal] 
 
(7.4) vs (3.7) g/d #0.68 (0.5, 0.92)  
 
 0.003 
(1399)  
 
Soluble fibre (based 
on Englyst)  
Fatal CHD & non fatal MI 
 
 
0.83 (0.68, 1.01)  
 
0.05 
(Rimm et al., 
1996) HPFS 
(740) 51529 
6 y 
(6%loss) 
Soluble fibre 
(Englyst) 
MI + fatal coronary 
disease 
 
10g/d #1.07 (0.57, 2.02)  
  
Saturated fat, vitamin E, age, BMI, 
physical activity, smoking, alcohol, 
hypertension, high cholesterol, 
familial MI, profession, insoluble 
fibre 
  
Insoluble fibre 
(Englyst) 
 
 
 
 
 
#0.75 (0.59, 0.94) 
  
Saturated fat, vitamin E, age, BMI, 
physical activity, smoking, alcohol, 
hypertension, high cholesterol, 
familial MI, profession, soluble fibre 
*Identified during update search; # Result was used in the soluble or insoluble fibre and CHD meta-analysis; ‡ Result was used in the soluble fibre and stroke meta-analysis 
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Table IV.iii: Results from cohort studies identified in the systematic review: Fibre from cereal foods and CVD, CHD and stroke events 
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure Outcome/ Assessment Details 
Sub-group 
Detail 
Contrast (mean) 
RR (CI)/ Mean 
Exposure (SD) 
p trend Adjustments 
*(Baer et al., 
2011) Nurses’ 
Health Study 
(1026)/ 
50112 
18y 
Cereal fibre (energy 
adjusted) (AOAC) 
Total CVD [fatal] 
 
Continuous risk 
estimate per 4g/d 
0.82 (0.69, 0.97) 
 
Competing risks model including: 
Age, BMI, weight change, height, 
smoking, physical activity, alcohol, 
nuts, PUFA, glycaemic load, dietary 
cholesterol, systolic blood pressure, 
medication, diabetes, parental MI, 
time since menopause 
*(Bernstein et al., 
2011) 
Nurses’ Health 
Study 
(2500)/ 
72266 
22y 
Cereal fibre, cumulative 
average intake (AOAC) 
Total CHD [fatal plus non-
fatal]  
Per 5g/d #0.77 (0.69, 0.85) <0.0001 
Stratified on age, assessment period. 
Adjusted for saturated fat, 
monounsaturated fat, 
polyunsaturated fat, GI score, folate, 
protein, energy intake, alcohol trans-
unsaturated fatty acids, BMI, 
smoking, menopausal status, 
parental eearly MI, multivitamin use, 
vitamin E supplement, weekly aspirin 
use, physical activity.  
*(Buyken et al., 
2010) Blue 
Mountains Eye 
Study 
(109)/ 
1490 
13y 
Cereal fibre (breakfast 
cereals, bread, pasta 
and rice) (AOAC) 
Total CVD [fatal] Women 10.9 vs 2.9 g/d 0.87 (0.55, 1.38) 0.54 
Age, energy, GI residuals, alcohol, 
smoking, diabetes 
(151)/ 
1245   
Men 11.5 vs 3.0 g/d 1.04 (0.67, 1.61) 0.89 
Age, energy, GI residuals, total fat, 
underweight, smoking, use of 
corticosteroids 
*(Crowe et al., 
2012)  
EPIC-Heart 
2381/ 
306331 
11.5y 
Cereal fibre assessed as 
AOAC in most countries 
and values were then 
calibrated across 
Europe 
IHD mortality 
 
Per 5g/d #0.91 (0.82, 1.01) 0.084 
Age, alcohol, BMI, physical activity, 
marital status, education, 
employment, hypertension, 
hyperlipidaemia, angina pectoris, 
diabetes, PUFA:SFA, energy intake, 
fibre from fruit, vegetables and other 
sources 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure Outcome/ Assessment Details 
Sub-group 
Detail 
Contrast (mean) 
RR (CI)/ Mean 
Exposure (SD) 
p trend Adjustments 
*(Eshak et al., 
2010) Japanese 
Collaborative 
cohort study 
(231)/ 
110792 
13.4y 
Cereal fibre (similar to 
AOAC) 
CHD [fatal] Men >2.1 vs. <1.4 g/d #0.89 (0.65, 1.01) 0.060 
Age, BMI, hypertension, diabetes, 
alcohol, smoking, education, 
exercise, walking, stress, sleep, 
saturated fatty acid, n3 fatty acid, 
sodium, folate, vitamin E, vegetable 
fibre, fruit fibre 
(191) 
   
Women >1.7 vs. <1.1 g/d #0.76 (0.59, 0.97) 0.044 
(Kaushik et al., 
2009)  Blue 
Mountains Eye 
Study 
(Cases 
not 
reported) 
/3654 
13 y 
Cereal fibre (Energy 
adjusted) 
CHD events [fatal]   (3) vs (11) g/d 0.94 (0.73, 1.22)  0.65 
Age, BMI, diastolic blood pressure, 
education ,MI, stroke, diabetes, self-
rated health status, sex, smoking, 
systolic blood pressure, hypertension 
medication    
(95) 
/3654 
 
 
Total stroke [fatal] 
 
(3) vs (11) g/d 2.13 (1.19, 3.8) 0.02 
(Larsson et al., 
2009)  ATBC Study 
(196) 
/29133 
13.6 years 
Cereal fibre (Englyst) 
Stroke, haemorrhage 
Subarachnoid  [fatal + non-
fatal]  
(27.5) vs (8.9) g/d 0.86 (0.5, 1.46)  0.6 
Age, alcohol, BMI, total cholesterol 
intake, diastolic and systolic blood 
pressure, energy intake, folate, HDL-
C, CHD, diabetes, physical activity, 
magnesium Intake, smoking, group 
allocation 
(383)  
 
 
Stroke, 
haemorrhageIntracerebral 
[fatal + non-fatal]   
0.94 (0.63, 1.42)  0.71 
(2702)  
 
 
Stroke, ischaemic [fatal + non-
fatal]   
1.06 (0.91, 1.23)  0.25 
(Liu et al., 2002a)  
The Women's 
Health Study 
(177) 
/39876 
6 y Cereal fibre (AOAC) MI  [fatal + non-fatal]   (6.5) vs (3) g/d #0.91 (0.56, 1.47)  0.74 
Age, alcohol, BMI, energy intake, 
familial MI, fat intake, folate, 
diabetes,  hypercholesterolaemia, 
hypertension, physical activity, 
protein intake, smoking, group 
allocation, supplements, 
postmenopausal HRT 
(570)  
  
Total CVD [fatal + non-fatal]  
 
(6.5) vs (3) g/d 1.11 (0.84, 1.46)  0.38 
(Mozaffarian et 
al., 2003)  
Cardiovascular 
Health Study 
(811) 
/5201 
8.6 y Cereal fibre (AOAC) CHD events [fatal + non-fatal]   >6.3 vs <1.7 g/d #0.79 (0.62, 0.99)  0.02 
Age, alcohol, education, fibre from 
fruit, fibre from Vegetables, diabetes, 
physical activity, sex, smoking 
(204)  
  
  Age 65-69y 
80th vs 20th 
Centile 
0.82 (0.67, 1.01) 
 
(255)  
  
  Age 70-74y 
80th vs 20th 
Centile 
0.89 (0.75, 1.06) 
 
(352)  
  
  Age >75y 
80th vs 20th 
Centile 
0.87 (0.73, 1.04) 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure Outcome/ Assessment Details 
Sub-group 
Detail 
Contrast (mean) 
RR (CI)/ Mean 
Exposure (SD) 
p trend Adjustments 
(434)  
  
  Women 
80th vs 20th 
Centile 
0.89 (0.74, 1.06) 
 
(377)  
  
  Men 
80th vs 20th 
Centile 
0.83 (0.68, 1.02) 
 
(575) 
  
  No T2DM 
80th vs 20th 
Centile 
0.85 (0.73, 1.0) 
 
(Oh et al., 2005)  
Nurses’ Health 
Study 
(1020) 
/121700 
18y 
Cereal fibre (AOAC) Total stroke [fatal + non-fatal] 
 
(5.7) vs (1.4) g/d 0.66 (0.52, 0.83) 0.001 
Age, alcohol, aspirin, BMI, 
carbohydrate intake, energy intake, 
familial: diabetes, 
hypertriglycerideaemia, 
hypertension, MI, menopausal 
status, physical activity, smoking, 
postmenopausal HRT, vitamin intake 
(279)   
 
Stroke, haemorrhagic [fatal + 
non-fatal]     
0.51 (0.33, 0.78)  0.01 
(515)  
 
 
Stroke, ischaemic   [fatal + 
non-fatal]   
0.8 (0.57, 1.12)  0.23 
*(Park et al., 2011) 
NIH-AARP Diet 
and Health Study 
5248 
/388122 
9y 
Fibre from grains 
(AOAC) 
Total CVD [fatal] Male Q5 vs. Q1 0.77 (0.71, 0.85) <0.05 Age, race, education, marital status, 
health status, BMI, physical activity, 
smoking, alcohol, red meat, fruit, 
vegetables, total energy 
2417 
/388122    
Female Q5 vs. Q1 0.72 (0.63, 0.82) <0.05 
(Pietinen et al., 
1996)  ATBC Study 
(635) 
/29133 
6.1 y Cereal fibre (Englyst) CHD events [fatal]   (26.3) vs (8.8) g/d #0.74 (0.57, 0.96)  0.01 
Age, alcohol, beta-carotene, BMI, 
diastolic and systolic blood pressure, 
education, saturated fatty acid 
intake, energy intake, physical 
activity, smoking, group allocation, 
vitamin C and E   
(1399)  
  
Fatal CHD, non-fatal MI  
 
(26.3) vs (8.8) g/d  0.91 (0.77, 1.09)  0.18    
(Rimm et al., 
1996)  HPFS 
(740) 
/51529 
6 y Cereal fibre (AOAC) MI  [fatal + non-fatal]   
Continuous risk 
estimate 10g/d 
#0.71 (0.55, 0.91) 
 
Age, alcohol, BMI, saturated fatty 
acid intake, familial MI,  hyper-
cholesterolaemia, occupation, 
physical activity, hypertension,  
smoking, vitamin E   
(Streppel et al., 
2008)  Zutphen 
Elderly Study 
(348) 
/1373 
40 y (0.2) 
Cereal fibre (Energy 
adjusted, fibre 
contained within bread 
and other cereal 
products - recent 
intake) 
CHD events [fatal]   
Continuous risk 
estimate 10 g/d 
#0.84 (0.64, 1.1) 
 
Trans fatty acid intake, alcohol, BMI, 
smoking, Cis-PUFA, energy intake, 
fish, prescribed diet, saturated fatty 
acid, SES/class 
  
Cereal fibre (Intake in CHD events [fatal]   Continuous risk 0.86 (0.64, 1.15) 
 
283 
 
 
 
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow Up 
(% loss) 
Exposure Outcome/ Assessment Details 
Sub-group 
Detail 
Contrast (mean) 
RR (CI)/ Mean 
Exposure (SD) 
p trend Adjustments 
middle age) estimate 10 g/d 
*(Ward et al., 
2012) 
EPIC-Norfolk 
(1294) / 
4347 
11y 
Cereal fibre (Englyst) 
assessed with 7-day 
food diaries 
Fatal and non + fatal CHD 
events 
Men 
Risk per 2g/day 
increase 
0.97 (0.93, 1.01) 0.092 
Age, BMI, physical activity, smoking, 
family history of MI, class, diabetes, 
antihypertensive medication, lipid-
lowering medication, aspirin use, 
total fat energy, energy from non-fat, 
saturated fat intake, alcohol, plasma 
ascorbic acid 
(712)/ 
2728  
Women 
 
0.97 (0.90, 1.04) 0.37 
(Wolk et al., 1999)  
Nurses’ Health 
Study 
(591) 
/121700 
10 y (20) 
Cereal fibre (Long-term 
intake over 6 years.  
AOAC) 
Non-fatal MI, fatal CHD    
Continuous risk 
estimate 5 g/d 
0.63 (0.49, 0.81)  <0.001 
Age, alcohol, aspirin, beta-carotene, 
BMI, carbohydrate intake, saturated 
fatty acid intake, energy intake, 
folate, hypertension, magnesium 
intake, menopausal status, parental 
MI, period of exposure, physical 
activity, smoking, post-menopausal 
HRT, vitamin B6 and C 
(289)  
   
Age <60 
 
0.63 (0.44, 0.90) 0.01 
(302)  
   
Age >60 
 
0.76 (0.57, 0.99) 0.05 
(319)  
   
Never or former 
smoker  
0.59 (0.43, 0.79) <0.001 
(272)  
   
Smokers 
 
0.87 (0.63, 1.2) 0.39 
(249)  
   
BMI <25 
 
0.58 (0.4, 0.82) 0.003 
(278)  
   
BMI >25 
 
0.85 (0.62, 1.17) 0.31 
(177) 
   
Lowest tertile of 
SFA  
0.62 (0.44, 0.88) 0.007 
(194)  
   
Middle tertile of 
SFA  
0.79 (0.54, 1.15) 0.21 
(220)  
   
Highest tertile of 
SFA  
0.68 (0.43, 1.07)  0.1 
(189)  
   
Lowest tertile of 
TFA  
0.69 (0.49, 0.97)  0.03 
(211)  
   
Middle tertile of 
TFA  
0.77 (0.53, 1.12)  0.18 
(191)  
   
Highest tertile of 
TFA  
0.57 (0.35, 0.92)  0.02 
*Identified during update search; # Result was used in the cereal fibre and CHD meta-analysis
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Table IV.iv: Results from cohort studies identified in the systematic review: Fruit fibre and CVD, CHD and stroke events  
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) / Mean 
Exposure (SD) 
p p trend Adjustments 
*(Buyken et 
al., 2010) Blue 
Mountains 
Eye Study 
(109)/ 
1490 
13y Fruit fibre (AOAC) Total CVD [fatal] Women 11.7 vs 2.8 g/d 1.03 (0.61, 1.75) 0.84 
 
Age, energy, GI residuals, alcohol, 
smoking, diabetes 
(151)/ 
1245    
Men 11.1 vs 2.4 g/d 0.61 (0.38, 0.99) 0.05 
 
Age, energy, GI residuals, total fat, 
underweight, smoking, use of 
corticosteroids 
*(Crowe et 
al., 2012) 
EPIC-Heart 
2381/ 
306331 
11.5y 
Fruit fibre assessed as 
AOAC in most countries 
and values were then 
calibrated across 
Europe 
IHD mortality 
 
Per 2.5g/d #0.94 (0.88, 1.01) 
 
0.090 
Age, alcohol, BMI, physical activity, 
marital status, education, 
employment, hypertension, 
hyperlipidaemia, angina pectoris, 
diabetes, PUFA:SFA, energy intake, 
fibre from cereals, vegetables and 
other sources 
*(Eshak et al., 
2010) 
Japanese 
Collaborative 
cohort study 
(231)/ 
110792 
13.4y 
Fruit fibre (similar to 
AOAC) 
CHD [fatal] Men >1.7 vs. <0.4 g/d #0.55(0.32, 0.96) 0.032 
 
Age, BMI, hypertension, DMT2, 
alcohol, smoking, education, exercise, 
walking, stress, sleep, SFA, n3 fatty 
acid, Sodium intake, folate, Vitamin E, 
vegetable fibre, cereal fibre (191) 
   
Women >2.2 vs. <0.7 g/d #0.42 (0.33, 0.81) 0.014 
 
(Larsson et al., 
2009)  ATBC 
Study 
(196) 
/29133 
13.6 
years 
Fruit fibre (Englyst) 
Stroke, haemorrhage, 
Subarachnoid [fatal + 
non-fatal]  
(6.2) vs (0.7) g/d 1.28 (0.8, 2.06)  
 
0.14 
Age, Alcohol, BMI, total cholesterol 
intake, Blood pressure, energy intake, 
Folate, HDL-C, CHD, diabetes, physical 
activity, magnesium Intake, Smoking, 
Group allocation 
(383)  
  
Stroke, haemorrhage, 
Intracerebral  [fatal + 
non-fatal]   
0.88 (0.61, 1.26)  
 
0.44 
(2702)  
  
Stroke, ischaemic  [fatal + 
non-fatal]   
0.91 (0.8, 1.04)  
 
0.83 
(Liu et al., 
2002a)  The 
Women's 
Health Study 
(177) 
/39876 
6 y Fruit fibre (AOAC) MI  [fatal + non-fatal]   (6) vs (2.5) g/d #1.11 (0.62, 1.96)  
 
0.63 
Age, Alcohol, BMI, energy intake, 
family history of MI, fat intake, Folate, 
Diabetes  Hypercholest-erolaemia, 
hypertension, protein intake, physical 
activity, Smoking, Group allocation, 
Supplements, Postmenopausal HRT 
(570)  6 y 
 
Total CVD  [fatal + non-
fatal]  
(6) vs (2.5) g/d 0.82 (0.61, 1.09)  
 
 0.09 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) / Mean 
Exposure (SD) 
p p trend Adjustments 
(Mozaffarian 
et al., 2003)  
Cardiovascula
r Health Study 
(811) 
/5201 
8.6 y Fruit fibre (AOAC) 
CHD events[fatal + non-
fatal] 
  >7.5 vs <2.8  g/d #0.99 (0.78, 1.25)  
 
0.98 
Age, Alcohol, Cereal Fibre, Education, 
Fibre from Vegetables, diabetes, 
physical activity, sex, Smoking   
(204)  
   
Age 65-69y 
80th  vs 20th  
Centile (C) 
0.92 (0.75, 1.13) 
  
(255)  
  
  Age 70-74y 80th  vs 20th C 1.04 (0.89, 1.23) 
  (352)  
  
  Age >75y 80
th  vs 20th C 1 (0.85, 1.19) 
  (434)  
  
  Women 80th  vs 20th C 1.04 (0.87, 1.24) 
  
(377)  
  
  Men 80
th  vs 20th C 0.94 (0.77, 1.16) 
  
(575)  
  
  No diabetics 80
th  vs 20th C 0.99 (0.85, 1.16) 
  
(Oh et al., 
2005)  Nurses’ 
Health Study 
(1020) 
/121700 
18 Fruit fibre (AOAC)  
Total stroke [fatal + non-
fatal]  
(7.3) vs (1.3) g/d 0.87 (0.7, 1.09)  
 
0.28 
Age, Alcohol, Aspirin, BMI, 
carbohydrate intake, energy intake, 
diabetes, family history of 
hypertriglycerideaemia/ 
hypertension/ MI, Menopause Status, 
physical activity, Smoking, 
Postmenopausal HRT, Vitamin intake 
(279)  
  
Stroke, haemorrhagic  
[fatal + non-fatal]   
0.86 (0.57, 1.29) 
 
0.64 
(515)  
  
Stroke, ischaemic [fatal + 
non-fatal]   
0.87 (0.63, 1.21)  
 
0.22 
*(Park et al., 
2011) 
NIH-AARP 
Diet and 
Health Study 
5248 / 
388122 
9y 
Fibre from fruits 
(AOAC) 
Total CVD [fatal] Male Q5 vs. Q1 1.03 (0.93, 1.13) 
  
Age, race, education, 
marital status, health status, BMI, 
physical activity, smoking, alcohol, red 
meat, fruit, vegetables, total energy 
intake 
2417 / 
388122    
Female Q5 vs. Q1 1.06 (0.93, 1.22) 
  
(Pietinen et 
al., 1996)  
ATBC Study 
(635) 
/29133 
6.1 y Fruit fibre (Englyst) CHD events  [fatal]   (5.3) vs (0.7) g/d #1.16 (0.8, 1.67)    0.77 Age, Alcohol, Beta-carotene, BMI, 
blood pressure, education, saturated 
fat intake, energy intake, physical 
activity, Smoking, Group allocation, 
Vitamin C, Vitamin E 
(1399)  
  
Fatal CHD, non-fatal MI 
 
(5.3) vs (0.7) g/d  0.99 (0.78, 1.27) 
 
0.57  
(Rimm et al., 
1996)  HPFS 
(740) 
/51529 
6 y Fruit fibre (AOAC) MI [fatal + non-fatal]   
Continuous risk 
estimate 10g/d 
#0.79 (0.6, 1.05) 
  
Age, Alcohol, BMI, saturated fat 
intake, family history of MI,  Smoking, 
Vitamin E Hypercholesterolaemia, 
Occupation, physical activity, 
hypertension 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ Assessment 
Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) / Mean 
Exposure (SD) 
p p trend Adjustments 
(Streppel et 
al., 2008)  
Zutphen 
Elderly Study 
(348)/ 
1373  
Fruit fibre (Energy 
adjusted - recent 
intake, AOAC) 
CHD events [fatal]   
Continuous risk 
estimate 10g/d 
#1.13 (0.75, 1.7)   
 
Trans fatty acid, Cis-PUFA and 
saturated fat intake, Alcohol, BMI, 
Smoking, energy intake, Fish intake, 
Prescribed diet, , SES/Class 
(348)/ 
1373 40y 
long term intake in 
middle age    
1.01 (0.43, 2.36)   
 
*(Ward et al., 
2012) EPIC-
Norfolk 
(1294) / 
4347 
11y 
Fruit fibre (Englyst) 
assessed with 7-day 
food diaries 
Fatal and non + fatal CHD 
events 
Men 
Risk per 2g/day 
increase 
0.93 (0.85, 1.02) 
 
0.10 
Age, BMI, physical activity, smoking, 
family history of MI, class, diabetes, 
antihypertensive medication, lipid-
lowering medication, aspirin use, total 
fat energy, energy from non-fat, 
saturated fat intake, alcohol, plasma 
ascorbic acid 
(712)/ 
2728  
Women 
 
0.90 (0.80, 1.01) 
 
0.063 
(Wolk et al., 
1999)  Nurses’ 
Health Study 
(591) / 
121700 
10 y (20) 
Fruit fibre (Long-term 
intake over 6 years. 
AOAC) 
Non-fatal MI, fatal CHD   
Continuous risk 
estimate 5g/d 
#0.93 (0.74, 1.16) 0.51 
 
Age, Alcohol, Aspirin, Beta-carotene, 
BMI, carbohydrate intake, saturated 
fatty acid intake, energy intake, Fibre, 
Folate, hypertension, Magnesium 
Intake, Menopause Status, Parental 
MI, Period of exposure, physical 
activity, Smoking, Postmenopausal 
HRT, Vitamin B6 intake, Vitamin C 
*Identified during update search; # Result was used in the fruit fibre and CHD meta-analysis 
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Table IV.v: Results from cohort studies identified in the systematic review: Fibre contained within vegetables and CVD, CHD and stroke events 
Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) /Mean 
Exposure (SD) 
p p trend Adjustments 
*(Buyken et 
al., 2010) Blue 
Mountains 
Eye Study 
109/ 
1490 
13y Vegetable fibre (AOAC) Total CVD [fatal] Women 13.5 vs 6.5 g/d 1.01 (0.64, 1.60) 0.88 
 
Age, energy, GI residuals, alcohol, 
smoking, diabetes 
151/ 
1245    
Men 13.7 vs 6.0 g/d 0.88 (0.60, 1.30) 0.6 
 
Age, energy, GI residuals, total fat, 
underweight, smoking, use of 
corticosteroids 
*(Crowe et al., 
2012)  
EPIC-Heart 
2381/ 
306331 
11.5y 
Vegetable fibre 
assessed as AOAC in 
most countries and 
values were then 
calibrated across 
Europe 
IHD mortality 
 
Per 2.5g/d #0.90 (0.76, 1.07) 
 
0.255 
Age, alcohol, BMI, physical activity, 
marital status, education, 
employment, hypertension, 
hyperlipidaemia, angina pectoris, 
diabetes, PUFA:SFA, energy intake, 
fibre from fruit, cereals and other 
sources 
*(Eshak et al., 
2010) 
Japanese 
Collaborative 
cohort study 
(231)/11
0792 
13.4y 
Vegetable fibre (similar 
to AOAC) 
CHD [fatal] Men >4.5 vs. <2.8 g/d #0.90(0.54, 1.51) 0.666 
 
Age, BMI, hypertension, diabetes, 
alcohol, smoking, education, 
exercise, walking, stress, sleep, 
saturated fat and n3 fatty acid 
intake, sodium intake, folate, Vitamin 
E, cereal fibre, fruit fibre 
(191) 
   
Women >5.6 vs. <3.1 g/d #0.97 (0.58, 1.62) 0.917 
 
(Larsson et al., 
2009)  ATBC 
Study 
(196) 
/29133 
13.6 
years 
Vegetable fibre 
(Englyst) 
Stroke, haemorrhage 
Subarachnoid [fatal + 
non-fatal]  
(7.1) vs (2.9) g/d 0.63 (0.43, 1.07)  
 
0.06 
Age, Alcohol, BMI, total cholesterol 
intake, blood pressure, energy 
intake, Folate, HDL-C, CHD, diabetes, 
physical activity, magnesium Intake, 
Smoking, Group allocation 
(383)  
  
Stroke, haemorrhage 
Intracerebral [fatal + 
non-fatal]   
0.81 (0.57, 1.14)  
 
0.62 
(2702)  
  
Stroke, ischaemic 
[fatal + non-fatal]   
0.86 (0.76, 0.99) 
 
0.001 
(Liu et al., 
2002a)  The 
Women's 
Health Study 
(177) 
/39876 
6 y Vegetable fibre (AOAC)  MI  [fatal + non-fatal]   (8) vs (5.9) g/d #0.89 (0.52, 1.53)    0.87 
Age, Alcohol, BMI, energy intake, 
family history of MI, fat intake, 
Folate, diabetes,  
Hypercholesterolaemia, 
hypertension, physical activity, 
protein intake, Smoking, Group 
allocation, Supplements, 
Postmenopausal HRT 
(570)  6 y 
 
Total CVD  [fatal + 
non-fatal]  
(8) vs (5.9) g/d 0.96 (0.72, 1.28) 
 
0.78 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) /Mean 
Exposure (SD) 
p p trend Adjustments 
(Mozaffarian 
et al., 2003)  
Cardiovascular 
Health Study 
(811) 
/5201 
8.6 y Vegetable fibre (AOAC) 
CHD events  [fatal + 
non-fatal] 
  >9.2 vs <4.2  g/d #1.08 (0.86, 1.36)    0.95 
Age, Alcohol, Cereal Fibre, Education, 
Fibre from fruit, diabetes, Smoking, 
physical activity, Sex 
(204) 
   
Age 65-69y 80th vs 20th Centile 0.9 (0.76, 1.04) 
  
(255) 
  
  Age 70-74y 80th vs 20th Centile 1.04 (0.9, 1.19) 
  
(352) 
  
  Age >75y 80th vs 20th Centile 1.09 (0.95, 1.25) 
 
  
(434) 
  
  Women 80th vs 20th Centile 1.08 (0.92, 1.27) 
 
  
(377) 
  
  Men 80th vs 20th Centile 0.96 (0.82, 1.14) 
  (575)  
  
  No diabetics 80th vs 20th Centile 1.05 (0.92, 1.2) 
  
(Oh et al., 
2005)  Nurses’ 
Health Study 
(1020) 
/121700 
18 Vegetable fibre (AOAC)  
Total stroke  [fatal + 
non-fatal]  
(8.5) vs (2.9) g/d 0.92 (0.74, 1.14)  
 
0.14 
Age, Alcohol, Aspirin, BMI, 
carbohydrate intake, energy intake, 
family history of diabetes/ 
hypertriglycerideaemia/ 
hypertension/MI, Menopause, 
physical activity, Smoking, 
Postmenopausal HRT, Vitamin intake 
(279)  
  
Haemorrhagic stroke  
[fatal + non-fatal]   
0.76 (0.51, 1.13) 
 
0.18 
(515)  
  
Ischaemic stroke 
[fatal + non-fatal]   
1.01 (0.74, 1.38)   
 
0.48 
*(Park et al., 
2011) 
NIH-AARP Diet 
and Health 
Study 
5248 
/388122 
9y 
Fibre from vegetables 
(AOAC) 
Total CVD [fatal] Male Q5 vs. Q1 0.96 (0.88, 1.05) 
  
Age, race, education, 
marital status, health status, BMI, 
physical activity, smoking, alcohol, 
red meat, fruit, vegetables, total 
energy 
2417 
/388122    
Female Q5 vs. Q1 0.96 (0.84, 1.10) 
  
(Pietinen et 
al., 1996)  
ATBC Study 
(635) 
/29133 
6.1 y 
Vegetable fibre (based 
on Englyst)  
CHD events [fatal]   (7.1) vs (2.9) g/d #0.88 (0.66, 1.19)    0.08 
Age, Alcohol, Beta-carotene, BMI, 
education, saturated-fatty acid 
intake, energy intake, physical 
activity, Smoking, Group allocation, 
blood pressure, Vitamin C, Vitamin E   
(1399)  6.1 y 
 
Fatal CHD, non-fatal 
MI  
(7.1) vs (2.9) g/d  0.94 (0.77, 1.14)   0.15        
(Rimm et al., 
1996)  HPFS 
(740) 
/51529 
6 y Vegetable fibre (AOAC) MI [fatal + non-fatal]   
Continuous risk 
estimate 10 g/d 
#0.78 (0.61, 1.0)   
 
Age, Alcohol, BMI, saturated fatty-
acid intake, mahily history of MI,  
Smoking, Vitamin E  
Hypercholesterolaemia, Occupation, 
physical activity, hypertension  
(Streppel et 
al., 2008)  
Zutphen 
Elderly Study 
(348) 
/1373 
40 y 
(0.2) 
Vegetable fibre (Energy 
adjusted recent intake, 
AOAC) 
CHD events  [fatal]   
Continuous risk 
estimate 10 g/d 
#0.88 (0.48, 1.65)     Trans-fat intake, Alcohol, BMI, 
Smoking, Cis-PUFA intake, energy 
intake, Fish, Prescribed diet, 
Saturated fat intake, SES/Class (348)  
40 y 
(0.2) 
Vegetable fibre (Energy 
adjusted long term 
intake in middle age)  
CHD events  [fatal]   
Continuous risk 
estimate 10 g/d 
1 (0.36, 2.77) 
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Result ID/ 
Reference/ 
Cohort Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Subgroup 
Detail 
Contrast (mean) 
RR (CI) /Mean 
Exposure (SD) 
p p trend Adjustments 
*(Ward et al., 
2012) EPIC-
Norfolk 
(1294) / 
4347 
11y 
Vegetable fibre 
(Englyst) assessed with 
7-day food diaries 
Fatal and non + fatal 
CHD events 
Men 
Risk per 2g/day 
increase 
0.97 (0.88, 1.05) 
 
0.43 
Age, BMI, physical activity, smoking, 
family history of MI, class, diabetes, 
antihypertensive medication, lipid-
lowering medication, aspirin use, 
total fat energy, energy from non-fat, 
saturated fat intake, alcohol, plasma 
ascorbic acid 
(712)/ 
2728    
Women 
 
0.96 (0.84, 1.09) 
 
0.50 
(Wolk et al., 
1999)  Nurses’ 
Health Study 
(591) / 
121700 
10 y 
(20) 
Vegetable fibre (Long-
term intake over 6 
years. AOAC) 
Non-fatal MI, fatal 
CHD 
  
Continuous risk 
estimate 5g/d 
#1.06 (0.84, 1.32)  0.63 
 
Age, Alcohol, Aspirin, Beta-carotene, 
BMI, carbohydrate intake, saturated 
fat intake, energy intake, Fibre, 
Folate, hypertension, magnesium 
intake, Menopause Status, Parental 
MI, Period of exposure, physical 
activity, Smoking, Postmenopausal 
HRT, Vitamin B6 intake, Vitamin C 
*Identified during update search; # Result was used in the vegetable fibre and CHD meta-analysis 
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Table IV.vi: Results from cohort studies identified in the systematic review: Fibre from other sources or types and CVD and CHD events 
Result ID/ 
Reference/ 
Cohort 
Name 
(Cases)/ 
Total 
Follow 
Up (% 
loss) 
Exposure 
Outcome/ 
Assessment Details 
Sub-group 
details 
Contrast (mean) RR (CI) 
p-trend 
Adjustments 
*(Crowe et 
al., 2012) 
EPIC-Heart 
2381/ 
306331 
11.5y 
‘Other fibre’ (Non cereal, fruit or 
vegetable based fibre. Assessed as 
AOAC in most countries and values 
were then calibrated across Europe) 
IHD mortality  Per 5g/d 1.01 (0.87, 1.17) 0.890 
Age, alcohol, BMI, physical 
activity, marital status, 
education, employment, 
hypertension, hyperlipidaemia, 
angina pectoris, diabetes, 
PUFA:SFA, energy intake, fibre 
from fruit, vegetables and 
cereals 
*(Park et 
al., 2011) 
NIH-AARP 
Diet and 
Health 
Study 
5248 
/388122 
9y Fibre from beans (AOAC) Total CVD [fatal] 
Men 
Q5 vs. Q1 0.93 (0.85, 1.01) 
 
Age, race, education,  
marital status, health status, 
BMI, physical activity, smoking, 
alcohol, red meat, fruit, 
vegetables, total energy 
2417 
/388122    
Women 
Q5 vs. Q1 0.83 (0.74, 0.95) 
<0.05 
(Pietinen 
et al., 
1996)  
ATBC 
Study 
(635) 
/29133 
6.1 y Cellulose  CHD events  [fatal]  (6.3) vs (3.1) g/d 
 
0.72 (0.54, 0.97)  
  
0.006 
Age, alcohol, beta-carotene, 
BMI, diastolic and systolic blood 
pressure, education, saturated 
fatty acid, energy intake, 
physical activity, smoking, group 
allocation, vitamin C and E   
(1399) 
/29133  
Cellulose 
Fatal CHD, non-fatal 
MI  
 (6.3) vs (3.1) g/d 0.90 (0.75, 1.10)    0.07 
(1399) 
/29133  
Lignin   
Fatal CHD, non-fatal 
MI  
 (5.8) vs (2.1) g/d 0.89 (0.75, 1.06)  0.21 
(635) 
/29133  
Lignin   CHD events [fatal]  (5.8) vs (2.1) g/d 0.75 (0.58, 0.97)   0.002 
(Streppel 
et al., 
2008)  
Zutphen 
Elderly 
Study 
(348) 
/1373 
40 y 
(0.2) 
Legume fibre (Energy adjusted long 
term intake in middle age, AOAC) 
CHD events [fatal] 
 
Continuous risk 
estimate 10 g/d 
0.52 (0.25, 1.09) 
 
TFA, Alcohol, BMI, Cis-PUFA, 
energy intake, Fish, Smoking, 
Prescribed diet, saturated fat, 
SES/Class 
  
Legume fibre (Energy adjusted recent 
intake) 
CHD events  [fatal]   
 
0.64 (0.34, 1.2)  
 
  
Potato fibre (Energy adjusted recent 
intake) 
CHD events[fatal]    
 
0.71 (0.48, 1.06) 
 
  
Potato fibre (Energy adjusted long 
term intake in middle age) 
CHD events[fatal]  
 
0.94 (0.62, 1.45) 
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Appendix V: FFQ items contributing to sources of fibre 
Items from the baseline FFQ which have been chosen to contribute to estimates of fibre from a 
range of food sources. Separate FFQ items are indicated with ‘|’ (some lines in the FFQ listed 
multiple foods e.g. Currants, raisins and sultanas). 
Fibre from fruit includes the following FFQ items: 
Apples | Avocado| Banana| Grapes| Kiwi| Mango| Citrus| Papaya| Pears| Pineapple| 
Apricots| Melon| Nectarines| Peaches| Plums| Raspberries| Currants red and white| 
Rhubarb| Strawberries| Dates| Figs| Prunes| Dried fruit| Currants, raisins and sultanas. 
 
Fibre from nuts & seeds includes the following FFQ items: 
Peanuts and pistachio| Cashews and almonds| Pecans and walnuts| Sunflower and sesame 
seeds. 
 
Fibre from total cereal foods includes the following FFQ items: 
White bread & rolls| Brown bread & rolls| Wholemeal bread & rolls| Chapattis, Nan, Paratha| 
Papadums| Tortillas| Pitta bread| Crispbread e.g. Ryvita| Cream crackers, cheese biscuits| 
Porridge, readybrek| Sugar coated cereals e.g. sugar puffs| Non-sugar coated cereals e.g. 
cornflakes, rice krispies| Muesli| All bran, bran flakes| Weetabix, shredded wheat| White 
pasta e.g. spaghetti, green pasta, red pasta, noodles| Wholemeal pasta, brown spaghetti| 
White rice| Brown rice| Wild rice| Barley| Bulgar wheat| Wheat germ| Cous-cous| Cereal 
bars & flapjack| Plain biscuits e.g. marie, nice, digestive| Chocolate biscuits| Sandwich or 
cream biscuit| Fruitcake| Sponge cake| Buns, pastries e.g. croissants doughnuts, tray bakes| 
Scones, pancakes, muffins, crumpets| Fruit pies, tarts crumbles| Sponge puddings. 
 
Fibre from breakfast cereals includes the following FFQ items: 
Porridge, readybrek| Sugar coated cereals e.g. sugar puffs| Non-sugar coated cereals e.g. 
cornflakes, rice krispies| Muesli| All bran, bran flakes| Weetabix, shredded wheat. 
 
Fibre from vegetables includes the following FFQ items: 
Bean sprouts| Beetroot| Broccoli, spring greens, kale| Brussels sprouts| Cabbage| 
Cauliflower| Celery| Coleslaw (low calorie coleslaw)| Courgettes, marrow, squash| Cucumber| 
Garlic| Green beans, runner beans| Leeks, lettuce, mushrooms| Aubergine, okra| Parsnips| 
Peas, mushy peas, mange-tout| Peppers| Swede| Sweet corn| Tomatoes (raw, canned, 
sauce)| Turnip| Watercress, mustard & cress. 
Fibre from pulses includes the following FFQ items: 
Lentils and dals| Chick peas, chanas| Hummus| Baked beans| Mung beans & red kidney 
beans| Black eyed beans| Butter beans and broad beans. 
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Appendix VI: Research Ethics Committee approval 
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Appendix VII: National Research Ethics Committee Section 251 
approval 
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Appendix VIII: Definition for final diagnosis field in the MINAP 
dataset  
Final diagnosis Definition and notes 
 
ST segment 
elevation MI 
There will normally be a history consistent with the diagnosis. The diagnosis 
requires the presence of cardiographic changes of ST elevation consistent with 
infarction of =>2mm in contiguous chest leads and/or ST elevation of =>1 mm ST 
elevation in 2 or more standard leads. (New LBBB is included; although ST 
elevation is usually apparent in the presence of LBBB). There must be enzyme or 
troponin elevation. Where CK is used the peak value should exceed twice the 
upper limit of the reference range. Where troponin assay is used the locally 
accepted cut off value should be used. (See Threatened MI) This group includes all 
patients with STEMI regardless of whether typical changes were evident on the 
admission ECG or developed subsequently. 
Threatened 
infarction 
After early reperfusion treatment there may be rapid resolution of existing ST 
elevation associated with a CK rise less than twice the upper limit of normal or a 
small troponin release. If only troponin has been measured and is elevated; it is a 
local decision whether this is recorded as 'Definite infarction' or 'Threatened 
infarction'. 
ACS troponin +ve ACS troponin positive includes all those patients previously defined as nSTEMI. 
There must be symptoms consistent with cardiac ischaemia and there will 
normally be cardiographic changes consistent with this diagnosis. Troponon 
elevation above locally determined reference level is mandatory. 
ACS troponin –ve Use where there are symptoms consistent with cardiac ischaemia without 
troponin release. There must be dynamic ECG changes consistent with fluctuating 
ischaemia. Synonym unstable angina. 
Chest pain cause 
uncertain 
Use in any patient admitted with chest pain not accompanied by significant 
cardiographic change, without any enzyme / troponin release, and where no other 
clear diagnosis emerges.  It is likely that at admission there was a high index of 
clinical suspicion that the pain was cardiac, but this remains unconfirmed. 
Other diagnosis Use where a patient is admitted with clinical suspicion of cardiac pain and where 
any diagnosis other than cardiac ischaemia is confirmed. 
ACS troponin not 
stated 
(unconfirmed MI) 
This diagnosis must only be applied to patients who die in hospital before 
biochemical confirmation of infarction can be confirmed. 
Source: (MINAP, 2010) 
 
 
 
 
